<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>Subtitle 34 BOARD OF PHARMACY | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.34/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.34/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|34|"/>
    <meta itemprop="doc-type" content="container" data-document=""/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|34" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="/us/md/exec/comar/10.34"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="Subtitle 34 BOARD OF PHARMACY | Library of Maryland Regulations"/>
    <meta property="og:image" content="/us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.34/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.34/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|34" data-search-heading="">
                  <span title="Subtitle 34 BOARD OF PHARMACY">Subtitle 34 BOARD OF PHARMACY</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|34">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/10.34">Subtitle 34 BOARD OF PHARMACY</h1>
                <h2 id="/us/md/exec/comar/10.34.01" data-order="|10|34|01|" data-ref-path="10|34|01" class="h__chapter">Chapter 01 Disciplinary Proceedings</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: September 1, 1971</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.01.03#A" title="">Regulation .03A</a>, E, G amended effective February 19, 1990 (17:3 Md. R. 298)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.01.03#D" title="">Regulation .03D</a> amended effective February 13, 1984 (11:3 Md. R. 202)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.01.04#A" title="">Regulation .04A</a>, G amended effective February 19, 1990 (17:3 Md. R. 298)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.01.04#D" title="">Regulation .04D</a>, G amended effective October 3, 1980 (7:20 Md. R. 1879)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.01.06" title=".06 Notice of Charges or Notice of Initial Denial.">Regulation .06</a> amended effective February 19, 1990 (17:3 Md. R. 298)</p>
                  <p>——————</p>
                  <p>Chapter revised effective January 24, 2000 (27:1 Md. R. 77)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.01.01" title=".01 Scope.">.01</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.01.07" title=".07 Notice of Hearing.">.07</a> repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.01.01" title=".01 Scope.">.01</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.01.15" title=".15 Reinstatement.">.15</a> adopted effective September 1, 2003 (30:17 Md. R. 1203)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.01.02#B" title="">Regulation .02B</a> amended effective January 28, 2008 (35:2 Md. R. 127); July 1, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.01.05" title=".05 Disposition of Complaints.">Regulation .05</a> amended effective January 28, 2008 (35:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.01.06#B" title="">Regulation .06B</a>, C amended effective January 28, 2008 (35:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.01.12" title=".12 Summary Suspensions.">Regulation .12</a> amended effective January 28, 2008 (35:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.01.13#A" title="">Regulation .13A</a> amended effective January 28, 2008 (35:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.01.14" title=".14 Probation and Violation of Probation.">Regulation .14</a> amended effective January 28, 2008 (35:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.01.15" title=".15 Reinstatement.">Regulation .15</a> amended effective January 28, 2008 (35:2 Md. R. 127)</p>
                  <p>——————</p>
                  <p>Annotation: COMAR 10.34.01.03G(1) cited in Eichberg v. Board of Pharmacy, 50 Md. App. 189 (1981)</p>
                  <h3>Authority</h3>
                  <p>Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-313" title="">12-313</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-315" title="">12-315</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">12-6</a>B-<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=09" title="">09</a> and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">12-6</a>D-11; <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-206" title="">State Government Article, §10-206</a>; Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.01.01" data-order="|10|34|01|.01|" data-ref-path="10|34|01|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter governs procedures for disciplinary matters and hearings before the Board.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.01.02" data-order="|10|34|01|.02|" data-ref-path="10|34|01|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(1)">(1)</span> "Administrative law judge" means the hearing officer assigned to preside over a hearing in a case that the Board has delegated to the Office of Administrative Hearings under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-205" title="">State Government Article, §10-205, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(2)">(2)</span> "Administrative Procedure Act" means <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gsg/gsg.pdf" title="">State Government Article, Title 10, Subtitle 2, Annotated Code of Maryland</a>, which governs contested cases arising from charges issued by the Board.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(3)">(3)</span> "Board" means the State Board of Pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(4)">(4)</span> "Case resolution conference" means a voluntary, informal, and confidential meeting between the parties to a contested case and the Board's case resolution conference committee to discuss possible settlement of a disciplinary matter pending before the Board.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(5)">(5)</span> "Case resolution conference committee" means a committee comprised of one or more members of the Board who make recommendations to the Board regarding settlement of disciplinary matters.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(6)">(6)</span> "Cease and desist letter" means a public letter issued by the Board ordering:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(6)(a)">(a)</span> A registrant or licensee to cease doing a specified activity; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(6)(b)">(b)</span> An unlicensed person to cease the unauthorized practice of pharmacy or the unauthorized operation of a pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(7)">(7)</span> "Charges" means a nonpublic record issued by the Board which:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(7)(a)">(a)</span> Alleges conduct by a registrant or licensee that the Board believes constitutes a violation under the Maryland Pharmacy Act;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(7)(b)">(b)</span> Sets forth sections of the Maryland Pharmacy Act that the Board believes were violated; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(7)(c)">(c)</span> Provides notice to the registrant or licensee of disciplinary proceedings before the Board.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(8)">(8)</span> "Complaint" means an allegation received by the Board that a registrant or licensee may have violated the Maryland Pharmacy Act, and which may be grounds for an investigation or disciplinary action by the Board.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(9)">(9)</span> "Consent order" means a final order issued by the Board that has been negotiated and agreed to by both the registrant or licensee and the Board to resolve a formal disciplinary action.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(10)">(10)</span> "Contested case" means a proceeding conducted under the Administrative Procedure Act.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(11)">(11)</span> "Final order" means a public record issued by the Board resolving a formal disciplinary action by consent or after an adjudication, which:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(11)(a)">(a)</span> Denies a registration or license;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(11)(b)">(b)</span> Sanctions by:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(11)(b)(i)">(i)</span> Reprimand;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(11)(b)(ii)">(ii)</span> Probation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(11)(b)(iii)">(iii)</span> Fine; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(11)(b)(iv)">(iv)</span> Suspension or revocation of a registration or license;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(11)(c)">(c)</span> Summarily suspends a registration or license;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(11)(d)">(d)</span> Dismisses charges;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(11)(e)">(e)</span> Surrenders a registration or license;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(11)(f)">(f)</span> Resolves the contested case by consent of the parties; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(11)(g)">(g)</span> Takes any other action that the Board may take by law.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(12)">(12)</span> "Formal disciplinary action" means action taken by the Board that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(12)(a)">(a)</span> Is initiated by:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(12)(a)(i)">(i)</span> Charges; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(12)(a)(ii)">(ii)</span> A notice of initial denial;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(12)(b)">(b)</span> Is resolved by a consent order;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(12)(c)">(c)</span> Results in a summary suspension; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(12)(d)">(d)</span> Results in a letter of surrender.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(13)">(13)</span> "Informal action" means that the Board closes a case, without formal disciplinary action or issuing a final order, by sending a:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(13)(a)">(a)</span> Letter of education;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(13)(b)">(b)</span> Letter of admonishment; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(13)(c)">(c)</span> Letter of agreement.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(14)">(14)</span> "Letter of admonishment" means an informal action taken by the Board consisting of a nonpublic letter closing the case if the Board believes a registrant or licensee engaged in conduct that violated the Maryland Pharmacy Act and may include a letter of agreement in which a registrant or licensee agrees to satisfy certain conditions instead of the Board issuing charges.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(15)">(15)</span> Letter of Education.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(15)(a)">(a)</span> "Letter of education" means an informal action consisting of a nonpublic letter:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(15)(a)(i)">(i)</span> Issued by the Board, closing the case if the Board does not believe that the registrant's or licensee's conduct rose to the level of a violation of the Maryland Pharmacy Act; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(15)(a)(ii)">(ii)</span> In which the Board educates the registrant or licensee regarding the laws and standards of the practice of pharmacy or operating a pharmacy.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(15)(b)">(b)</span> "Letter of education" may include a letter of agreement in which a registrant or licensee agrees to satisfy certain conditions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(16)">(16)</span> Letter of Surrender.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(16)(a)">(a)</span> "Letter of surrender" means a public record accepted by the Board in which:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(16)(a)(i)">(i)</span> The licensee agrees to surrender the licensee's license or permit; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(16)(a)(ii)">(ii)</span> The registrant agrees to surrender the registrant's registration.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(16)(b)">(b)</span> "Letter of surrender" may include conditions for the Board's acceptance of the surrender as a resolution of the case.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(17)">(17)</span> "Licensee" means the holder of a license or permit issued by the Board.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(18)">(18)</span> "Maryland Pharmacy Act" means <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(19)">(19)</span> "Notice of initial denial" means a nonpublic record issued by the Board by which an applicant, registrant, or licensee is notified that the Board intends to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(19)(a)">(a)</span> Change a registration or licensure status;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(19)(b)">(b)</span> Deny a registration, license, or permit; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(19)(c)">(c)</span> Deny some other benefit sought by the registrant or licensee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(20)">(20)</span> "Party" means the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(20)(a)">(a)</span> Respondent or person named or admitted as a party, or properly seeking and entitled as a right to be a party in a formal disciplinary proceeding; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(20)(b)">(b)</span> Administrative prosecutor from the Office of the Attorney General presenting a case on behalf of the Board.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(21)">(21)</span> "Postdeprivation hearing" means a show cause or an evidentiary hearing scheduled by the Board after the Board has issued an order for summary suspension under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-226" title="">State Government Article, §10-226(c)(2), Annotated Code of Maryland</a>, in which the registrant or licensee may challenge the Board's basis for issuing the order of summary suspension.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(22)">(22)</span> "Predeprivation hearing" means a show cause hearing in which the registrant or licensee has an opportunity to demonstrate to the Board why the Board should not:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(22)(a)">(a)</span> Issue an order for summary suspension under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-226" title="">State Government Article, §10-226(c)(2), Annotated Code of Maryland</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(22)(b)">(b)</span> Take some other action that the Board may take.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(23)">(23)</span> "Presiding officer" means the president of the Board or, in the president's absence, a Board member designated by the president, who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(23)(a)">(a)</span> Conducts hearings before the Board; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(23)(b)">(b)</span> Issues prehearing orders.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(24)">(24)</span> "Probation" means a sanction imposed by the Board in a public final order under which the registrant or licensee is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(24)(a)">(a)</span> Monitored by the Board for a period of time; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(24)(b)">(b)</span> Required to comply with certain conditions in order to avoid further disciplinary action.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(25)">(25)</span> "Public record" means a document that the Board is permitted or required to disclose to the public under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gsg/gsg.pdf" title="">State Government Article, Title 10, Subtitle 6, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(26)">(26)</span> "Recommended decision" means a nonpublic record issued to the Board by an administrative law judge which sets out proposed findings of fact, proposed conclusions of law, a proposed sanction, or any combination of these actions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(27)">(27)</span> "Recusal" means the disqualification of a member of the Board to participate in a proceeding because of interest, bias, or some other reason that may interfere with the Board member's participation in the case.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(28)">(28)</span> “Registrant” means the holder of a:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(28)(a)">(a)</span> Pharmacy technician registration issued by the Board; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(28)(b)">(b)</span> Pharmacy intern registration issued by the Board.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(29)">(29)</span> "Respondent" means a registrant or licensee subject to the jurisdiction of the Board, who has been:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(29)(a)">(a)</span> Given formal notice of allegations concerning violations of the Maryland Pharmacy Act; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(29)(b)">(b)</span> Notified as to the possible imposition of sanctions or a summary suspension.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(30)">(30)</span> "Revocation" means the removal of a registrant's registration or licensee's license or permit.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(31)">(31)</span> "Sanction" means an action by the Board which:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(31)(a)">(a)</span> Reprimands;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(31)(b)">(b)</span> Places on probation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(31)(c)">(c)</span> Fines; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(31)(d)">(d)</span> Suspends or revokes a registration, license, or permit.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(32)">(32)</span> "Show cause hearing" means a nonevidentiary hearing in which the registrant or licensee may demonstrate to the Board why the Board should not issue a proposed order or continue to take an action that the Board may take.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(33)">(33)</span> "Summary suspension" means the indefinite suspension of a registration or license under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-226" title="">State Government Article, §10-226(c)(2), Annotated Code of Maryland</a>, issued if the Board believes emergency action is necessary to protect the public health, safety, or welfare.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(34)">(34)</span> "Suspension" means the temporary denial of the right to use a registration, license, or permit and is usually defined by:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(34)(a)">(a)</span> A specified period of time;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(34)(b)">(b)</span> Specific dates; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.02#B(34)(c)">(c)</span> Specific conditions.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.01.03" data-order="|10|34|01|.03|" data-ref-path="10|34|01|.03" class="h__section">.03 Confidentiality of Proceedings.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.03#A">A.</span> Except as otherwise provided by law, the proceedings of the Board are confidential and that confidentiality may not be waived by the parties.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.03#B">B.</span> The Office of Administrative Hearings' proceedings involving the adjudication of a Board formal disciplinary action and the administrative law judge's recommended decision are confidential.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.03#C">C.</span> The respondent may not waive the confidentiality of the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.03#C(1)">(1)</span> Proceedings; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.03#C(2)">(2)</span> Patients whose medical records or care are reflected in the record of the proceedings.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.03#D">D.</span> To the extent possible, even after the close of a formal disciplinary action, the parties shall refrain from revealing:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.03#D(1)">(1)</span> Legal documents;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.03#D(2)">(2)</span> Oral statements; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.03#D(3)">(3)</span> Information that would reveal the identity of patients involved in the matter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.01.04" data-order="|10|34|01|.04|" data-ref-path="10|34|01|.04" class="h__section">.04 Representation by Counsel.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.04#A">A.</span> A respondent may be represented by counsel at any stage of a formal disciplinary action.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.04#B">B.</span> If a hearing is held on a matter, the respondent shall be represented:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.04#B(1)">(1)</span> In proper person; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.04#B(2)">(2)</span> By an attorney who has been:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.04#B(2)(a)">(a)</span> Admitted to the Maryland Bar; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.04#B(2)(b)">(b)</span> Specially admitted to practice law under Maryland Rules, Rules Governing Admission to the Bar of Maryland, Rule 14, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.04#C">C.</span> The Board may request the Office of the Attorney General to participate in a hearing to present the case on behalf of the State.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.04#D">D.</span> The member of the Office of the Attorney General presenting the case on behalf of the State has the same rights as any party with regard to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.04#D(1)">(1)</span> Submission of evidence, examination, and cross-examination of witnesses; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.04#D(2)">(2)</span> The filing of objections, exceptions, and motions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.04#E">E.</span> The Board may request a member of the Office of the Attorney General to act as legal advisor to the Board on questions of:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.04#E(1)">(1)</span> Procedure;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.04#E(2)">(2)</span> Evidence; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.04#E(3)">(3)</span> Law.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.01.05" data-order="|10|34|01|.05|" data-ref-path="10|34|01|.05" class="h__section">.05 Disposition of Complaints.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.05#A">A.</span> For each complaint, after reviewing any completed investigative information or reports, the Board shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.05#A(1)">(1)</span> Dismiss the complaint;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.05#A(2)">(2)</span> Close the case with informal action;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.05#A(3)">(3)</span> Issue a cease and desist order;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.05#A(4)">(4)</span> Refer the matter for further investigation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.05#A(5)">(5)</span> Refer the matter to an administrative prosecutor; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.05#A(6)">(6)</span> Vote to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.05#A(6)(a)">(a)</span> Charge a registrant or licensee with a violation of the Maryland Pharmacy Act;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.05#A(6)(b)">(b)</span> Consider the matter as a basis for a summary suspension;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.05#A(6)(c)">(c)</span> Initially deny a registration, license, or permit or reinstatement of a registration, license, or permit; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.05#A(6)(d)">(d)</span> Accept the surrender of a registration, license, or permit subject to conditions acceptable to the Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.05#B">B.</span> The Board may refer a complaint or other disciplinary matter to the administrative prosecutor at any time, whether or not the Board has voted to charge a registrant or licensee with violations of the Maryland Pharmacy Act.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.01.06" data-order="|10|34|01|.06|" data-ref-path="10|34|01|.06" class="h__section">.06 Notice of Charges or Notice of Initial Denial.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.06#A">A.</span> If the Board issues charges or a notice of initial denial, the document shall be:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.06#A(1)">(1)</span> Served on the respondent by certified mail at the address the respondent is required to maintain with the Board; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.06#A(2)">(2)</span> Hand delivered in person.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.06#B">B.</span> Charges or notice of initial denial shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.06#B(1)">(1)</span> Inform the respondent of the statutory basis for the charges or denial of a registration, license, or permit;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.06#B(2)">(2)</span> Allege sufficient facts that the Board believes constitute a basis for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.06#B(2)(a)">(a)</span> Violation of the Maryland Pharmacy Act; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.06#B(2)(b)">(b)</span> Denial of a registration, license, or permit; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.06#B(3)">(3)</span> Include the notice of hearing.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.06#C">C.</span> If the Board issues a notice of initial denial to an applicant for a registration or license, the applicant may not withdraw the application without approval from the Board.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.01.07" data-order="|10|34|01|.07|" data-ref-path="10|34|01|.07" class="h__section">.07 Notice of Hearing.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.07#A">A.</span> Except for a show cause hearing, written notice of hearings shall be sent by the Executive Director or an officer of the Board to the parties at least 20 days before the hearing.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.07#B">B.</span> The Board shall serve the notice of hearing by:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.07#B(1)">(1)</span> Certified mail at the address the respondent is required to maintain with the Board; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.07#B(2)">(2)</span> Hand delivery in person.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.07#C">C.</span> The notice of hearing shall state, if applicable:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.07#C(1)">(1)</span> The date, time, place, and nature of the hearing;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.07#C(2)">(2)</span> The right to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.07#C(2)(a)">(a)</span> Representation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.07#C(2)(b)">(b)</span> Call witnesses;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.07#C(2)(c)">(c)</span> Submit documents or other relevant evidence;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.07#C(2)(d)">(d)</span> Request subpoenas for witnesses and evidence and the costs associated with such a request;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.07#C(3)">(3)</span> That a failure to appear for the scheduled hearing may result in an adverse action against the party; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.07#C(4)">(4)</span> That the parties may agree to the evidence and waive their right to appear at the hearing.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.07#D">D.</span> The notice of hearing may include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.07#D(1)">(1)</span> Deadlines for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.07#D(1)(a)">(a)</span> Discovery; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.07#D(1)(b)">(b)</span> Motions; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.07#D(2)">(2)</span> Dates for the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.07#D(2)(a)">(a)</span> Prehearing conference; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.07#D(2)(b)">(b)</span> Case resolution conference.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.01.08" data-order="|10|34|01|.08|" data-ref-path="10|34|01|.08" class="h__section">.08 Prehearing Conferences and Case Resolution Conferences.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#A">A.</span> The Board may set a prehearing conference or a case resolution conference, or both.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#B">B.</span> The prehearing conference may be used to prepare for the hearing by:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#B(1)">(1)</span> Delineating the issues;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#B(2)">(2)</span> Stipulating to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#B(2)(a)">(a)</span> Facts;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#B(2)(b)">(b)</span> Laws; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#B(2)(c)">(c)</span> Other matters;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#B(3)">(3)</span> Arranging a schedule for the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#B(3)(a)">(a)</span> Exchange of documents and witness information; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#B(3)(b)">(b)</span> Submission of motions and responses to motions; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#B(4)">(4)</span> Addressing other matters that will promote the orderly and efficient conduct of the hearing.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#C">C.</span> Prehearing Orders.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#C(1)">(1)</span> If a prehearing conference has been held, a prehearing order may be issued by the presiding officer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#C(2)">(2)</span> The prehearing order shall set forth the actions taken or to be taken with regard to any matter addressed at the prehearing conference.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#C(3)">(3)</span> If a prehearing conference is not held, the presiding officer may issue a prehearing order to regulate the conduct of the proceedings.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#C(4)">(4)</span> Absent an exception from the presiding officer, the prehearing order shall be binding on the parties.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#D">D.</span> The Case Resolution Conference.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#D(1)">(1)</span> Matters admitted, revealed, negotiated, or otherwise discussed are without prejudice and may not be used by the respondent, administrative prosecutor, or the Board in subsequent proceedings, unless the information is otherwise discoverable or available through another source.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#D(2)">(2)</span> The Board is not bound by the recommendations of the case resolution conference committee and may:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#D(2)(a)">(a)</span> Modify the proposed settlement;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#D(2)(b)">(b)</span> Require additional conditions; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#D(2)(c)">(c)</span> Reject the recommendation and require the respondent to proceed to a hearing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#D(3)">(3)</span> If the respondent disagrees with the recommendation of the case resolution conference committee, the respondent may elect to proceed to a hearing on the matter, regardless of whether the Board has ratified the recommendation of the case resolution conference committee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#D(4)">(4)</span> Participation in a case resolution conference is not a basis for recusal of a Board member, Board counsel, or Board prosecutor from further proceedings.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#E">E.</span> Motions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#E(1)">(1)</span> Unless otherwise set forth in a prehearing order or notice of hearing, motions shall be:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#E(1)(a)">(a)</span> Accompanied by a memorandum of points and authorities; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#E(1)(b)">(b)</span> Filed with the Board at least 15 working days before the hearing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#E(2)">(2)</span> A copy of a motion filed with the Board shall be served on the opposing party by the party filing the motion.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#E(3)">(3)</span> A response shall be filed with the Board at least 10 working days before the hearing and a copy served on the opposing party.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.08#E(4)">(4)</span> The Board may refuse to consider a motion or response that is not timely filed.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.01.09" data-order="|10|34|01|.09|" data-ref-path="10|34|01|.09" class="h__section">.09 Discovery.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#A">A.</span> Discovery on Request. By written request served on the other party and filed with the Board or the Office of Administrative Hearings, as appropriate, a party may require another party to produce, within 15 days, the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#A(1)">(1)</span> A list of witnesses to be called;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#A(2)">(2)</span> Copies of documents intended to be produced at the hearing; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#A(3)">(3)</span> Both §A(1) and (2) of this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#B">B.</span> Mandatory Discovery.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#B(1)">(1)</span> Each party shall provide to the other party not later than 15 days before the prehearing conference, if scheduled, or 45 days before the scheduled hearing date, whichever is earlier:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#B(1)(a)">(a)</span> The name and curriculum vitae of any expert witness who will testify at the hearing; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#B(1)(b)">(b)</span> A detailed written report summarizing the expert's testimony, which includes the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#B(1)(b)(i)">(i)</span> Opinion offered;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#B(1)(b)(ii)">(ii)</span> Factual basis for the opinion; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#B(1)(b)(iii)">(iii)</span> Reasons underlying the opinion.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#B(2)">(2)</span> If the Board or the Office of Administrative Hearings, as appropriate, finds that the report is not sufficiently specific, or otherwise fails to comply with the requirements of <a class="internal-link " href="/us/md/exec/comar/10.34.01.09#B(1)" title="">§B(1) of this regulation</a>, the Board or the Office of Administrative Hearings, as appropriate, shall exclude from the hearing the testimony of the expert and any report of the expert.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#B(3)">(3)</span> The Board or the Office of Administrative Hearings, as appropriate, shall consider and decide arguments regarding the sufficiency of the report:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#B(3)(a)">(a)</span> At the prehearing conference, if scheduled; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#B(3)(b)">(b)</span> Immediately before the scheduled hearing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#B(4)">(4)</span> If an expert adopts a sufficiently specific charging document as the expert's report, that adoption satisfies the requirements set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.01.09#B(1)" title="">§B(1) of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#C">C.</span> Parties are not entitled to discovery of items other than as listed in §§A and B of this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#D">D.</span> Both parties have a continuing duty to supplement their disclosure of witnesses and documents.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#E">E.</span> Absent unforeseen circumstances that would otherwise impose an extraordinary hardship on a party, witnesses or documents may not be added to the list:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#E(1)">(1)</span> After the prehearing conference, if scheduled; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#E(2)">(2)</span> Later than 15 days before the hearing, if no prehearing conference is scheduled.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#F">F.</span> The prohibition against adding witnesses does not apply to witnesses or documents to be used for impeachment or rebuttal purposes.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#G">G.</span> Construction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#G(1)">(1)</span> In hearings conducted by an administrative law judge of the Office of Administrative Hearings, this regulation shall, whenever possible, be construed as supplementing and in harmony with <a class="internal-link no-wrap" href="/us/md/exec/comar/28.02.01" title="Chapter 01 Rules of Procedure">COMAR 28.02.01</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.09#G(2)">(2)</span> In the event of a conflict between this regulation and <a class="internal-link no-wrap" href="/us/md/exec/comar/28.02.01" title="Chapter 01 Rules of Procedure">COMAR 28.02.01</a>, this regulation applies.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.01.10" data-order="|10|34|01|.10|" data-ref-path="10|34|01|.10" class="h__section">.10 Evidentiary Hearings.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#A">A.</span> Hearings shall be conducted under the Administrative Procedure Act.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#B">B.</span> The Board may delegate its authority to conduct hearings to the Office of Administrative Hearings.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#C">C.</span> Hearings are not open to the public.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#D">D.</span> Records, including the recommended decision, shall be treated as confidential and sealed.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#E">E.</span> Records.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#E(1)">(1)</span> The Board shall prepare an official record of hearings that shall include all:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#E(1)(a)">(a)</span> Pleadings;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#E(1)(b)">(b)</span> Testimony;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#E(1)(c)">(c)</span> Exhibits; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#E(1)(d)">(d)</span> Other memoranda or material filed in the proceeding.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#E(2)">(2)</span> Unless waived by all parties, a stenographic record of the proceedings shall be made at the expense of the Board.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#E(3)">(3)</span> The stenographic record may not be transcribed, unless requested by a party or by the Board.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#E(4)">(4)</span> The cost of transcribing all or part of a proceeding, shall be paid by the party requesting the typewritten transcript.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#F">F.</span> Quorum.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#F(1)">(1)</span> A majority of the members serving on the Board is a quorum of the Board.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#F(2)">(2)</span> Hearings shall be held before a quorum of the Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#G">G.</span> Presiding Officer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#G(1)">(1)</span> The presiding officer shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#G(1)(a)">(a)</span> Conduct a full, fair, and impartial hearing;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#G(1)(b)">(b)</span> Take action to avoid unnecessary delay in the disposition of the proceedings;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#G(1)(c)">(c)</span> Maintain order; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#G(1)(d)">(d)</span> Adjourn or recess the hearing from time to time.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#G(2)">(2)</span> The presiding officer may regulate the course of the hearing and the conduct of the parties, including the authority to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#G(2)(a)">(a)</span> Permit the examination of witnesses;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#G(2)(b)">(b)</span> Rule on offers of proof and admit relevant and material evidence;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#G(2)(c)">(c)</span> Consider and rule on motions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#G(2)(d)">(d)</span> Grant a continuance or postponement;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#G(2)(e)">(e)</span> Determine the order in which the parties shall present their cases;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#G(2)(f)">(f)</span> Limit unduly repetitious testimony;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#G(2)(g)">(g)</span> Reasonably limit the time for presentation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#G(2)(h)">(h)</span> Issue orders necessary to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#G(2)(h)(i)">(i)</span> Secure procedural simplicity and administrative fairness; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#G(2)(h)(ii)">(ii)</span> Eliminate unjustifiable expense and delay.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#H">H.</span> Examination of Witnesses and Introduction of Evidence.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#H(1)">(1)</span> The rules of evidence in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-213" title="">State Government Article, §10-213, Annotated Code of Maryland</a> apply to hearings before the Board.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#H(2)">(2)</span> A party may:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#H(2)(a)">(a)</span> Submit evidence;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#H(2)(b)">(b)</span> Examine and cross-examine witnesses; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#H(2)(c)">(c)</span> File objections, exceptions, and motions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#H(3)">(3)</span> If a party is represented by counsel, submission of evidence, examination and cross-examination of witnesses, and filing of objections, exceptions, and motions shall be done and presented solely by the counsel.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#H(4)">(4)</span> The presiding officer, or a person designated by the presiding officer for that purpose, may examine a witness called by a party.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#H(5)">(5)</span> The presiding officer may call as a witness a person necessary to ensure a full and complete record.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#H(6)">(6)</span> Any Board member may examine any witness.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#I">I.</span> Briefs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#I(1)">(1)</span> A party may submit a brief on the issues of fact and law involved in the hearing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#I(2)">(2)</span> The presiding officer may designate:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#I(2)(a)">(a)</span> The form of the brief;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#I(2)(b)">(b)</span> The number of copies to be submitted; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#I(2)(c)">(c)</span> The date and time of submission.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#I(3)">(3)</span> The Board may refuse to consider a brief that is not timely filed or fails to conform to requirements imposed by the presiding officer.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#J">J.</span> If a party who is the respondent in the proceedings fails to appear at a hearing after due notice, the Board may:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#J(1)">(1)</span> Reschedule the hearing; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#J(2)">(2)</span> In the Board's discretion, proceed upon the investigation, report, documents, witnesses, and records before it.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#K">K.</span> The Board shall take testimony under oath.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#L">L.</span> Decision and Order.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#L(1)">(1)</span> A decision and order rendered by the Board shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#L(1)(a)">(a)</span> Be in writing; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#L(1)(b)">(b)</span> Include the findings of fact and conclusions of law.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#L(2)">(2)</span> A copy of the decision and order and accompanying findings and conclusions shall be delivered or mailed promptly to each party or the party's attorney of record.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#L(3)">(3)</span> The findings of fact, conclusions of law, and order referred to in <a class="internal-link " href="/us/md/exec/comar/10.34.01.10#L" title="">§L of this regulation</a> shall be retained as a permanent record by the Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#M">M.</span> A party aggrieved by a final decision of the Board under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-313" title="">Health Occupations Article, §12-313, Annotated Code of Maryland</a>, may seek judicial review of the Board's decision.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#N">N.</span> The review referenced in §M shall be in accordance with State Government Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-222" title="">10-222</a> — 10-223, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#O">O.</span> Rehearings.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#O(1)">(1)</span> Within 10 days after service on a party of the decision of the Board, the party may apply to the Board for rehearing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#O(2)">(2)</span> The application shall state the grounds for rehearing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#O(3)">(3)</span> The Board shall grant or deny the application within 20 days of submission to the Board.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#O(4)">(4)</span> Unless otherwise ordered, neither the rehearing nor the application for rehearing shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#O(4)(a)">(a)</span> Stay the enforcement of the order; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#O(4)(b)">(b)</span> Excuse the persons affected by the order for failure to comply with the terms of the order.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#O(5)">(5)</span> At a rehearing, the Board shall only consider facts not presented in the original proceeding, including facts arising after the date of the original proceeding.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.10#O(6)">(6)</span> By new order, the Board may abrogate, change, or modify its original order.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.01.11" data-order="|10|34|01|.11|" data-ref-path="10|34|01|.11" class="h__section">.11 Exceptions Hearings.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.11#A">A.</span> If a case has been delegated to the Office of Administrative Hearings under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-205" title="">State Government Article, §10-205, Annotated Code of Maryland</a>, for proposed findings of fact, conclusions of law, and disposition, a party may file exceptions with the Board within 30 days of receipt of the recommended decision.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.11#B">B.</span> The opposing party to the exceptions shall respond within 15 days of receipt of the exceptions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.11#C">C.</span> If a party files exceptions, the Board shall schedule a hearing to be held before a quorum of the Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.11#D">D.</span> The exceptions hearing shall be a nonevidentiary hearing to provide the parties with an opportunity for oral argument on the exceptions to the recommended decision.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.11#E">E.</span> The Board shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.11#E(1)">(1)</span> Consider:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.11#E(1)(a)">(a)</span> The exceptions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.11#E(1)(b)">(b)</span> Responses to exceptions; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.11#E(1)(c)">(c)</span> The record in the case; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.11#E(2)">(2)</span> Issue an order containing accepted findings of fact, conclusions of law, and disposition.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.11#F">F.</span> The presiding officer:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.11#F(1)">(1)</span> Shall determine procedural issues governed by this regulation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.11#F(2)">(2)</span> May:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.11#F(2)(a)">(a)</span> Impose reasonable time limitations; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.11#F(2)(b)">(b)</span> Make rulings reasonably necessary to facilitate the effective and efficient operation of the exceptions hearing.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.11#G">G.</span> If the parties do not file timely exceptions, a quorum of the Board shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.11#G(1)">(1)</span> Consider the recommended decision from the Office of Administrative Hearings; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.11#G(2)">(2)</span> Issue an order based on the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.11#G(2)(a)">(a)</span> Board's accepted findings of fact and conclusions of law; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.11#G(2)(b)">(b)</span> The record of the case.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.01.12" data-order="|10|34|01|.12|" data-ref-path="10|34|01|.12" class="h__section">.12 Summary Suspensions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#A">A.</span> The Board shall order the summary suspension of a registration, license, or permit if the Board determines that there is a substantial likelihood that a registrant or licensee poses a risk of harm to the public health, safety, or welfare.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#B">B.</span> Based on information gathered in an investigation or otherwise provided to the Board, the Board may vote to issue:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#B(1)">(1)</span> A notice of an intent to summarily suspend a registration, license, or permit; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#B(2)">(2)</span> An order of summary suspension.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#C">C.</span> If the Board votes to issue a notice of intent to summarily suspend a registration, license, or permit or an order of summary suspension, the Board shall refer the matter to an administrative prosecutor for prosecution.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#D">D.</span> Service of the notice of intent to summarily suspend a registration, license, or permit shall be made by:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#D(1)">(1)</span> Hand delivery in person;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#D(2)">(2)</span> Certified mail to the address the respondent is required to maintain with the Board; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#D(3)">(3)</span> Other reasonable means to effect service.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#E">E.</span> Notice of Intent to Summarily Suspend.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#E(1)">(1)</span> A notice of intent to summarily suspend a registration, license, or permit shall include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#E(1)(a)">(a)</span> A proposed order of summary suspension which is unexecuted by the Board and which includes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#E(1)(a)(i)">(i)</span> The statutory authority on which the action has been taken;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#E(1)(a)(ii)">(ii)</span> Allegations of fact which the Board believes demonstrate a substantial likelihood that the registrant or licensee poses a risk of harm to the public health, safety, or welfare; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#E(1)(a)(iii)">(iii)</span> Notice to the respondent of the right to request an evidentiary hearing of the summary suspension if the Board executes the proposed order of summary suspension; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#E(1)(b)">(b)</span> An order or summons to appear before the Board:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#E(1)(b)(i)">(i)</span> To show cause why the Board should not execute the order of summary suspension; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#E(1)(b)(ii)">(ii)</span> Which notifies the respondent of the consequences of failing to appear.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#E(2)">(2)</span> Predeprivation Hearing.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#E(2)(a)">(a)</span> If the Board issues a notice of intent to summarily suspend a registration, license, or permit, the Board shall offer the respondent the opportunity to appear before the Board to show cause why the respondent's registration, license, or permit should not be summarily suspended.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#E(2)(b)">(b)</span> The show cause hearing shall be a nonevidentiary hearing to provide the parties with an opportunity for oral argument on the proposed summary suspension.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#E(2)(c)">(c)</span> The presiding officer:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#E(2)(c)(i)">(i)</span> Shall determine procedural issues;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#E(2)(c)(ii)">(ii)</span> May impose reasonable time limits on each party's oral argument; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#E(2)(c)(iii)">(iii)</span> Shall make rulings reasonably necessary to facilitate the effective and efficient operation of the show cause hearing.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#F">F.</span> Order of Summary Suspension.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#F(1)">(1)</span> The Board may order the summary suspension of a registration, license, or permit without first issuing a notice of intent to summarily suspend or providing a respondent with a predeprivation hearing if the Board determines that the threat to public health, safety, and welfare requires the immediate suspension of the registration, license, or permit.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#F(2)">(2)</span> Postdeprivation Hearing.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#F(2)(a)">(a)</span> The respondent shall be provided with a show cause hearing within a reasonable time after the effective date of the order of summary suspension.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#F(2)(b)">(b)</span> The show cause hearing under <a class="internal-link " href="/us/md/exec/comar/10.34.01.12#F(2)(a)" title="">§F(2)(a) of this regulation</a> shall:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#F(2)(b)(i)">(i)</span> Be conducted before the Board as provided in <a class="internal-link " href="/us/md/exec/comar/10.34.01.12#E(2)" title="">§E(2) of this regulation</a>; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#F(2)(b)(ii)">(ii)</span> Provide the respondent with an opportunity to show cause why the Board should lift the summary suspension.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#F(3)">(3)</span> After the show cause hearing, if the Board votes to continue the summary suspension, the respondent may request an evidentiary hearing before the Board.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#F(4)">(4)</span> An evidentiary hearing:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#F(4)(a)">(a)</span> May be consolidated with a hearing on charges issued by the Board that include the facts that form the basis for the summary suspension; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#F(4)(b)">(b)</span> Shall be conducted under the Administrative Procedure Act.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#G">G.</span> Disposition.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#G(1)">(1)</span> If the Board issues a notice of intent to summarily suspend a registration, license, or permit, the Board may, after the show cause hearing, vote to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#G(1)(a)">(a)</span> Order a summary suspension;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#G(1)(b)">(b)</span> Deny the summary suspension;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#G(1)(c)">(c)</span> Enter into a consent order; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#G(1)(d)">(d)</span> Enter into any interim order warranted by the circumstances of the case, including one providing for the stay of the summary suspension subject to certain conditions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#G(2)">(2)</span> If the Board orders a summary suspension before a show cause hearing, the Board may, at the conclusion of the show cause hearing, vote to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#G(2)(a)">(a)</span> Affirm the order of summary suspension;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#G(2)(b)">(b)</span> Rescind the order of summary suspension;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#G(2)(c)">(c)</span> Enter into a consent order; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#G(2)(d)">(d)</span> Enter into an interim order warranted by the circumstances of the case, including one providing for a stay of the summary suspension subject to certain conditions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#G(3)">(3)</span> An order for summary suspension or any other order of the Board issued after the initiation of summary suspension proceedings is a:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#G(3)(a)">(a)</span> Final order of the Board; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.12#G(3)(b)">(b)</span> Public record.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.01.13" data-order="|10|34|01|.13|" data-ref-path="10|34|01|.13" class="h__section">.13 Surrender of a Registration, License, or Permit.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.13#A">A.</span> The Board may:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.13#A(1)">(1)</span> Accept the surrender of a registration, license, or permit;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.13#A(2)">(2)</span> Require conditions for surrender of a registration, license, or permit, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.13#A(2)(a)">(a)</span> The admission of a violation of the Maryland Pharmacy Act;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.13#A(2)(b)">(b)</span> The admission of facts;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.13#A(2)(c)">(c)</span> A statement of the circumstances under which the surrender was offered or accepted;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.13#A(2)(d)">(d)</span> Restrictions on future registration, licensing, or permit;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.13#A(2)(e)">(e)</span> Conditions for reinstatement of the registration, license, or permit; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.01.13#A(2)(f)">(f)</span> An agreement that the respondent may not again apply for a registration, license, or permit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.13#B">B.</span> A letter of surrender is a final order of the Board and is a public record.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.01.14" data-order="|10|34|01|.14|" data-ref-path="10|34|01|.14" class="h__section">.14 Probation and Violation of Probation.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#A">A.</span> If the Board imposes a period of probation as a sanction, the Board may impose conditions of probation that the Board considers appropriate, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#A(1)">(1)</span> Re-education or completion of approved courses;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#A(2)">(2)</span> Payment of a fine;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#A(3)">(3)</span> Practicing pharmacy or operating a pharmacy under supervision;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#A(4)">(4)</span> Monitoring by the Board or by an individual or entity approved by the Board with periodic reporting to the Board;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#A(5)">(5)</span> Periodic review of a licensee's practice or operations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#A(6)">(6)</span> Periodic audits of a licensee's billing practice;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#A(7)">(7)</span> An examination by a physician or other appropriate health care provider;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#A(8)">(8)</span> Limitation of the licensee's practice or operations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#A(9)">(9)</span> Limitation of the pharmacy technician's scope of duties;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#A(10)">(10)</span> Drug screenings;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#A(11)">(11)</span> Individual or group counseling or therapy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#A(12)">(12)</span> Obtaining a passing score on an appropriate examination; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#A(13)">(13)</span> Any other condition the Board considers appropriate for the rehabilitation or retraining of a registrant or a licensee.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#B">B.</span> A term of probation may be defined by a specific period of time or the successful completion of certain conditions or acts by the registrant or licensee.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#C">C.</span> A registrant or licensee seeking release from probation shall do so by petitioning the Board to terminate the probation when the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#C(1)">(1)</span> Specific period of time has passed; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#C(2)">(2)</span> Registrant or licensee has successfully completed the conditions or acts required for release.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#D">D.</span> If, at any time, the Board has reason to believe that the registrant or licensee is not in compliance with the conditions of probation, the Board shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#D(1)">(1)</span> Charge the registrant or licensee with a violation of probation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#D(2)">(2)</span> Take an action provided for in the final order in the event of a violation of probation, including suspension of the registration, license, or permit;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#D(3)">(3)</span> Consider a summary suspension of the registration, license, or permit; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#D(4)">(4)</span> Take any other action the Board considers appropriate and which the Board may take by law.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#E">E.</span> If the Board determines that the respondent has violated probation, the Board shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#E(1)">(1)</span> Take an action provided for in the final order in the event of a violation of probation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#E(2)">(2)</span> Impose additional conditions or probation; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.14#E(3)">(3)</span> Impose a sanction or take any other action that the Board considers appropriate and may take by law.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.01.15" data-order="|10|34|01|.15|" data-ref-path="10|34|01|.15" class="h__section">.15 Reinstatement.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.15#A">A.</span> A registrant or licensee shall petition the Board for a lifting of the suspension of a registration, license, or permit or a reinstatement following revocation or surrender of a registration, license, or permit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.15#B">B.</span> The Board may reinstate a registration, license, or permit in accordance with:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.15#B(1)">(1)</span> The terms and conditions of the order of revocation or suspension;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.15#B(2)">(2)</span> A letter of surrender;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.15#B(3)">(3)</span> An order of reinstatement issued by the Board; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.15#B(4)">(4)</span> A final judgment in any proceeding for judicial review.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.15#C">C.</span> If not otherwise specified in a document under <a class="internal-link " href="/us/md/exec/comar/10.34.01.15#B" title="">§B of this regulation</a>, the licensee shall meet the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.13" title="Chapter 13 Reinstatement of Expired Licenses for Pharmacists">COMAR 10.34.13</a> to reinstate a license or permit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.15#C-1">C-1.</span> If not otherwise specified in a document under <a class="internal-link " href="/us/md/exec/comar/10.34.01.15#B" title="">§B of this regulation</a>, the registrant shall meet the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.34" title="Chapter 34 Pharmacy Technicians">COMAR 10.34.34</a> to reinstate a registration.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.15#D">D.</span> If a time period is not specified in the Board's final order, a petition for reinstatement may not be considered by the Board before the expiration of 1 year after the date of the order.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.15#E">E.</span> The form of a reinstated registration, license, or permit shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.15#E(1)">(1)</span> Be similar in every respect to an original registration, license, or permit; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.15#E(2)">(2)</span> Bear the new date of issue.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.15#F">F.</span> If the Board grants reinstatement of a registration, license, or permit, it may impose any restrictions or conditions on the registration, license, or the licensee's practice that it considers appropriate.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.01.15#G">G.</span> The Board may reinstate the license of an individual whose license has been revoked under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-702" title="">Criminal Law Article, §5-702, Annotated Code of Maryland</a>, if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.15#G(1)">(1)</span> The individual has petitioned the Board for reinstatement;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.15#G(2)">(2)</span> The petition for reinstatement is made to the Board after the expiration of 5 years after the revocation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.15#G(3)">(3)</span> The individual has met the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.13" title="Chapter 13 Reinstatement of Expired Licenses for Pharmacists">COMAR 10.34.13</a> to reinstate a license; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.01.15#G(4)">(4)</span> The individual has made restitution to aggrieved persons that may have resulted from a violation and conviction of <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=5-702" title="">Criminal Law Article, §5-702, Annotated Code of Maryland</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.02" data-order="|10|34|02|" data-ref-path="10|34|02" class="h__chapter">Chapter 02 Examination for Licensure and Professional Experience Programs</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: August 6, 1975 (2:17 Md. R. 1188)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.02.02" title=".02 Definitions.">Regulation .02</a> adopted effective February 19, 1990 (17:3 Md. R. 298)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.02.02#B" title="">Regulation .02B</a> amended effective November 1, 1994 (21:14 Md. R. 1229); November 3, 1997 (24:22 Md. R. 1551)</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.02.02" title=".02 Definitions.">.02</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.02.05" title=".05 Partial or Non-Pharmacy-School-Supervised Program of Internship.">.05</a> recodified as Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.02.03" title=".03 Licensure Examinations.">.03</a>—.06 effective February 19, 1990 (17:3 Md. R. 298)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.02.03" title=".03 Licensure Examinations.">Regulation .03</a> amended effective April 9, 1984 (11:7 Md. R. 625); February 19, 1990 (17:3 Md. R. 298); November 1, 1994 (21:14 Md. R. 1229); November 3, 1997 (24:22 Md. R. 1551)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.02.04" title=".04 Internship Program or Training Required.">Regulation .04</a> amended effective April 9, 1984 (11:7 Md. R. 625)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.02.05#A" title="">Regulation .05A</a>, B amended effective February 19, 1990 (17:3 Md. R. 298)</p>
                  <p>——————</p>
                  <p>Chapter revised effective February 17, 2003 (30:3 Md. R. 180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.02.03" title=".03 Licensure Examinations.">Regulation .03</a> amended effective June 20, 2005 (32:12 Md. R. 1047)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.02.03#D" title="">Regulation .03D</a> amended effective July 3, 2017 (44:13 Md. R. 621)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.02.04" title=".04 Internship Program or Training Required.">Regulation .04</a> amended effective July 1, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.02.05#A" title="">Regulation .05A</a>, D amended effective July 1, 2015 (42:7 Md. R. 569)</p>
                  <h3>Authority</h3>
                  <p>Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">12-205</a> and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-302" title="">12-302</a>, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.02.01" data-order="|10|34|02|.01|" data-ref-path="10|34|02|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter applies to:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.02.01#A">A.</span> Applicants for licensure as a pharmacist; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.02.01#B">B.</span> Internship programs for student pharmacists for which credit may be allowed toward licensure.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.02.02" data-order="|10|34|02|.02|" data-ref-path="10|34|02|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.02.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.02.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.02.02#B(1)">(1)</span> "Board" means the State Board of Pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.02.02#B(2)">(2)</span> "Licensure examinations" means the Board-administered or Board-approved examinations required of applicants for licensure which include the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.02.02#B(2)(a)">(a)</span> Exam I:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.02.02#B(2)(a)(i)">(i)</span> Part I: NAPLEX, and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.02.02#B(2)(a)(ii)">(ii)</span> Part II: Pharmacy Law Test;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.02.02#B(2)(b)">(b)</span> Exam II:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.02.02#B(2)(b)(i)">(i)</span> Prescreening Test of Oral English Competency, or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.02.02#B(2)(b)(ii)">(ii)</span> Test of Oral English Competency.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.02.03" data-order="|10|34|02|.03|" data-ref-path="10|34|02|.03" class="h__section">.03 Licensure Examinations.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#A">A.</span> An applicant may take Exam I upon satisfactory proof that the applicant has graduated, or is expected to graduate at the completion of the immediate semester, from a school or college of pharmacy that has been:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#A(1)">(1)</span> Approved by the Board; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#A(2)">(2)</span> Accredited by the American Council on Pharmaceutical Education.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#B">B.</span> An applicant may not receive a license until the applicant has provided satisfactory proof to the Board of the applicant's graduation from a college or school of pharmacy approved by the Board or accredited by the American Council on Pharmaceutical Education.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#C">C.</span> Passing Grades — Exam I.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#C(1)">(1)</span> The passing grade for each of the two parts of the Exam I is 75.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#C(2)">(2)</span> If a candidate receives a passing grade on Part I or Part II of Exam I, the candidate is not required to retake that part unless the passing grade was received more than 1 year before the date the candidate successfully completed all of the other examination requirements set forth in this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D">D.</span> Passing Grades — Exam II.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(1)">(1)</span> Prescreening Test of Oral English Competency.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(1)(a)">(a)</span> On completion of a prescreening test application form provided by the Board, an applicant may elect to take a standardized prescreening test of oral English competency given by the Board's agents at times to be determined by the Board.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(1)(b)">(b)</span> An agent of the Board possessing post-secondary credentials in an academic discipline acceptable to the Board shall score the prescreening test of oral English competency through the use of a standardized rating system.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(1)(c)">(c)</span> An agent of the Board shall design the rating system of the prescreening test so that a passing score demonstrates that an applicant speaks fluent English as proficiently as typical United States native speakers whose English is easily understood by the average pharmacy patient or customer.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(1)(d)">(d)</span> By choosing to take the prescreening test of oral English competency, an applicant is certifying to the Board that the applicant speaks English as proficiently as typical United States native speakers whose English is easily understood by the average pharmacy patient or customer.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(1)(e)">(e)</span> By choosing to take the prescreening test to verify this certification, the applicant consents to pay the costs of test administration and shall pay the fee indicated on the Board's prescreening application form directly to the Board's agent.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(1)(f)">(f)</span> An applicant who passes the prescreening test passes Exam II, the Test of Oral English Competency required under <a class="internal-link " href="/us/md/exec/comar/10.34.02.02#B(2)(b)" title="">Regulation .02B(2)(b) of this chapter</a>.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(1)(g)">(g)</span> An applicant who fails the prescreening test for oral English competency may take the Test of Oral English Competency required under <a class="internal-link " href="/us/md/exec/comar/10.34.02.02#B(2)(b)" title="">Regulation .02B(2)(b) of this chapter</a> without prejudice to the applicant's licensure application if the applicant pays all related fees.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(1)(h)">(h)</span> An applicant who has graduated from a recognized English-speaking professional school accredited by the Accreditation Council for Pharmacy Education is deemed to be proficient in the oral communication of the English language in satisfaction of requirements of the prescreening test.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(2)">(2)</span> Test of Oral English Competency.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(2)(a)">(a)</span> In order to obtain a license to practice pharmacy, an applicant shall pass a standardized test of oral English competency approved by the Board or the board of pharmacy of another state with a score acceptable to the Board, based upon the Board's standards and the examination taken.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(2)(b)">(b)</span> The Board shall provide the applicant with a list of Board-approved testing services and the passing score for each approved test of oral English competency.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(2)(c)">(c)</span> Waiver. The Board shall waive the requirement as set forth under <a class="internal-link " href="/us/md/exec/comar/10.34.02.03#D(2)(a)" title="">§D(2)(a) of this regulation</a> if the applicant graduated from a recognized English-speaking professional school accredited by the Accreditation Council for Pharmacy Education.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(3)">(3)</span> Claims of Speech Impairment.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(3)(a)">(a)</span> An applicant who claims to have a speech impairment shall submit documentation of the impairment on forms supplied by the Board and completed by a Board-approved:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(3)(a)(i)">(i)</span> Licensed physician; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(3)(a)(ii)">(ii)</span> Speech-language pathologist licensed to practice speech pathology in the United States.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(3)(b)">(b)</span> The applicant shall submit the documentation with:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(3)(b)(i)">(i)</span> The applicant's initial application; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(3)(b)(ii)">(ii)</span> Before the applicant's second attempt at passing the test of oral English competency.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(3)(c)">(c)</span> After the second examination, the applicant may not submit documentation of impairment unless:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(3)(c)(i)">(i)</span> An intervening medical or surgical event caused the impairment;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(3)(c)(ii)">(ii)</span> The applicant claims the impairment before a third examination; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(3)(c)(iii)">(iii)</span> The applicant provides documentation that is approved by the Board.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(3)(d)">(d)</span> The Board may accept documentation of a speech impairment as a passing score on Exam II if the applicant also:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(3)(d)(i)">(i)</span> Provides documentation from a Board-approved licensed pharmacist or a Board-approved instructor in a school of pharmacy that the applicant can communicate in a professionally competent manner with patients and health care providers; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(3)(d)(ii)">(ii)</span> Describes, in a hearing before the Board, the manner in which the applicant would communicate with a licensed prescriber regarding a prescription and would counsel a typical patient on proper drug usage.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(4)">(4)</span> The certifying or verifying authority shall send all certificates and verifications directly to the Board for the applicants.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(5)">(5)</span> The Board-approved testing services may not accept certificates and verifications sent to or by the applicant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(6)">(6)</span> If any of the documents required under this regulation are in a language other than English, the certifying or verifying authority shall submit a certified translation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(7)">(7)</span> The applicant shall bear the costs of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(7)(a)">(a)</span> Translation by a certified translator;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(7)(b)">(b)</span> Taking the test of oral English competency; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.02.03#D(7)(c)">(c)</span> Obtaining documents required under this regulation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.02.04" data-order="|10|34|02|.04|" data-ref-path="10|34|02|.04" class="h__section">.04 Internship Program or Training Required.</h3>
                <p>An applicant shall complete one of the following as a prerequisite to Board licensure:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.02.04#A">A.</span> 1,000 hours of a school-supervised professional experience program conducted by a school of pharmacy accredited by the American Council of Pharmaceutical Education; or</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.02.04#B">B.</span> 1,560 hours of full-time training, as a registered pharmacy intern under the direct supervision of licensed pharmacists pursuant to <a class="internal-link " href="/us/md/exec/comar/10.34.02.05" title=".05 Partial or Non-Pharmacy-School-Supervised Program of Internship.">Regulation .05 of this chapter</a> as an applicant who:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.02.04#B(1)">(1)</span> Has graduated from a foreign school of pharmacy; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.02.04#B(2)">(2)</span> Does not meet the requirements of <a class="internal-link " href="/us/md/exec/comar/10.34.02.04#A" title="">§A of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.02.04#C">C.</span> An applicant may receive credit for any of the 1,560 hours earned up to 10 months before the effective date of this regulation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.02.05" data-order="|10|34|02|.05|" data-ref-path="10|34|02|.05" class="h__section">.05 Partial or Non-Pharmacy-School-Supervised Program of Internship.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.02.05#A">A.</span> Applicants may complete the requirement for internship training by having at least 1,560 hours of full-time training as a registered pharmacy intern, under the direct supervision of licensed pharmacists.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.02.05#B">B.</span> The licensed pharmacists providing direct supervision shall be approved by the Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.02.05#C">C.</span> The applicant shall present evidence satisfactory to the Board that the applicant has completed the training under this regulation, validated by the supervising pharmacist or pharmacists.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.02.05#D">D.</span> If an approved school or college of pharmacy offers a partial fulfillment of internship requirements as a part of its curriculum, time spent in a program by an applicant may be accepted by the Board on an equivalent basis to replace a portion of the required 1,560-hour internship pharmacy internship training under this regulation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.03" data-order="|10|34|03|" data-ref-path="10|34|03" class="h__chapter">Chapter 03 Institutional Pharmacy</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: November 6, 1995 (22:22 Md. R. 1666)</p>
                  <p>——————</p>
                  <p>Chapter revised effective October 1, 2011 (38:19 Md. R. 1147)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.03.02#B" title="">Regulation .02B</a> amended effective May 31, 2014 (40:19 Md. R. 1547)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.03.03" title=".03 Issuance of Permits.">Regulation .03</a> amended effective May 31, 2014 (40:19 Md. R. 1547)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.03.06#C" title="">Regulation .06C</a> amended effective May 31, 2014 (40:19 Md. R. 1547)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.03.12#B" title="">Regulation .12B</a> amended effective May 31, 2014 (40:19 Md. R. 1547)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.03.17" title=".17 Requirements for a Decentralized Pharmacy.">Regulation .17</a> adopted effective May 31, 2014 (40:19 Md. R. 1547)</p>
                  <h3>Authority</h3>
                  <p><a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">Health Occupations Article, §12-205, </a>Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.03.01" data-order="|10|34|03|.01|" data-ref-path="10|34|03|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter applies to:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.01#A">A.</span> A permit holder that operates a pharmacy that services an inpatient setting; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.01#B">B.</span> A person or entity that holds a pharmacy permit and operates a pharmacy in or for an institutional facility.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.03.02" data-order="|10|34|03|.02|" data-ref-path="10|34|03|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(1)">(1)</span> “Decentralized pharmacy” means an institutional pharmacy which provides services for the population of an institutional facility and is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(1)(a)">(a)</span> Dependent on another institutional pharmacy for:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(1)(a)(i)">(i)</span> Administrative control;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(1)(a)(ii)">(ii)</span> Staffing with a licensed pharmacist physically available on site in the decentralized pharmacy to supervise the performance of delegated pharmacy acts; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(1)(a)(iii)">(iii)</span> Drug procurement; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(1)(b)">(b)</span> Located in the same building or pavilion as the other institutional pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(1-1)">(1-1)</span> “Direct supervision” means that a licensed pharmacist is physically available to supervise the performance of delegated pharmacy acts.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(1-2)">(1-2)</span> “Director of pharmacy” means a pharmacist who is responsible for the pharmacy services provided by an institutional pharmacy in compliance with appropriate State and federal laws and regulations.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(2)">(2)</span> “Dispense” or “dispensing” means the procedure which results in the receipt of a prescription or nonprescription drug or device by a patient or the patient’s agent and which entails the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(2)(a)">(a)</span> Interpretation of an authorized prescriber’s prescription for a drug or device;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(2)(b)">(b)</span> Selection and labeling of the drug or device prescribed pursuant to that prescription; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(2)(c)">(c)</span> Measuring and packaging of the prescribed drug or device in accordance with State and federal laws.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(3)">(3)</span> Distribute.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(3)(a)">(a)</span> “Distribute” means the process resulting in the provision of a prescription or nonprescription drug or device to a separate, intervening individual, licensed and practicing under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>, prior to administration of the provided drug or device to the patient pursuant to a prescription issued by an authorized prescriber.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(3)(b)">(b)</span> “Distribute” does not include the operations of a person who holds a permit issued under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12" title="">Health Occupations Article, §12</a>–6C–03, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(4)">(4)</span> "Drug" means a prescription or non-prescription medication or other material used in the diagnosis or treatment of injury, illness, or disease.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(5)">(5)</span> “Drug recall” means the recall of a drug by a manufacturer or the U.S. Food and Drug Administration (FDA) in the event that there is a reasonable possibility that the use of or exposure to an affected product may cause either:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(5)(a)">(a)</span> Adverse effects on health; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(5)(b)">(b)</span> Death.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(6)">(6)</span> “Emergency drug supply” means a process for supplying drugs which:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(6)(a)">(a)</span> May be required for the emergency need of a patient; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(6)(b)">(b)</span> Is not available from an authorized source in a timely manner.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(7)">(7)</span> "Institutional facility" or "institution" means an entity other than a comprehensive care facility, assisted living facility, developmental disabilities facility, or correctional facility whose primary purpose is to provide a physical environment for patients to obtain inpatient, outpatient, or emergency care, except for urgent care facilities that are not part of an institution.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(8)">(8)</span> “Institutional medication protocol” means a course of therapy including drug treatment predetermined and documented by the institution and the generally accepted medical practice for proper completion of a particular therapeutic or diagnostic intervention ordered by an authorized prescriber and which allows the pharmacist to execute the protocol.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(9)">(9)</span> "Institutional pharmacy" means a pharmacy which:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(9)(a)">(a)</span> Provides services to an acute care, rehabilitation, transitional care, chronic care, or mental health hospital;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(9)(b)">(b)</span> Engages in compounding, distributing, or dispensing of drugs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(9)(c)">(c)</span> May provide nondispensing functions as described in <a class="internal-link " href="/us/md/exec/comar/10.34.03.16" title=".16 Pharmaceutical Care Functions of the Pharmacist.">Regulation .16 of this chapter</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(9)(d)">(d)</span> Has been issued a pharmacy permit pursuant to Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-401" title="">12-401</a> and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-403" title="">12-403</a>(c), Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(10)">(10)</span> “Licensed pharmacist” means an individual who is licensed by the Board to practice pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(11)">(11)</span> "Medication order" means a patient-specific order entered on the chart or a medical record of a patient by an authorized prescriber or the authorized prescriber’s designee for a drug or device that is transmitted in writing, verbally or by electronic means and includes the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(11)(a)">(a)</span> Date ordered;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(11)(b)">(b)</span> Drug name;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(11)(c)">(c)</span> Dosage;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(11)(d)">(d)</span> Dosage form;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(11)(e)">(e)</span> Patient name with second identifier such as date of birth or medical record number;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(11)(f)">(f)</span> Route of administration;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(11)(g)">(g)</span> Administration instructions, if appropriate; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(11)(h)">(h)</span> Signature, if appropriate, of an:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(11)(h)(i)">(i)</span> Authorized prescriber, as defined in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-101" title="">Health Occupations Article, §12-101(b), Annotated Code of Maryland</a>; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(11)(h)(ii)">(ii)</span> Individual permitted to practice medicine without a license as defined in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=14-302" title="">Health Occupations Article, §14-302, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(12)">(12)</span> “Order-sets” means predefined orders, including medication orders, that are based on an institutionally approved protocol.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(12-1)">(12-1)</span> “Pavilion” means a detached or semidetached part of a hospital devoted to a special use.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(13)">(13)</span> Pharmaceutical care.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(13)(a)">(a)</span> "Pharmaceutical care" means the provision of a patient’s drug regimen for the purpose of:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(13)(a)(i)">(i)</span> Achieving definite outcomes related to the cure or prevention of a disease;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(13)(a)(ii)">(ii)</span> Elimination or reduction of a patient’s symptoms; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(13)(a)(iii)">(iii)</span> Arresting or slowing of a disease process by identifying, resolving, or preventing actual or potential drug therapy problems.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(13)(b)">(b)</span> "Pharmaceutical care" may include patient counseling and providing information to licensed and certified health care providers.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(14)">(14)</span> “Prescription Drug.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(14)(a)">(a)</span> “Prescription drug” means any drug required by federal law or regulation to be dispensed only by a prescription.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(14)(b)">(b)</span> “Prescription drug” includes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(14)(b)(i)">(i)</span> A biological product; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(14)(b)(ii)">(ii)</span> Finished dosage forms and bulk drug substances subject to §503(b) of the Federal Food, Drug and Cosmetic Act.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(14)(c)">(c)</span> “Prescription drug” does not include blood and blood components intended for transfusion or biological products that are also medical devices.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(15)">(15)</span> “Second identifier” means a reliable method to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(15)(a)">(a)</span> Identify a patient for whom service or treatment is intended; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(15)(b)">(b)</span> Match the service or treatment intended to the patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(16)">(16)</span> “Verbal order” means a medication order from an authorized prescriber which is received by an authorized licensed practitioner using appropriate read back procedures that is subsequently recorded in the patient’s chart and countersigned by the prescriber within a time period required by the institution.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.02#B(17)">(17)</span> "Written order" means a medication order that is recorded as a written document by an authorized prescriber.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.03.03" data-order="|10|34|03|.03|" data-ref-path="10|34|03|.03" class="h__section">.03 Issuance of Permits.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.03#A">A.</span> An institutional pharmacy shall obtain required permits in compliance with State and federal laws and regulations.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.03#B">B.</span> An institutional pharmacy shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.03#B(1)">(1)</span> Staff a pharmacist at each decentralized pharmacy site within the building or pavilion in which it is located; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.03#B(2)">(2)</span> List decentralized pharmacy sites within the building in which it is located, on the initial application, or on the renewal application;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.03#C">C.</span> A decentralized pharmacy that meets the definition as set forth in this chapter may operate under the same permit as the institutional pharmacy located in the same building or pavilion.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.03#D">D.</span> If full service pharmacy services are provided to discharge patients, employees, clinic patients, or others, an institutional pharmacy shall obtain a full service pharmacy permit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.03#E">E.</span> Any other pharmacy that does not meet the requirements of a decentralized pharmacy and is located on the campus or affiliated with an institutional pharmacy shall be separately licensed.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.03.04" data-order="|10|34|03|.04|" data-ref-path="10|34|03|.04" class="h__section">.04 Policies and Procedures.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#A">A.</span> The director of pharmacy shall establish and operate under a policies and procedures manual which:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#A(1)">(1)</span> Complies with this chapter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#A(2)">(2)</span> Defines the scope and method of pharmacy services provided to the patients of the institutional facility;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#A(3)">(3)</span> Determines when personnel may have access to the pharmacy area;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#A(4)">(4)</span> Provides for the safe and efficient dispensing and delivery of pharmaceutical products as outlined in this subtitle;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#A(5)">(5)</span> Includes:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#A(5)(a)">(a)</span> Labeling requirements that meet the requirements of this chapter;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#A(5)(b)">(b)</span> Distribution methods for medication that assures that a patient receives the correct dose ordered by the prescriber;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#A(5)(c)">(c)</span> Packaging methods that assure the medication is appropriately identified, designed to maintain stability until expiration and traceable throughout the distribution chain to facilitate recall;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#A(5)(d)">(d)</span> Distribution methods that provide for safe handling of medications that may be manual or computerized employing centralized, decentralized, or remote devices that meet the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.28" title="Chapter 28 Automated Medication Systems">COMAR 10.34.28</a>.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#A(5)(e)">(e)</span> Pharmacy security methods that comply with this chapter;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#A(5)(f)">(f)</span> Conditions in which an emergency drug supply may be replenished or prepared, delivered, and stored by the institutional facility;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#A(5)(g)">(g)</span> Duties that may be performed by a licensed pharmacist, registered pharmacy technician and unlicensed personnel; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#A(5)(h)">(h)</span> Methods for proper disposal of pharmaceuticals as required by State and federal law;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#A(6)">(6)</span> Is provided to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#A(6)(a)">(a)</span> The personnel of the pharmacy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#A(6)(b)">(b)</span> The institutional facility; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#A(6)(c)">(c)</span> Upon request, an agent of the Board; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#A(7)">(7)</span> Is in a form that is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#A(7)(a)">(a)</span> Written or electronic; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#A(7)(b)">(b)</span> Readily retrievable;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.04#B">B.</span> The director of pharmacy shall provide annual training on the policies and procedures manual to the personnel of the pharmacy.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.03.05" data-order="|10|34|03|.05|" data-ref-path="10|34|03|.05" class="h__section">.05 Personnel.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.05#A">A.</span> The permit holder shall appoint a licensed pharmacist as director of pharmacy who shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.05#A(1)">(1)</span> Be in full and actual charge of the pharmacy and its personnel;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.05#A(2)">(2)</span> Be responsible for the operations of the pharmacy and for compliance with the requirements of <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>, and the regulations promulgated under that title; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.05#A(3)">(3)</span> Review the policies and procedures of the pharmacy annually and revise them as necessary.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.05#B">B.</span> Staff.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.05#B(1)">(1)</span> The pharmacy permit holder shall employ licensed pharmacists, registered pharmacy technicians, and unlicensed personnel as required to competently and safely provide pharmacy services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.05#B(2)">(2)</span> The director of pharmacy shall delegate responsibility for the operations of the pharmacy to a designated pharmacist when the director of pharmacy is not available.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.03.06" data-order="|10|34|03|.06|" data-ref-path="10|34|03|.06" class="h__section">.06 Security.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.06#A">A.</span> If a pharmacist is not present within the pharmacy, the pharmacist shall lock and secure the pharmacy and any of its decentralized areas that contain pharmaceuticals before leaving the pharmacy or the decentralized area.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.06#B">B.</span> The  director of pharmacy shall establish policies and procedures for emergency access to the pharmacy or any of its decentralized areas.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.06#C">C.</span> Security Requirements. Entry into an institutional pharmacy area where prescription drugs or devices are held shall be limited to authorized personnel under a pharmacist’s direct supervision.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.06#D">D.</span> An institutional pharmacy shall be equipped with:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.06#D(1)">(1)</span> A security system to detect entry after hours, if applicable;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.06#D(2)">(2)</span> A security system that provides additional protection against theft and diversion;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.06#D(3)">(3)</span> Appropriate software to facilitate the identification of evidence of tampering with computers or electronic records;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.06#D(4)">(4)</span> An inventory management and control system designed to protect against, detect, and document instances of theft, diversion, or counterfeiting;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.06#D(5)">(5)</span> A security system designed to protect the integrity and confidentiality of data and documents;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.06#D(6)">(6)</span> Video monitoring of entrances and exits, or alternate acceptable security; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.06#D(7)">(7)</span> A means to make the data and documentation required under this chapter readily available to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.06#D(7)(a)">(a)</span> The Board;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.06#D(7)(b)">(b)</span> An agent of the Board; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.06#D(7)(c)">(c)</span> Federal and State regulatory and law enforcement officials.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.03.07" data-order="|10|34|03|.07|" data-ref-path="10|34|03|.07" class="h__section">.07 Physical Requirements and Equipment.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.07#A">A.</span> The institutional pharmacy shall have floor space, shelving, and equipment to ensure that drugs and supplies within the institutional pharmacy are properly stored and prepared with respect to sanitation, temperature, light, ventilation, moisture control, segregation, and security.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.07#B">B.</span> The institutional pharmacy shall have professional and technical equipment, supplies, and adequate physical facilities for proper compounding, dispensing, and storage of drugs.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.07#C">C.</span> The institutional pharmacy shall have reference materials as required by <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.07.03" title=".03 Reference Libraries.">COMAR 10.34.07.03</a> to enable personnel to prepare and dispense drugs properly and perform pharmaceutical care functions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.07#D">D.</span> The institutional pharmacy shall store alcohol and flammables in areas that meet basic local building code requirements for the storage of volatiles and such other laws, ordinances, or regulations as may apply.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.07#E">E.</span> An institutional pharmacy that provides parenteral preparations shall comply with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19" title="Chapter 19 Sterile Pharmaceutical Compounding">COMAR 10.34.19</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.07#F">F.</span> The institutional pharmacy shall dispose of hazardous materials consistent with State and federal laws and regulations;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.07#G">G.</span> The institutional pharmacy is responsible for the maintenance of the institution’s automated medication systems in compliance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.28" title="Chapter 28 Automated Medication Systems">COMAR 10.34.28</a></p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.03.08" data-order="|10|34|03|.08|" data-ref-path="10|34|03|.08" class="h__section">.08 Responsibilities of Director of Pharmacy.</h3>
                <p>The director of pharmacy or designee shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#A">A.</span> Be responsible for the safe and efficient dispensing, control, security, and accountability of drugs;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#B">B.</span> Work in cooperation with the other professional staff of the institutional facility with respect to the duties listed in this regulation and in ordering, administering, and controlling drug products and materials, including prescription blanks;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#C">C.</span> Supervise the preparation of parenteral and other medications compounded within the institutional facility;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#D">D.</span> Provide written policies and procedures to hospital professional and technical staff with regard to admixtures prepared within the institution outside of the institutional pharmacy including, but not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#D(1)">(1)</span> Establishing policies and procedures for preparation and handling of the admixtures; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#D(2)">(2)</span> Providing incompatibility information with respect to the admixtures;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#E">E.</span> Recommend specifications for procurement, storage and disposal of drugs, chemicals, and biologicals administered to patients to the appropriate committee of the institutional facility as determined by the governing body;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#F">F.</span> Participate in the development of a formulary for the facility;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#G">G.</span> Establish procedures for the development of a standard format and ongoing procedures for checking the accuracy and placement of labels on medications throughout the institution;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#H">H.</span> Maintain and make available an inventory of antidotes and other emergency drugs, both in the pharmacy and in patient care areas, as well as:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#H(1)">(1)</span> Current antidote information;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#H(2)">(2)</span> Telephone numbers of a regional poison information center;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#H(3)">(3)</span> Other emergency assistance organizations; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#H(4)">(4)</span> Such other materials and information as may be considered necessary by the governing body of the institutional facility;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#I">I.</span> Maintain records of transactions of the institutional pharmacy as may be required by applicable law and as may be necessary to maintain accurate control and accountability for pharmaceuticals;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#J">J.</span> Participate in those aspects of the institutional facility's quality assurance and improvement program which relate to medication safety and pharmaceutical utilization and effectiveness;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#K">K.</span> Participate in teaching or research programs, or both, in the institutional facility as required;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#L">L.</span> Implement the policies, procedures, and decisions of the governing body of the institutional facility;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#M">M.</span> Ensure that a system is in place that provides a safe, secure, and efficient distribution system for pharmaceutical products within the facility;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#N">N.</span> Ensure that the institutional pharmacy meets inspection and other requirements of <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>, and these regulations;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#O">O.</span> Develop and implement policies and procedures to ensure that discontinued and outdated drugs and drug containers with worn, illegible, or missing labels are returned to the pharmacy for proper disposition;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#P">P.</span> Establish policies and procedures for identification, handling, storage, and disposition of medications brought into the institution by the patients;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#Q">Q.</span> Conduct an on-going plan for a quality assurance program that will review and evaluate pharmaceutical services and recommend improvements in these services;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#R">R.</span> Establish policies and procedures for identification and handling of investigational drugs that include the provision of pharmacologic and toxicologic information to the medical and nursing staff according to institutional policies ;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#S">S.</span> Arrange for the inspection of drug storage areas throughout the institution on a monthly basis and maintain written records of these reviews; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#T">T.</span> Participate in developing and monitoring the policies and procedures pertaining to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#T(1)">(1)</span> Administration of drugs at an institutional facility to ensure that only authorized individuals administer drugs; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#T(2)">(2)</span> Self-administration of drugs not on the hospital formulary by patients to ensure that the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#T(2)(a)">(a)</span> Administration occurs in accordance with procedures established by the appropriate committee of the institution; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.08#T(2)(b)">(b)</span> That the self-administration is ordered by an authorized prescriber.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.03.09" data-order="|10|34|03|.09|" data-ref-path="10|34|03|.09" class="h__section">.09 Medication Packaging — Record Keeping.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#A">A.</span> A licensed pharmacist shall verify the selection of medication to be packaged and verify the completed packaging of medication performed by a registered pharmacy technician for the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#A(1)">(1)</span> Accuracy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#A(2)">(2)</span> Completeness:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#A(3)">(3)</span> Appropriateness; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#A(4)">(4)</span> Compliance with the U.S. Food and Drug Administration and current United States Pharmacopeia approved packaging.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#B">B.</span> Packaging from the Manufacturer’s Original Container. The pharmacy shall use a master log with respect to drugs that are packaged within the pharmacy facility from the original manufacturer’s container which includes the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#B(1)">(1)</span> Lot number assigned by the distributor or manufacturer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#B(2)">(2)</span> Manufacturer’s expiration date;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#B(3)">(3)</span> Manufacturer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#B(4)">(4)</span> Lot number assigned by the pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#B(5)">(5)</span> Quantity packaged;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#B(6)">(6)</span> Expiration date as defined in <a class="internal-link " href="/us/md/exec/comar/10.34.03.09#C" title="">§C of this regulation</a>s;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#B(7)">(7)</span> Generic name of the drug;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#B(8)">(8)</span> Strength;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#B(9)">(9)</span> Date of packaging;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#B(10)">(10)</span> Name of person packaging; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#B(11)">(11)</span> Initials of verifying licensed pharmacist.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#C">C.</span> Unless the licensed pharmacist has reason to reduce the time period, the expiration date of the medication is the lesser of:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#C(1)">(1)</span> Twelve months from the date of packaging;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#C(2)">(2)</span> The manufacturer’s or distributor’s listed expiration date; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#C(3)">(3)</span> The maximum time period allowed for the specific packaging used for the medication.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#D">D.</span> The licensed pharmacist shall ensure that labeling of the medication container includes the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#D(1)">(1)</span> Generic name of the medication;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#D(2)">(2)</span> Brand name of the medication, if appropriate</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#D(3)">(3)</span> Strength of the medication, if appropriate;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#D(4)">(4)</span> Lot number of the distributor or manufacturer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#D(5)">(5)</span> Expiration date of the medication; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.09#D(6)">(6)</span> Beyond use date of the medication, if appropriate.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.03.10" data-order="|10|34|03|.10|" data-ref-path="10|34|03|.10" class="h__section">.10 Labeling for Use Outside the Institutional Facility.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.10#A">A.</span> The director of pharmacy or designee shall ensure that the labels on drugs dispensed for use outside the facility by an institutional pharmacy to clinics, ambulatory patients, or other patients about to be discharged meet the requirements of <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-505" title="">Health Occupations Article, §12-505, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.10#B">B.</span> The director of pharmacy or designee shall ensure that the labels contain other information that may be required by federal or State law or regulations including, but not limited to, cautionary information.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.03.11" data-order="|10|34|03|.11|" data-ref-path="10|34|03|.11" class="h__section">.11 Drug Dispensing — Emergency Supplies and Procedures.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#A">A.</span> The director of pharmacy shall participate in the development and maintenance of the formulary for emergency drugs and supplies that are maintained throughout the institutional facility.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#B">B.</span> The director of pharmacy or designee shall, in conjunction with the medical staff of the institutional facility, develop and implement written policies and procedures to ensure compliance with the provisions of this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C">C.</span> The institutional pharmacy shall furnish emergency drugs and supplies only if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C(1)">(1)</span> The emergency drugs and supplies are stored in an environment which:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C(1)(a)">(a)</span> Maintains the integrity of the drugs; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C(1)(b)">(b)</span> Provides accessibility only to authorized personnel;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C(2)">(2)</span> The institution follows a policy that drugs will be dispensed from the emergency drugs and supplies formulary only upon written or verbal order by an authorized prescriber;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C(3)">(3)</span> The emergency drugs and supplies are stocked and maintained in a manner that complies with the standards of applicable State law;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C(4)">(4)</span> The emergency drugs and supplies are:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C(4)(a)">(a)</span> Stored and secured:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C(4)(a)(i)">(i)</span> With a tamper evident seal; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C(4)(a)(ii)">(ii)</span> Via electronic means; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C(4)(b)">(b)</span> Kept in a secure area;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C(5)">(5)</span> The emergency drugs and supplies are labeled as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C(5)(a)">(a)</span> Clearly indicating that the emergency drugs and supplies are for use in emergencies only;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C(5)(b)">(b)</span> Listing the expiration dates of the emergency drugs and supplies;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C(5)(c)">(c)</span> Listing the name or initials of the pharmacist who checked the emergency drugs and supplies; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C(5)(d)">(d)</span> Highlighting the expiration date of the medication with the shortest expiration date;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C(6)">(6)</span> When the emergency drugs and supplies are contained within an emergency cart, the pharmacist checking the emergency cart shall ensure that the exterior of the cart is labeled with the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C(6)(a)">(a)</span> Contents of the emergency cart; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C(6)(b)">(b)</span> Name or initials of the pharmacist; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C(7)">(7)</span> The director of pharmacy or designee shall ensure that repackaged drugs contained in emergency drugs and supplies are labeled:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C(7)(a)">(a)</span> In accordance with <a class="internal-link " href="/us/md/exec/comar/10.34.03.10" title=".10 Labeling for Use Outside the Institutional Facility.">Regulation .10 of this chapter</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#C(7)(b)">(b)</span> With other information as may be required by the medical staff.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#D">D.</span> Upon notification that emergency drugs and supplies have been opened, a pharmacist or registered pharmacy technician shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#D(1)">(1)</span> Restock the emergency drugs and supplies; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#D(2)">(2)</span> Provide a replacement supply.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#E">E.</span> The director of pharmacy or designee shall ensure:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#E(1)">(1)</span> That the expiration date of emergency drugs and supplies is the earliest date of expiration of any drug supplied; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.11#E(2)">(2)</span> Before the expiration date, the pharmacist or designee shall replace the expired drug and relabel the emergency drugs and supplies as provided in <a class="internal-link " href="/us/md/exec/comar/10.34.03.11#C(5)" title="">§C(5) of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.03.12" data-order="|10|34|03|.12|" data-ref-path="10|34|03|.12" class="h__section">.12 Drug Dispensing — Prescribers' Orders.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.12#A">A.</span> Drugs may be dispensed from the institutional pharmacy only in response to medication orders issued by prescribers who have been authorized to do so by law and by the governing body of the institution.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.12#B">B.</span> Documentation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.12#B(1)">(1)</span> Institutional Medication Protocols.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.12#B(1)(a)">(a)</span> The pharmacist may dispense, or make available, drugs for an approved institutional medication protocol if conditions designated by the institution are met.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.12#B(1)(b)">(b)</span> The director of pharmacy or designee shall assist in establishing institutional policies and procedures governing the development of order-sets for each individual situation for which institutional medication protocol orders exist.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.12#B(1)(c)">(c)</span> The appropriate committee of the institution shall approve any order-sets before the pharmacist may provide the medications based on the institutional medication protocol.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.12#B(2)">(2)</span> A pharmacist may provide medications based on orders which do not contain unapproved abbreviations as published by the appropriate committee of the institutional facility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.12#B(3)">(3)</span> The director of pharmacy or designee shall ensure that authorized personnel have access to patient information necessary for drug monitoring including the patient's:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.12#B(3)(a)">(a)</span> Sex;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.12#B(3)(b)">(b)</span> Age;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.12#B(3)(c)">(c)</span> Weight;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.12#B(3)(d)">(d)</span> Height;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.12#B(3)(e)">(e)</span> Diagnosis;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.12#B(3)(f)">(f)</span> Medication and food allergies;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.12#B(3)(g)">(g)</span> Pregnancy and lactation status;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.12#B(3)(h)">(h)</span> Vaccination status; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.12#B(3)(i)">(i)</span> Name.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.03.13" data-order="|10|34|03|.13|" data-ref-path="10|34|03|.13" class="h__section">.13 Controlled Dangerous Substances.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#A">A.</span> Drug Accountability.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#A(1)">(1)</span> The director of pharmacy is responsible for establishing procedures and maintaining adequate written or electronic records regarding dispensing and accountability of controlled dangerous substances which specify at least the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#A(1)(a)">(a)</span> Name and strength of the drug;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#A(1)(b)">(b)</span> Dose;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#A(1)(c)">(c)</span> Dosage form;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#A(1)(d)">(d)</span> Prescriber;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#A(1)(e)">(e)</span> Patient name with second identifier;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#A(1)(f)">(f)</span> Date and time of administration; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#A(1)(g)">(g)</span> Individual administering the drug;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#A(2)">(2)</span> The director of pharmacy shall be responsible for establishing and maintaining adequate procedures for documentation of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#A(2)(a)">(a)</span> Recording of receipt of delivery to the pharmacy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#A(2)(b)">(b)</span> Entering into pharmacy inventory;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#A(2)(c)">(c)</span> Receiving into Schedule II inventory; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#A(2)(d)">(d)</span> Dispensing of controlled dangerous substances, Schedule II — Schedule V.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#A(3)">(3)</span> The director of pharmacy or designee shall be responsible for establishing and maintaining adequate procedures for documenting partially administered controlled dangerous substances:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#A(3)(a)">(a)</span> For disposal by hospital policy; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#A(3)(b)">(b)</span> Return of unused drugs to the pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#A(4)">(4)</span> The director of pharmacy or designee shall establish procedures to ensure that controlled dangerous substance records include the handwritten or electronic signature of the individual authorized:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#A(4)(a)">(a)</span> By the institution to dispose of drugs or to return them to the pharmacy; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#A(4)(b)">(b)</span> To witness the disposal, as defined by the institution's policies and procedures.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#B">B.</span> Storage and Security in the Institutional pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#B(1)">(1)</span> On at least a monthly basis, a pharmacist or registered pharmacy technician shall perform a physical count of each Schedule II controlled dangerous substance in the pharmacy and shall then compare that count with the perpetual inventory maintained by the pharmacy with reference to each drug;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#B(2)">(2)</span> On at least a monthly basis, the director of pharmacy or designee shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#B(2)(a)">(a)</span> Investigate discrepancies within the pharmacy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#B(2)(b)">(b)</span> Report losses as required by law; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#B(2)(c)">(c)</span> Take appropriate action; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#B(3)">(3)</span> The director of pharmacy or designee shall establish a procedure by which previously dispensed controlled dangerous substances that are no longer necessary for medical reasons are returned to the pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#C">C.</span> Storage and Security in the Institution. The director of pharmacy shall develop policies that only permit the dispensing of controlled dangerous substances when the following security precautions exist in the institution and the pharmacy:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#C(1)">(1)</span> Access to controlled dangerous substances outside the pharmacy is restricted to authorized personnel approved by institutional policy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#C(2)">(2)</span> Controlled dangerous substances stored outside the pharmacy are accounted for at least at the change of each shift by licensed personnel authorized by the institution, unless a controlled access automated dispensing system provides an on-demand report of a perpetual inventory; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.13#C(3)">(3)</span> A pharmacist reviews the discrepancies in counts of controlled dangerous substances previously reported by other professional personnel.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.03.14" data-order="|10|34|03|.14|" data-ref-path="10|34|03|.14" class="h__section">.14 Drug Recalls.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.14#A">A.</span> The director of pharmacy or designee shall develop and implement a drug recall procedure that can be readily activated to assure that drugs which have been recalled are returned to the pharmacy for proper disposition.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.14#B">B.</span> If a recall has been initiated for a drug that has been purchased by the institution, the director of pharmacy or designee shall issue a notice in a timely manner informing affected departments of the institution that the drug shall be returned to the pharmacy for proper return or disposal.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.14#C">C.</span> The institutional pharmacy is responsible for the timely retrieval of affected drugs.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.03.15" data-order="|10|34|03|.15|" data-ref-path="10|34|03|.15" class="h__section">.15 Adverse Drug Events.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.15#A">A.</span> The director of pharmacy or designee shall participate in the appropriate committee or committees to establish procedures to report and record adverse drug events including medication errors and adverse drug reactions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.15#B">B.</span> The director of pharmacy or designee shall immediately report adverse drug events to the prescriber, or the prescriber's designee, and make a written or electronic report to the appropriate committee or committees, as determined by the governing body of the institutional facility.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.15#C">C.</span> The director of pharmacy shall participate in the deliberations of the institutional committee charged with the development of the programmatic and operational changes that result from the analysis of medication errors or other adverse events.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.15#D">D.</span> The director of pharmacy, in collaboration with the medical staff and other appropriate departments and services, shall develop and maintain a process for training staff regarding detecting and reporting medication errors to prevent future occurrences.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.15#E">E.</span> The director of pharmacy or designee shall make further reports of adverse reactions as required by federal or State law.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.03.16" data-order="|10|34|03|.16|" data-ref-path="10|34|03|.16" class="h__section">.16 Pharmaceutical Care Functions of the Pharmacist.</h3>
                <p>The pharmacist shall be available as necessary to provide pharmaceutical care to individual patients including, but not limited to:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#A">A.</span> Participating in decisions about medication use for patients including decisions not to use medication therapy as well as judgments about:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#A(1)">(1)</span> Medication selection;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#A(2)">(2)</span> Dosages;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#A(3)">(3)</span> Routes and methods of administration;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#A(4)">(4)</span> Medication therapy monitoring; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#A(5)">(5)</span> The provision of medication-related information and counseling to individual patients;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#B">B.</span> Cooperating directly with health care professionals and the patient in designing, implementing, and monitoring a therapeutic outcome.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#C">C.</span> Providing care directly to the patient to improve a patient’s quality of life through achieving definite and predefined, medication-related therapeutic outcomes such as:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#C(1)">(1)</span> Curing the disease;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#C(2)">(2)</span> Eliminating or reducing a symptomatology;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#C(3)">(3)</span> Arresting or slowing a disease process;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#C(4)">(4)</span> Preventing a disease or symptomatology; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#C(5)">(5)</span> Improving patient’s quality of life.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#D">D.</span> Identifying potential and actual medication-related problems, resolving actual medication-related problems, and preventing potential medication-related problems caused by:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#D(1)">(1)</span> Untreated indications;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#D(2)">(2)</span> Improper drug selection;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#D(3)">(3)</span> Sub-therapeutic dosage;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#D(4)">(4)</span> Failure to received medication;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#D(5)">(5)</span> Over dosage;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#D(6)">(6)</span> Adverse drug reactions;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#D(7)">(7)</span> Drug interactions, including drug-drug, drug-food, drug-laboratory test interactions; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.16#D(8)">(8)</span> Medication use without appropriate indication.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.03.17" data-order="|10|34|03|.17|" data-ref-path="10|34|03|.17" class="h__section">.17 Requirements for a Decentralized Pharmacy.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.17#A">A.</span> A decentralized pharmacy is subject to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.17#A(1)">(1)</span> <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.17#A(2)">(2)</span> This subtitle; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.17#A(3)">(3)</span> Other applicable State and federal laws and regulations.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.17#B">B.</span> A decentralized pharmacy shall ensure that a licensed pharmacist is immediately available on the premises of the decentralized pharmacy to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.17#B(1)">(1)</span> Supervise pharmacy operations; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.17#B(2)">(2)</span> Provide the final check for preparing medication orders for administration in the institutional facility.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.17#C">C.</span> Notwithstanding <a class="internal-link " href="/us/md/exec/comar/10.34.03.17#B" title="">§B of this regulation</a>, a pharmacist assigned to a decentralized pharmacy may leave the decentralized pharmacy for a short period of time to perform pharmaceutical care functions in the institutional facility.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.17#D">D.</span> A director of pharmacy of the institutional pharmacy shall be responsible for pharmacy operations involving a decentralized pharmacy, including direct supervision of decentralized pharmacy personnel by a pharmacist and compliance with this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.17#E">E.</span> A pharmacy department may store prescription medications and over the counter medications that are approved for use by the institutional pharmacy as required for the treatment of patients in the nursing unit served by the decentralized pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.17#F">F.</span> An institutional pharmacy and the decentralized pharmacy shall have shared common electronic files or appropriate technology to allow access to sufficient information necessary or required to process functions required for the care of patients within the service area of the decentralized pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.17#G">G.</span> A decentralized pharmacy shall have a pharmacist physically located at the decentralized pharmacy to directly supervise pharmacy technicians and pharmacy technician trainees during hours of operation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.17#H">H.</span> An institutional pharmacy shall notify the Board in writing within 14 days of a change of location, discontinuance of service, or closure of a decentralized pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.03.17#I">I.</span> Security.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.17#I(1)">(1)</span> In addition to the security requirements outlined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.05" title="Chapter 05 Pharmacy Security">COMAR 10.34.05</a>, a decentralized pharmacy shall have adequate security and procedures to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.17#I(1)(a)">(a)</span> Prohibit unauthorized access;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.17#I(1)(b)">(b)</span> Comply with federal and State regulations; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.03.17#I(1)(c)">(c)</span> Maintain patient confidentiality.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.03.17#I(2)">(2)</span> Access to the decentralized pharmacy shall be limited to pharmacists, pharmacy technicians, and pharmacy technician trainees employed by the institutional pharmacy, and other personnel authorized by the director of pharmacy.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.04" data-order="|10|34|04|" data-ref-path="10|34|04" class="h__chapter">Chapter 04 Transfer and Outsourcing of Prescriptions and Prescription Orders</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: May 4, 1979 (6:9 Md. R. 728)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.04.01" title=".01 Scope.">Regulation .01</a> amended effective February 19, 1990 (17:3 Md. R. 298)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.04.02" title=".02 Definitions.">Regulation .02</a> amended effective February 19, 1990 (17:3 Md. R. 298)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.04.03#A" title="">Regulation .03A</a> amended effective February 19, 1990 (17:3 Md. R. 298)</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.04.01" title=".01 Scope.">.01</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.04.04" title=".04 Refilling of Permanently Transferred Prescriptions.">.04</a>, Transfer of Prescriptions Between Pharmacies repealed effective June 25, 2001 (28:12 Md. R. 1110)</p>
                  <p>——————</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.04.01" title=".01 Scope.">Regulation .01</a> — .09 Transfer and Outsourcing of Prescriptions and Prescription Orders adopted effective June 25, 2001 (28:12 Md. R. 1110)</p>
                  <h3>Authority</h3>
                  <p><a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">Health Occupations Article, §12-205(a)(3)(ii), </a>Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.04.01" data-order="|10|34|04|.01|" data-ref-path="10|34|04|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter governs the:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.01#A">A.</span> Transfer of prescriptions between pharmacies;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.01#B">B.</span> Filling of prescriptions at one pharmacy pursuant to the request of staff of a second pharmacy; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.01#C">C.</span> Preparation of medication for stock and investigational use.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.04.02" data-order="|10|34|04|.02|" data-ref-path="10|34|04|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.02#B(1)">(1)</span> "Outsourcing" means the transmitting of a prescription order from a primary pharmacy to a secondary pharmacy that prepares the prescription.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.02#B(2)">(2)</span> "Patient specific" means a prescription order prepared and labeled for a specific individual.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.02#B(3)">(3)</span> "Preparation" means compounding or packaging of medication.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.02#B(4)">(4)</span> "Primary pharmacy" means the pharmacy that initially receives a prescription order.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.02#B(5)">(5)</span> "Secondary pharmacy" means the pharmacy to which a prescription order is transmitted for subsequent dispensing to a patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.02#B(6)">(6)</span> "Stock medication" means medication that is not labeled for, or intended for, use by a specific patient when it leaves the pharmacy, but is intended to be stored and ultimately administered by a licensed health care professional in accordance with applicable laws and regulations.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.04.03" data-order="|10|34|04|.03|" data-ref-path="10|34|04|.03" class="h__section">.03 Permanent Transfer of a Prescription Between Pharmacies.</h3>
                <p>A pharmacist from a primary pharmacy may permanently transfer a prescription order to a secondary pharmacy to be dispensed to a specific patient if:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.03#A">A.</span> The prescription is lawfully refillable;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.03#B">B.</span> The prescription is not for a Schedule II controlled dangerous substance noted in <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gcr/gcr.pdf" title="">Criminal Law Article, Title 5, Subtitle 4, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.03#C">C.</span> The pharmacist transferring the prescription from the primary pharmacy indicates on the prescription, within the prescription computer database and within any appropriate other records used for dispensing:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.03#C(1)">(1)</span> That the prescription has been permanently transferred;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.03#C(2)">(2)</span> The name of the secondary pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.03#C(3)">(3)</span> The name of the pharmacist who transferred the prescription to the secondary pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.03#C(4)">(4)</span> The name of the pharmacist at the secondary pharmacy to whom the prescription was transferred if the transfer occurred in an oral manner; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.03#C(5)">(5)</span> The date on which the prescription was transferred to the secondary pharmacy.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.04.04" data-order="|10|34|04|.04|" data-ref-path="10|34|04|.04" class="h__section">.04 Refilling of Permanently Transferred Prescriptions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.04#A">A.</span> A pharmacist at the primary pharmacy may not refill a prescription that has been permanently transferred to a secondary pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.04#B">B.</span> The use of unified prescription records by more than one pharmacy through a computerized prescription database does not constitute a permanent transfer of a prescription order.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.04.05" data-order="|10|34|04|.05|" data-ref-path="10|34|04|.05" class="h__section">.05 Documentation by the Secondary Pharmacy Receiving a Permanent Prescription Transfer.</h3>
                <p>The pharmacist at the secondary pharmacy who receives a permanently transferred prescription document is responsible for maintaining documentation in a readily retrievable and identifiable manner which includes:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.05#A">A.</span> That the prescription was transferred from another pharmacy;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.05#B">B.</span> The name and information identifying the specific location of the primary pharmacy;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.05#C">C.</span> The name of the pharmacist who transferred the prescription to the secondary pharmacy;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.05#D">D.</span> The name of the pharmacist at the secondary pharmacy who accepted the transferred prescription;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.05#E">E.</span> The date of issuance of the original prescription order;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.05#F">F.</span> The date on which the prescription order was first filled;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.05#G">G.</span> The date of the last refill;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.05#H">H.</span> The number of remaining refills;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.05#I">I.</span> The original prescription number; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.05#J">J.</span> The date on which the prescription was transferred to the secondary pharmacy.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.04.06" data-order="|10|34|04|.06|" data-ref-path="10|34|04|.06" class="h__section">.06 Outsourcing of a Prescription Order.</h3>
                <p>A pharmacist from a primary pharmacy may transmit a prescription order to a secondary pharmacy for preparation and final dispensing to a specific patient or for return to the primary pharmacy for final dispensing to a specific patient if:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.06#A">A.</span> The label contains the name, address, and phone number of the primary pharmacy;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.06#B">B.</span> The patient is informed in writing of the name and address of the secondary pharmacy;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.06#C">C.</span> The patient is informed in writing that the prescription order was prepared at a secondary pharmacy;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.06#D">D.</span> The original prescription order is filed as a prescription order at the primary pharmacy;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.06#E">E.</span> The pharmacist from the primary pharmacy documents in a readily retrievable and identifiable manner:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.06#E(1)">(1)</span> That the prescription order was prepared by a secondary pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.06#E(2)">(2)</span> The name of the secondary pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.06#E(3)">(3)</span> The name of the pharmacist who transmitted the prescription order to the secondary pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.06#E(4)">(4)</span> The name of the pharmacist at the secondary pharmacy to whom the prescription order was transmitted if the transmission occurred in an oral manner;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.06#E(5)">(5)</span> The date on which the prescription was transmitted to the secondary pharmacy; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.06#E(6)">(6)</span> The date on which the medication was sent to the primary pharmacy;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.06#F">F.</span> Both the primary and secondary pharmacies are licensed in this State, or operated by the federal government; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.06#G">G.</span> The primary pharmacy maintains, in a readily retrievable and identifiable manner, a record of preparations received from the secondary pharmacy.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.04.07" data-order="|10|34|04|.07|" data-ref-path="10|34|04|.07" class="h__section">.07 Documentation by the Secondary Pharmacy when a Prescription Order is Outsourced.</h3>
                <p>The permit holder at the secondary pharmacy is responsible for maintaining documentation in a readily retrievable and identifiable manner, which includes:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.07#A">A.</span> That the prescription order was transmitted from another pharmacy;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.07#B">B.</span> The name and information identifying the specific location of the primary pharmacy;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.07#C">C.</span> The name of the pharmacist who transmitted the prescription to the secondary pharmacy if the transmission occurred in an oral manner;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.07#D">D.</span> The name of the pharmacist at the secondary pharmacy who accepted the transmitted prescription order;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.07#E">E.</span> The name of the pharmacist at the secondary pharmacy who prepared the prescription order;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.07#F">F.</span> The date on which the prescription order was received at the secondary pharmacy; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.07#G">G.</span> The date on which the prepared product was sent to the primary pharmacy if it was sent back to the primary pharmacy.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.04.08" data-order="|10|34|04|.08|" data-ref-path="10|34|04|.08" class="h__section">.08 Preparation of Stock and Investigational Medications.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.08#A">A.</span> A pharmacist may provide medication for use as stock medication for a licensed health care facility in accordance with applicable laws, if the pharmacy providing the medication also serves as the primary provider of patient specific medication for the facility.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.08#B">B.</span> A pharmacist may provide medication for use as stock medication for final dispensing or administration by an authorized prescriber who is permitted by law to administer or dispense medication if the pharmacist receives a written stock medication order from the authorized prescriber for each delivery of medication to the authorized prescriber.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.08#C">C.</span> A pharmacist may prepare, package, and label investigational drugs not destined for a specific individual at the time of preparation, packaging, and labeling if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.08#C(1)">(1)</span> The study for which medications are prepared, packaged, and labeled is approved by an institutional review board as defined in federal law; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.08#C(2)">(2)</span> The pharmacy permit holder ensures that records disclosing the identity of the subject who eventually receives the medication are:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.04.08#C(2)(a)">(a)</span> Received by a pharmacist on duty at the pharmacy within 30 days after being provided to a patient; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.04.08#C(2)(b)">(b)</span> Maintained in the pharmacy.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.04.09" data-order="|10|34|04|.09|" data-ref-path="10|34|04|.09" class="h__section">.09 Permit and Quality Assurance.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.09#A">A.</span> The permit holder of a pharmacy which prepares patient specific prescriptions as a secondary pharmacy such that these prescriptions account for 5 percent or more of the pharmacy's total number of prescriptions filled shall submit to the Board of Pharmacy, for approval by the Board or a designee of the Board, a plan detailing the steps it has taken to ensure the safety and quality of prescriptions filled as a secondary pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.09#B">B.</span> The plan under <a class="internal-link " href="/us/md/exec/comar/10.34.04.09#A" title="">§A of this regulation</a> shall include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.09#B(1)">(1)</span> Measures to be taken to comply with State and federal laws;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.09#B(2)">(2)</span> The method by which each pharmacist responsible for each prescription is identified in the records;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.09#B(3)">(3)</span> Measures taken to maintain the security, integrity, and confidentiality of patient records; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.04.09#B(4)">(4)</span> The establishment and maintenance of a quality assurance program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.04.09#C">C.</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.34.04.06" title=".06 Outsourcing of a Prescription Order.">Regulation .06 of this chapter</a>, a permit holder of a pharmacy shall obtain manufacturing and distribution permits in order to compound or package medication that is not prepared as a prescription destined for a specific patient, but is forwarded to another pharmacy, authorized prescriber, licensed distributor, or other person or entity.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.05" data-order="|10|34|05|" data-ref-path="10|34|05" class="h__chapter">Chapter 05 Pharmacy Security</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: July 25, 1980 (7:15 Md. R. 1425)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.05.02#C" title="">Regulation .02C</a> adopted effective February 19, 1990 (17:3 Md. R. 298)</p>
                  <p>——————</p>
                  <p>Chapter, Security of a Pharmacy Facility, repealed and new chapter, Pharmacy Security, adopted effective November 1, 1999 (26:22 Md. R. 1692)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.05.02#C" title="">Regulation .02C</a> adopted effective July 1, 2010 (37:10 Md. R. 722)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.05.05" title=".05 Security Responsibility.">Regulation .05</a> amended effective July 1, 2010 (37:10 Md. R. 722); May 20, 2019 (46:10 Md. R. 489)</p>
                  <h3>Authority</h3>
                  <p><a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">Health Occupations Article, §12-205, </a>Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.05.01" data-order="|10|34|05|.01|" data-ref-path="10|34|05|.01" class="h__section">.01 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.05.01#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.05.01#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.01#B(1)">(1)</span> "Emergency" means an event such as a fire, water leak, electrical failure, public disaster, or catastrophe which may impact the prescription area.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.01#B(2)">(2)</span> "Means of access" means the manner of entry into the secure prescription area.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.01#B(3)">(3)</span> "Prescription area" means the portion of an establishment for which a pharmacy permit has been issued which contains:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.01#B(3)(a)">(a)</span> Patient records;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.01#B(3)(b)">(b)</span> Prescription devices; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.01#B(3)(c)">(c)</span> Prescription drugs.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.05.02" data-order="|10|34|05|.02|" data-ref-path="10|34|05|.02" class="h__section">.02 Prescription Area.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#A">A.</span> The pharmacy permit holder shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#A(1)">(1)</span> Ensure that the prescription area:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#A(1)(a)">(a)</span> Maintains temperature and ventilation at levels that do not affect the prescription drugs or devices stored in the area; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#A(1)(b)">(b)</span> Permits reasonable communication between the pharmacist and the public when the pharmacy is open;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#A(2)">(2)</span> Provide a means of securing the prescription area;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#A(3)">(3)</span> Prevent an individual from being in the prescription area unless a pharmacist is immediately available on the premises to provide pharmacy services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#A(4)">(4)</span> Monitor unauthorized or emergency entry after the prescription area has been secured by the pharmacist; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#A(5)">(5)</span> Prevent unauthorized entry when the prescription area is closed during a period that the rest of the establishment is open.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#B">B.</span> The pharmacist shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#B(1)">(1)</span> Secure the prescription area and its contents in order that the pharmacy permit holder or the pharmacy permit holder's agent may:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#B(1)(a)">(a)</span> Monitor unauthorized or emergency entry after the prescription area has been secured by the pharmacist; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#B(1)(b)">(b)</span> Prevent unauthorized entry when the prescription area is closed during a period that the rest of the establishment is open;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#B(2)">(2)</span> Have sole possession of a means of access to the pharmacy, except in emergencies; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#B(3)">(3)</span> Establish a means of access for use in an emergency when the pharmacist is not available to access the prescription area.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#C">C.</span> Security.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#C(1)">(1)</span> A pharmacy shall be secure from unauthorized entry as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#C(1)(a)">(a)</span> Access from outside the premises shall be:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#C(1)(a)(i)">(i)</span> Kept to a minimum; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#C(1)(a)(ii)">(ii)</span> Well controlled;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#C(1)(b)">(b)</span> The outside perimeter of the premises shall be well lit; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#C(1)(c)">(c)</span> Entry into areas where prescription drugs or devices and patient records are stored shall be limited to authorized personnel.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#C(2)">(2)</span> A pharmacy shall be equipped with:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#C(2)(a)">(a)</span> An alarm system to detect entry after hours;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#C(2)(b)">(b)</span> A security system that provides protection against theft and diversion;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#C(2)(c)">(c)</span> Appropriate software to facilitate the identification of evidence of tampering with computers or electronic records;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#C(2)(d)">(d)</span> An inventory management and control system that protects against, detects, and documents any instances of theft, diversion, or counterfeiting;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#C(2)(e)">(e)</span> A security system to protect the integrity and confidentiality of data and documents limited to authorized personnel; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.02#C(2)(f)">(f)</span> A means to make the data and documentation required under this section readily available to the Board, an agent of the Board, the Division of Drug Control, or federal and other State law enforcement officials.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.05.03" data-order="|10|34|05|.03|" data-ref-path="10|34|05|.03" class="h__section">.03 Pharmacy Operation.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.05.03#A">A.</span> A pharmacist shall be immediately available on the premises to provide pharmacy services at all times the pharmacy is in operation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.05.03#B">B.</span> If the prescription area is not open the same hours as the establishment, the pharmacy permit holder shall prominently display signs indicating the business hours of the prescription area.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.05.04" data-order="|10|34|05|.04|" data-ref-path="10|34|05|.04" class="h__section">.04 Records.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.05.04#A">A.</span> A pharmacy permit holder shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.04#A(1)">(1)</span> Prevent unauthorized disclosure or loss by securing all patient records;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.04#A(2)">(2)</span> Designate personnel with authorized access to computerized patient records; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.04#A(3)">(3)</span> Maintain current computerized records in a manner which permits reconstruction within 48 hours, except:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.04#A(3)(a)">(a)</span> In an emergency as defined in <a class="internal-link " href="/us/md/exec/comar/10.34.05.01" title=".01 Definitions.">Regulation .01 of this chapter</a>, or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.04#A(3)(b)">(b)</span> With the prior approval of the Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.05.04#B">B.</span> A pharmacy permit holder may store patient records away from the prescription area in a manner that prevents unauthorized disclosure or loss.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.05.05" data-order="|10|34|05|.05|" data-ref-path="10|34|05|.05" class="h__section">.05 Security Responsibility.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.05.05#A">A.</span> The pharmacy permit holder is responsible for ensuring that pharmacists, employees, and others who enter the pharmacy:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.05#A(1)">(1)</span> Know and abide by the requirements of this chapter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.05#A(2)">(2)</span> Maintain those measures necessary to ensure this chapter’s enforcement;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.05#A(3)">(3)</span> Report theft or significant loss of controlled dangerous substances to the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.05#A(3)(a)">(a)</span> Board;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.05#A(3)(b)">(b)</span> Local police;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.05#A(3)(c)">(c)</span> Office of Controlled Substances Administration; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.05.05#A(3)(d)">(d)</span> U.S. Drug Enforcement Administration; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.05#A(4)">(4)</span> Report theft of non-controlled prescription drugs or devices to the Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.05.05#B">B.</span> In determining whether a loss is significant pursuant to <a class="internal-link " href="/us/md/exec/comar/10.34.05.05#A(3)" title="">§A(3) of this regulation</a>, the pharmacy permit holder shall consider at least the following factors:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.05#B(1)">(1)</span> The actual quantity of controlled dangerous substances lost in relation to the type of business;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.05#B(2)">(2)</span> The specific controlled dangerous substances lost;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.05#B(3)">(3)</span> Whether the loss of the controlled dangerous substances can be associated with access to those controlled dangerous substances by specific individuals, or whether the loss can be attributed to unique activities that may take place involving controlled dangerous substances;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.05#B(4)">(4)</span> A pattern of losses over a specific time period, whether the losses appear to be random, and the results of efforts taken to resolve the losses;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.05#B(5)">(5)</span> Whether the specific controlled dangerous substances are likely candidates for diversion, if known; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.05.05#B(6)">(6)</span> Local trends and other indicators of the diversion potential of the missing controlled dangerous substances, if known.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.06" data-order="|10|34|06|" data-ref-path="10|34|06" class="h__chapter">Chapter 06 Reporting Pharmacist's, Pharmacy Intern's, and Pharmacy Technician's Mailing Address and Location of Employment</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: July 25, 1980 (7:15 Md. R. 1425)</p>
                  <p>Chapter, Posting of Prescription Prices and Services, repealed effective April 9, 1984 (11:7 Md. R. 625)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.06.01" title=".01 Scope.">.01</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.06.05" title=".05 Grounds for Disciplinary Action.">.05</a>, Reporting Pharmacist's Mailing Address and Location of Employment, adopted effective February 19, 1990 (17:3 Md. R. 298)</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.06.01" title=".01 Scope.">.01</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.06.05" title=".05 Grounds for Disciplinary Action.">.05</a>, Reporting Pharmacist's and Pharmacy Technician's Mailing Address and Location of Employment amended effective March 18, 2013 (40:5 Md. R. 411)</p>
                  <p>Regulations .01, .03, .04, and .05, Reporting Pharmacist's, Pharmacy Intern's, and Pharmacy Technician's Mailing Address and Location of Employment amended effective  July 1, 2015 (42:7 Md. R. 569)</p>
                  <h3>Authority</h3>
                  <p><a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">Health Occupations Article, §12-205, </a>Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.06.01" data-order="|10|34|06|.01|" data-ref-path="10|34|06|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter applies to each pharmacist, pharmacy intern, and pharmacy technician licensed or registered by the Maryland Board of Pharmacy.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.06.02" data-order="|10|34|06|.02|" data-ref-path="10|34|06|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.06.02#A">A.</span> In these regulations, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.06.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.06.02#B(1)">(1)</span> "Board" means the State Board of Pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.06.02#B(2)">(2)</span> "Mailing address" means the address the pharmacist or pharmacy technician specifies that the Board use when communicating with the pharmacist or pharmacy technician.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.06.02#B(3)">(3)</span> "Primary employment location" means the establishment where the pharmacist or pharmacy technician is employed on a regular basis or works most often.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.06.03" data-order="|10|34|06|.03|" data-ref-path="10|34|06|.03" class="h__section">.03 Mailing Address.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.06.03#A">A.</span> Each licensed pharmacist, pharmacy intern, and registered pharmacy technician shall report to the Board the pharmacist’s, pharmacy intern’s, or pharmacy technician’s current mailing address on the pharmacist’s, pharmacy intern’s, or pharmacy technician’s biennial license or registration renewal form.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.06.03#B">B.</span> The mailing address:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.06.03#B(1)">(1)</span> May be the pharmacist’s residence address;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.06.03#B(2)">(2)</span> Shall be the pharmacy intern’s residence address; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.06.03#B(3)">(3)</span> Shall be the pharmacy technician’s residence address.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.06.03#C">C.</span> Within 30 days of the date a pharmacist, pharmacy intern, or pharmacy technician changes the pharmacist’s, pharmacy intern’s, or pharmacy technician’s mailing address, the pharmacist, pharmacy intern, or pharmacy technician shall notify the Board in writing of any change in the information in <a class="internal-link " href="/us/md/exec/comar/10.34.06.03#A" title="">§A of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.06.04" data-order="|10|34|06|.04|" data-ref-path="10|34|06|.04" class="h__section">.04 Place of Employment.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.06.04#A">A.</span> This regulation applies only to pharmacists, pharmacy interns, and pharmacy technicians employed in Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.06.04#B">B.</span> Each licensed pharmacist, registered pharmacy intern, and registered pharmacy technician shall report to the Board the pharmacist’s, pharmacy intern’s, or pharmacy technician’s place of employment on the pharmacist, pharmacy intern, or pharmacy technician biennial license or registration renewal form. A pharmacist, pharmacy intern, or pharmacy technician employed at more than one location shall report the primary employment location at the time the renewal form is submitted to the Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.06.04#C">C.</span> Within 30 days of a change in the pharmacist’s, pharmacy intern’s, or pharmacy technician’s primary employment location, the pharmacist, pharmacy intern, or pharmacy technician shall notify the Board in writing of any change in the information required by this regulation. If the pharmacist’s, pharmacy intern’s, or pharmacy technician’s primary employment location changes and the pharmacist’s, pharmacy intern’s, or pharmacy technician’s new primary employment location is owned by the same corporation, partnership, or individual owner, the pharmacist, pharmacy intern, or pharmacy technician is not required to report the change except when completing a biennial license or registration renewal form.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.06.05" data-order="|10|34|06|.05|" data-ref-path="10|34|06|.05" class="h__section">.05 Grounds for Disciplinary Action.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.06.05#A">A.</span> A pharmacist’s failure to report the information required in Regulations .03 and .04 of this chapter or failure to provide the Board with complete, up-to-date, and accurate information shall constitute grounds for action under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-313" title="">Health Occupations Article, §12-313(b)(25), Annotated Code of Maryland</a>, and may, in appropriate cases, constitute grounds for action under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-313" title="">Health Occupations Article, §12-313(b)(1), </a>(7), or (8), Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.06.05#B">B.</span> A pharmacy technician’s failure to report the information required in Regulations .03 and .04 of this chapter or failure to provide the Board with complete, up-to-date, and accurate information shall constitute grounds for action under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">Health Occupations Article, §12-6</a>B-09(25), Annotated Code of Maryland, and may, in appropriate cases, constitute grounds for action under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">Health Occupations Article, §12-6</a>B-09(2), (7), or (8), Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.06.05#C">C.</span> A pharmacy intern’s failure to report the information required in Regulations .03 and .04 of this chapter or failure to provide the Board with complete, up-to-date, and accurate information:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.06.05#C(1)">(1)</span> Shall constitute grounds for action under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">Health Occupations Article, §12-6</a>D-11(18), Annotated Code of Maryland; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.06.05#C(2)">(2)</span> May, in appropriate cases, constitute grounds for action under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">Health Occupations Article, §12-6</a>D-11(3), (7), or (8), Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.07" data-order="|10|34|07|" data-ref-path="10|34|07" class="h__chapter">Chapter 07 Pharmacy Equipment</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: March 21, 1980 (7:6 Md. R. 608)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.07.03" title=".03 Reference Libraries.">Regulation .03</a> adopted effective September 10, 1984 (11:18 Md. R. 1585)</p>
                  <p>——————</p>
                  <p>Chapter revised effective February 19, 1990 (17:3 Md. R. 298)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.07.03" title=".03 Reference Libraries.">Regulation .03</a> amended effective November 7, 1994 (21:22 Md. R. 1877)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.07.01#A" title="">Regulation .01A</a> amended effective August 30, 2004 (31:17 Md. R. 1312)</p>
                  <p>——————</p>
                  <p>Chapter revised effective July 1, 2010 (37:10 Md. R. 722)</p>
                  <h3>Authority</h3>
                  <p>Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">12-205</a> and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-403" title="">12-403</a>, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.07.01" data-order="|10|34|07|.01|" data-ref-path="10|34|07|.01" class="h__section">.01 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.07.01#A">A.</span> In this chapter, the following term has the meaning indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.07.01#B">B.</span> Term Defined. "Material safety data sheets" means a list of hazardous chemicals that provides detailed information on each hazardous chemical, including its potential hazardous effects, its physical and chemical characteristics and recommendations for appropriate protective measures.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.07.01-1" data-order="|10|34|07|.01-1|" data-ref-path="10|34|07|.01-1" class="h__section">.01-1 Equipment.</h3>
                <p>A pharmacy shall have the following equipment to carry out the practice of pharmacy in Maryland:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.07.01-1#A">A.</span> If applicable, a Class A prescription balance and weights, or a prescription balance with equivalent or superior sensitivity to a Class A prescription balance;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.07.01-1#B">B.</span> A refrigerator, solely for the storage of drugs requiring refrigeration, with a thermometer or a temperature monitoring device; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.07.01-1#C">C.</span> A freezer, if applicable.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.07.02" data-order="|10|34|07|.02|" data-ref-path="10|34|07|.02" class="h__section">.02 Additional Equipment.</h3>
                <p>The pharmacy shall maintain additional equipment to enable it to prepare and dispense prescriptions properly consistent with its scope of practice.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.07.03" data-order="|10|34|07|.03|" data-ref-path="10|34|07|.03" class="h__section">.03 Reference Libraries.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.07.03#A">A.</span> A pharmacy permit holder shall maintain an adequate reference library to enable it to prepare and dispense prescriptions properly, consistent with its scope of practice.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.07.03#B">B.</span> A pharmacy permit holder shall maintain a library of reference sources appropriate to the type of pharmacy practice at that particular location. A pharmacy permit holder shall include in the pharmacy's library current material regarding the technical, clinical, and professional aspects of practice with emphasis in the area in which the pharmacy specializes.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.07.03#B-1">B-1.</span> A pharmacy permit holder may utilize websites and electronic references created by established medical publishers which are recognized as standard for a particular type of pharmacy practice as a supplement to its printed library.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.07.03#C">C.</span> A pharmacy permit holder shall maintain a library containing reference sources that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.07.03#C(1)">(1)</span> Enable the pharmacist to compound medications in a safe and effective manner;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.07.03#C(2)">(2)</span> List the possible drug interactions and possible adverse effects of medications dispensed by the pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.07.03#C(3)">(3)</span> List the therapeutic usage and dosages of medications dispensed by the pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.07.03#C(4)">(4)</span> List the therapeutic equivalents for medications; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.07.03#C(5)">(5)</span> Provide guidelines for the counseling of patients.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.07.03#D">D.</span> A pharmacy permit holder that specializes in nuclear or parenteral prescriptions may limit the library it maintains pursuant to <a class="internal-link " href="/us/md/exec/comar/10.34.07.03#B" title="">§B of this regulation</a> to the pharmacy permit holder's area of specialization.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.07.03#E">E.</span> A pharmacy permit holder shall maintain material safety data sheets, if applicable.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.08" data-order="|10|34|08|" data-ref-path="10|34|08" class="h__chapter">Chapter 08 Information Required on Prescriptions or Patient Drug Profiles</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: February 6, 1981 (8:3 Md. R. 227)</p>
                  <p>Chapter revised effective March 15, 1982 (9.5 Md. R. 527)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.08.01#B" title="">Regulation .01B</a> amended effective January 28, 2008 (35:2 Md. R. 127)</p>
                  <h3>Authority</h3>
                  <p><a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">Health Occupations Article, §12-205, </a>Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.08.01" data-order="|10|34|08|.01|" data-ref-path="10|34|08|.01" class="h__section">.01 Information Required on All Original and Refill Prescriptions or Patient Drug Profiles or Computerized Patient Drug Records.</h3>
                <p>In addition to the information required by law on every prescription, patient drug profile, or computerized patient drug record, the following information shall be legibly entered on all original and refill prescriptions or patient drug profiles or computerized patient drug records:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.08.01#A">A.</span> The date of filling or refilling;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.08.01#B">B.</span> The initials of, or other identifying symbol for:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.08.01#B(1)">(1)</span> The pharmacist responsible for filling or refilling the prescription; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.08.01#B(2)">(2)</span> The data-entry pharmacy technician involved in the dispensing process.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.08.02" data-order="|10|34|08|.02|" data-ref-path="10|34|08|.02" class="h__section">.02 Access to Records.</h3>
                <p>The information required in <a class="internal-link " href="/us/md/exec/comar/10.34.08.01" title=".01 Information Required on All Original and Refill Prescriptions or Patient Drug Profiles or Computerized Patient Drug Records.">Regulation .01 of this chapter</a> shall be readily retrievable for inspection during business hours by authorized personnel.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.09" data-order="|10|34|09|" data-ref-path="10|34|09" class="h__chapter">Chapter 09 Fees</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: July 1, 1981 (8:8 Md. R. 721)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09.03" title=".03 Change of Fees.">Regulation .03</a> amended effective February 19, 1990 (17:3 Md. R. 299)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09.01" title=".01 Scope.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09.03" title=".03 Change of Fees.">.03</a> repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09.01" title=".01 Scope.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09.03" title=".03 Change of Fees.">.03</a> adopted as an emergency provision effective July 1, 1992 (19:12 Md. R. 1131); adopted permanently effective October 1, 1992 (19:15 Md. R. 1391)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09.01" title=".01 Scope.">Regulation .01</a> amended effective July 1, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09.02" title=".02 Fees.">Regulation .02</a> amended as an emergency provision effective October 8, 1998 (25:22 Md. R. 1650); amended permanently effective January 14, 1999 (26:1 Md. R. 24)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09.02" title=".02 Fees.">Regulation .02</a> amended effective November 1, 1999 (26:22 Md. R. 1693)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09.02#A" title="">Regulation .02A</a> amended as an emergency provision effective June 6, 1997 (24:13 Md. R. 928); amended permanently effective September 22, 1997 (24:19 Md. R. 1340)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09.02#C" title="">Regulation .02C</a> amended effective July 4, 1994 (21:13 Md. R. 1158)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09.02" title=".02 Fees.">Regulation .02</a> repealed and new Regulation .02 adopted as an emergency provision effective February 1, 2002 (29:3 Md. R. 213); adopted permanently effective June 10, 2002 (29:11 Md. R. 889)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09.02" title=".02 Fees.">Regulation .02</a> amended effective October 14, 2002 (29:20 Md. R. 1589); January 28, 2008 (35:2 Md. R. 127); February 1, 2010 (36:26 Md. R. 1995); December 21, 2015 (42:25 Md. R. 1543)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09.02#B" title="">Regulation .02B</a> amended as an emergency provision effective October 1, 2002 (29:25 Md. R. 1979); amended permanently effective March 3, 2003 (30:4 Md. R. 316)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09.02#D" title="">Regulation .02D</a> amended effective May 20, 2019 (46:10 Md. R. 489)</p>
                  <p>Regulation .02K, L amended effective November 10, 2003 (30:22 Md. R. 1582)</p>
                  <p>Regulations .03 amended as an emergency provision effective June 28, 1996 (23:15 Md. R. 1083); amended permanently effective October 7, 1996 (23:20 Md. R. 1424)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09.03" title=".03 Change of Fees.">Regulation .03</a> amended as an emergency provision effective October 8, 1998 (25:22 Md. R. 1650); amended permanently effective January 14, 1999 (26:1 Md. R. 24)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09.03" title=".03 Change of Fees.">Regulation .03</a> amended effective November 1, 1999 (26:22 Md. R. 1693); July 1, 2015 (42:7 Md. R. 569)</p>
                  <p>Regulation .04 adopted effective July 1, 2015 (42:7 Md. R. 569)</p>
                  <p>Regulation .04 repealed effective December 21, 2015 (42:25 Md. R. 1543)</p>
                  <h3>Authority</h3>
                  <p>Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">12-205</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-206" title="">12-206</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-302" title="">12-302</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-303" title="">12-303</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-305" title="">12-305</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-308" title="">12-308</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-310" title="">12-310</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-404" title="">12-404</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-407" title="">12-407</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-601" title="">12-601</a>,<br/>12-6B-02, 12-6B-03, 12-6B-04, 12-6B-07, 12-6C-03, 12-6C-04, 12-6C-05, 12-6C-06, 12-6D-05, 12-6D-06, and 12-6D-09, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.09.01" data-order="|10|34|09|.01|" data-ref-path="10|34|09|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter governs all licensees, permit holders, registrants, or applicants for licenses or permits issued by the Board.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.09.02" data-order="|10|34|09|.02|" data-ref-path="10|34|09|.02" class="h__section">.02 Fees.</h3>
                <p>The following fees are established by the Board:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#A">A.</span> Pharmacist Fees.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#A(1)">(1)</span> Pharmacist examination fee — $150;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#A(2)">(2)</span> Pharmacist reciprocity fee — $300;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#A(3)">(3)</span> Pharmacist renewal fee — $225;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#A(4)">(4)</span> Pharmacist reinstatement fee for up to 2 years after license expiration, payable in addition to renewal fee — $300; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#A(5)">(5)</span> Pharmacist reinstatement fee for more than 2 years after license expiration, payable in addition to renewal fee — $315.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#B">B.</span> Pharmacy Fees.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#B(1)">(1)</span> Pharmacy initial fee — $700;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#B(2)">(2)</span> Pharmacy renewal fee — $500; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#B(3)">(3)</span> Pharmacy — late fee (payable if renewal fee is received between May 2 and June 30) — $200; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#B(4)">(4)</span> Pharmacy reinstatement fee (payable if renewal fee is received after June 30) — $550.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#C">C.</span> Distributor Fees.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#C(1)">(1)</span> Distributor initial fee — 1,750;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#C(2)">(2)</span> Distributor renewal fee — $1,750; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#C(3)">(3)</span> Distributor reinstatement fee after May 31 — $1,500.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#D">D.</span> Pharmacy Technician Fees.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#D(1)">(1)</span> Pharmacy technician registration fee — $45;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#D(2)">(2)</span> Pharmacy technician renewal fee — $45;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#D(3)">(3)</span> Pharmacy technician reinstatement fee — $45;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#D(4)">(4)</span> Review of pharmacy technician training programs submitted to the Board for approval — $100; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#D(5)">(5)</span> Review of pharmacy technician training programs submitted to the Board for approval that include a didactic portion that is comprised entirely of a didactic program that has already been approved by the Board — no charge.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#D-1">D-1.</span> Pharmacy Intern Fees.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#D-1(1)">(1)</span> Pharmacy intern registration fee — $45; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#D-1(2)">(2)</span> Pharmacy intern renewal fee — $45.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#E">E.</span> Miscellaneous Fees.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#E(1)">(1)</span> Duplicate registration fee — $10;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#E(2)">(2)</span> Duplicate pharmacist license fee — $30;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#E(2-1)">(2-1)</span> Duplicate pharmacy permit fee — $10;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#E(2-2)">(2-2)</span> Duplicate wholesale distributor permit fee — $30;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#E(3)">(3)</span> Written verification of good standing fee — $25;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#E(4)">(4)</span> Returned check fee — $35;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#E(5)">(5)</span> Roster printed on labels fee — $150; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.09.02#E(6)">(6)</span> Failure to maintain current address fee — $25.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.09.03" data-order="|10|34|09|.03|" data-ref-path="10|34|09|.03" class="h__section">.03 Change of Fees.</h3>
                <p>Fees are subject to change by action of the Board of Pharmacy. Licensees, registrants, and applicants shall be notified of the change.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.10" data-order="|10|34|10|" data-ref-path="10|34|10" class="h__chapter">Chapter 10 Pharmacist, Pharmacy Intern, and Pharmacy Technician Code of Conduct</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: August 3, 1981 (8:15 Md. R. 1307)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.10.01" title=".01 Patient Safety and Welfare.">Regulation .01</a> amended effective February 19, 1990 (17:3 Md. R. 299)</p>
                  <p>——————</p>
                  <p>Chapter, Standards of Pharmacy Practice, repealed and new chapter, Pharmacist Code of Conduct, adopted effective July 12, 1999 (26:14 Md. R. 1082)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.10.01" title=".01 Patient Safety and Welfare.">Regulation .01</a> amended effective November 12, 2001 (28:22 Md. R. 1937)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.10.02" title=".02 Compensation.">Regulation .02</a> amended effective January 28, 2008 (35:2 Md. R. 127); July 1, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.10.03" title=".03 Patient Privacy.">Regulation .03</a> amended effective January 28, 2008 (35:2 Md. R. 127); July 1, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.10.04" title=".04 Competence.">Regulation .04</a> amended effective January 28, 2008 (35:2 Md. R. 127); July 1, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.10.05" title=".05 Duty to Report.">Regulation .05</a> amended effective January 28, 2008 (35:2 Md. R. 127); July 1, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.10.06#A" title="">Regulation .06A</a>, B amended effective January 28, 2008 (35:2 Md. R. 127); July 1, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.10.07#A" title="">Regulation .07A</a>, C amended effective July 1, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.10.07#C" title="">Regulation .07C</a> adopted effective January 28, 2008 (35:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.10.09" title=".09 Sanctions.">Regulation .09</a> amended effective January 28, 2008 (35:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.10.10" title=".10 Whole or Substantial Ownership of a Pharmacy by an Authorized Prescriber.">Regulation .10</a> adopted effective February 1, 2016 (43:2 Md. R. 127)</p>
                  <h3>Authority</h3>
                  <p>Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=1-212" title="">1-212</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">12-205</a>, and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-601" title="">12-601</a>, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.10.01" data-order="|10|34|10|.01|" data-ref-path="10|34|10|.01" class="h__section">.01 Patient Safety and Welfare.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.01#A">A.</span> A pharmacist shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.01#A(1)">(1)</span> Abide by all federal and State laws relating to the practice of pharmacy and the dispensing, distribution, storage, and labeling of drugs and devices, including but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.10.01#A(1)(a)">(a)</span> United States Code, Title 21,</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.10.01#A(1)(b)">(b)</span> Health-General Article, Titles 21 and 22, Annotated Code of Maryland,</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.10.01#A(1)(c)">(c)</span> <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>,</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.10.01#A(1)(d)">(d)</span> <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gcr/gcr.pdf" title="">Criminal Law Article, Title 5, Annotated Code of Maryland</a>, and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.10.01#A(1)(e)">(e)</span> <a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.03" title="Chapter 03 Controlled Dangerous Substances">COMAR 10.19.03</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.01#A(2)">(2)</span> Verify the accuracy of the prescription before dispensing the drug or device if the pharmacist has reason to believe that the prescription contains an error; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.01#A(3)">(3)</span> Maintain proper sanitation, hygiene, biohazard precautions, and infection control when performing tasks in the prescription process.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.01#B">B.</span> A pharmacist may not:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.01#B(1)">(1)</span> Engage in conduct which departs from the standard of care ordinarily exercised by a pharmacist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.01#B(2)">(2)</span> Practice pharmacy under circumstances or conditions which prevent the proper exercise of professional judgment; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.01#B(3)">(3)</span> Engage in unprofessional conduct.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.01#C">C.</span> Therapeutic Interchange.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.01#C(1)">(1)</span> A pharmacist may not perform a therapeutic interchange without the prior approval of the authorized prescriber except as provided in <a class="internal-link " href="/us/md/exec/comar/10.34.10.01#C(2)" title="">§C(2) of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.01#C(2)">(2)</span> A pharmacist who provides a pharmacy service to a patient of a hospital, as defined in Health-General Article, §19-301, Annotated Code of Maryland, or a resident of a comprehensive care or extended care facility, as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.02.01#B" title="">COMAR 10.07.02.01B</a>, may perform a therapeutic interchange without the prior approval of the authorized prescriber if the governing body of the hospital, comprehensive care facility, or extended care facility has established procedures for therapeutic interchange.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.01#C(3)">(3)</span> This section does not permit any act not otherwise authorized by <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.10.02" data-order="|10|34|10|.02|" data-ref-path="10|34|10|.02" class="h__section">.02 Compensation.</h3>
                <p>A pharmacy technician, pharmacy intern, or a pharmacist may not fraudulently seek or accept compensation for a pharmacy product or service not provided.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.10.03" data-order="|10|34|10|.03|" data-ref-path="10|34|10|.03" class="h__section">.03 Patient Privacy.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.03#A">A.</span> The pharmacy technician, pharmacy intern, pharmacist, and pharmacy permit holder shall ensure confidentiality in creating, storing, accessing, transferring, and disposing of a patient record.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.03#B">B.</span> A pharmacy technician, pharmacy intern, or pharmacist may not disclose identifiable information contained in a patient’s medical record:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.03#B(1)">(1)</span> Without the patient's consent;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.03#B(2)">(2)</span> Without order or direction of a court; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.03#B(3)">(3)</span> Unless the disclosure is authorized pursuant to Health-General Article, §§4-301 — 4-307, Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.10.04" data-order="|10|34|10|.04|" data-ref-path="10|34|10|.04" class="h__section">.04 Competence.</h3>
                <p>A pharmacy technician, pharmacy intern, or a pharmacist shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.04#A">A.</span> Maintain knowledge of the current pharmacy and drug laws and health and sanitation laws relevant to the practice of pharmacy; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.04#B">B.</span> Provide a pharmaceutical service only within the scope of the pharmacy technician’s, pharmacy intern’s, or pharmacist’s training and education.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.10.05" data-order="|10|34|10|.05|" data-ref-path="10|34|10|.05" class="h__section">.05 Duty to Report.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.05#A">A.</span> Except when the conduct in question includes drug or alcohol abuse or dependency, a pharmacy technician, pharmacy intern, or pharmacist shall report to the Board:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.05#A(1)">(1)</span> Conduct which violates a statute or regulation pertaining to the practice of pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.05#A(2)">(2)</span> Conduct by a pharmacy technician, pharmacy intern, or pharmacist that deceives, defrauds, or harms the public; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.05#A(3)">(3)</span> The unauthorized practice of pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.05#B">B.</span> A pharmacy technician, pharmacy intern, or pharmacist shall report to the pharmacist rehabilitation committee, as defined in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-317" title="">Health Occupations Article, §12-317, Annotated Code of Maryland</a>, conduct by a pharmacist technician, pharmacy intern, or pharmacist that involves drug or alcohol abuse or dependency.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.10.06" data-order="|10|34|10|.06|" data-ref-path="10|34|10|.06" class="h__section">.06 Discrimination, Harassment, and Sexual Misconduct.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.06#A">A.</span> In the practice of pharmacy, a pharmacy technician, pharmacy intern, or pharmacist may not:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.06#A(1)">(1)</span> Discriminate based on age, gender, race, ethnicity, national origin, religion, sexual orientation, disability, socioeconomic status, or other basis as proscribed by law; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.06#A(2)">(2)</span> Sexually harass a patient, coworker, employee, or supervisee, which includes but is not limited to an unwanted, deliberate, or repeated comment, gesture, or physical contact of a sexual nature.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.06#B">B.</span> Sexual Misconduct. A pharmacy technician, pharmacy intern, or pharmacist may not:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.06#B(1)">(1)</span> Dispense or offer to dispense a prescription drug or device in exchange for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.10.06#B(1)(a)">(a)</span> A sexual act such as anal intercourse, analingus, cunnilingus, fellatio, or vaginal intercourse as specified in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=3-301" title="">Criminal Law Article, §3-301(e) </a>and (g), Annotated Code of Maryland, or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.10.06#B(1)(b)">(b)</span> Sexual contact such as the intentional touching of an intimate part of an individual's body, whether clothed or unclothed, for the purpose of sexual arousal, gratification, abuse of either party, or penetration as specified in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcr&amp;section=3-301" title="">Criminal Law Article, §3-301(f), Annotated Code of Maryland</a>; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.06#B(2)">(2)</span> Engage in sexual behavior including but not limited to a sexual act or sexual contact as specified in <a class="internal-link " href="/us/md/exec/comar/10.34.10.06#B(1)(a)" title="">§B(1)(a) of this regulation</a>, with a client or patient:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.10.06#B(2)(a)">(a)</span> In the context of a professional evaluation, treatment, procedure, or other service to the client or patient, regardless of the setting in which the professional service is provided, or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.10.06#B(2)(b)">(b)</span> Under the pretense of diagnostic or therapeutic intent or benefit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.06#C">C.</span> Sexual contact does not include an act commonly expressive of familial or friendly affection.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.10.07" data-order="|10|34|10|.07|" data-ref-path="10|34|10|.07" class="h__section">.07 Disposition and Return of a Prescription Drug or Device.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.07#A">A.</span> A pharmacist may accept the return of a properly labeled and properly sealed manufacturer’s package or individual unit dose of a drug or device that the pharmacist determines to have been handled in a manner which preserves the strength, quality, purity, and identity of the drug or device during an interim period between the sale of the drug or device and its return to the pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.07#B">B.</span> A pharmacist may not:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.07#B(1)">(1)</span> Return to the pharmacy's stock or offer for sale a prescribed drug or device that has been previously sold and has left the pharmacy's possession except as provided in <a class="internal-link " href="/us/md/exec/comar/10.34.10.07#A" title="">§A of this regulation</a>; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.07#B(2)">(2)</span> Sell, give away, or otherwise dispose of a drug, drug accessory, chemical, or device if the pharmacist knows or should know that the drug, drug accessory, chemical, or device is to be used in an illegal activity.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.07#C">C.</span> A pharmacy technician or pharmacy intern may not accept the return of prescription drugs or devices from a patient.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.10.08" data-order="|10|34|10|.08|" data-ref-path="10|34|10|.08" class="h__section">.08 Refusing to Dispense a Controlled Substance.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.08#A">A.</span> If, based on generally accepted professional standards for the practice of pharmacy, a pharmacist has reason to believe, or should have reason to believe, that a prescription for a controlled dangerous substance was not issued for a legitimate medical purpose in the usual course of the prescriber's practice, the pharmacist may not dispense the controlled dangerous substance until the pharmacist:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.08#A(1)">(1)</span> Consults with the prescriber; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.08#A(2)">(2)</span> Verifies the medical legitimacy of the prescription.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.08#B">B.</span> If, after consulting with the prescriber, and based on generally accepted professional standards for the practice of pharmacy, a pharmacist has reason to believe that the prescription for a controlled dangerous substance was not issued for a legitimate medical purpose in the usual course of the prescriber's practice, the pharmacist shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.08#B(1)">(1)</span> Refuse to dispense the drug; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.10.08#B(2)">(2)</span> Report the incident to the regulatory board that licenses the prescriber.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.10.09" data-order="|10|34|10|.09|" data-ref-path="10|34|10|.09" class="h__section">.09 Sanctions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.09#A">A.</span> The Board may take action to reprimand a licensee, place the licensee on probation, or suspend or revoke the licensee's license if the licensee commits a violation of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.09#B">B.</span> The Board may take action to reprimand a registrant, place the registrant on probation, or suspend or revoke the registrant's registration if the registrant commits a violation of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.09#C">C.</span> The Board may impose a monetary penalty as authorized under Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-314" title="">12-314</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-410" title="">12-410</a>, and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">12-6</a>B-10, Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.10.10" data-order="|10|34|10|.10|" data-ref-path="10|34|10|.10" class="h__section">.10 Whole or Substantial Ownership of a Pharmacy by an Authorized Prescriber.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.10#A">A.</span> In this regulation, ”owned wholly or substantially” means ownership of 10 percent or more of a pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.10.10#B">B.</span> A pharmacist may not associate as a partner, coowner, or employee of a pharmacy that is owned wholly or substantially by an authorized prescriber or group of authorized prescribers.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.11" data-order="|10|34|11|" data-ref-path="10|34|11" class="h__chapter">Chapter 11 Disciplinary Sanctions, Monetary Penalties, and Civil Fines</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: June 4, 1984 (11:11 Md. R. 962)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.11.01" title=".01 Scope.">Regulation .01</a> amended effective January 20, 2003 (30:1 Md. R. 25); January 28, 2008 (35:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.11.02" title=".02 Definitions.">Regulation .02</a> amended effective January 28, 2008 (35:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.11.03" title=".03 Imposition of Disciplinary Sanctions or Monetary Penalties Generally.">Regulation .03</a> amended effective February 19, 1990 (17:3 Md. R. 299); January 20, 2003 (30:1 Md. R. 25)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.11.03#A" title="">Regulation .03A</a> amended effective January 28, 2008 (35:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.11.04" title=".04 Guidelines for Imposition of Disciplinary Sanctions or Monetary Penalties on Pharmacists.">Regulation .04</a> amended effective January 20, 2003 (30:1 Md. R. 25)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.11.04" title=".04 Guidelines for Imposition of Disciplinary Sanctions or Monetary Penalties on Pharmacists.">Regulation .04</a>-1 adopted effective January 28, 2008 (35:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.11.05" title=".05 Guidelines for Imposition of Disciplinary Sanctions or Monetary Penalties on Pharmacy Technicians.">Regulation .05</a> amended effective January 20, 2003 (30:1 Md. R. 25)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.11.06" title=".06 Guidelines for Imposition of Disciplinary Sanctions or Monetary Penalties on Pharmacy Permit Holder.">Regulation .06</a> amended effective January 28, 2008 (35:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.11.06#C" title="">Regulation .06C</a>, D amended and .06E, F adopted effective January 20, 2003 (30:1 Md. R. 25)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.11.07#B" title="">Regulation .07B</a> amended effective February 19, 1990 (17:3 Md. R. 299)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.11.07#B" title="">Regulation .07B</a>, D amended effective January 20, 2003 (30:1 Md. R. 25)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.11.07#C" title="">Regulation .07C</a> amended effective January 28, 2008 (35:2 Md. R. 127)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.11.01" title=".01 Scope.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.11.07" title=".07 Guidelines for Imposition of Disciplinary Sanctions or Monetary Penalties on Wholesale Distributor Permit Holder.">.07</a> repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.11.01" title=".01 Scope.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.11.11" title=".11 Payment of a Penalty.">.11</a> adopted effective December 24, 2012 (39:25 Md. R. 1613)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.11.02#B" title="">Regulation .02B</a> amended effective July 1, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.11.03#A" title="">Regulation .03A</a> amended effective July 1, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.11.04#A" title="">Regulation .04A</a> amended effective July 1, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.11.04" title=".04 Guidelines for Imposition of Disciplinary Sanctions or Monetary Penalties on Pharmacists.">Regulation .04</a>-1 adopted effective July 1, 2015 (42:7 Md. R. 569)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.11.09#B" title="">Regulation .09B</a>, D amended effective July 1, 2015 (42:7 Md. R. 569)</p>
                  <h3>Authority</h3>
                  <p>Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=1-606" title="">1-606</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-313" title="">12-313</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-314" title="">12-314</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-409" title="">12-409</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-410" title="">12-410</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-601" title="">12-601</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">12-6</a>B-<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=09" title="">09</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">12-6</a>B-<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=10" title="">10</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">12-6</a>C-<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=11" title="">11</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">12-6</a>D-<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=11" title="">11</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">12-6</a>D-<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12" title="">12</a>, and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-707" title="">12-707</a>, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.11.01" data-order="|10|34|11|.01|" data-ref-path="10|34|11|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter establishes standards for the imposition of disciplinary sanctions, monetary penalties, and civil fines for violations of <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.11.02" data-order="|10|34|11|.02|" data-ref-path="10|34|11|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.02#B(1)">(1)</span> “Act” means <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.02#B(2)">(2)</span> "Board" means the State Board of Pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.02#B(3)">(3)</span> “Civil fine” means a fine assessed by the Board against a person for practicing without an active license, pharmacy permit, registration, or wholesale distributor permit.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.02#B(4)">(4)</span> "License" means, unless the context requires otherwise, a license issued by the Board to practice pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.02#B(5)">(5)</span> "Penalty" means monetary penalty.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.02#B(6)">(6)</span> “Pharmacy permit” means a permit issued by the Board to establish and operate a pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.02#B(7)">(7)</span> “Registration” means, unless the context requires otherwise, a registration issued by the Board to practice pharmacy as a registered pharmacy intern under the direct supervision of a licensed pharmacist or perform delegated pharmacy acts as a registered pharmacy technician under the direct supervision of a licensed pharmacist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.02#B(8)">(8)</span> “Sanction” means a disciplinary action reprimanding, restricting, suspending, or revoking a license, pharmacy permit, registration, or wholesale distributor permit.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.02#B(9)">(9)</span> “Wholesale distributor permit” means a permit issued by the Board to establish and operate a wholesale distributor as defined in the <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">Health Occupations Article, §12-6</a>C-01(v), Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.11.03" data-order="|10|34|11|.03|" data-ref-path="10|34|11|.03" class="h__section">.03 Imposition of Disciplinary Sanctions or Monetary Penalties Generally.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.03#A">A.</span> After a hearing pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-315" title="">Health Occupations Article, §12-315, </a>12-601, 12-6B-09, or 12-6D-11, Annotated Code of Maryland, the Board may impose a penalty against a pharmacy technician, pharmacy intern, pharmacist, or wholesale distributor permit holder pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-314" title="">Health Occupations Article, §12-314, </a>12-6B-10, 12-6C-11, or 12-6D-12, Annotated Code of Maryland, instead of or in addition to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.03#A(1)">(1)</span> Reprimanding the registrant, licensee, or wholesale distributor permit holder;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.03#A(2)">(2)</span> Placing the registrant, licensee, or wholesale distributor permit holder on probation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.03#A(3)">(3)</span> Suspending a registration, license, or wholesale distributor permit; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.03#A(4)">(4)</span> Revoking a registration, license, or wholesale distributor permit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.03#B">B.</span> After a hearing pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-411" title="">Health Occupations Article, §12-411, Annotated Code of Maryland</a>, the Board may impose a penalty against a pharmacy permit holder pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-410" title="">Health Occupations Article, §12-410, Annotated Code of Maryland</a>:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.03#B(1)">(1)</span> Instead of or in addition to suspending the pharmacy permit; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.03#B(2)">(2)</span> In addition to revoking the pharmacy permit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.03#C">C.</span> Notwithstanding the guidelines set forth in this chapter, in order to resolve a pending disciplinary action, the Board and the registrant, licensee, pharmacy permit holder, or wholesale distributor permit holder may agree to a surrender of a registration, license, pharmacy permit, or wholesale distributor permit or a consent order with terms, sanction, and penalty agreed to by the Board and the registrant, licensee, pharmacy permit holder, or wholesale distributor permit holder.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.03#D">D.</span> Nothing in this chapter prohibits the Board from staying any period of nonactive suspension.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.11.04-1" data-order="|10|34|11|.04-1|" data-ref-path="10|34|11|.04-1" class="h__section">.04-1 Guidelines for Imposition of Disciplinary Sanctions or Monetary Penalties on Pharmacy Interns.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.04-1#A">A.</span> Subject to the provisions of this chapter, the Board may impose the following sanctions and, if appropriate, penalties for violations of the Act and its regulations according to the minimum and maximum sanctions and penalties set forth in the following categories:</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th/>
                        <th>Violation</th>
                        <th>Minimum<br/>Sanction</th>
                        <th>Maximum<br/>Sanction</th>
                        <th>Minimum<br/>Penalty</th>
                        <th>Maximum<br/>Penalty</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">(1)</td>
                        <td>False application or registration</td>
                        <td data-text-align="center">Probation for 1 year</td>
                        <td data-text-align="center">Denial of registration application or revocation</td>
                        <td data-text-align="center">$50</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(2)</td>
                        <td>Performing an act restricted to a licensed pharmacist</td>
                        <td data-text-align="center">Reprimand</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$50</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(3)</td>
                        <td>Practicing pharmacy without appropriate supervision</td>
                        <td data-text-align="center">Probation for 1 year</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$50</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(4)</td>
                        <td>Aiding an unauthorized individual to practice pharmacy</td>
                        <td data-text-align="center">Reprimand</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$50</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(5)</td>
                        <td>Providing professional services while under the influence of alcohol or drugs</td>
                        <td data-text-align="center">Probation for 6 months</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$250</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(6)</td>
                        <td>Knowingly aids a pharmacist in dispensing any drug, device, or diagnostic for which a prescription is required without a prescription</td>
                        <td data-text-align="center">Reprimand</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$100</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(7)</td>
                        <td>Convicted of, or pled guilty to, a felony or crime of moral turpitude</td>
                        <td data-text-align="center">Probation for 1 year</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$500</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(8)</td>
                        <td>Reciprocal discipline</td>
                        <td data-text-align="center">Reprimand</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$250</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(9)</td>
                        <td>Physical or mental incompetence</td>
                        <td data-text-align="center">Probation for 1 year</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">NA</td>
                        <td data-text-align="center">NA</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(10)</td>
                        <td>Confidentiality violation</td>
                        <td data-text-align="center">Probation for 1 year</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$500</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(11)</td>
                        <td>Diversion</td>
                        <td data-text-align="center">Active suspension for 1 year</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$1,000</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(12)</td>
                        <td>Professional incompetence</td>
                        <td data-text-align="center">Reprimand</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$100</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(13)</td>
                        <td>Sexual misconduct</td>
                        <td data-text-align="center">Active suspension for 1 year</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$1,000</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(14)</td>
                        <td>Failure to cooperate in an investigation of the Board or the Division of Drug Control</td>
                        <td data-text-align="center">Reprimand</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$50</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(15)</td>
                        <td>Failure to comply with an order of the Board</td>
                        <td data-text-align="center">Probation for 1 year</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$50</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(16)</td>
                        <td>Other violation of the Act not specifically enumerated in this chapter</td>
                        <td data-text-align="center">Reprimand</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$50</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.04-1#B">B.</span> If a registrant is found in violation of more than one category enumerated in this regulation, the category or categories containing the highest maximum sanction and penalty shall control.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.04-1#C">C.</span> A departure from the guidelines set forth in this regulation, on its own, is not grounds for any hearing or appeal of a Board action.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.11.04" data-order="|10|34|11|.04|" data-ref-path="10|34|11|.04" class="h__section">.04 Guidelines for Imposition of Disciplinary Sanctions or Monetary Penalties on Pharmacists.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.04#A">A.</span> Subject to the provisions of this chapter, the Board may impose the following sanctions and, if appropriate, penalties for violations of the Act and its regulations according to the minimum and maximum sanctions and penalties set forth in the following categories:</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th colspan="2">Violation</th>
                        <th>Minimum Sanction</th>
                        <th>Maximum <br/>Sanction</th>
                        <th>Minimum Penalty</th>
                        <th>Maximum Penalty</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">(1)</td>
                        <td>Fraudulently or deceptively obtaining or attempting to obtain a license</td>
                        <td data-text-align="center">Probation for 1 year</td>
                        <td data-text-align="center">Denial of license application or revocation</td>
                        <td data-text-align="center">$500</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(2)</td>
                        <td>Fraudulently or deceptively using a license</td>
                        <td data-text-align="center">Suspension for 30 days</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$1,000</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(3)</td>
                        <td>Aiding an unauthorized individual to practice pharmacy</td>
                        <td data-text-align="center">Reprimand</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$250</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(4)</td>
                        <td>Failure to appropriately supervise a pharmacy intern or pharmacy technician</td>
                        <td data-text-align="center">Reprimand</td>
                        <td data-text-align="center">Probation for 3 years</td>
                        <td data-text-align="center">$250</td>
                        <td data-text-align="center">$5,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(5)</td>
                        <td>Delegating a pharmacy act to an unauthorized individual</td>
                        <td data-text-align="center">Reprimand</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$250</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(6)</td>
                        <td>Providing professional services while under the influence of alcohol or drugs</td>
                        <td data-text-align="center">Probation for 6 months</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$500</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(7)</td>
                        <td>Submitting a false statement to collect a fee</td>
                        <td data-text-align="center">Reprimand</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$250</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(8)</td>
                        <td>Record keeping violation</td>
                        <td data-text-align="center">Probation for 1 year</td>
                        <td data-text-align="center">Active suspension for 5 years</td>
                        <td data-text-align="center">$500</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(9)</td>
                        <td>Adulteration or misbranding</td>
                        <td data-text-align="center">Probation for 1 year</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$500</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(10)</td>
                        <td>Providing or causing to provide any prescription form that bears the name, address, or other means of identification of a pharmacist or pharmacy to any authorized prescriber</td>
                        <td data-text-align="center">Reprimand</td>
                        <td data-text-align="center">Probation for 5 years</td>
                        <td data-text-align="center">$250</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(11)</td>
                        <td>Providing remuneration to an authorized prescriber for referring an individual to a pharmacist or pharmacy for a product or service</td>
                        <td data-text-align="center">Probation for 1 year</td>
                        <td data-text-align="center">Active suspension for 5 years</td>
                        <td data-text-align="center">$1,000</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(12)</td>
                        <td>Knowingly associating as a partner, co-owner, or employee of a pharmacy that is owned wholly or substantially by an authorized prescriber or group of authorized prescribers</td>
                        <td data-text-align="center">Probation for 2 years</td>
                        <td data-text-align="center">Active suspension for 5 years</td>
                        <td data-text-align="center">$1,000</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(13)</td>
                        <td>Dispensing any drug, device, or diagnostic for which a prescription is required without a prescription</td>
                        <td data-text-align="center">Reprimand</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$250</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(14)</td>
                        <td>Convicted of, or pled guilty to, a felony or crime of moral turpitude</td>
                        <td data-text-align="center">Probation for 2 years</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$500</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(15)</td>
                        <td>Reciprocal discipline</td>
                        <td data-text-align="center">Reprimand</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$250</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(16)</td>
                        <td>Failure to cooperate in an investigation of the Board or its agent</td>
                        <td data-text-align="center">Probation for 1 year</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$500</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(17)</td>
                        <td>Physical or mental incompetence</td>
                        <td data-text-align="center">Probation for 2 years</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">N/A</td>
                        <td data-text-align="center">N/A</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(18)</td>
                        <td>Confidentiality violation</td>
                        <td data-text-align="center">Reprimand</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$250</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(19)</td>
                        <td>Diversion</td>
                        <td data-text-align="center">Active suspension for 1 year</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$1,000</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(20)</td>
                        <td>Standard of care violation</td>
                        <td data-text-align="center">Reprimand</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$500</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(21)</td>
                        <td>Sexual misconduct</td>
                        <td data-text-align="center">Active suspension for 1 year</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$2,500</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(22)</td>
                        <td>Failure to comply with an order of the Board</td>
                        <td data-text-align="center">Probation for 1 year</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$500</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(23)</td>
                        <td>Other violation of the Act not specifically enumerated in this chapter</td>
                        <td data-text-align="center">Reprimand</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$250</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.04#B">B.</span> If a licensee is found in violation of more than one category enumerated in this regulation, the category or categories containing the highest maximum sanction and penalty shall control.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.04#C">C.</span> A departure from the guidelines set forth in this regulation, on its own, is not grounds for any hearing or appeal of a Board action.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.04#D">D.</span> The Board may not consider a petition for reinstatement of a license that has been revoked until at least 5 years have passed from the date of revocation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.11.05" data-order="|10|34|11|.05|" data-ref-path="10|34|11|.05" class="h__section">.05 Guidelines for Imposition of Disciplinary Sanctions or Monetary Penalties on Pharmacy Technicians.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.05#A">A.</span> Subject to the provisions of this chapter, the Board may impose the following sanctions and, if appropriate, penalties for violations of the Act and its regulations according to the minimum and maximum sanctions and penalties set forth in the following categories:</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th colspan="2">Violation</th>
                        <th>Minimum Sanction</th>
                        <th>Maximum <br/>Sanction</th>
                        <th>Minimum Penalty</th>
                        <th>Maximum Penalty</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">(1)</td>
                        <td>False application and registration</td>
                        <td data-text-align="center">Probation for 1 year</td>
                        <td data-text-align="center">Denial of registration application or revocation</td>
                        <td data-text-align="center">$50</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(2)</td>
                        <td>Performing acts outside of permissible scope</td>
                        <td data-text-align="center">Probation for 1 year</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$50</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(3)</td>
                        <td>Convicted of, or pled guilty to, a felony or crime of moral turpitude</td>
                        <td data-text-align="center">Probation for 1 year</td>
                        <td data-text-align="center">Denial of registration application or revocation</td>
                        <td data-text-align="center">$500</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(4)</td>
                        <td>Physical or mental incompetence</td>
                        <td data-text-align="center">Active suspension for 1 year</td>
                        <td data-text-align="center">Denial of registration application or revocation</td>
                        <td data-text-align="center">N/A</td>
                        <td data-text-align="center">N/A</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(5)</td>
                        <td>Diversion</td>
                        <td data-text-align="center">Active suspension for 1 year</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$1,000</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(6)</td>
                        <td>Reciprocal discipline</td>
                        <td data-text-align="center">Reprimand</td>
                        <td data-text-align="center">Denial of registration application or revocation</td>
                        <td data-text-align="center">$250</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(7)</td>
                        <td>Lack of good moral character</td>
                        <td data-text-align="center">Probation for 1 year</td>
                        <td data-text-align="center">Denial of registration application or revocation</td>
                        <td data-text-align="center">N/A</td>
                        <td data-text-align="center">N/A</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(8)</td>
                        <td>Sexual misconduct</td>
                        <td data-text-align="center">Active suspension for 1 year</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$1,000</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(9)</td>
                        <td>Professional incompetence</td>
                        <td data-text-align="center">Probation for 1 year</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$100</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(10)</td>
                        <td>Confidentiality violation</td>
                        <td data-text-align="center">Probation for 1 year</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$1,000</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(11)</td>
                        <td>Failure to cooperate in Board or Division of Drug Control investigation</td>
                        <td data-text-align="center">Reprimand</td>
                        <td data-text-align="center">Denial of registration application or revocation</td>
                        <td data-text-align="center">$1,000</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(12)</td>
                        <td>Other violation of the Act not specifically enumerated in this chapter</td>
                        <td data-text-align="center">Reprimand</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$50</td>
                        <td data-text-align="center">$2,500</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.05#B">B.</span> If a registrant is found in violation of more than one category enumerated in this regulation, the category or categories containing the highest maximum sanction and penalty shall control.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.05#C">C.</span> A departure from the guidelines set forth in this regulation, on its own, is not grounds for any hearing or appeal of a Board action.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.05#D">D.</span> The Board may not consider a petition for reinstatement of a registration that has been revoked until at least 5 years have passed from the date of revocation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.11.06" data-order="|10|34|11|.06|" data-ref-path="10|34|11|.06" class="h__section">.06 Guidelines for Imposition of Disciplinary Sanctions or Monetary Penalties on Pharmacy Permit Holder.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.06#A">A.</span> Subject to the provisions of this chapter, the Board may impose the following sanctions and, if appropriate, penalties for violations of the Act and its regulations according to the minimum and maximum sanctions and penalties set forth in the following categories:</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th colspan="2">Violation</th>
                        <th>Minimum Sanction</th>
                        <th>Maximum <br/>Sanction</th>
                        <th>Minimum Penalty</th>
                        <th>Maximum Penalty</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">(1)</td>
                        <td>False application and registration</td>
                        <td data-text-align="center">Suspension for 30 days</td>
                        <td data-text-align="center">Denial of permit application or revocation</td>
                        <td data-text-align="center">$500</td>
                        <td data-text-align="center">$5,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(2)</td>
                        <td>Misrepresenting a permit</td>
                        <td data-text-align="center">Active suspension for 1 year</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$250</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(3)</td>
                        <td>Failure to notify the Board of closing</td>
                        <td data-text-align="center">N/A</td>
                        <td data-text-align="center">N/A</td>
                        <td data-text-align="center">$500</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(4)</td>
                        <td>Failure to notify the Board of a change in ownership</td>
                        <td data-text-align="center">Suspension for 30 days</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$750</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(5)</td>
                        <td>Failure to maintain necessary equipment and appliances</td>
                        <td data-text-align="center">Suspension for 30 days</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$250</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(6)</td>
                        <td>Failure to keep pharmacy clean and orderly</td>
                        <td data-text-align="center">Suspension for 30 days</td>
                        <td data-text-align="center">Active suspension for 6 months</td>
                        <td data-text-align="center">$250</td>
                        <td data-text-align="center">$5,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(7)</td>
                        <td>Failure to maintain proper security</td>
                        <td data-text-align="center">Suspension for 30 days</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$250</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(8)</td>
                        <td>Employing unlicensed or unregistered personnel</td>
                        <td data-text-align="center">Suspension for 30 days</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$1,000</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(9)</td>
                        <td>Reciprocal discipline</td>
                        <td data-text-align="center">Suspension for 30 days</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$1,000</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(10)</td>
                        <td>Failure to cooperate in Board or Division of Drug Control investigation</td>
                        <td data-text-align="center">Suspension for 30 days</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$250</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(11)</td>
                        <td>Failure to store drugs or devices in accordance with Board regulations</td>
                        <td data-text-align="center">Suspension for 30 days</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$1,000</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(12)</td>
                        <td>Failure to have a pharmacist on the premises at all times the pharmacy is operational</td>
                        <td data-text-align="center">Suspension for 30 days</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$2,500</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(13)</td>
                        <td>Record keeping violation</td>
                        <td data-text-align="center">Suspension for 30 days</td>
                        <td data-text-align="center">Active suspension for 1 year</td>
                        <td data-text-align="center">$500</td>
                        <td data-text-align="center">$5,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(14)</td>
                        <td>Standard of practice violation</td>
                        <td data-text-align="center">Suspension for 30 days</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$500</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(15)</td>
                        <td>Purchasing prescription drugs from an unlicensed wholesale distributor</td>
                        <td data-text-align="center">Suspension for 30 days</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$2,500</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(16)</td>
                        <td>Other violation of the Act not specifically enumerated in this chapter</td>
                        <td data-text-align="center">Suspension for 30 days</td>
                        <td data-text-align="center">Revocation</td>
                        <td data-text-align="center">$50</td>
                        <td data-text-align="center">$10,000</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.06#B">B.</span> If a pharmacy permit holder is found in violation of more than one category enumerated in this regulation, the category or categories containing the highest maximum sanction and penalty shall control.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.06#C">C.</span> A departure from the guidelines set forth in this regulation, on its own, is not grounds for any hearing or appeal of a Board action.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.06#D">D.</span> The Board may not consider a petition for reinstatement of a pharmacy permit that has been revoked until at least 5 years have passed from the date of revocation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.11.07" data-order="|10|34|11|.07|" data-ref-path="10|34|11|.07" class="h__section">.07 Guidelines for Imposition of Disciplinary Sanctions or Monetary Penalties on Wholesale Distributor Permit Holder.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.07#A">A.</span> Subject to the provisions of this chapter, the Board may impose the following sanctions and, if appropriate, penalties for violations of the Act and its regulations according to the minimum and maximum sanctions and penalties set forth in the following categories:</p>
                <div class="table_wrap">
                  <table>
                    <thead>
                      <tr>
                        <th colspan="2">Violation</th>
                        <th>Minimum Sanction</th>
                        <th>Maximum <br/>Sanction</th>
                        <th>Minimum Penalty</th>
                        <th>Maximum Penalty</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td data-vertical-align="middle">(1)</td>
                        <td>False application and registration</td>
                        <td data-text-align="center" data-vertical-align="middle">Probation for 1 year</td>
                        <td data-text-align="center" data-vertical-align="middle">Denial of permit application or revocation</td>
                        <td data-text-align="center" data-vertical-align="middle">$1,000</td>
                        <td data-text-align="center" data-vertical-align="middle">$10,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(2)</td>
                        <td>Operating without a necessary permit</td>
                        <td data-text-align="center" data-vertical-align="middle">Probation for 1 year</td>
                        <td data-text-align="center" data-vertical-align="middle">Revocation</td>
                        <td data-text-align="center" data-vertical-align="middle">$1,000</td>
                        <td data-text-align="center" data-vertical-align="middle">$500,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(3)</td>
                        <td>Record keeping violation</td>
                        <td data-text-align="center" data-vertical-align="middle">Reprimand</td>
                        <td data-text-align="center" data-vertical-align="middle">Active suspension for 5 years</td>
                        <td data-text-align="center" data-vertical-align="middle">$500</td>
                        <td data-text-align="center" data-vertical-align="middle">$50,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(4)</td>
                        <td>Failure to cooperate in an inspection or investigation by the Board or its agent</td>
                        <td data-text-align="center" data-vertical-align="middle">Reprimand</td>
                        <td data-text-align="center" data-vertical-align="middle">Revocation</td>
                        <td data-text-align="center" data-vertical-align="middle">$2,500</td>
                        <td data-text-align="center" data-vertical-align="middle">$500,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(5)</td>
                        <td>Receiving, creating, or distributing altered, misbranded, or counterfeit drugs or devices</td>
                        <td data-text-align="center" data-vertical-align="middle">Reprimand</td>
                        <td data-text-align="center" data-vertical-align="middle">Revocation</td>
                        <td data-text-align="center" data-vertical-align="middle">$1,000</td>
                        <td data-text-align="center" data-vertical-align="middle">$500,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(6)</td>
                        <td>Pedigree violation</td>
                        <td data-text-align="center" data-vertical-align="middle">Probation for 1 year</td>
                        <td data-text-align="center" data-vertical-align="middle">Revocation</td>
                        <td data-text-align="center" data-vertical-align="middle">$10,000</td>
                        <td data-text-align="center" data-vertical-align="middle">$500,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(7)</td>
                        <td>Purchasing, receiving, selling, or transferring prescription drugs or devices to or from and unlicensed source</td>
                        <td data-text-align="center" data-vertical-align="middle">Probation for 1 year</td>
                        <td data-text-align="center" data-vertical-align="middle">Revocation</td>
                        <td data-text-align="center" data-vertical-align="middle">$1,000</td>
                        <td data-text-align="center" data-vertical-align="middle">$500,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(8)</td>
                        <td>Providing false or fraudulent documents or statements to the Board</td>
                        <td data-text-align="center" data-vertical-align="middle">Active suspension for 1 year</td>
                        <td data-text-align="center" data-vertical-align="middle">Revocation</td>
                        <td data-text-align="center" data-vertical-align="middle">$25,000</td>
                        <td data-text-align="center" data-vertical-align="middle">$500,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(9)</td>
                        <td>Distributing or receiving drugs or devices that were purchased by a public or private hospital or other health care entity</td>
                        <td data-text-align="center" data-vertical-align="middle">Probation for 2 years</td>
                        <td data-text-align="center" data-vertical-align="middle">Revocation</td>
                        <td data-text-align="center" data-vertical-align="middle">$2,500</td>
                        <td data-text-align="center" data-vertical-align="middle">$500,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(10)</td>
                        <td>Distributing or receiving drugs or devices that were stolen or obtained by fraud or deceit</td>
                        <td data-text-align="center" data-vertical-align="middle">Probation for 3 years</td>
                        <td data-text-align="center" data-vertical-align="middle">Revocation</td>
                        <td data-text-align="center" data-vertical-align="middle">$50,000</td>
                        <td data-text-align="center" data-vertical-align="middle">$500,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(11)</td>
                        <td>Convicted of, or pled guilty to, a felony or crime of moral turpitude</td>
                        <td data-text-align="center" data-vertical-align="middle">Probation for 2 years</td>
                        <td data-text-align="center" data-vertical-align="middle">Denial of permit application or revocation</td>
                        <td data-text-align="center" data-vertical-align="middle">$5,000</td>
                        <td data-text-align="center" data-vertical-align="middle">$500,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(12)</td>
                        <td>Convicted of, or pled guilty to, a violation of federal, state, or local drug or device law or regulation</td>
                        <td data-text-align="center" data-vertical-align="middle">Reprimand</td>
                        <td data-text-align="center" data-vertical-align="middle">Denial of permit application or revocation</td>
                        <td data-text-align="center" data-vertical-align="middle">$2,500</td>
                        <td data-text-align="center" data-vertical-align="middle">$500,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(13)</td>
                        <td>Distributing a prescription drug or device that was previously dispensed by a pharmacy or distributed by a practitioner</td>
                        <td data-text-align="center" data-vertical-align="middle">Active suspension for 2 years</td>
                        <td data-text-align="center" data-vertical-align="middle">Revocation</td>
                        <td data-text-align="center" data-vertical-align="middle">$50,000</td>
                        <td data-text-align="center" data-vertical-align="middle">$500,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(14)</td>
                        <td>Failure to report prohibited acts</td>
                        <td data-text-align="center" data-vertical-align="middle">Reprimand</td>
                        <td data-text-align="center" data-vertical-align="middle">Revocation</td>
                        <td data-text-align="center" data-vertical-align="middle">$500</td>
                        <td data-text-align="center" data-vertical-align="middle">$500,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(15)</td>
                        <td>Reciprocal discipline</td>
                        <td data-text-align="center" data-vertical-align="middle">Reprimand</td>
                        <td data-text-align="center" data-vertical-align="middle">Revocation</td>
                        <td data-text-align="center" data-vertical-align="middle">$500</td>
                        <td data-text-align="center" data-vertical-align="middle">$500,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(16)</td>
                        <td>Failure to comply with conditions of probation</td>
                        <td data-text-align="center" data-vertical-align="middle">Probation for 1 year</td>
                        <td data-text-align="center" data-vertical-align="middle">Revocation</td>
                        <td data-text-align="center" data-vertical-align="middle">$10,000</td>
                        <td data-text-align="center" data-vertical-align="middle">$500,000</td>
                      </tr>
                      <tr>
                        <td data-vertical-align="middle">(17)</td>
                        <td>Other violation of the Act not specifically enumerated in this chapter</td>
                        <td data-text-align="center" data-vertical-align="middle">Reprimand</td>
                        <td data-text-align="center" data-vertical-align="middle">Revocation</td>
                        <td data-text-align="center" data-vertical-align="middle">$500</td>
                        <td data-text-align="center" data-vertical-align="middle">$500,000</td>
                      </tr>
                    </tbody>
                  </table>
                </div>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.07#B">B.</span> If a wholesale distributor permit holder is found in violation of more than one category enumerated in this regulation, the category or categories containing the highest maximum sanction and penalty shall control.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.07#C">C.</span> A departure from the guidelines set forth in this regulation, on its own, is not grounds for any hearing or appeal of a Board action.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.07#D">D.</span> The Board may not consider a petition for reinstatement of a wholesale distributor permit that has been revoked until at least 5 years have passed from the date of revocation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.11.08" data-order="|10|34|11|.08|" data-ref-path="10|34|11|.08" class="h__section">.08 Mitigating and Aggravating Factors to Be Considered in the Assessment of the Sanction and Penalty.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#A">A.</span> Depending upon the facts and circumstances of each case, and to the extent that they apply, the Board may consider the following mitigating and aggravating factors in determining whether the sanction in a particular case should fall outside the range of sanctions established by the guidelines. These factors may include, but are not limited to, the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#A(1)">(1)</span> Mitigating Factors:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#A(1)(a)">(a)</span> The licensee’s, registrant’s, or permit holder’s lack of a prior disciplinary record;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#A(1)(b)">(b)</span> The licensee, registrant, or permit holder self-reported the violation to the Board;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#A(1)(c)">(c)</span> The licensee’s, registrant’s, or permit holder’s full and voluntary admission of misconduct to the Board and cooperation during Board proceedings;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#A(1)(d)">(d)</span> The licensee, registrant, or permit holder implemented remedial measures to correct or mitigate harm arising from the misconduct;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#A(1)(e)">(e)</span> The licensee, registrant, or permit holder made a timely good-faith effort to make restitution or to rectify the consequences of the misconduct;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#A(1)(f)">(f)</span> Evidence of rehabilitation or rehabilitative potential;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#A(1)(g)">(g)</span> Absence of premeditation to commit the misconduct;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#A(1)(h)">(h)</span> Absence of potential harm to public or adverse impact; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#A(1)(i)">(i)</span> The licensee’s, registrant’s, or permit holder’s conduct was an isolated incident and not likely to recur; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#A(2)">(2)</span> Aggravating Factors:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#A(2)(a)">(a)</span> The licensee, registrant, or permit holder has a previous criminal or administrative disciplinary history;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#A(2)(b)">(b)</span> The violation was committed deliberately or with gross negligence or recklessness;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#A(2)(c)">(c)</span> The violation had the potential for, or caused, serious patient harm;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#A(2)(d)">(d)</span> The violation was part of a pattern of detrimental conduct;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#A(2)(e)">(e)</span> The licensee, registrant, or permit holder was motivated to perform the violation for financial gain;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#A(2)(f)">(f)</span> The vulnerability of the patient or customer;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#A(2)(g)">(g)</span> The licensee, registrant, or permit holder attempted to hide error or misconduct from patients or others;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#A(2)(h)">(h)</span> Previous attempts at rehabilitation of the licensee, registrant, or permit holder were unsuccessful; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#A(2)(i)">(i)</span> The licensee, registrant, or permit holder committed the violation under the guise of treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#B">B.</span> The existence of one or more of these factors does not impose on the Board or an Administrative Law Judge any requirement to articulate its reasoning for not exercising its discretion to impose a sanction outside of the range of sanctions set forth in this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.08#C">C.</span> Nothing in this regulation requires the Board or an Administrative Law Judge to make findings of fact with respect to any of these factors.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.11.09" data-order="|10|34|11|.09|" data-ref-path="10|34|11|.09" class="h__section">.09 Civil Fines to Pharmacists, Pharmacy Technicians, and Pharmacy Permit Holders.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.09#A">A.</span> Practicing on an Expired License. The Board may assess a civil fine against a pharmacist who practices on an expired license in the amount of $1,000 per month of practice past the expiration date of the license, up to a maximum fine of $50,000.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.09#B">B.</span> Working on an Expired Registration. The Board may assess a civil fine against a pharmacy technician or pharmacy intern who works on an expired registration in the amount of $25 per month of practice past the expiration date of the registration, up to a maximum fine of $250.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.09#C">C.</span> Operating a Pharmacy on an Expired Permit. The Board may assess a civil fine against a permit holder that operates a pharmacy on an expired permit in the amount of $5,000 per month of operation past the expiration date of the permit, up to a maximum fine of $50,000.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.09#D">D.</span> Practicing or Operating Without a License, Registration, or Pharmacy Permit.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.09#D(1)">(1)</span> The Board may assess a civil fine of no less than $5,000 and no more than $50,000 against:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.09#D(1)(a)">(a)</span> An individual who practices pharmacy without a license; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.09#D(1)(b)">(b)</span> An individual or entity that operates a pharmacy without a permit.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.09#D(2)">(2)</span> The Board may assess a civil fine of no less than $250 and no more than $50,000 against an individual who works as an unregistered pharmacy technician or unregistered pharmacy intern.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.09#D(3)">(3)</span> Factors in determining the amount of a fine include, but are not limited to, the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.09#D(3)(a)">(a)</span> The extent to which the individual or entity derived any financial benefit from the unauthorized practice or operation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.09#D(3)(b)">(b)</span> The willfulness of the unauthorized practice or operation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.09#D(3)(c)">(c)</span> Actual or potential public harm caused by the unauthorized practice or operation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.09#D(3)(d)">(d)</span> The length of time in which the individual or entity engaged in the unauthorized practice or operation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.11.10" data-order="|10|34|11|.10|" data-ref-path="10|34|11|.10" class="h__section">.10 Civil Fines to Wholesale Distributor Permit Holders.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.10#A">A.</span> Operating on an Expired Wholesale Distributor Permit. The Board may assess a civil fine against a permit holder that operates on an expired wholesale distributor permit in the following amount:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.10#A(1)">(1)</span> A maximum of $10,000 per month of operation past the expiration date of the permit, if the annual gross receipts in Maryland of the permit holder for the previous tax year were less than $10,000,000, up to a maximum fine of $500,000; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.10#A(2)">(2)</span> A maximum of $25,000 per month of operation past the expiration date of the permit, if the annual gross receipts in Maryland of the permit holder for the previous tax year were $10,000,000 or more, up to a maximum fine of $500,000.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.10#B">B.</span> Practicing Without a License.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.10#B(1)">(1)</span> The Board may assess a civil fine of no less than $10,000 and no more than $500,000 against an individual or entity that operates a wholesale distributor without a license.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.10#B(2)">(2)</span> Factors in determining the amount of a fine include, but are not limited to, the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.10#B(2)(a)">(a)</span> The size of the wholesale distributor;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.10#B(2)(b)">(b)</span> The gravity of the violation for which the fine is to be imposed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.10#B(2)(c)">(c)</span> The good faith of the wholesale distributor;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.10#B(2)(d)">(d)</span> Any previous violations by the wholesale distributor;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.10#B(2)(e)">(e)</span> Actual or potential public harm caused by the unauthorized operation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.10#B(2)(f)">(f)</span> The length of time in which the entity engaged in the unauthorized operation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.11.11" data-order="|10|34|11|.11|" data-ref-path="10|34|11|.11" class="h__section">.11 Payment of a Penalty.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.11#A">A.</span> A licensee, registrant, or permit holder shall pay to the Board a penalty imposed under this chapter within 30 days of the date the Board's order is issued, unless the Board's order specifies otherwise.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.11#B">B.</span> Filing an appeal under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-222" title="">State Government Article, §10-222, Annotated Code of Maryland</a>, or <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-316" title="">Health Occupations Article, §12-316, </a>12-412, or 12-601, Annotated Code of Maryland, does not automatically stay payment of a penalty imposed by the Board pursuant to this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.11#C">C.</span> If a licensee, registrant, or permit holder fails to pay, in whole or in part, a penalty imposed by the Board pursuant to this chapter, the Board may not restore, reinstate, or renew a license, registration, or permit until the penalty has been paid in full.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.11#D">D.</span> In its discretion, the Board may refer cases of delinquent payment to the Central Collection Unit of the Department of Budget and Management to institute and maintain proceedings to ensure prompt payment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.11.11#E">E.</span> Deposit of Monies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.11#E(1)">(1)</span> The Board shall pay monies collected pursuant to this chapter, except for civil fines collected under <a class="internal-link " href="/us/md/exec/comar/10.34.11.09" title=".09 Civil Fines to Pharmacists, Pharmacy Technicians, and Pharmacy Permit Holders.">Regulation .09 of this chapter</a>, into the State's General Fund.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.11.11#E(2)">(2)</span> Civil Fines.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.11#E(2)(a)">(a)</span> The Board shall pay civil fines collected under <a class="internal-link " href="/us/md/exec/comar/10.34.11.09" title=".09 Civil Fines to Pharmacists, Pharmacy Technicians, and Pharmacy Permit Holders.">Regulation .09 of this chapter</a> into the State Board of Pharmacy Fund, in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-707" title="">Health Occupations Article, §12-707(e)(2), Annotated Code of Maryland</a>.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.11.11#E(2)(b)">(b)</span> The Board shall pay civil fines collected under <a class="internal-link " href="/us/md/exec/comar/10.34.11.10" title=".10 Civil Fines to Wholesale Distributor Permit Holders.">Regulation .10 of this chapter</a> into the State’s General Fund.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.12" data-order="|10|34|12|" data-ref-path="10|34|12" class="h__chapter">Chapter 12 Removal of Expired Medications</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: April 9, 1984 (11:7 Md. R. 625)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.12.01" title=".01 Manufacturer's Expiration Date.">Regulation .01</a> amended effective July 1, 2010 (37:10 Md. R. 722)</p>
                  <h3>Authority</h3>
                  <p><a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">Health Occupations Article, §12-205, </a>Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.12.01" data-order="|10|34|12|.01|" data-ref-path="10|34|12|.01" class="h__section">.01 Manufacturer's Expiration Date.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.12.01#A">A.</span> A wholesale distributor, pharmacist, or pharmacy shall distribute or hold for sale medications bearing a manufacturer's expiration date pursuant to 21 C.F.R. §211.137.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.12.01#B">B.</span> A wholesale distributor, pharmacist, or pharmacy shall have adequate and credible provisions for return of outdated drugs, including but not limited to partials, through its wholesaler distributor or reverse distributor.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.13" data-order="|10|34|13|" data-ref-path="10|34|13" class="h__chapter">Chapter 13 Reinstatement of Expired Licenses for Pharmacists</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: April 9, 1984 (11:7 Md. R. 625)</p>
                  <p>Recodified from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.15" title="Chapter 15 Licensure by Reciprocity">COMAR 10.34.15</a> to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.13" title="Chapter 13 Reinstatement of Expired Licenses for Pharmacists">10.34.13</a></p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.13.01" title=".01 Definitions.">Regulation .01</a> amended effective September 5, 1988 (15:18 Md. R. 2152)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.13.01#B" title="">Regulation .01B</a> amended effective October 24, 1994 (21:21 Md. R. 1814); November 1, 1999 (26:22 Md. R. 1693); February 17, 2003 (30:3 Md. R. 180); July 1, 2010 (37:10 Md. R. 722)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.13.02" title=".02 Reinstatement Fee.">Regulation .02</a> amended effective October 24, 1994 (21:21 Md. R. 1814)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.13.03" title=".03 Reinstatement Requirements.">Regulation .03</a> amended effective February 19, 1990 (17:3 Md. R. 299); October 24, 1994 (21:21 Md. R. 1814)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.13.03#B" title="">Regulation .03B</a>, C amended effective September 5, 1988 (15:18 Md. R. 2152)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.13.03" title=".03 Reinstatement Requirements.">Regulation .03</a> repealed and new Regulation .03 adopted effective November 1, 1999 (26:22 Md. R. 1693)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.13.03" title=".03 Reinstatement Requirements.">Regulation .03</a> amended effective July 1, 2010 (37:10 Md. R. 722)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.13.03#B" title="">Regulation .03B</a> amended effective October 14, 2002 (29:20 Md. R. 1589); February 17, 2003 (30:3 Md. R. 180)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.13.04" title=".04 Waiver.">Regulation .04</a> adopted effective February 19, 1990 (17:3 Md. R. 299)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.13.04" title=".04 Waiver.">Regulation .04</a> amended effective July 1, 2010 (37:10 Md. R. 722)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.13.04" title=".04 Waiver.">Regulation .04</a> amended as an emergency provision effective January 7, 2022 (49:4 Md. R. 299); emergency status expired effective July 6, 2022</p>
                  <h3>Authority</h3>
                  <p><a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-310" title="">Health Occupations Article, §12-310, </a>Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.13.01" data-order="|10|34|13|.01|" data-ref-path="10|34|13|.01" class="h__section">.01 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.13.01#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.13.01#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.13.01#B(1)">(1)</span> "Board" means the State Board of Pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.13.01#B(2)">(2)</span> "MPJE" means the Multistate Pharmacy Jurisprudence Examination.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.13.01#B(3)">(3)</span> "NAPLEX" means the North American Pharmacist Licensure Examination.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.13.01#B(4)">(4)</span> "Reinstatement" means renewal of a license after the license has expired.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.13.01#B(5)">(5)</span> "Renewal" means renewing a license before the date of expiration.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.13.02" data-order="|10|34|13|.02|" data-ref-path="10|34|13|.02" class="h__section">.02 Reinstatement Fee.</h3>
                <p>The reinstatement fee authorized by <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-310" title="">Health Occupations Article, §12-310(a)(2), Annotated Code of Maryland</a>, shall be as determined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09" title="Chapter 09 Fees">COMAR 10.34.09</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.13.03" data-order="|10|34|13|.03|" data-ref-path="10|34|13|.03" class="h__section">.03 Reinstatement Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#A">A.</span> General Requirements. A pharmacist who wishes to reinstate an expired license to practice pharmacy shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#A(1)">(1)</span> Provide evidence of the completed amount of approved continuing education required by the Board in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.18" title="Chapter 18 Continuing Education for Pharmacists">COMAR 10.34.18</a> in conjunction with the reinstatement application;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#A(2)">(2)</span> Provide evidence of good standing in any other state in which the pharmacist has been licensed, if applicable; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#A(3)">(3)</span> Pay to the Board the reinstatement fee established by the Board in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09" title="Chapter 09 Fees">COMAR 10.34.09</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B">B.</span> Specific Requirements.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(1)">(1)</span> The Board:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(1)(a)">(a)</span> May reinstate the license of a pharmacist who has actively engaged in the practice of pharmacy in Maryland after the expiration of the pharmacist's license if the pharmacist:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(1)(a)(i)">(i)</span> Meets the requirements of <a class="internal-link " href="/us/md/exec/comar/10.34.13.03#A" title="">§A of this regulation</a>; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(1)(a)(ii)">(ii)</span> Pays the pharmacist reinstatement fee established in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09.02" title=".02 Fees.">COMAR 10.34.09.02</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(1)(b)">(b)</span> May bring charges against a pharmacist who has practiced without a license; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(1)(c)">(c)</span> When determining sanctions for practicing pharmacy without a license under <a class="internal-link " href="/us/md/exec/comar/10.34.13.03#B(1)" title="">§B(1) of this regulation</a>, shall consider:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(1)(c)(i)">(i)</span> The length of time during which the pharmacist practiced without a license; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(1)(c)(ii)">(ii)</span> Any violations of <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>, committed by the pharmacist during the period of unlicensed practice.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(2)">(2)</span> A pharmacist not actively engaged in the practice of pharmacy, whose Maryland license expired less than 2 years before applying for reinstatement, shall meet the requirements of <a class="internal-link " href="/us/md/exec/comar/10.34.13.03#A" title="">§A of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(3)">(3)</span> A pharmacist licensed in another state and actively engaged in the practice of pharmacy in that state, whose Maryland license expired less than 2 years before applying for license reinstatement, shall meet the requirements of <a class="internal-link " href="/us/md/exec/comar/10.34.13.03#A" title="">§A of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(4)">(4)</span> A pharmacist licensed in another state and actively engaged in the practice of pharmacy in that state, whose Maryland license expired 2 years but less than 5 years before applying for license reinstatement, shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(4)(a)">(a)</span> Meet the requirements of <a class="internal-link " href="/us/md/exec/comar/10.34.13.03#A" title="">§A of this regulation</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(4)(b)">(b)</span> Submit evidence satisfactory to the Board which documents the applicant's pharmacy experience during the 2 years immediately preceding the date of the applicant's reinstatement application; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(4)(c)">(c)</span> Pass the MPJE.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(5)">(5)</span> A pharmacist not actively engaged in the practice of pharmacy, whose Maryland license expired more than 2 years but less than 5 years before applying for reinstatement, shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(5)(a)">(a)</span> Meet the requirements of <a class="internal-link " href="/us/md/exec/comar/10.34.13.03#A" title="">§A of this regulation</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(5)(b)">(b)</span> Pass the MPJE.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(6)">(6)</span> A pharmacist not actively engaged in the practice of pharmacy in another state, whose Maryland license expired more than 5 years but less than 10 years before applying for reinstatement, shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(6)(a)">(a)</span> Meet the requirements of <a class="internal-link " href="/us/md/exec/comar/10.34.13.03#A" title="">§A of this regulation</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(6)(b)">(b)</span> Pass the MPJE; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(6)(c)">(c)</span> Submit evidence satisfactory to the Board of having performed 1,000 hours of service in a pharmacy with a valid pharmacy permit under the supervision of a licensed pharmacist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(7)">(7)</span> A pharmacist not actively engaged in the practice of pharmacy, whose Maryland license expired 10 or more years before applying for reinstatement, shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(7)(a)">(a)</span> Meet the requirements of §A(2) and (3) of this regulation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(7)(b)">(b)</span> Pass the MPJE;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(7)(c)">(c)</span> Submit evidence satisfactory to the Board of having performed 1,000 hours of service in a pharmacy with a valid pharmacy permit under the supervision of a licensed pharmacist; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.13.03#B(7)(d)">(d)</span> Pass the NAPLEX.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.13.04" data-order="|10|34|13|.04|" data-ref-path="10|34|13|.04" class="h__section">.04 Waiver.</h3>
                <p>The Board may waive any of the requirements set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.13.03" title=".03 Reinstatement Requirements.">Regulation .03 of this chapter</a> in reinstating a pharmacist's expired license.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.14" data-order="|10|34|14|" data-ref-path="10|34|14" class="h__chapter">Chapter 14 Opening and Closing of Pharmacies</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: December 3, 1984 (11:24 Md. R. 2069)</p>
                  <p>Regulation .01C adopted effective February 19, 1990 (17:3 Md. R. 299)</p>
                  <p>Regulations .02E amended effective February 19, 1990 (17:3 Md. R. 299)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.14.01" title=".01 Definitions.">.01</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.14.04" title=".04 Required Information and Procedure.">.04</a> repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.14.01" title=".01 Definitions.">.01</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.14.06" title=".06 Disposition of Prescription Drugs Other than Controlled Dangerous Substances.">.06</a> adopted effective April 16, 2001 (28:7 Md. R. 690)</p>
                  <p>——————</p>
                  <p>Chapter revised effective June 1, 2012 (39:7 Md. R. 493)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.14.01#B" title="">Regulation .01B</a> amended effective July 8, 2013 (40:13 Md. R. 1076); June 26, 2023 (50:12 Md. R. 475)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.14.03" title=".03 Notification of Closing of a Pharmacy.">Regulation .03</a> amended effective July 8, 2013 (40:13 Md. R. 1076); June 26, 2023 (50:12 Md. R.475)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.14.04" title=".04 Required Information and Procedure.">Regulation .04</a> amended effective July 8, 2013 (40:13 Md. R. 1076)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.14.05" title=".05 Information and Documentation Due at the Closing Inspection.">Regulation .05</a> amended effective July 8, 2013 (40:13 Md. R. 1076)</p>
                  <h3>Authority</h3>
                  <p>Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">12-205</a> and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-513" title="">12-513</a>, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.14.01" data-order="|10|34|14|.01|" data-ref-path="10|34|14|.01" class="h__section">.01 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.01#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.01#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.01#B(1)">(1)</span> <em>“</em>Closing of a pharmacy” means a licensed pharmacy will cease operations for more than 7 consecutive days, except when:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.14.01#B(1)(a)">(a)</span> A licensed pharmacy is destroyed or otherwise rendered inoperable, and the licensed pharmacy is moving its operations to a temporary site in accordance with the Board’s regulations; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.14.01#B(1)(b)">(b)</span> A licensed pharmacy is undergoing a change of ownership:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.14.01#B(1)(b)(i)">(i)</span> That will not result in any cessation of pharmacy operations at the location; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.14.01#B(1)(b)(ii)">(ii)</span> The anticipated new pharmacy permit holder has submitted a change of ownership application to the Board at least 30 days prior to the change of ownership transaction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.01#B(2)">(2)</span> “Operational pharmacy” means a pharmacy that is actively compounding, dispensing, or distributing prescription or nonprescription drugs or devices in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-101" title="">Health Occupations Article, §12-101(p), Annotated Code of Maryland</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.14.02" data-order="|10|34|14|.02|" data-ref-path="10|34|14|.02" class="h__section">.02 Opening a Pharmacy.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.02#A">A.</span> To apply for a pharmacy permit, an applicant shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.02#A(1)">(1)</span> Submit an application to the Board on the form that the Board requires;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.02#A(2)">(2)</span> Pay to the Board an application fee set by the Board in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09" title="Chapter 09 Fees">COMAR 10.34.09</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.02#A(3)">(3)</span> Submit to an opening inspection, at which time the applicant shall have, at a minimum, the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.14.02#A(3)(a)">(a)</span> If applicable, a Class A prescription balance and weights, or a prescription balance with equivalent or superior sensitivity;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.14.02#A(3)(b)">(b)</span> A refrigerator, solely for the storage of medications requiring refrigeration, with a thermometer or a temperature monitoring device;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.14.02#A(3)(c)">(c)</span> Additional equipment to enable the pharmacy to prepare and dispense prescriptions properly consistent with the pharmacy’s scope of practice;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.14.02#A(3)(d)">(d)</span> Hot and cold running water;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.14.02#A(3)(e)">(e)</span> A library of current reference sources, consistent with the pharmacy’s scope of practice, that is accessible to appropriate personnel;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.14.02#A(3)(f)">(f)</span> A current edition of Maryland Pharmacy Laws;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.14.02#A(3)(g)">(g)</span> A security system in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.05.02" title=".02 Prescription Area.">COMAR 10.34.05.02</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.14.02#A(3)(h)">(h)</span> A pharmacist on the premises during the opening inspection, if prescription drugs are present.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.02#B">B.</span> A pharmacy may not be located in a residence.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.02#C">C.</span> A permit holder who has been issued a pharmacy permit by the Board shall, within 60 days following the initial issuance of the pharmacy permit, have and maintain an operational pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.02#D">D.</span> The Board shall inspect a pharmacy after the initial issuance of a pharmacy permit to ensure that the pharmacy is an operational pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.02#E">E.</span> If a pharmacy is not an operational pharmacy within 60 days following the initial issuance of a pharmacy permit, the Board shall notify the permit holder of the Board’s intent to rescind the pharmacy permit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.02#F">F.</span> A permit holder who has been notified of the Board’s intent to rescind the pharmacy permit under this regulation shall return the permit to the Board within 10 days of notification, unless the permit holder submits documentation satisfactory to the Board to show that the pharmacy is an operational pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.02#G">G.</span> If a pharmacy permit has been rescinded under this regulation, the permit holder may reapply if application requirements are met.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.02#H">H.</span> The Board may waive any of the requirements set forth in this regulation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.14.03" data-order="|10|34|14|.03|" data-ref-path="10|34|14|.03" class="h__section">.03 Notification of Closing of a Pharmacy.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03#A">A.</span> At least 14 days before a licensed pharmacy’s anticipated date of closing, the pharmacy permit holder shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03#A(1)">(1)</span> Notify the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03#A(1)(a)">(a)</span> Board in writing by certified mail, return receipt requested, or hand delivery to the Board’s office<em>,</em> of the day on which the licensed pharmacy will close;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03#A(1)(b)">(b)</span> Office of Controlled Substances Administration by certified mail, return receipt requested, of the day on which the licensed pharmacy will close;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03#A(1)(c)">(c)</span> Public by conspicuously posting a notice inside the pharmacy and on the pharmacy’s website of the anticipated day on which the pharmacy will close; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03#A(1)(d)">(d)</span> Pharmacy’s customers who pick up a new or refilled prescription via written and verbal communication of the anticipated day on which the licensed pharmacy will close; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03#A(2)">(2)</span> Request a closing inspection date.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03#B">B.</span> The notice shall contain the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03#B(1)">(1)</span> Anticipated date of closing;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03#B(2)">(2)</span> Name and location of the pharmacy to which the closing pharmacy will transfer patient prescriptions and records; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03#B(3)">(3)</span> Manner in which a patient may request the closing pharmacy to send the patient’s prescriptions and records to an alternative pharmacy of the patient’s choice.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03#C">C.</span> Upon notification by a pharmacy permit holder of the proposed date on which a licensed pharmacy will close, the Board or its agent shall schedule a closing inspection to be performed within 14 days, excluding federal and State holidays, of the pharmacy’s closing.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.14.03-1" data-order="|10|34|14|.03-1|" data-ref-path="10|34|14|.03-1" class="h__section">.03-1 Notification by Pharmacy Permit Holder of Anticipated Sale of Pharmacy Operations.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03-1#A">A.</span> At least 30 days before a licensed pharmacy’s sale or transfer of its pharmacy operations at the permitted establishment, the pharmacy permit holder shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03-1#A(1)">(1)</span> Notify the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03-1#A(1)(a)">(a)</span> Board in writing by certified mail, return receipt requested, or hand delivery to the Board’s office; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03-1#A(1)(b)">(b)</span> Office of Controlled Substances Administration by certified mail, return receipt requested; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03-1#A(2)">(2)</span> Request a closing inspection of the pharmacy permit holder’s pharmacy inventory and records.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03-1#B">B.</span> The notice shall contain:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03-1#B(1)">(1)</span> The anticipated date of the pharmacy permit holder’s sale or transfer of its pharmacy operations; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03-1#B(2)">(2)</span> The name of the anticipated purchaser or transferee of the pharmacy permit holder’s pharmacy operations.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03-1#C">C.</span> Upon notification by a pharmacy permit holder of the proposed date on which the licensed pharmacy’s operations will be sold or transferred, the Board or its agent shall schedule a closing inspection of the pharmacy permit holder’s inventory and records to be performed within 14 days, excluding State and federal holidays.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03-1#D">D.</span> In the event the purchaser or transferee of the pharmacy’s operations is not issued a new pharmacy permit by the Board on or prior to the date of the sale or transfer of the pharmacy operations that results in the cessation of pharmacy operations, the existing pharmacy permit holder shall immediately provide notice to the public, posted outside the pharmacy and on the pharmacy’s website, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03-1#D(1)">(1)</span> The anticipated day on which pharmacy operations may resume; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.03-1#D(2)">(2)</span> The pharmacy permit holder’s contact information for patients who wish to transfer prescriptions or records to another licensed pharmacy of the patient’s choice.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.14.04" data-order="|10|34|14|.04|" data-ref-path="10|34|14|.04" class="h__section">.04 Required Information and Procedure.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.04#A">A.</span> At the closing inspection of a licensed pharmacy, the pharmacy permit holder shall provide to the Board, or the Board’s agent, information and documentation required by <a class="internal-link " href="/us/md/exec/comar/10.34.14.05" title=".05 Information and Documentation Due at the Closing Inspection.">Regulation .05 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.04#B">B.</span> The pharmacy permit holder shall remove or completely cover indications that the premises was a pharmacy within 30 days after the date the licensed pharmacy ceases to operate as a pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.04#C">C.</span> The pharmacy permit holder shall notify prescription drug suppliers to the pharmacy, before ceasing to operate as a pharmacy, of the date that the location will cease to operate as a pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.04#D">D.</span> The pharmacy permit holder shall notify the public of the date that the pharmacy will cease to operate as a pharmacy by that date.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.04#E">E.</span> The pharmacy permit holder shall notify the public of the location to which the patients' records have been transferred, by the date the pharmacy ceases to operate.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.04#F">F.</span> If patient records are not transferred, the pharmacy permit holder shall notify the public of the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.04#F(1)">(1)</span> Location of the patient records;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.04#F(2)">(2)</span> Method by which the patient records shall be maintained; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.04#F(3)">(3)</span> Procedure by which patients and other authorized individuals or entities may access the patient records.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.04#G">G.</span> The pharmacy permit holder shall comply with all federal and State laws and regulations.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.04#H">H.</span> If the Board’s agent performs the closing inspection, the Board’s agent shall obtain information and documentation required by <a class="internal-link " href="/us/md/exec/comar/10.34.14.05" title=".05 Information and Documentation Due at the Closing Inspection.">Regulation .05 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.14.05" data-order="|10|34|14|.05|" data-ref-path="10|34|14|.05" class="h__section">.05 Information and Documentation Due at the Closing Inspection.</h3>
                <p>Information and documentation due at the closing inspection shall include:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.05#A">A.</span> The exact date on which the pharmacy ceased to operate as a pharmacy;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.05#B">B.</span> A copy of the inventory required by the Drug Enforcement Administration;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.05#C">C.</span> The pharmacy permit and Maryland Department of Health controlled dangerous substance registration for cancellation;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.05#D">D.</span> The names, address, telephone numbers, and Drug Enforcement Administration registration numbers of the persons or business entities to whom any prescription drugs in stock were returned or transferred under <a class="internal-link " href="/us/md/exec/comar/10.34.14.05" title=".05 Information and Documentation Due at the Closing Inspection.">Regulation .05 of this chapter</a> and for any prescription files or patient records transferred;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.05#E">E.</span> If prescription drugs are destroyed pursuant to <a class="internal-link " href="/us/md/exec/comar/10.34.14.06" title=".06 Disposition of Prescription Drugs Other than Controlled Dangerous Substances.">Regulation .06 of this chapter</a>, and <a class="internal-link " href="/us/md/exec/comar/10.34.14.07" title=".07 Disposition of Controlled Dangerous Substances.">Regulation .07 of this chapter</a> does not apply to the prescription drugs, the pharmacy permit holder shall provide the Board with a letter, signed under oath by the pharmacy permit holder, stating the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.05#E(1)">(1)</span> Date, place and manner in which the prescription drugs were destroyed;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.05#E(2)">(2)</span> Names, addresses, and telephone numbers of the persons responsible for destroying the prescription drugs; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.05#E(3)">(3)</span> Name, dosage unit, and quantity of each type of prescription drug destroyed;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.05#F">F.</span> If any patient records which are not required to be maintained by law, or other documents containing patient information are destroyed, the pharmacy permit holder shall provide the Board with a letter, signed under oath by the pharmacy permit holder, stating:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.05#F(1)">(1)</span> That the documents were destroyed;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.05#F(2)">(2)</span> The date of the destruction of the documents;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.05#F(3)">(3)</span> The name and address of the person who destroyed the documents;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.05#F(4)">(4)</span> That the records or other documents were destroyed in a manner so as to avoid breaches of patients' confidentiality; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.05#F(5)">(5)</span> The identity of the records destroyed; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.05#G">G.</span> If any patient records or other documents containing patient information are transferred, the pharmacy permit holder shall provide the Board with a letter, signed under oath by the pharmacy permit holder, stating:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.05#G(1)">(1)</span> The date, time, place to which and manner in which the records or other documents were transferred;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.05#G(2)">(2)</span> The names, addresses, and telephone numbers of the persons responsible for transferring the records or other documents;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.05#G(3)">(3)</span> That the records or other documents were transferred in a manner so as to avoid breaches of patients' confidentiality; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.14.05#G(4)">(4)</span> The identity of the records transferred.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.14.06" data-order="|10|34|14|.06|" data-ref-path="10|34|14|.06" class="h__section">.06 Disposition of Prescription Drugs Other than Controlled Dangerous Substances.</h3>
                <p>With the exception of controlled dangerous substances, prescription drugs in stock shall be disposed of by one or more of the following means:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.06#A">A.</span> Returning them to a distributor or manufacturer; or</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.14.06#B">B.</span> Transferring them to another licensed pharmacy, authorized prescriber, or other person or entity approved by the Board or the Division of Drug Control.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.14.07" data-order="|10|34|14|.07|" data-ref-path="10|34|14|.07" class="h__section">.07 Disposition of Controlled Dangerous Substances.</h3>
                <p>The pharmacy permit holder shall comply with the procedures set forth in this chapter in addition to those set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.03.10#C" title="">COMAR 10.19.03.10C</a> — E governing the disposal of controlled dangerous substances.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.15" data-order="|10|34|15|" data-ref-path="10|34|15" class="h__chapter">Chapter 15 Licensure by Reciprocity</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: December 3, 1984 (11:24 Md. R. 2069)</p>
                  <p>Chapter recodified from <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.18" title="Chapter 18 Continuing Education for Pharmacists">COMAR 10.34.18</a> to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.15" title="Chapter 15 Licensure by Reciprocity">10.34.15</a></p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.15.01" title=".01 Requirements.">Regulation .01</a> amended effective April 16, 1990 (17:7 Md. R. 849)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.15.01" title=".01 Requirements.">Regulation .01</a> repealed and new Regulation .01 adopted effective April 6, 1998 (25:7 Md. R. 527)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.15.01" title=".01 Requirements.">Regulation .01</a> amended as an emergency provision effective January 7, 2022 (49:4 Md. R. 299) ); emergency status expired effective July 6, 2022</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.15.01#A" title="">Regulation .01A</a> amended effective July 1, 2010 (37:10 Md. R. 722)</p>
                  <h3>Authority</h3>
                  <p>Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">12-205</a> and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-305" title="">12-305</a>, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.15.01" data-order="|10|34|15|.01|" data-ref-path="10|34|15|.01" class="h__section">.01 Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.15.01#A">A.</span> An individual applying for licensure as a pharmacist by reciprocity shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.15.01#A(1)">(1)</span> Submit to the Board an application on a form provided by the Board;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.15.01#A(2)">(2)</span> Pay to the Board the fee as specified in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09" title="Chapter 09 Fees">COMAR 10.34.09</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.15.01#A(3)">(3)</span> Submit to the Board evidence of completion of at least 520 hours of pharmacy experience after graduation from a school or college of pharmacy approved by the Board or accredited by the American Council on Pharmaceutical Education;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.15.01#A(4)">(4)</span> Pass the MPJE; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.15.01#A(5)">(5)</span> Pass the exam of oral English competency described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.02" title="Chapter 02 Examination for Licensure and Professional Experience Programs">COMAR 10.34.02</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.15.01#B">B.</span> The Board shall waive the requirements of <a class="internal-link " href="/us/md/exec/comar/10.34.15.01#A(5)" title="">§A(5) of this regulation</a> if the candidate for licensure by reciprocity submits to the Board written documentation that the candidate has passed an equivalent oral English competency exam in another state that was required by the other state's licensing procedures.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.16" data-order="|10|34|16|" data-ref-path="10|34|16" class="h__chapter">Chapter 16 Portable Drug Kits for Licensed Home Health Agencies, Hospices, and Home Infusion Providers Licensed as Residential Services Agencies</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: September 6, 1999 (26:18 Md. R. 1376)</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.16.01" title=".01 Definitions.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.16.04" title=".04 Requirements of the Portable Drug Kit.">.04</a> amended effective April 16, 2001 (28:7 Md. R. 690)</p>
                  <p>Regulations .05 and.06 adopted effective April 16, 2001 (28:7 Md. R. 690)</p>
                  <h3>Authority</h3>
                  <p><a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">Health Occupations Article, §12-205, </a>Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.16.01" data-order="|10|34|16|.01|" data-ref-path="10|34|16|.01" class="h__section">.01 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.16.01#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.16.01#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.16.01#B(1)">(1)</span> "Committee" means, in this chapter, a joint committee of representatives from the Board of Pharmacy and the Board of Nursing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.16.01#B(2)">(2)</span> "Portable drug kit" means a container comprising prescription drugs and other emergency medical supplies or drugs for use in licensed home health and licensed hospice settings, and by home infusion providers licensed as residential services agencies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.16.01#B(3)">(3)</span> "Prescription protocol" means an order for a portable drug kit signed by the medical director of a licensed home health agency, licensed general hospice, or a home infusion provider licensed as a residential services agency.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.16.02" data-order="|10|34|16|.02|" data-ref-path="10|34|16|.02" class="h__section">.02 Requirements for Prescription Protocol.</h3>
                <p>Before distributing a portable drug kit, the pharmacist shall ensure that the prescription protocol includes:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.16.02#A">A.</span> The name, strength, and quantity of a drug to be included in the portable drug kit;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.16.02#B">B.</span> The name of the receiving agency or designated agent;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.16.02#C">C.</span> The directions for use;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.16.02#D">D.</span> Conditions for use;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.16.02#E">E.</span> Contraindications for use; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.16.02#F">F.</span> The signature, printed name, and telephone number of the physician authorizing the kit.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.16.03" data-order="|10|34|16|.03|" data-ref-path="10|34|16|.03" class="h__section">.03 Records.</h3>
                <p>A pharmacist shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.16.03#A">A.</span> File the prescription protocol in a readily retrievable manner;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.16.03#B">B.</span> Document the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.16.03#B(1)">(1)</span> Date of distribution of the portable drug kit,</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.16.03#B(2)">(2)</span> Name of the person or agency to whom the kit is delivered, and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.16.03#B(3)">(3)</span> Date of delivery for each kit distributed;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.16.03#C">C.</span> File an administration record for all drugs administered from a kit upon return of the kit to the pharmacy; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.16.03#D">D.</span> Notify the Board of Pharmacy before distributing portable drug kits under this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.16.04" data-order="|10|34|16|.04|" data-ref-path="10|34|16|.04" class="h__section">.04 Requirements of the Portable Drug Kit.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#A">A.</span> The pharmacist shall ensure that the portable drug kit:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#A(1)">(1)</span> Is sealed with a tamper evident tag or other means for detecting entry to the kit;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#A(2)">(2)</span> Displays on the outside of the kit:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#A(2)(a)">(a)</span> A serial number unique to the kit;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#A(2)(b)">(b)</span> An expiration date which reflects the earliest expiration date of any item contained in the kit;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#A(2)(c)">(c)</span> The contents of the kit;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#A(2)(d)">(d)</span> That the contents are or are not sterile;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#A(2)(e)">(e)</span> The legend "To be returned to the pharmacy within 5 days of breaking seal, with a completed administration record or prescription enclosed"; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#A(2)(f)">(f)</span> Storage requirements for the contents;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#A(3)">(3)</span> Contains:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#A(3)(a)">(a)</span> Only prescription drugs and nonprescription items approved for the kit by a committee as defined in <a class="internal-link " href="/us/md/exec/comar/10.34.16.01#B(1)" title="">Regulation .01B(1) of this chapter</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#A(3)(b)">(b)</span> A temperature monitor to indicate maintenance of proper storage conditions; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#A(3)(c)">(c)</span> A written administration record to be completed by the licensed health care provider using the kit, which includes the administration record indicating:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#A(3)(c)(i)">(i)</span> The name of the patient,</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#A(3)(c)(ii)">(ii)</span> The name of the prescriber,</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#A(3)(c)(iii)">(iii)</span> Drug name, form, and dosage,</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#A(3)(c)(iv)">(iv)</span> Date the drug was used or wasted,</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#A(3)(c)(v)">(v)</span> The reason for administration or wastage of the drug, and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#A(3)(c)(vi)">(vi)</span> The name of the licensed health care provider utilizing the kit;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#A(4)">(4)</span> Displays or includes written information inside the kit listing contraindications to use of the kit; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#A(5)">(5)</span> Does not contain a controlled dangerous substance.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.16.04#B">B.</span> A pharmacist shall only distribute a portable drug kit which complies with the requirements of this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.16.05" data-order="|10|34|16|.05|" data-ref-path="10|34|16|.05" class="h__section">.05 Contents of Portable Drug Kit.</h3>
                <p>The committee shall review annually the approved prescription drugs and nonprescription items to ensure that the contents of a portable drug kit are appropriate.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.16.06" data-order="|10|34|16|.06|" data-ref-path="10|34|16|.06" class="h__section">.06 Distribution of Portable Drug Kits.</h3>
                <p>Portable drug kits may only be distributed to licensed health care providers who are authorized by law to administer the contents of a portable drug kit.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.17" data-order="|10|34|17|" data-ref-path="10|34|17" class="h__chapter">Chapter 17 Waiver of Full Service Requirements for Recognized Pharmaceutical Specialties</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: June 15, 1987 (14:12 Md. R. 1350)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.17.04#A" title="">Regulation .04A</a> amended effective January 17, 1994 (20:1 Md. R. 34)</p>
                  <p>——————</p>
                  <p>Chapter revised effective October 19, 2009 (36:21 Md. R. 1591)</p>
                  <h3>Authority</h3>
                  <p><a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-403" title="">Health Occupations Article, §12-403, </a>Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.17.01" data-order="|10|34|17|.01|" data-ref-path="10|34|17|.01" class="h__section">.01 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(1)">(1)</span> "Board" means the State Board of Pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(2)">(2)</span> "Comprehensive care facility" means a facility which admits patients suffering from disease, disabilities, or advanced age, requiring medical service and nursing service rendered by or under the supervision of a registered nurse.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(3)">(3)</span> "Continuing care in a retirement community" means providing shelter and providing either medical and nursing or other health related services or making the services readily accessible through the provider or an affiliate of the provider, whether or not the services are specifically offered in the written agreement for shelter:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(3)(a)">(a)</span> To an individual who is 60 years old or older and not related by blood or marriage to the provider;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(3)(b)">(b)</span> For the life of the individual or for a period exceeding 1 year; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(3)(c)">(c)</span> Under one or more written agreements that require a transfer of assets or an entrance fee notwithstanding periodic charges.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(4)">(4)</span> "Full service pharmacy" means a pharmacy that provides complete pharmaceutical services to the general public and does not restrict or limit its services to any group of individuals.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(5)">(5)</span> Pharmaceutical Specialty.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(5)(a)">(a)</span> "Pharmaceutical specialty" means a limited pharmaceutical service provided by a pharmacy that:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(5)(a)(i)">(i)</span> Is in or makes use of a specialized setting by virtue of certain equipment, systems, location, or physical structure; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(5)(a)(ii)">(ii)</span> Restricts or limits its services to a group or groups of individuals requiring such specialty services.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(5)(b)">(b)</span> "Pharmaceutical specialty" includes the following services:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(5)(b)(i)">(i)</span> Assisted living facilities;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(5)(b)(ii)">(ii)</span> Comprehensive care facilities;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(5)(b)(iii)">(iii)</span> Developmental disabilities facilities;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(5)(b)(iv)">(iv)</span> Home infusion;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(5)(b)(v)">(v)</span> Inpatient hospital;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(5)(b)(vi)">(vi)</span> Nonsterile compounding;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(5)(b)(vii)">(vii)</span> Nuclear pharmaceutical;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(5)(b)(viii)">(viii)</span> Research;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(5)(b)(ix)">(ix)</span> Sterile compounding;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(5)(b)(x)">(x)</span> Veterinary care;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(5)(b)(xi)">(xi)</span> Provision of pharmaceutical services across all settings of care within a continuing care in a retirement community; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(5)(b)(xii)">(xii)</span> Other services approved by the Board.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.17.01#B(6)">(6)</span> "Waiver pharmacy" means a pharmacy that has been issued a waiver permit by the Board.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.17.02" data-order="|10|34|17|.02|" data-ref-path="10|34|17|.02" class="h__section">.02 Pharmaceutical Specialty.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.17.02#A">A.</span> The Board may recognize as a pharmaceutical specialty not listed under <a class="internal-link " href="/us/md/exec/comar/10.34.17.01#B(4)" title="">Regulation .01B(4) of this chapter</a>, upon written application and supporting documentation to the Board by an applicant for a waiver permit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.17.02#B">B.</span> When evaluating an application for a waiver pharmacy, the Board shall consider whether:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.17.02#B(1)">(1)</span> The pharmaceutical specialty service is necessary to meet a specific therapeutic need;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.17.02#B(2)">(2)</span> The location is accessible without endangering public health and safety;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.17.02#B(3)">(3)</span> The pharmacy is properly equipped to perform the pharmaceutical specialty;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.17.02#B(4)">(4)</span> The applicant has provided a full and detailed description of the pharmaceutical specialty that clearly substantiates the basis for the request of a waiver permit; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.17.02#B(5)">(5)</span> A policy and procedure manual is included with the application which sets forth a detailed description of the pharmacy operation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.17.02#C">C.</span> No one criterion or combination of criteria listed in <a class="internal-link " href="/us/md/exec/comar/10.34.17.02#B" title="">§B of this regulation</a> shall be binding upon the Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.17.02#D">D.</span> The Board's determination of whether a limited practice or setting constitutes a pharmaceutical specialty is final.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.17.03" data-order="|10|34|17|.03|" data-ref-path="10|34|17|.03" class="h__section">.03 Requirements of a Waiver Pharmacy.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.17.03#A">A.</span> The Board shall issue a waiver permit to an applicant that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.17.03#A(1)">(1)</span> Meets the requirements of this chapter; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.17.03#A(2)">(2)</span> Performs pharmaceutical specialty services:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.17.03#A(2)(a)">(a)</span> Listed in <a class="internal-link " href="/us/md/exec/comar/10.34.17.01#B(4)" title="">Regulation .01B(4) of this chapter</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.17.03#A(2)(b)">(b)</span> Approved by the Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.17.03#B">B.</span> The applicant shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.17.03#B(1)">(1)</span> Submit an application form approved by the Board;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.17.03#B(2)">(2)</span> Pay a fee as set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09" title="Chapter 09 Fees">COMAR 10.34.09</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.17.03#B(3)">(3)</span> Submit any other documentation as required by the Board;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.17.03#B(4)">(4)</span> Employ at least one pharmacist at the applicant's proposed facility who has received education or training in the pharmaceutical specialty in addition to that required for licensure; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.17.03#B(5)">(5)</span> Notify the Board in writing within 30 days of any change in the information given on the initial or renewal waiver pharmacy application.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.17.04" data-order="|10|34|17|.04|" data-ref-path="10|34|17|.04" class="h__section">.04 Restricted Practice.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.17.04#A">A.</span> A waiver pharmacy is restricted to the pharmaceutical specialty services approved by the Board in the waiver permit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.17.04#B">B.</span> A waiver pharmacy may not perform functions of a full service pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.17.04#C">C.</span> A full service pharmacy may perform pharmaceutical specialty services as long as the full service pharmacy is able to demonstrate competency in performing the pharmaceutical specialty.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.17.04#D">D.</span> A full service pharmacy and a waiver pharmacy may operate on the same premises provided that the full service pharmacy and the waiver pharmacy:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.17.04#D(1)">(1)</span> Obtain separate permits from the Board;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.17.04#D(2)">(2)</span> Are supervised by separate licensed pharmacists who are responsible for the operations of their respective pharmacies at all times the pharmacies are in operation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.17.04#D(3)">(3)</span> Maintain separate inventory and record keeping for each pharmacy permit.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.18" data-order="|10|34|18|" data-ref-path="10|34|18" class="h__chapter">Chapter 18 Continuing Education for Pharmacists</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: August 8, 1988 (15:16 Md. R. 1915)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.18.06#A" title="">Regulation .06A</a> amended effective July 3, 1995 (22:13 Md. R. 967)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.18.07" title=".07 Acceptance of Previously Unapproved Continuing Education Programs.">Regulation .07</a> amended effective July 3, 1995 (22:13 Md. R. 967)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.18.08" title=".08 Miscellaneous.">Regulation .08</a> adopted effective November 3, 1997 (24:22 Md. R. 1552)</p>
                  <p>——————</p>
                  <p>Chapter revised effective July 1, 2010 (37:10 Md. R. 722)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.18.01" title=".01 Scope.">Regulation .01</a>-1 adopted effective April 30, 2012 (39:8 Md. R. 536)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.18.03#C" title="">Regulation .03C</a> amended effective June 5, 2017 (44:11 Md. R. 525)</p>
                  <h3>Authority</h3>
                  <p>Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">12-205</a> and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-309" title="">12-309</a>, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.18.01" data-order="|10|34|18|.01|" data-ref-path="10|34|18|.01" class="h__section">.01 Scope.</h3>
                <p>These regulations govern any person who desires to renew a license to practice pharmacy in Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.18.01-1" data-order="|10|34|18|.01-1|" data-ref-path="10|34|18|.01-1" class="h__section">.01-1 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.18.01-1#A">A.</span> In this chapter, the following term has the meaning indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.18.01-1#B">B.</span> Live Instruction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.18.01-1#B(1)">(1)</span> “Live instruction” means a course offering the ability for the participant to have real-time interaction with the presenter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.18.01-1#B(2)">(2)</span> “Live instruction” includes programs approved by the American Council on Pharmaceutical Education (ACPE) that are designated by the letter “L” in the course identification number.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.18.02" data-order="|10|34|18|.02|" data-ref-path="10|34|18|.02" class="h__section">.02 Exceptions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.18.02#A">A.</span> This chapter does not apply to pharmacists applying for renewal for the first renewal period following the issuance of the original license, if the pharmacist obtains a license within 1 year of the completion of the pharmacist's pharmaceutical education.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.18.02#B">B.</span> The Board may grant an exception from the continuing education requirements if the pharmacist presents evidence that failure to comply was due to circumstances beyond the pharmacist's control.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.18.03" data-order="|10|34|18|.03|" data-ref-path="10|34|18|.03" class="h__section">.03 Requirements for Pharmacists Practicing in Maryland.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.18.03#A">A.</span> A pharmacist license expires on the last day of the pharmacist's birth month every other year.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.18.03#B">B.</span> Before the expiration date of the pharmacist's license, the pharmacist shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.18.03#B(1)">(1)</span> File a renewal application;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.18.03#B(2)">(2)</span> Pay any applicable fees; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.18.03#B(3)">(3)</span> Earn continuing pharmaceutical education (CE) credits required by this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.18.03#C">C.</span> CE Requirements.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.18.03#C(1)">(1)</span> A pharmacist licensed to practice in Maryland applying for renewal shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.18.03#C(1)(a)">(a)</span> Earn 30 hours of approved CE within the 2-year period immediately preceding the license expiration date that include:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.18.03#C(1)(a)(i)">(i)</span> 1 hour on the topic of preventing medication errors, such as appropriate dispensing of opioids; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.18.03#C(1)(a)(ii)">(ii)</span> 2 hours of CE obtained through live instruction;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.18.03#C(1)(b)">(b)</span> Attest to the fact that the pharmacist has completed the CE requirement on a Board approved form; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.18.03#C(1)(c)">(c)</span> Retain supporting documents for inspection by the Board for 4 years after the date of renewal for which the CE credits were used.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.18.03#C(2)">(2)</span> A pharmacist certified to administer vaccinations in Maryland applying for renewal shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.18.03#C(2)(a)">(a)</span> As part of the 30 hours of approved CE requirement, complete 4 hours of CE credits related to vaccinations; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.18.03#C(2)(b)">(b)</span> If registered to administer vaccines before October 1, 2008 for the first renewal of the registration after that date, demonstrate that 4 CE credits taken include education about the herpes zoster and pneumococcal pneumonia vaccines.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.18.04" data-order="|10|34|18|.04|" data-ref-path="10|34|18|.04" class="h__section">.04 Requirements for Pharmacists Not Practicing in Maryland.</h3>
                <p>A licensed pharmacist not practicing in Maryland shall fulfill the continuing education requirements of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.18.05" data-order="|10|34|18|.05|" data-ref-path="10|34|18|.05" class="h__section">.05 Requirements for Pharmacists who are Authorized Prescribers.</h3>
                <p>A pharmacist who is also an authorized prescriber licensed by a board (in Maryland or another state) may use the continuing education (CE) credits applied toward that board toward the Board of Pharmacy's CE requirements.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.18.06" data-order="|10|34|18|.06|" data-ref-path="10|34|18|.06" class="h__section">.06 Accredited Continuing Education Programs.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#A">A.</span> The Board and the following providers are approved for any programs they offer which otherwise qualify for continuing education (CE) credit:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#A(1)">(1)</span> American Council on Pharmaceutical Education (ACPE);</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#A(2)">(2)</span> Schools of pharmacy accredited by ACPE;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#A(3)">(3)</span> Food and Drug Administration (FDA);</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#A(4)">(4)</span> Drug Enforcement Administration (DEA); and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#A(5)">(5)</span> Additional providers of programs approved by the Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#B">B.</span> Procedures for Approval of Additional Programs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#B(1)">(1)</span> An additional provider shall request approval for an individual program by submitting a Board application at least 60 days before the date of offering of their individual program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#B(2)">(2)</span> An approval request shall fulfill the program requirements set forth in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-309" title="">Health Occupations Article, §12-309(g), Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#B(3)">(3)</span> An approval request shall include a description of course work including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#B(3)(a)">(a)</span> Measurable learning objectives;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#B(3)(b)">(b)</span> A course outline; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#B(3)(c)">(c)</span> Self-assessment questions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#B(4)">(4)</span> The Board's decision to approve or disapprove a program is final.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#C">C.</span> Record Keeping for Providers of Approved Programs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#C(1)">(1)</span> Providers of approved programs shall maintain program records for 3 years from the date of presentation of the program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#C(2)">(2)</span> Providers of approved programs of CE shall furnish a certificate of completion to participants who qualify. The provider shall include the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#C(2)(a)">(a)</span> Name of the participant;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#C(2)(b)">(b)</span> Name of the provider;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#C(2)(c)">(c)</span> Title of the course;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#C(2)(d)">(d)</span> Number of CE hours;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#C(2)(e)">(e)</span> Date of completion; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#C(2)(f)">(f)</span> A program identification number or provider number on the certificate.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.18.06#D">D.</span> The Board may rescind approval of a CE program if it determines that the program no longer meets the requirements of <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-309" title="">Health Occupations Article, §12-309, Annotated Code of Maryland</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.18.07" data-order="|10|34|18|.07|" data-ref-path="10|34|18|.07" class="h__section">.07 Acceptance of Previously Unapproved Continuing Education Programs.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.18.07#A">A.</span> A pharmacist who completes a program of continuing education that is not previously approved by the Board may request in writing that the Board approve the program for credit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.18.07#B">B.</span> The pharmacist making a request for Board approval under <a class="internal-link " href="/us/md/exec/comar/10.34.18.07#A" title="">§A of this regulation</a> shall make the request at least 90 days before licensed expiration.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.18.08" data-order="|10|34|18|.08|" data-ref-path="10|34|18|.08" class="h__section">.08 Miscellaneous.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.18.08#A">A.</span> Credits may not be carried over from one licensing renewal period to another.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.18.08#B">B.</span> Falsifying continuing education CE records is grounds for disciplinary action.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.18.08#C">C.</span> The pharmacist shall use a Board approved form to supply the pharmacist's CE information to the Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.18.08#D">D.</span> CE requirements imposed by the Board upon a pharmacist as part of an informal action, consent order, or final order, as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.01.02" title=".02 Definitions.">COMAR 10.34.01.02</a>, shall be in addition to the requirements of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.18.08#E">E.</span> Pharmacists may receive 2 CE credits for attending a public Board meeting in its entirety.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.18.08#E(1)">(1)</span> The Board shall issue a certificate of proof of attendance at a public Board meeting.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.18.08#E(2)">(2)</span> A pharmacist may not earn more than 4 CE credits per renewal period for attendance of a public Board meeting.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.19" data-order="|10|34|19|" data-ref-path="10|34|19" class="h__chapter">Chapter 19 Sterile Pharmaceutical Compounding</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: February 19, 1990 (17:3 Md. R. 299)</p>
                  <p>Regulation .04B amended effective July 20, 1992 (19:14 Md. R. 1284)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.05" title=".05 General Requirements.">Regulation .05</a> amended effective July 20, 1992 (19:14 Md. R. 1284)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.01" title=".01 Scope.">.01</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.06" title=".06 Special Handling, Packaging, Labeling, and Beyond Use Dating.">.06</a> repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.01" title=".01 Scope.">.01</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.16" title=".16 Reference Library.">.16</a> adopted effective September 10, 2007 (34:18 Md. R. 1580)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.01" title=".01 Scope.">Regulation .01</a> amended effective February 23, 2009 (36:4 Md. R. 354)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.02" title=".02 Incorporation by Reference.">Regulation .02</a> amended effective February 23, 2009 (36:4 Md. R. 354)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.03#B" title="">Regulation .03B</a> amended effective February 23, 2009 (36:4 Md. R. 354); February 1, 2016 (43:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.05#A" title="">Regulation .05A</a> amended effective February 1, 2016 (43:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.06#A" title="">Regulation .06A</a> amended effective February 1, 2016 (43:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.06#A" title="">Regulation .06A</a>, D amended effective February 23, 2009 (36:4 Md. R. 354)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.07#A" title="">Regulation .07A</a> amended effective February 1, 2016 (43:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.09" title=".09 Minimum Facility Requirements.">Regulation .09</a> amended effective February 23, 2009 (36:4 Md. R. 354)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.09#A" title="">Regulation .09A</a> amended effective February 1, 2016 (43:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.10" title=".10 Minimum Requirements for Equipment.">Regulation .10</a> amended effective February 23, 2009 (36:4 Md. R. 354)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.11" title=".11 Minimum Requirements for Supplies.">Regulation .11</a> amended effective February 23, 2009 (36:4 Md. R. 354)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.13" title=".13 Attire.">Regulation .13</a> amended effective February 23, 2009 (36:4 Md. R. 354)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.14#E" title="">Regulation .14E</a> amended effective February 23, 2009 (36:4 Md. R. 354)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.15#C" title="">Regulation .15C</a>, E amended effective February 23, 2009 (36:4 Md. R. 354)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.16#A" title="">Regulation .16A</a> amended effective February 23, 2009 (36:4 Md. R. 354)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.17" title=".17 Minimum Requirements for Inspections.">Regulation .17</a> adopted effective February 1, 2016 (43:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.18" title=".18 Reporting Requirements Pharmacies.">Regulation .18</a> adopted effective February 1, 2016 (43:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19.19" title=".19 Office Use.">Regulation .19</a> adopted effective February 1, 2016 (43:2 Md. R. 127)</p>
                  <h3>Authority</h3>
                  <p>Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">12-205</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-403" title="">12-403</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-503" title="">12-503</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-505" title="">12-505</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">12-6</a>C-<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=01" title="">01</a>, and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">12-6</a>C-03, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.19.01" data-order="|10|34|19|.01|" data-ref-path="10|34|19|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter applies to a licensed pharmacy in Maryland engaging in:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.01#A">A.</span> Compounding or mixing sterile prescription solutions or suspensions to be administered parenterally or by irrigation, inhalation, or intraocular routes; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.01#B">B.</span> Compounding of radiopharmaceuticals, except where U.S. Pharmacopeia (USP) General Chapter 797 Pharmaceutical Compounding — Sterile Preparations addresses radiopharmaceuticals, U.S. Pharmacopeia (USP) Chapter 821 Radioactivity, and U.S. Pharmacopeia (USP) Chapter 823 Radiopharmaceuticals for Positron Emission Tomography — Compounding would apply.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.19.02" data-order="|10|34|19|.02|" data-ref-path="10|34|19|.02" class="h__section">.02 Incorporation by Reference.</h3>
                <p>In this chapter, the following documents are incorporated by reference:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.02#A">A.</span> U.S. Pharmacopeia (USP) General Chapter 797 Pharmaceutical Compounding — Sterile Preparations (USP 797 Standards), which has been incorporated by reference in 21 U.S.C. §351(b) (as amended).</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.02#B">B.</span> U.S. Pharmacopeia (USP) General Chapter 795 Pharmaceutical Compounding — Non-Sterile Preparations (USP 795 Standards), which has been incorporated by reference in 21 U.S.C. §351(b) (as amended).</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.02#C">C.</span> U.S. Pharmacopeia (USP) Chapter 821 Radioactivity, which has been incorporated by reference in 21 U.S.C. §351(b) (as amended).</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.02#D">D.</span> U.S. Pharmacopeia (USP) Chapter 823 Radiopharmaceuticals for Positron Emission Tomography — Compounding, which has been incorporated by reference in 21 U.S.C. §351(b) (as amended).</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.19.03" data-order="|10|34|19|.03|" data-ref-path="10|34|19|.03" class="h__section">.03 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(1)">(1)</span> “Adverse event” means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(1)(a)">(a)</span> Any adverse patient outcome related to the sterile compounding process; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(1)(b)">(b)</span> Evidence of environmental contamination, including microbial contamination above the threshold set forth in USP 797 Standards.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(2)">(2)</span> "Antineoplastic" means an agent that prevents the development, growth, or proliferation of malignant cells.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(3)">(3)</span> "Anteroom" means the area, room, or rooms where personnel perform hand hygiene and garbing immediately adjacent to the designated clean room where the compounding of sterile preparations is performed.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(4)">(4)</span> Batch.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(4)(a)">(a)</span> "Batch" means a preparation compounded in advance of receipt of a prescription, or a preparation compounded in a supply that will be used on more than one dispensing to a patient or patients or any preparation compounded in excess of the filling of an individual prescription.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(4)(b)">(b)</span> "Batch" includes a limited quantity of identical preparations compounded in a single, discrete process, by the same individuals, carried out during one limited time period.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(5)">(5)</span> "Biological safety cabinet" means a containment unit:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(5)(a)">(a)</span> Suitable for work involving agents that pose higher risk of exposure to operators during compounding; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(5)(b)">(b)</span> Used when there is a need for protection of the preparation, personnel, and environment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(6)">(6)</span> “Clean room” means a room with an International Standards Organization (ISO) Class 5 environment or an ISO Class 7 environment that meets USP 797 Standards, inside which compounding occurs within an ISO Class 5 engineering control device such as a laminar airflow workstation or a biological safety cabinet.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(7)">(7)</span> "Closed system vial transfer device (CSTD)" means a closed system drug transfer device that mechanically, not by means of vents or filters, prohibits the transfer of environmental contaminants into the system and the escape of hazardous drug aerosols or vapors into the environment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(8)">(8)</span> "Compounded sterile preparation" means sterile medication preparations, such as intravenous, epidural, and intraocular medications, compounded in the pharmacy using currently accepted aseptic compounding techniques under acceptable compounding conditions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(9)">(9)</span> “Compounding” means the preparation, mixing, assembling, packaging, or labeling of a drug:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(9)(a)">(a)</span> As the result of a practitioner’s prescription drug order or initiative based on the practitioner/patient relationship in the course of professional practice;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(9)(b)">(b)</span> For the purpose of, or incidental to, research, teaching, or chemical analysis and not for the sale or dispensing of the drug or device; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(9)(c)">(c)</span> In anticipation of a prescription drug order based on routine, regularly observed prescribing patterns.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(10)">(10)</span> "Compounding aseptic isolator" means an enclosed positive or negative pressure environment especially designed for sterile preparation compounding that maintains a physical barrier between the workspace and the operator.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(11)">(11)</span> "Controlled environment" means a designated area for compounding sterile preparations that consists of a clean room and an anteroom.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(12)">(12)</span> "Cytotoxic" means drug entities that are damaging or debilitating to cells, tissues, or organs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(13)">(13)</span> “Designee” means a public agency or private entity trained in:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(13)(a)">(a)</span> USP 797 Standards;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(13)(b)">(b)</span> FDA good manufacturing practices approved by the Board to conduct inspections of nonresident pharmacies that perform sterile compounding; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(13)(c)">(c)</span> Both §B(13)(a) and (b) of this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(14)">(14)</span> "Laminar air flow workstation" means an ISO Class 5 ("Class 100") laminar airflow hood inside which sterile compounding occurs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(15)">(15)</span> "Media fill verification" means a process of practical examination to verify the aseptic technique of personnel or an aseptic process by manual manipulation of microbiological growth media which simulates compounding processes and techniques used in actual compounding procedures.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(16)">(16)</span> "Parenteral" means routes of drug administration or fluid administration other than via the gastrointestinal tract.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(17)">(17)</span> "Pharmacist" means an individual who is licensed to practice pharmacy regardless of the location where the activities of practice are performed.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(18)">(18)</span> "Pharmacy" means an establishment in which prescription or nonprescription drugs or devices are compounded, dispensed, or distributed.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(19)">(19)</span> "Pyrogen testing" means an analysis of sterile preparations for the presence of cell material from microbiological organisms in sufficient quantity to elicit a febrile reaction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(20)">(20)</span> “Risk level” means a risk level of low, medium, or high as defined in USP 797 Standards.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(21)">(21)</span> "Sterile" means free from living microorganisms or any other contaminants.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(22)">(22)</span> “Sterile compounding” means compounding of biologics, diagnostics, drugs, nutrients, and radiopharmaceuticals that, under USP 797 Standards, are prepared using aseptic techniques.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(23)">(23)</span> "Total parenteral nutrition" means providing caloric needs by the parenteral route for a patient who is unable to ingest sufficient calories.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(24)">(24)</span> "USP 795 Standards" means standards set forth in the US Pharmacopeia (USP) General Chapter 795 Pharmaceutical Compounding — Non-Sterile Preparations.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.03#B(25)">(25)</span> "USP 797 Standards" means standards set forth in the U.S. Pharmacopeia (USP) General Chapter 797 Pharmaceutical Compounding — Sterile Preparations.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.19.04" data-order="|10|34|19|.04|" data-ref-path="10|34|19|.04" class="h__section">.04 Pharmacy Environment.</h3>
                <p>The compounding, preparation, and dispensing of compounded sterile preparations shall be accomplished in a pharmacy environment subject to State and federal laws, regulations, and standards.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.19.05" data-order="|10|34|19|.05|" data-ref-path="10|34|19|.05" class="h__section">.05 General Requirements.</h3>
                <p>A licensed pharmacist who has appropriate practical and didactic training in compounding sterile preparations, clean room technology, laminar flow technology, quality assurance techniques, and clinical application of intravenous drug therapy shall control and supervise the section of the pharmacy that prepares compounded sterile preparations and is responsible for, at a minimum, the following:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.05#A">A.</span> Preparation of compounded sterile preparations within the pharmacy or decentralized pharmacy;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.05#B">B.</span> Storage of materials pertinent to the preparation of compounded sterile preparations, including drugs, chemicals, and biologicals, and the establishment of specifications for procurement of the materials;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.05#C">C.</span> Labeling of containers of compounded sterile preparations compounded within the pharmacy;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.05#D">D.</span> Recording of transactions of the pharmacy as may be applicable to State and federal laws and regulations, as may be necessary to maintain accurate control over, and accountability for, pharmaceutical materials; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.05#E">E.</span> Ensuring that licensed pharmacists meeting the requirements of <a class="internal-link " href="/us/md/exec/comar/10.34.19.05#A" title="">§A of this regulation</a>, or registered pharmacy technicians under direct supervision of a licensed pharmacist meeting the requirements of <a class="internal-link " href="/us/md/exec/comar/10.34.19.05#A" title="">§A of this regulation</a>, prepare, compound, and dispense compounded sterile preparations.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.19.06" data-order="|10|34|19|.06|" data-ref-path="10|34|19|.06" class="h__section">.06 Special Handling, Packaging, Labeling, and Beyond Use Dating.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.06#A">A.</span> The pharmacy shall make available special handling and packaging materials to maintain container integrity and drug stability of the prepared prescription orders, including antineoplastic or other hazardous sterile preparations, during handling and administration to the patient including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.06#A(1)">(1)</span> A reasonable effort to provide tamper-evident packaging if appropriate to setting;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.06#A(2)">(2)</span> Proper in-transit storage consistent with preparation labeling; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.06#A(3)">(3)</span> Delivery to the patient within a reasonable time.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.06#B">B.</span> The dispensed container for any compounded sterile preparation shall include labeling according to Maryland law and regulations, in addition to the following information that is required by federal law:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.06#B(1)">(1)</span> The date of preparation unless otherwise readily retrievable from prescription records;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.06#B(2)">(2)</span> Time prepared, if applicable;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.06#B(3)">(3)</span> The pertinent requirements for proper storage;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.06#B(4)">(4)</span> The name of the prescriber, unless in an inpatient hospital setting;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.06#B(5)">(5)</span> The name of the patient;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.06#B(6)">(6)</span> Directions for use;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.06#B(7)">(7)</span> The name of the base solution for infusion preparations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.06#B(8)">(8)</span> The name and concentration or amount of active drugs contained in the final sterile preparation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.06#B(9)">(9)</span> The name or identifying initials of the pharmacist who checked or prepared the compounded sterile preparation unless otherwise readily retrievable from prescription records;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.06#B(10)">(10)</span> The name, address, and telephone number of the pharmacy unless in an inpatient hospital facility;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.06#B(11)">(11)</span> The beyond-use/expiration dating and time of the compounded sterile preparation, and if no time is stated, the time is presumed to be at 11:59 p.m. of the stated beyond use date;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.06#B(12)">(12)</span> Any ancillary and cautionary instructions as needed; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.06#B(13)">(13)</span> A pertinent warning consistent with applicable federal and State law that cytotoxic preparations are biohazardous, when applicable.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.06#C">C.</span> A pharmacy compounding sterile infusion preparations shall provide a 24-hour telephone number to allow its patients or other health care providers who may be administering its prescriptions to contact its pharmacists.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.06#D">D.</span> Expiration or Beyond-Use Dating. In the absence of direct testing evidence, as detailed in the Stability Criteria and Beyond Use Dating section of USP 795 Standards, the pharmacist shall use "beyond-use dating" as determined by USP 797 Standards and reference materials as cited in <a class="internal-link " href="/us/md/exec/comar/10.34.19.16" title=".16 Reference Library.">Regulation .16 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.19.07" data-order="|10|34|19|.07|" data-ref-path="10|34|19|.07" class="h__section">.07 Record-Keeping Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#A">A.</span> Patient Prescription Records.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#A(1)">(1)</span> The pharmacy shall maintain records of patient prescriptions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#A(2)">(2)</span> Patient prescription records shall contain:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#A(2)(a)">(a)</span> Available medical information consistent with prevailing pharmacy standards; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#A(2)(b)">(b)</span> The complete record of the formulations of the solutions that were compounded.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#A(3)">(3)</span> The pharmacy shall keep completed patient prescription records in a retrievable manner for at least 5 years, either:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#A(3)(a)">(a)</span> At the inspection site; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#A(3)(b)">(b)</span> So as to be immediately retrievable by computer or other electronic means.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#B">B.</span> Compounded Sterile Preparations Records.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#B(1)">(1)</span> For a pharmacy preparing compounded sterile preparations, the following records shall be maintained for at least 5 years:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#B(1)(a)">(a)</span> The training and competency evaluation of employees in sterile preparation procedures;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#B(1)(b)">(b)</span> Refrigerator and freezer temperatures;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#B(1)(c)">(c)</span> Certification of the sterile compounding environment, including ISO 5 workstations and the clean and anterooms;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#B(1)(d)">(d)</span> Other facility quality control logs specific to the pharmacy's policies and procedures, for example, cleaning logs for facilities and equipment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#B(1)(e)">(e)</span> Records documenting inspection for expired or recalled pharmaceutical preparations or raw ingredients;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#B(1)(f)">(f)</span> Preparation records including compounding work sheets, and records of the registered pharmacy technicians' checking/sign-off process; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#B(1)(g)">(g)</span> Preparation records including compounding work sheets and records of the pharmacists' checking/sign-off process.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#B(2)">(2)</span> In addition to the records requirement in <a class="internal-link " href="/us/md/exec/comar/10.34.19.07#B(1)" title="">§B(1) of this regulation</a>, for batch compounded sterile preparations, a pharmacy compounding sterile batch preparations for future use shall have records indicating the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#B(2)(a)">(a)</span> Drug and ingredient names;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#B(2)(b)">(b)</span> Lot numbers;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#B(2)(c)">(c)</span> Expiration dates;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#B(2)(d)">(d)</span> Drug/diluent amounts; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#B(2)(e)">(e)</span> Date on which the compounded sterile batch preparations were prepared.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.07#B(3)">(3)</span> A pharmacy shall maintain records of media fill verification results for 5 years.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.19.08" data-order="|10|34|19|.08|" data-ref-path="10|34|19|.08" class="h__section">.08 Batch Preparation.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.08#A">A.</span> A pharmacist may prepare batched sterile preparations for future use in limited quantities supported by prior valid prescriptions or physician orders before receiving a valid written prescription or medication order.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.08#B">B.</span> Batch preparation of specific compounded sterile preparations is acceptable if the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.08#B(1)">(1)</span> Pharmacist can document a history of valid prescriptions or physician orders that have been generated solely within an established professional prescriber-patient-pharmacist relationship; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.08#B(2)">(2)</span> Pharmacy maintains the prescription on file for such preparations dispensed.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.19.09" data-order="|10|34|19|.09|" data-ref-path="10|34|19|.09" class="h__section">.09 Minimum Facility Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#A">A.</span> Controlled Environment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#A(1)">(1)</span> The pharmacy shall have a controlled environment that meets USP 797 Standards.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#A(2)">(2)</span> A pharmacist shall ensure that the controlled environment is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#A(2)(a)">(a)</span> Accessible only to designated personnel; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#A(2)(b)">(b)</span> Used only for the preparation of compounded sterile preparations, or such other tasks that require a controlled environment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#A(3)">(3)</span> The permit holder shall ensure that the controlled environment is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#A(3)(a)">(a)</span> Structurally isolated from other areas within the pharmacy by means of restricted entry or access; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#A(3)(b)">(b)</span> Air conditioned to maintain a temperature of the controlled environment according to USP 797 standards.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#B">B.</span> Controlled Environment — Clean Room. The permit holder shall ensure that the clean room in the controlled environment:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#B(1)">(1)</span> Meets USP 797 Standards for design and USP 797 performance criteria quality standards for clean rooms;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#B(2)">(2)</span> Contains no sinks or floor drains;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#B(3)">(3)</span> Contains work surfaces constructed of smooth, impervious materials, such as stainless steel or molded plastic, so that the work surfaces may be readily cleaned and sanitized;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#B(4)">(4)</span> If cytotoxic agents are routinely used in compounding preparations, contains room or rooms equipped with special pressurization requirements consistent with USP 797 Standards and the National Institute for Occupational Safety and Health (NIOSH) standards;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#B(5)">(5)</span> Has in place appropriate environmental engineering control devices capable of maintaining USP 797 air-quality standards during normal compounding activity; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#B(6)">(6)</span> Contains the following equipment:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#B(6)(a)">(a)</span> A laminar airflow workstation or other suitable International Standards Organization (ISO) Class 5 compounding environment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#B(6)(b)">(b)</span> Waste containers that are approved by Occupational Safety and Health Administration (OSHA) for used needles and syringes, and for chemotherapy waste; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#B(6)(c)">(c)</span> Ancillary supplies required for proper compounding.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#C">C.</span> Controlled Environment — Anteroom. The permit holder shall ensure that the anteroom in the controlled environment:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#C(1)">(1)</span> Meets USP 797 Standards for design and USP 797 performance criteria quality standards for anterooms; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#C(2)">(2)</span> Contains the following equipment:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#C(2)(a)">(a)</span> A sink with hot and cold running water;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#C(2)(b)">(b)</span> Waste containers for personal protective equipment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#C(2)(c)">(c)</span> An eyewash station or sink design suitable for flushing an eye injury; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#C(2)(d)">(d)</span> A hazardous waste spill kit, if applicable.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#D">D.</span> The requirements specified in §§B(1) and C(1) of this regulation are not applicable if a compounding aseptic isolator is used to compound sterile preparations in accordance with the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#D(1)">(1)</span> Compounding aseptic isolator conditions set forth in USP 797 Standards; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.09#D(2)">(2)</span> Isolator vendor or manufacturer specifications.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.19.10" data-order="|10|34|19|.10|" data-ref-path="10|34|19|.10" class="h__section">.10 Minimum Requirements for Equipment.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.10#A">A.</span> The permit holder shall provide at least the following equipment that is maintained in working order:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.10#A(1)">(1)</span> Adequate refrigerator and freezer space (if applicable);</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.10#A(2)">(2)</span> A sink and wash area in the anteroom;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.10#A(3)">(3)</span> Appropriate waste containers for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.10#A(3)(a)">(a)</span> Used needles and syringes; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.10#A(3)(b)">(b)</span> Cytotoxic waste including disposable apparel used in its preparation, if applicable;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.10#A(4)">(4)</span> Laminar air flow workstation or compounding aseptic isolator that meets USP 797 Standards, dedicated for products other than antineoplastics;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.10#A(5)">(5)</span> If applicable to types of preparations compounded, biological safety cabinet, or compounding aseptic isolator that meets USP 797 Standards, dedicated for use with antineoplastics or other hazardous sterile preparations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.10#A(6)">(6)</span> Appropriate filters and filtration equipment; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.10#A(7)">(7)</span> A device for light/dark field examination.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.10#B">B.</span> If used, the permit holder shall provide the following equipment that is maintained in working order, calibrated, or certified where appropriate:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.10#B(1)">(1)</span> Autoclave;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.10#B(2)">(2)</span> Automated compounding devices (for example, total parenteral nutrition compounding pumps);</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.10#B(3)">(3)</span> Electronic balance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.10#B(4)">(4)</span> Convection oven;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.10#B(5)">(5)</span> Thermometers or other temperature device; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.10#B(6)">(6)</span> Incubator.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.19.11" data-order="|10|34|19|.11|" data-ref-path="10|34|19|.11" class="h__section">.11 Minimum Requirements for Supplies.</h3>
                <p>A pharmacy engaging in compounding sterile preparations shall maintain adequate stock levels of the following supplies according to USP 797 Standards, including but not limited to:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.11#A">A.</span> Personal protective equipment:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.11#A(1)">(1)</span> Sterile gloves;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.11#A(2)">(2)</span> Masks;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.11#A(3)">(3)</span> Non-shedding gowns;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.11#A(4)">(4)</span> Shoe covers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.11#A(5)">(5)</span> Hair covers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.11#A(6)">(6)</span> Beard covers; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.11#A(7)">(7)</span> Other personal protective equipment;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.11#B">B.</span> Disposable syringes and needles in necessary sizes;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.11#C">C.</span> Disinfectant cleaning agents as specified in USP 797 Standards, including 70 percent sterile isopropyl alcohol;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.11#D">D.</span> Disposable lint free towels;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.11#E">E.</span> Hand washing materials, including antimicrobial skin cleanser;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.11#F">F.</span> Adequate equipment and materials for antineoplastic or cytotoxic agent spills;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.11#G">G.</span> Supplies necessary for the aseptic preparation of compounded sterile preparations; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.11#H">H.</span> Closed system vial transfer devices (CSTD), as required for cytotoxic compounding, if applicable.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.19.12" data-order="|10|34|19|.12|" data-ref-path="10|34|19|.12" class="h__section">.12 Minimum Requirements for Policies and Procedures.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#A">A.</span> The permit holder shall ensure that the pharmacist or the pharmacist's designee shall maintain a policy and procedure manual, reviewed annually, that sets forth in detail the permit holder's standard operating procedures with regard to compounding sterile preparations.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#B">B.</span> The permit holder shall insure that the policy and procedure manual that sets forth the standard operating procedures with regard to compounding sterile preparations is implemented and adhered to.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C">C.</span> The policy and procedure manual shall include policies and procedures governing the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(1)">(1)</span> A risk-management program which includes documentation of outcomes including, but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(1)(a)">(a)</span> An incident reporting system;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(1)(b)">(b)</span> An adverse drug reaction reporting system; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(1)(c)">(c)</span> A preparation contamination reporting system;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(2)">(2)</span> Security measures ensuring that the premises where sterile compounded preparations are stored and prepared are secured, to prevent access by unauthorized personnel;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(3)">(3)</span> Equipment including, but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(3)(a)">(a)</span> Procedures for use;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(3)(b)">(b)</span> Documentation of appropriate certifications; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(3)(c)">(c)</span> Documentation of appropriate calibration and preventive maintenance if applicable;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(4)">(4)</span> Sanitation standards and procedures including monitoring for bacterial microorganisms to demonstrate effectiveness of cleaning activities;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(5)">(5)</span> Reference materials as set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.19.16" title=".16 Reference Library.">Regulation .16 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(6)">(6)</span> Information concerning drug:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(6)(a)">(a)</span> Preparation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(6)(b)">(b)</span> Storage and handling;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(6)(c)">(c)</span> Dispensing;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(6)(d)">(d)</span> Labeling;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(6)(e)">(e)</span> Beyond-use/expiration dating;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(6)(f)">(f)</span> Delivery;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(6)(g)">(g)</span> Destruction;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(6)(h)">(h)</span> Recalls; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(6)(i)">(i)</span> Returns;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(7)">(7)</span> Patient record keeping as set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.19.07" title=".07 Record-Keeping Requirements.">Regulation .07 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(8)">(8)</span> Handling, dispensing, and documentation of investigational drugs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(9)">(9)</span> A quality assurance program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(10)">(10)</span> Verification of training and competency guidelines;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(11)">(11)</span> Compounding process media fill verification procedures;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(12)">(12)</span> Description of appropriate garb;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(13)">(13)</span> Conduct guidelines for personnel in the controlled areas;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(14)">(14)</span> Personnel responsibilities;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(15)">(15)</span> Patient education, if appropriate;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(16)">(16)</span> Protocol and procedures to maintain the integrity of the interior work area of the laminar air flow workstations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(17)">(17)</span> Written procedures as applicable for handling antineoplastic agents and other hazardous substances including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(17)(a)">(a)</span> Utilizing the proper equipment and supplies;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(17)(b)">(b)</span> A statement that compounding shall be conducted within a properly certified biological safety cabinet or negative pressure compounding aseptic isolator;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(17)(c)">(c)</span> Proper use of protective attire; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(17)(d)">(d)</span> Proper techniques to prevent both contamination of the preparation and chemical exposure of the individual preparing the prescription;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(18)">(18)</span> Written procedures as applicable for the disposal of infectious materials or materials containing cytotoxic residues, or hazardous waste;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(19)">(19)</span> Written documentation of policy and procedure changes based on data gathered from quality assurance evaluations; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.12#C(20)">(20)</span> Written documentation of policies and procedures assuring the sterility and stability of compounded sterile preparations.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.19.13" data-order="|10|34|19|.13|" data-ref-path="10|34|19|.13" class="h__section">.13 Attire.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.13#A">A.</span> When compounding sterile preparations, individuals shall comply with the following standards:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.13#A(1)">(1)</span> Sequencing of garbing that complies with USP 797 Standards;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.13#A(2)">(2)</span> Thorough hand-washing before gowning;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.13#A(3)">(3)</span> Wearing clean room garb inside the designated area at all times, which consists of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.13#A(3)(a)">(a)</span> A non-shedding coverall or gown;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.13#A(3)(b)">(b)</span> Head and facial hair covers;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.13#A(3)(c)">(c)</span> A face mask; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.13#A(3)(d)">(d)</span> Shoe covers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.13#A(4)">(4)</span> Clean room garb, with the exception of sterile gloves, shall be donned and removed outside the designated clean room area;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.13#A(5)">(5)</span> All jewelry shall be removed;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.13#A(6)">(6)</span> Sterile gloves are required; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.13#A(7)">(7)</span> Make-up may not be worn in the clean room.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.13#B">B.</span> The requirements of this regulation are not applicable if a compounding aseptic isolator is used to compound sterile preparations in accordance with USP 797 Standards and isolator vendor/manufacturer specifications.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.19.14" data-order="|10|34|19|.14|" data-ref-path="10|34|19|.14" class="h__section">.14 Training of Staff, Patient, and Caregiver.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#A">A.</span> The pharmacist shall make counseling available to the patient or primary caregiver, or both, concerning proper use of compounded sterile preparations and related supplies furnished by the pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#B">B.</span> The permit holder shall ensure that pharmacy personnel engaging in compounding sterile preparations are trained and demonstrate competence in the safe handling and compounding of compounded sterile preparations and parenteral solutions, including cytotoxic agents if applicable.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#C">C.</span> The permit holder shall maintain records of training and demonstrated competence for individual employees for 5 years.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#D">D.</span> The permit holder shall ensure the continuing competence of pharmacy personnel engaged in compounding sterile preparations.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#E">E.</span> A pharmacy that compounds sterile preparations shall comply with the following training requirements:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#E(1)">(1)</span> The pharmacy shall establish and follow a written program of training and performance evaluation designed to ensure that individuals working in the designated area have the knowledge and skills necessary to perform the assigned tasks properly and include at least the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#E(1)(a)">(a)</span> Aseptic technique with media fill verification at a frequency defined by risk level as described in USP 797 Standards:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#E(1)(a)(i)">(i)</span> 12 months for low and medium risk; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#E(1)(a)(ii)">(ii)</span> 6 months for high risk;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#E(1)(b)">(b)</span> Pharmaceutical calculations and terminology;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#E(1)(c)">(c)</span> Compounding sterile preparation documentation process;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#E(1)(d)">(d)</span> Quality assurance procedures;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#E(1)(e)">(e)</span> Aseptic preparation procedures;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#E(1)(f)">(f)</span> Proper cleansing, gowning, and gloving techniques;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#E(1)(g)">(g)</span> General conduct in the controlled area;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#E(1)(h)">(h)</span> Cleaning, sanitizing, and maintaining equipment used in the controlled area;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#E(1)(i)">(i)</span> Sterilization techniques for high risk preparations; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#E(1)(j)">(j)</span> Container, equipment, and closure system selection.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#E(2)">(2)</span> Individuals assigned to the controlled area shall successfully complete practical skills training in aseptic technique and aseptic area practices.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#E(3)">(3)</span> Evaluations shall include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#E(3)(a)">(a)</span> Written testing;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#E(3)(b)">(b)</span> Observation for adherence to aseptic technique and aseptic area policies and procedures; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.19.14#E(3)(c)">(c)</span> Media fill verification as set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.19.14#E(1)(a)" title="">§E(1)(a) of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.19.15" data-order="|10|34|19|.15|" data-ref-path="10|34|19|.15" class="h__section">.15 Quality Assurance.</h3>
                <p>The permit holder shall ensure that the compounded sterile preparation retains its potency and sterility throughout the assigned "beyond use" dating period through a written quality assurance program that includes:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.15#A">A.</span> A reasonable effort by the pharmacist to assure that compounded sterile preparations shall be kept under appropriate controlled conditions before dispensing, during transport, and at the location of use by providing adequate labeling and verbal or written instructions regarding proper storage and administration, as set forth by the product manufacturer and established standards and literature, with each compounded sterile preparation dispensed;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.15#B">B.</span> The phases of compounded sterile preparation, distribution, storage, administration, and directions for use for each type of preparation dispensed;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.15#C">C.</span> Environmental sampling for microbial organisms in laminar air flow workstations and clean rooms is performed according to methods and schedules specified by USP 797 Standards and if microbial contamination is suspected, for example, in the event of positive media fill verification results;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.15#D">D.</span> Laminar air flow workstations, biological safety cabinets, and compounding aseptic isolators certified by a trained and qualified operator;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.15#E">E.</span> Clean room and anteroom certification by a trained and qualified operator according to USP 797 Standards;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.15#F">F.</span> The proper disposal in accordance with accepted professional standards and applicable State and federal laws of unused drugs and materials used in the preparation of compounded sterile preparations, including antineoplastic agents and hazardous materials;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.15#G">G.</span> A formal written review process to report and evaluate compliance with this chapter; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.15#H">H.</span> A process that complies with applicable USP 797 Standards for performing sterility checks or pyrogen testing, or both, for applicable compounded sterile preparations.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.19.16" data-order="|10|34|19|.16|" data-ref-path="10|34|19|.16" class="h__section">.16 Reference Library.</h3>
                <p>Minimum reference materials in a pharmacy shall include:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.16#A">A.</span> U.S. Pharmaceutical, General Chapter 797, Pharmaceutical Compounding — Sterile Preparations and other applicable reference materials in order to perform sterile compounding;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.16#B">B.</span> Reference materials containing drug stability and compatibility data; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.16#C">C.</span> Reference materials concerning drug interactions and incompatibility.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.19.17" data-order="|10|34|19|.17|" data-ref-path="10|34|19|.17" class="h__section">.17 Minimum Requirements for Inspections.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.17#A">A.</span> The Board shall inspect pharmacies located in Maryland at least annually.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.17#B">B.</span> The pharmacy shall provide as part of the inspection process:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.17#B(1)">(1)</span> Quality assurance testing reports;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.17#B(2)">(2)</span> Documentation of reporting adverse events as required in <a class="internal-link " href="/us/md/exec/comar/10.34.19.18" title=".18 Reporting Requirements Pharmacies.">Regulation .18 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.17#B(3)">(3)</span> Microbial testing of a sampling of the sterile compounded preparations of the pharmacy if applicable according to USP 797 Standards; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.17#B(4)">(4)</span> Any other information requested to ensure compliance with USP 797 Standards.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.17#C">C.</span> Within 90 days before the date of application, inspections of nonresident pharmacies may be conducted by:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.17#C(1)">(1)</span> A designee of the Board;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.17#C(2)">(2)</span> The U.S. Food and Drug Administration; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.17#C(3)">(3)</span> Another appropriate state entity which indicates compliance with USP 797 Standards.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.17#D">D.</span> The Board or designee shall inspect nonresident pharmacies upon initial application and upon renewal.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.17#E">E.</span> The Board may inspect a pharmacy at any time to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.17#E(1)">(1)</span> Verify compliance with permit requirements; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.17#E(2)">(2)</span> Investigate a complaint.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.19.18" data-order="|10|34|19|.18|" data-ref-path="10|34|19|.18" class="h__section">.18 Reporting Requirements Pharmacies.</h3>
                <p>A pharmacy shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.18#A">A.</span> Document and perform routine testing as required by USP 797 Standards for the appropriate risk levels of sterile compounded preparations; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.18#B">B.</span> Report to the Board within 5 calendar days:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.18#B(1)">(1)</span> Adverse events that have been discovered including corrective actions taken or proposed;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.18#B(2)">(2)</span> Deficiencies related to the sterile compounding process;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.18#B(3)">(3)</span> Disciplinary actions in other states or by other state agencies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.18#B(4)">(4)</span> Changes in accreditation status;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.18#B(5)">(5)</span> Disciplinary actions taken against a pharmacist who is an owner, operator, or employee of the pharmacy; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.19.18#B(6)">(6)</span> Disciplinary actions taken against any other known permit, or any other authorization, held by the pharmacy permit holder.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.19.19" data-order="|10|34|19|.19|" data-ref-path="10|34|19|.19" class="h__section">.19 Office Use.</h3>
                <p>Unless otherwise authorized, a person that prepares and distributes sterile compounded medications for office use into, out of, or within the State shall hold:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.19#A">A.</span> A manufacturer’s permit or other permit designated by the U.S. Food and Drug Administration to ensure the safety of sterile compounded medications for office use; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.19.19#B">B.</span> If applicable, a wholesale distributor’s permit, issued by the Board under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Subtitle 6C, Annotated Code of Maryland</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.20" data-order="|10|34|20|" data-ref-path="10|34|20" class="h__chapter">Chapter 20 Format of Prescription Transmission</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: December 24, 1990 (17:25 Md. R. 2908)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.20.03" title=".03 Prescription Records.">Regulation .03</a> amended effective December 18, 1995 (22:25 Md. R. 1962)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.20.04" title=".04 Controlled Dangerous Substances.">Regulation .04</a> amended effective December 18, 1995 (22:25 Md. R. 1962)</p>
                  <p>Regulation .05 adopted effective December 18, 1995 (22:25 Md. R. 1962)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.20.01" title=".01 Scope.">.01</a>—.05, Prescription Orders Submitted by Facsimile Devices, repealed and Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.20.01" title=".01 Scope.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.20.04" title=".04 Controlled Dangerous Substances.">.04</a>, Format of Prescription Transmission, adopted effective December 25, 2000 (27:25 Md. R. 2282)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.20.01" title=".01 Scope.">Regulation .01</a> amended effective October 4, 2010 (37:20 Md. R. 1394)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.20.02" title=".02 Requirements for Prescription Validity.">Regulation .02</a> amended effective October 4, 2010 (37:20 Md. R. 1394)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.20.03" title=".03 Prescription Records.">Regulation .03</a> amended effective October 4, 2010 (37:20 Md. R. 1394)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.20.04" title=".04 Controlled Dangerous Substances.">Regulation .04</a> amended effective October 4, 2010 (37:20 Md. R. 1394)</p>
                  <h3>Authority</h3>
                  <p><a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">Health Occupations Article, §12-205(a)(3)(ii), </a>Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.20.01" data-order="|10|34|20|.01|" data-ref-path="10|34|20|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter applies to the conveyance or transmission of prescription orders from authorized prescribers to pharmacies in the State.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.20.02" data-order="|10|34|20|.02|" data-ref-path="10|34|20|.02" class="h__section">.02 Requirements for Prescription Validity.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.20.02#A">A.</span> A valid prescription shall be:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.20.02#A(1)">(1)</span> Valid in the professional judgment of the pharmacist responsible for filling the prescription; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.20.02#A(2)">(2)</span> Conveyed:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.20.02#A(2)(a)">(a)</span> In a manner that contains the handwritten, pen-to-paper signature of the prescriber;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.20.02#A(2)(b)">(b)</span> In a manner that is transmitted to the pharmacy electronically, provided that the prescription is:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.20.02#A(2)(b)(i)">(i)</span> Transmitted via electronic intermediaries that are certified by the Maryland Health Care Commission;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.20.02#A(2)(b)(ii)">(ii)</span> Received by the permit holder’s computer, facsimile machine, or other electronic device; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.20.02#A(2)(b)(iii)">(iii)</span> Maintained by the permit holder in accordance with <a class="internal-link " href="/us/md/exec/comar/10.34.20.03" title=".03 Prescription Records.">Regulation .03 of this chapter</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.20.02#A(2)(c)">(c)</span> In an oral manner where:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.20.02#A(2)(c)(i)">(i)</span> Only a pharmacist may take an original oral prescription by a voice messaging system or by phone with the pharmacist reading back the prescription to the prescriber or the prescriber’s agent; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.20.02#A(2)(c)(ii)">(ii)</span> The pharmacist promptly reduces the oral prescription to writing.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.20.02#B">B.</span> The requirement of <a class="internal-link " href="/us/md/exec/comar/10.34.20.02#A(2)(b)(i)" title="">§A(2)(b)(i) of this regulation</a> does not apply to prescriptions transmitted electronically within:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.20.02#B(1)">(1)</span> A closed system of a group model health maintenance organization as defined in Health-General Article, §19-713.6, Annotated Code of Maryland; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.20.02#B(2)">(2)</span> Any other closed system that does not utilize an intermediary for transmission of prescriptions.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.20.03" data-order="|10|34|20|.03|" data-ref-path="10|34|20|.03" class="h__section">.03 Prescription Records.</h3>
                <p>The pharmacy permit holder shall maintain prescription records in a form that:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.20.03#A">A.</span> Is readily and accurately retrievable;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.20.03#B">B.</span> Is maintained for at least 5 years from the date of dispensing; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.20.03#C">C.</span> Protects the confidentiality and security of the prescription information.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.20.04" data-order="|10|34|20|.04|" data-ref-path="10|34|20|.04" class="h__section">.04 Controlled Dangerous Substances.</h3>
                <p>Transmission and dispensing of controlled dangerous substances shall be in accordance with applicable State and federal statutes and regulations.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.21" data-order="|10|34|21|" data-ref-path="10|34|21" class="h__chapter">Chapter 21 Standard of Practice for Unlicensed Personnel</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: March 5, 2001 (28:4 Md. R. 419)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.21.02#B" title="">Regulation .02B</a> amended effective January 28, 2008 (35:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.21.03" title=".03 Duties of the Permit Holder.">Regulation .03</a> amended effective January 28, 2008 (35:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.21.03#B" title="">Regulation .03B</a> amended effective December 10, 2001 (28:24 Md. R. 2128)</p>
                  <p>Regulation .03E amended effective November 25, 2002 (29:23 Md. R. 1811)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.21.04" title=".04 Duties of the Pharmacist.">Regulation .04</a> amended effective January 28, 2008 (35:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.21.05" title=".05 Duties of Unlicensed Personnel.">Regulation .05</a> amended effective January 28, 2008 (35:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.21.06" title=".06 Grounds for Discipline.">Regulation .06</a> amended effective January 28, 2008 (35:2 Md. R. 127)</p>
                  <h3>Authority</h3>
                  <p><a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">Health Occupations Article, §12-205(a)(3)(ii), </a>Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.21.01" data-order="|10|34|21|.01|" data-ref-path="10|34|21|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter establishes standards of practice and the responsibilities of licensed pharmacists and pharmacy permit holders when using unlicensed personnel in the prescription area of a pharmacy.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.21.02" data-order="|10|34|21|.02|" data-ref-path="10|34|21|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.21.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.21.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.21.02#B(1)">(1)</span> "Board" means the State Board of Pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.21.02#B(2)">(2)</span> "Operational support" means tasks performed by:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.21.02#B(2)(a)">(a)</span> An administrative clerk;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.21.02#B(2)(b)">(b)</span> A billing clerk;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.21.02#B(2)(c)">(c)</span> A cashier;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.21.02#B(2)(d)">(d)</span> Delivery personnel;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.21.02#B(2)(e)">(e)</span> A file clerk;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.21.02#B(2)(f)">(f)</span> An inventory control clerk; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.21.02#B(2)(g)">(g)</span> An individual engaged in janitorial services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.21.02#B(3)">(3)</span> "Permit holder" means a person or corporation or other legal entity holding a permit issued by the Board to establish and operate a pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.21.02#B(4)">(4)</span> "Pharmacy" means an establishment holding a permit under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-401" title="">Health Occupations Article, §12-401, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.21.02#B(5)">(5)</span> "Prescription area" means that portion of an establishment to which a pharmacy permit has been issued, which contains:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.21.02#B(5)(a)">(a)</span> Prescription drugs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.21.02#B(5)(b)">(b)</span> Prescription devices; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.21.02#B(5)(c)">(c)</span> Patient records.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.21.02#B(6)">(6)</span> "Supervision" means the on-site provision of management, direction, oversight, and review of tasks assigned to personnel.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.21.02#B(7)">(7)</span> "Unlicensed personnel" means individuals employed by the permit holder who provide operational support in the prescription area under the supervision of a licensed pharmacist.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.21.03" data-order="|10|34|21|.03|" data-ref-path="10|34|21|.03" class="h__section">.03 Duties of the Permit Holder.</h3>
                <p>The permit holder shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.21.03#A">A.</span> Determine which operational support tasks the pharmacist may assign unlicensed personnel to perform in the prescription area;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.21.03#B">B.</span> Ensure that unlicensed personnel:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.21.03#B(1)">(1)</span> Receive appropriate training for the tasks that the pharmacist assigns unlicensed personnel to perform in the prescription area;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.21.03#B(2)">(2)</span> Receive training that will enable unlicensed personnel to understand how the provisions of Health-General Article, Title 4, Subtitle 3, Annotated Code of Maryland, apply to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.21.03#B(2)(a)">(a)</span> Prescription records, and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.21.03#B(2)(b)">(b)</span> The requirements for confidentiality of patient specific information; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.21.03#B(3)">(3)</span> When performing tasks in the prescription area, maintain proper:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.21.03#B(3)(a)">(a)</span> Sanitation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.21.03#B(3)(b)">(b)</span> Hygiene;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.21.03#B(3)(c)">(c)</span> Biohazard precautions; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.21.03#B(3)(d)">(d)</span> Infection control; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.21.03#C">C.</span> Ensure that unlicensed personnel are clearly identified to the consumer.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.21.04" data-order="|10|34|21|.04|" data-ref-path="10|34|21|.04" class="h__section">.04 Duties of the Pharmacist.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.21.04#A">A.</span> The pharmacist shall provide supervision to unlicensed personnel.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.21.04#B">B.</span> The pharmacist may not delegate any pharmacy acts to unlicensed personnel.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.21.05" data-order="|10|34|21|.05|" data-ref-path="10|34|21|.05" class="h__section">.05 Duties of Unlicensed Personnel.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.21.05#A">A.</span> Unlicensed personnel under the supervision of a pharmacist may perform operational support which the unlicensed personnel have been trained to adequately perform in the prescription area.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.21.05#B">B.</span> Unlicensed personnel who perform duties in the prescription area shall maintain the confidentiality of patient specific data in accordance with Health-General Article, Title 4, Subtitle 3, Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.21.06" data-order="|10|34|21|.06|" data-ref-path="10|34|21|.06" class="h__section">.06 Grounds for Discipline.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.21.06#A">A.</span> A pharmacist licensee may be subject to discipline if the pharmacist licensee violates any provision of <a class="internal-link " href="/us/md/exec/comar/10.34.21.04" title=".04 Duties of the Pharmacist.">Regulation .04 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.21.06#B">B.</span> A permit holder may be subject to disciplinary action if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.21.06#B(1)">(1)</span> The permit holder fails to take reasonable safeguards to ensure compliance with the regulations of the Board; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.21.06#B(2)">(2)</span> The permit holder otherwise violates any of the provisions of <a class="internal-link " href="/us/md/exec/comar/10.34.21.03" title=".03 Duties of the Permit Holder.">Regulation .03 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.22" data-order="|10|34|22|" data-ref-path="10|34|22" class="h__chapter">Chapter 22 Licensing of Wholesale Prescription Drug or Device Distributors</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: August 31, 1992 (19:17 Md. R. 1607)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.03#B" title="">Regulation .03B</a> amended effective November 7, 1994 (21:22 Md. R. 1877)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.04" title=".04 Personnel.">Regulation .04</a> amended effective November 7, 1994 (21:22 Md. R. 1877)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.01" title=".01 Scope.">.01</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.10" title=".10 Required Information and Procedures for Ceasing to Operate.">.10</a> repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.01" title=".01 Scope.">.01</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.09" title=".09 Reinstatement.">.09</a> adopted effective March 28, 2005 (32:6 Md. R. 636)</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.01" title=".01 Scope.">.01</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.09" title=".09 Reinstatement.">.09</a> repealed and new Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.01" title=".01 Scope.">.01</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.08" title=".08 Due Diligence.">.08</a> adopted effective April 7, 2008 (35:7 Md. R. 748)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.02#B" title="">Regulation .02B</a> amended as an emergency provision effective June 18, 2009 (36:15 Md. R. 1163); amended permanently effective October 5, 2009 (36:20 Md. R. 1529)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.02#B" title="">Regulation .02B</a> amended effective July 1, 2014 (41:10 Md. R. 561)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.03" title=".03 Minimum Application Requirements for Applicants Holding Product.">Regulation .03</a> amended effective July 1, 2014 (41:10 Md. R. 561)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.03#E" title="">Regulation .03E</a> amended as an emergency provision effective June 18, 2009 (36:15 Md. R. 1163); amended permanently effective October 5, 2009 (36:20 Md. R. 1529)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.03" title=".03 Minimum Application Requirements for Applicants Holding Product.">Regulation .03</a>-1 adopted effective July 1, 2014 (41:10 Md. R. 561)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.05#A" title="">Regulation .05A</a> amended effective July 1, 2014 (41:10 Md. R. 561)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.09" title=".09 Reinstatement.">Regulation .09</a> adopted effective July 1, 2014 (41:10 Md. R. 561)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.10" title=".10 Required Information and Procedures for Ceasing to Operate.">Regulation .10</a> adopted effective July 1, 2014 (41:10 Md. R. 561)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.11" title=".11 Relocation.">Regulation .11</a> adopted effective July 1, 2014 (41:10 Md. R. 561)</p>
                  <h3>Authority</h3>
                  <p>Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">12-205</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-601" title="">12-601</a>, and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">12-6</a>C-01 — 12-6C-13, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.22.01" data-order="|10|34|22|.01|" data-ref-path="10|34|22|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter applies to any person engaged in the wholesale distribution of prescription drugs or devices in Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.22.02" data-order="|10|34|22|.02|" data-ref-path="10|34|22|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(1)">(1)</span> “ANDA” means an Abbreviated New Drug Application number and contains data that, when submitted to the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research, Office of Generic Drugs, provides for the review and ultimate approval of a generic drug product.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(1-1)">(1-1)</span> "Authenticate" means to affirmatively verify, before any wholesale distribution of a prescription drug occurs, that each transaction listed on the pedigree for the prescription drug has occurred.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(2)">(2)</span> "Authorized distributor of record" means a wholesale distributor with whom a manufacturer has established an ongoing relationship to distribute the manufacturer's prescription drug.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(3)">(3)</span> "Blood" means whole blood collected from a single donor and processed either for transfusion or further manufacturing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(4)">(4)</span> "Blood component" means that part of blood separated by physical or mechanical means.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(5)">(5)</span> "Board" means the State Board of Pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(5-1)">(5-1)</span> “Cease to operate” means the date on which the last prescription drug or prescription device is distributed by the permit holder.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(5-2)">(5-2)</span> “Central repository” means the Criminal Justice Information System Central Repository of the Department of Public Safety and Correctional Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(6)">(6)</span> "Co-licensed partner" means a person in a relationship in which two or more persons have the right to engage in the manufacturing or marketing of a prescription drug, consistent with the U.S. Food and Drug Administration's implementation of the Federal Prescription Drug Marketing Act.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(7)">(7)</span> "DEA" means the U. S. Drug Enforcement Administration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(8)">(8)</span> "Designated representative" means an individual who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(8)(a)">(a)</span> Is designated by the wholesale distributor;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(8)(b)">(b)</span> Serves as the primary contact of the wholesale distributor with the Board; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(8)(c)">(c)</span> Is actively involved in, and aware of, the daily operation of the wholesale distributor.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(8-1)">(8-1)</span> “Designee” means a Board contracted or Board recognized entity.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(9)">(9)</span> "Drop shipment" means the sale of a prescription drug:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(9)(a)">(a)</span> To a wholesale distributor by:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(9)(a)(i)">(i)</span> The manufacturer of the prescription drug; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(9)(a)(ii)">(ii)</span> The manufacturer's co-licensed partner, third-party logistics provider, or manufacturer's exclusive distributor; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(9)(b)">(b)</span> Through which:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(9)(b)(i)">(i)</span> The wholesale distributor or a pharmacy warehouse takes title to, but not physical possession of, the prescription drug;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(9)(b)(ii)">(ii)</span> The wholesale distributor invoices the pharmacy, pharmacy warehouse, or other person authorized by law to dispense or administer the prescription drug to a patient; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(9)(b)(iii)">(iii)</span> The pharmacy, pharmacy warehouse, or other authorized person receives delivery of the prescription drug directly from the manufacturer, the manufacturer's third-party logistics provider, or the manufacturer's exclusive distributor.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(10)">(10)</span> "FDA" means the U. S. Food and Drug Administration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(11)">(11)</span> "Gross receipts" means gross receipts from sales of prescription drugs and devices in the State.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(12)">(12)</span> Health Care Entity.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(12)(a)">(a)</span> "Health care entity" means a person that provides diagnostic, medical, surgical, or dental treatment, or chronic or rehabilitative care.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(12)(b)">(b)</span> "Health care entity" does not include a community pharmacy or a wholesale distributor.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(12)(c)">(c)</span> "Health care entity" may not simultaneously be a health care entity and a community pharmacy or wholesale distributor.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(12-1)">(12-1)</span> “Intracompany sales” means a:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(12-1)(a)">(a)</span> Transaction or transfer of prescription drugs between a division, subsidiary, parent, or affiliated or related company under common ownership and control of a corporate entity, other than a transaction or transfer of prescription drugs from a pharmacy to a wholesale distributor; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(12-1)(b)">(b)</span> Transaction or transfer of a co–licensed product between co–licensed partners.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(13)">(13)</span> "Manufacturer" means a person licensed or approved by the U.S. Food and Drug Administration to engage in the manufacture of prescription drugs or prescription devices, consistent with the definition of "Manufacturer" under the U.S. Food and Drug Administration's regulations and guidelines implementing the Prescription Drug Marketing Act.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(14)">(14)</span> "Manufacturer's exclusive distributor" means a person who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(14)(a)">(a)</span> Contracts with a manufacturer to provide or coordinate warehousing, distribution, or other services on behalf of the manufacturer; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(14)(b)">(b)</span> Takes title to the manufacturer's prescription drug, but does not have general responsibility to direct the sale or disposition of the manufacturer's prescription drug.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(14-1)">(14-1)</span> “NDA” means a New Drug Application number assigned by the FDA for drugs formally proposed to the FDA as a new pharmaceutical for sale and marketing in the U.S.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(15)">(15)</span> "Normal distribution channel" means a chain of custody for a prescription drug that, directly or by drop shipment, goes:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(15)(a)">(a)</span> From:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(15)(a)(i)">(i)</span> A manufacturer of the prescription drug; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(15)(a)(ii)">(ii)</span> The manufacturer's co-licensed partner, third-party logistics provider, or manufacturer's exclusive distributor; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(15)(b)">(b)</span> To:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(15)(b)(i)">(i)</span> A pharmacy or other designated person authorized by law to dispense or administer the prescription drug to a patient;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(15)(b)(ii)">(ii)</span> A wholesale distributor to a pharmacy or other designated person authorized by law to dispense or administer the prescription drug to a patient;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(15)(b)(iii)">(iii)</span> A wholesale distributor to a pharmacy warehouse to the pharmacy warehouse's intracompany pharmacy or other designated person authorized by law to dispense or administer the prescription drug to a patient;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(15)(b)(iv)">(iv)</span> A pharmacy warehouse to the pharmacy warehouse's intracompany pharmacy, or other designated person authorized by law to dispense or administer the prescription drug to a patient; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(15)(b)(v)">(v)</span> An authorized distributor of record to another authorized distributor of record solely for distribution to an office-based health care practitioner authorized by law to dispense or administer the prescription drug to a patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(16)">(16)</span> "Pedigree" means a document or electronic file containing information that records each wholesale distribution of a prescription drug.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(16-1)">(16-1)</span> “Pharmacy” means a pharmacy that has been issued a:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(16-1)(a)">(a)</span> Waiver pharmacy permit in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.17" title="Chapter 17 Waiver of Full Service Requirements for Recognized Pharmaceutical Specialties">COMAR 10.34.17</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(16-1)(b)">(b)</span> Full service pharmacy permit.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(17)">(17)</span> "Prescription device" means any device required by federal law or regulation to be dispensed only by a prescription.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(18)">(18)</span> Prescription Drug.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(18)(a)">(a)</span> "Prescription drug" means any drug required by federal law or regulation to be dispensed only by a prescription.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(18)(b)">(b)</span> "Prescription drug" includes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(18)(b)(i)">(i)</span> A biological product; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(18)(b)(ii)">(ii)</span> Finished dosage forms and bulk drug substances subject to §503(b) of the Federal Food, Drug and Cosmetic Act.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(18)(c)">(c)</span> "Prescription drug" does not include blood and blood components intended for transfusion or biological products that are also medical devices.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(18-1)">(18-1)</span> “Reinstatement” means renewal of a wholesale distributor permit after the permit has expired.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(18-2)">(18-2)</span> “Renewal” means renewing a wholesale distributor permit before the date of expiration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(19)">(19)</span> Repackage.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(19)(a)">(a)</span> "Repackage" means to repackage or otherwise change the container, wrapper, or labeling of a prescription drug to further the distribution of the prescription drug.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(19)(b)">(b)</span> "Repackage" does not include changes to a container, wrapper, or labeling of a prescription drug completed by the pharmacist responsible for dispensing the prescription drug to a patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(20)">(20)</span> "Repackager" means a person who repackages prescription drugs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21)">(21)</span> "Third-party logistics provider" means a person who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21)(a)">(a)</span> Contracts with a manufacturer to provide or coordinate warehousing, distribution, or other services on behalf of the manufacturer; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21)(b)">(b)</span> Does not take title to the prescription drug, or have general responsibility to direct the prescription drug's sale or disposition.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21-1)">(21-1)</span> “UDI” means a Unique Device Identification number that is created through a globally accepted device identification and coding standard that allows the unambiguous identification of a specific medical device.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21-2)">(21-2)</span> Virtual Manufacturer.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21-2)(a)">(a)</span> “Virtual Manufacturer” means an entity that engages in the manufacture of drug or device products for which it:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21-2)(a)(i)">(i)</span> Owns the NDA or ANDA number, if a prescription drug;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21-2)(a)(ii)">(ii)</span> Owns the UDI number, as available, for a prescription device;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21-2)(a)(iii)">(iii)</span> Contracts with a contract manufacturing organization for the physical manufacture of the drug or device product;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21-2)(a)(iv)">(iv)</span> Is not involved in the physical manufacture of the drug or device product; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21-2)(a)(v)">(v)</span> At no time takes physical possession of, or stores, the drug or device product.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(21-2)(b)">(b)</span> “Virtual Manufacturer” may include entities that are identified as a broker, own-label distributor, sponsor manufacturer, private-label manufacturer, or contract manufacturer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)">(22)</span> Wholesale Distribution.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(a)">(a)</span> "Wholesale distribution" means the distribution of prescription drugs or prescription devices to persons other than a consumer or patient.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)">(b)</span> "Wholesale distribution" does not include:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)(i)">(i)</span> Intracompany sales;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)(ii)">(ii)</span> The sale, purchase, distribution, trade, or transfer of a prescription drug or an offer to sell, purchase, distribute, trade, or transfer a prescription drug for emergency medical reasons which include transfers of prescription drugs or devices by a retail pharmacy to another retail pharmacy to alleviate a temporary shortage;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)(iii)">(iii)</span> The distribution of samples of a prescription drug by a manufacturer's representative;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)(iv)">(iv)</span> Prescription drug returns conducted by a hospital, health care entity, or charitable institution in accordance with 21 CFR §203.23, as amended;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)(v)">(v)</span> The sale of minimal quantities of prescription drugs by retail pharmacies to licensed health care practitioners for office use;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)(vi)">(vi)</span> The sale, purchase, or trade of a prescription drug, an offer to sell, purchase, or trade a prescription drug, or the dispensing of a prescription drug in accordance with a prescription;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)(vii)">(vii)</span> The sale, transfer, merger, or consolidation of all or part of the business of a pharmacy to or with another pharmacy, whether accomplished as a purchase and sale of stock or business assets;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)(viii)">(viii)</span> The sale, purchase, distribution, trade, or transfer of a prescription drug from one authorized distributor of record to one additional authorized distributor of record, if the manufacturer has stated in writing to the receiving authorized distributor of record that the manufacturer is unable to supply the prescription drug, and the supplying authorized distributor of record states in writing that the prescription drug being supplied had until that time been exclusively in the normal distribution channel;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)(ix)">(ix)</span> The delivery of, or offer to deliver, a prescription drug by a common carrier solely in the common carrier's usual course of business of transporting prescription drugs, if the common carrier does not store, warehouse, or take legal ownership of the prescription drug; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(22)(b)(x)">(x)</span> The sale or transfer from a pharmacy or pharmacy warehouse of expired, damaged, returned, or recalled prescription drugs to the original wholesale distributor, the original manufacturer, or a third-party returns processor.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)">(23)</span> Wholesale Distributor.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(a)">(a)</span> "Wholesale distributor" means a person that is engaged in the wholesale distribution of prescription drugs or prescription devices.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)">(b)</span> "Wholesale distributor" includes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(i)">(i)</span> A manufacturer;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(ii)">(ii)</span> A repackager;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(iii)">(iii)</span> An own-label distributor;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(iv)">(iv)</span> A private-label distributor;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(v)">(v)</span> A jobber;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(vi)">(vi)</span> A broker;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(vii)">(vii)</span> A warehouse, including a manufacturer's or distributor's warehouse;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(viii)">(viii)</span> A manufacturer's exclusive distributor, or an authorized distributor of record;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(ix)">(ix)</span> A drug wholesaler or distributor;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(x)">(x)</span> An independent wholesale drug trader;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(xi)">(xi)</span> A third-party logistics provider;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(xii)">(xii)</span> A pharmacy that conducts wholesale distribution, if the wholesale distribution business accounts for more than 5 percent of the pharmacy's annual sales; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.02#B(23)(b)(xiii)">(xiii)</span> A pharmacy warehouse that conducts wholesale distribution.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.22.03-1" data-order="|10|34|22|.03-1|" data-ref-path="10|34|22|.03-1" class="h__section">.03-1 Minimum Application Requirements for Virtual Manufacturers.</h3>
                <p>The information and qualification requirements for obtaining a permit under <a class="internal-link " href="/us/md/exec/comar/10.34.22.03" title=".03 Minimum Application Requirements for Applicants Holding Product.">Regulation .03 of this chapter</a>, beyond that required by federal law, do not apply to a virtual manufacturer that meets the following requirements:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#A">A.</span> Provides a list of drug or device products it distributes;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#B">B.</span> Provides a list of the NDA or ANDA numbers associated with each drug it distributes;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#C">C.</span> Provides a list of the UDI numbers, as available, associated with each device it distributes;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#D">D.</span> Provides the name and facility address of the contract manufacturer for each drug or device product it distributes;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#E">E.</span> Provides verification of current FDA registration for each contract manufacturing facility listed;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#F">F.</span> If the contract manufacturer distributes into this State, provides the wholesale distributor permit number for the contract manufacturer;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#G">G.</span> If the contract manufacturer does not distribute into this State, provides name and Maryland’s wholesale distributor permit number for the entity that physically distributes the product into this State;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#H">H.</span> Provides a statement affirming that the virtual manufacturer does not contract the manufacture or distribution for drugs or devices other than those for which it owns the NDA, ANDA, or UDI numbers;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#I">I.</span> Provides an attestation by the owner of the virtual manufacturer that it does not hold product;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#J">J.</span> Provides a copy of existing licensure from the state in which it is located, if applicable; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03-1#K">K.</span> Has valid federal licensure or registration, as verified by the Board.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.22.03" data-order="|10|34|22|.03|" data-ref-path="10|34|22|.03" class="h__section">.03 Minimum Application Requirements for Applicants Holding Product.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A">A.</span> The Board shall require the following minimum information from a wholesale distributor as part of an application for a permit and as part of a renewal of a permit:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(1)">(1)</span> The type of business form under which the applicant operates, such as partnership, corporation, or sole proprietorship;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)">(2)</span> The full name or names of the owner and the operator of the wholesale distributor applying for or renewing a permit, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(a)">(a)</span> For an individual, the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(a)(i)">(i)</span> Full name of the individual;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(a)(ii)">(ii)</span> Telephone number of the individual;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(a)(iii)">(iii)</span> Business address of the individual; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(a)(iv)">(iv)</span> Date of birth of the individual;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(b)">(b)</span> For a partnership, the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(b)(i)">(i)</span> Full name of each partner;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(b)(ii)">(ii)</span> Telephone number of the partnership;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(b)(iii)">(iii)</span> Address of each partner;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(b)(iv)">(iv)</span> Date of birth of each partner;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(b)(v)">(v)</span> Business address of the partnership; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(b)(vi)">(vi)</span> Federal employer identification number of the partnership;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(c)">(c)</span> For a publicly traded corporation, the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(c)(i)">(i)</span> Full name and title of each corporate officer and director;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(c)(ii)">(ii)</span> Telephone number of the publicly traded corporation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(c)(iii)">(iii)</span> Business address of the corporation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(c)(iv)">(iv)</span> Federal employer identification number of the corporation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(c)(v)">(v)</span> Name of parent company or companies if applicable;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(c)(vi)">(vi)</span> Corporate names;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(c)(vii)">(vii)</span> Name of the state of incorporation; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(c)(viii)">(viii)</span> Name and address of the resident agent of the corporation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(d)">(d)</span> For a nonpublicly traded corporation, the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(d)(i)">(i)</span> Full name and title of each corporate officer and director;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(d)(ii)">(ii)</span> The telephone number of the nonpublicly traded corporation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(d)(iii)">(iii)</span> Business address of the corporation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(d)(iv)">(iv)</span> Federal employer identification number of the corporation;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(d)(v)">(v)</span> Name of parent company or companies if applicable;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(d)(vi)">(vi)</span> Corporate names;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(d)(vii)">(vii)</span> Full name and business address of shareholders of more than 10 percent of the corporation, including over-the-counter stock, unless the stock is traded on a major stock exchange;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(d)(viii)">(viii)</span> Name of the state of incorporation; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(d)(ix)">(ix)</span> Name and address of the resident agent of the corporation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(e)">(e)</span> For a sole proprietorship, the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(e)(i)">(i)</span> Full name of the sole proprietor;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(e)(ii)">(ii)</span> The telephone number of the sole proprietor;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(e)(iii)">(iii)</span> Full name of the business entity;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(e)(iv)">(iv)</span> Business address; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(e)(v)">(v)</span> Date of birth of the sole proprietor;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(f)">(f)</span> For a limited liability company, the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(f)(i)">(i)</span> Full name and business address of the limited liability company;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(f)(ii)">(ii)</span> Telephone number of the limited liability company;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(f)(iii)">(iii)</span> Full name of each member;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(f)(iv)">(iv)</span> Full name of each manager;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(f)(v)">(v)</span> Federal employer identification number of the limited liability company;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(f)(vi)">(vi)</span> Name of the state in which the limited liability company was organized; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(2)(f)(vii)">(vii)</span> Name and address of the resident agent of the company;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(3)">(3)</span> Addresses, telephone numbers, and the names of contact persons for the facility used by the applicant for the storage, handling, and distribution of prescription drugs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(4)">(4)</span> All trade or business names used by the permit holder which may not be identical to the name used by another unrelated applicant in the State;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(5)">(5)</span> A list of federal and state licenses, registrations, or permits, including the license, registration, or permit numbers issued to the wholesale distributor by federal authority or another state that authorizes the wholesale distributor to purchase, possess, and distribute prescription drugs or devices;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(6)">(6)</span> A list of disciplinary actions by federal or state agencies against the wholesale distributor as well as any such actions against principals, owners, directors, or officers;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)">(7)</span> For the designated representative and the immediate supervisor of the designated representative at the applicant's place of business the following information:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)(a)">(a)</span> Names;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)(b)">(b)</span> Places of residence for the past 7 years;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)(c)">(c)</span> Dates and places of birth;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)(d)">(d)</span> The name and address of each business where the individual was employed during the past 7 years, and the individual's job title or office held at each business;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)(e)">(e)</span> A statement of whether, during the past 7 years, the individual has been the subject of any proceeding for the revocation of any professional or business license or any criminal violation and, if so, the nature and disposition of the proceeding;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)(f)">(f)</span> A statement of whether, during the past 7 years, the individual has been enjoined, either temporarily or permanently, by a court of competent jurisdiction from violating any federal or state law regulating the possession, control, or distribution of prescription drugs, together with details concerning the event;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)(g)">(g)</span> A description of any involvement, including any investments other than the ownership of stock in a publicly traded company or mutual fund, by the individual during the past 7 years, with any business that manufactures, administers, prescribes, distributes, or stores prescription drugs, and any lawsuits in which the business was named as a party;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)(h)">(h)</span> A description of any misdemeanor or felony offense of which the individual, as an adult, was found guilty, regardless of whether adjudication of the guilt was withheld or whether the individual pled guilty or nolo contendere;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)(i)">(i)</span> If the individual indicates that a criminal conviction is under appeal and submits a copy of the notice of appeal, within 15 days after the disposition of the appeal, a copy of the final written order of disposition; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(7)(j)">(j)</span> A photograph of the individual taken in the previous 180 days;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(8)">(8)</span> A full description of the facility and warehouse including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(8)(a)">(a)</span> Square footage;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(8)(b)">(b)</span> Security and alarm system descriptions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(8)(c)">(c)</span> Terms of lease or ownership;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(8)(d)">(d)</span> Address; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(8)(e)">(e)</span> Description of temperature and humidity controls;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(9)">(9)</span> Written evidence that the wholesale distributor has obtained general and product liability insurance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(10)">(10)</span> A description of the wholesale distributor's import and export activities; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#A(11)">(11)</span> Other relevant information that the Board may require.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B">B.</span> Criminal Background Check Requirements for an Applicant Located in this State. The Board shall require the designated representative and the immediate supervisor of the designated representative at the applicant's place of business as part of the application for a permit to submit to the Central Repository and the Federal Bureau of Investigation:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B(1)">(1)</span> Electronically or digitally captured fingerprints at approved electronic fingerprint locations approved by the Director of the Central Repository;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B(2)">(2)</span> The fee authorized under the <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gcp&amp;section=10-221" title="">Criminal Procedure Article, §10-221(b)(7), Annotated Code of Maryland</a>, for access to State criminal history records; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B(3)">(3)</span> The processing fee required by the Federal Bureau of Investigation for a national criminal history records check.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B-1">B-1.</span> Criminal Background Check Requirements for an Applicant Located Outside this State.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B-1(1)">(1)</span> The Board shall require the designated representative and the immediate supervisor of the designated representative at the applicant's place of business as part of the application for a permit to submit to a criminal history records check by the applicant’s state of residence, in accordance with the laws of the applicant’s state of residence.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B-1(2)">(2)</span> The criminal history records check shall consist of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B-1(2)(a)">(a)</span> A state criminal history records check for the applicant’s state of residence; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B-1(2)(b)">(b)</span> A national criminal history records check.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B-1(3)">(3)</span> The designated representative and the immediate supervisor of the designated representative of an applicant shall request the appropriate entity in the applicant’s state of residence to forward the results of the criminal history records check to the Board and the applicant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#B-1(4)">(4)</span> If the appropriate entity in the applicant’s state of residence is unable to forward the results of the criminal history records check, then the designated representative and the immediate supervisor of the designated representative of an applicant shall ensure that the results of the criminal history records check are forwarded to the Board in a manner approved by the Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#C">C.</span> The information required under <a class="internal-link " href="/us/md/exec/comar/10.34.22.03#A" title="">§A of this regulation</a> shall be provided under oath.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D">D.</span> The Board may not issue an initial or renewal wholesale distributor permit to an applicant unless the Board or its designee:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(1)">(1)</span> If the applicant holds prescription drugs or devices, conducts a physical inspection of the applicant's place of business, including any facility of the applicant;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(2)">(2)</span> Finds that the place of business and facility, if any, meets the Board's requirements;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(3)">(3)</span> Determines that the designated representative of the applicant meets the following qualifications:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(3)(a)">(a)</span> Is 21 years old or older;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(3)(b)">(b)</span> Has been employed full time for at least 3 years in a pharmacy or with a wholesale distributor in a capacity related to the dispensing and distribution of, and record keeping relating to, prescription drugs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(3)(c)">(c)</span> Is employed by the applicant full time in a managerial level position;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(3)(d)">(d)</span> Is actively involved in, and aware of, the daily operation of the wholesale distributor;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(3)(e)">(e)</span> Is physically present, except for an authorized absence such as sick leave or vacation leave, at the facility of the applicant during regular business hours;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(3)(f)">(f)</span> Is serving as a designated representative for only one applicant at a time, or for two or more wholesale distributors who are located in the same facility and are members of an affiliated group, as defined in §1504 of the Internal Revenue Code;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(3)(g)">(g)</span> Does not have any convictions for a violation of any federal, State, or local laws relating to wholesale or retail prescription drug distribution or distribution of controlled substances; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(3)(h)">(h)</span> Does not have any convictions for a felony under federal, State, or local laws; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(4)">(4)</span> Determines that the immediate supervisor of the designated representative of the applicant meets the following qualifications:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(4)(a)">(a)</span> Is 21 years old or older;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(4)(b)">(b)</span> Has been employed full time for at least 3 years in a pharmacy or with a wholesale distributor in a capacity related to the dispensing and distribution of, and record keeping relating to, prescription drugs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(4)(c)">(c)</span> Is employed by the applicant full time in a managerial level position;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(4)(d)">(d)</span> Is actively involved in, and aware of, the daily operation of the wholesale distributor;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(4)(e)">(e)</span> Does not have any convictions for a violation of any federal, state, or local laws relating to wholesale or retail prescription drug distribution, or distribution of controlled substances; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#D(4)(f)">(f)</span> Does not have any convictions for a felony under federal, state, or local laws.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E">E.</span> Surety Bond.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E(1)">(1)</span> An applicant for a wholesale distributor permit shall submit a surety bond or other equivalent means of security acceptable to the State such as an irrevocable letter of credit, or a deposit in a trust account or financial institution, payable to the State Board of Pharmacy to be deposited into an account established by the State under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">Health Occupations Article, §12-6</a>C-05(f)(7), Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E(2)">(2)</span> The surety bond, or other security, shall be in the amount of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E(2)(a)">(a)</span> $100,000, if the annual gross receipts of the applicant for the previous tax year are $10,000,000 or more; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E(2)(b)">(b)</span> $50,000, if the annual gross receipts of the applicant for the previous tax year are less than $10,000,000.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E(3)">(3)</span> An applicant shall submit the following documentation to verify the applicant's annual gross receipts in the State are less than $10,000,000 for the previous tax year:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E(3)(a)">(a)</span> A federal tax return; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E(3)(b)">(b)</span> An annual sales report specifying the sales of prescription drugs and devices in the State audited by a certified public accountant.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E(4)">(4)</span> A surety bond is not required for a pharmacy warehouse that is not engaged in wholesale distribution.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E(5)">(5)</span> An applicant shall obtain a surety bond for each facility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#E(6)">(6)</span> A single surety bond may cover all facilities operated by the applicant within this State.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#F">F.</span> If a wholesale distributor distributes prescription drugs or prescription devices from more than one facility, the wholesale distributor shall obtain a permit for each facility.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#G">G.</span> The Board shall notify the applicant of the Board's acceptance or rejection of the application within 30 days after the date the Board receives a completed application, including the results of all required criminal history records checks.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#H">H.</span> The applicant shall pay to the Board an application fee set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09.02" title=".02 Fees.">COMAR 10.34.09.02</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#I">I.</span> The wholesale distributor shall provide changes in information provided pursuant to <a class="internal-link " href="/us/md/exec/comar/10.34.22.03" title=".03 Minimum Application Requirements for Applicants Holding Product.">Regulation .03 of this chapter</a> to the Board within 30 days of the effective date of the change.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#J">J.</span> Information and qualification requirements for obtaining a permit under this regulation, beyond that required by federal law, does not apply to a manufacturer who distributes its own prescription:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#J(1)">(1)</span> Drugs approved by the U.S. Food and Drug Administration; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.03#J(2)">(2)</span> Devices that are approved or authorized by the U.S. Food and Drug Administration.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.22.04" data-order="|10|34|22|.04|" data-ref-path="10|34|22|.04" class="h__section">.04 Personnel.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.04#A">A.</span> The permit holder shall affirm in the initial application and subsequent renewal applications that personnel employed in wholesale distribution have appropriate education and experience to assume responsibilities related to compliance with State licensing requirements.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.04#B">B.</span> Registered Agent.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.04#B(1)">(1)</span> Each licensed wholesale distributor located outside of this State that wholesale distributes prescription drugs or devices in this State shall designate a registered agent in this State for service of process.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.04#B(2)">(2)</span> If any wholesale distributor is not licensed in this State, service on the Director of the State Department of Assessments and Taxation only shall be sufficient service.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.04#C">C.</span> Requirements and Responsibilities of the Designated Representative.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.04#C(1)">(1)</span> The designated representative shall be aware of, and knowledgeable about, all policies and procedures pertaining to the operations of the wholesale distributor, including applicable State and federal laws.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.04#C(2)">(2)</span> The designated representative shall have documented training sufficient to ensure that operations of the wholesale distributor are in compliance with applicable State and federal laws and are provided by qualified in-house specialists, outside counsel, or consulting specialists with capabilities to help ensure compliance with all applicable State and federal laws and regulations.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.04#C(3)">(3)</span> The designated representative shall maintain current working knowledge of the requirements for wholesale distributor and assure ongoing training for personnel to ensure compliance.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.04#C(4)">(4)</span> The designated representative shall be responsible for all record keeping requirements and make all records available for inspection.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.22.05" data-order="|10|34|22|.05|" data-ref-path="10|34|22|.05" class="h__section">.05 Violations and Penalties.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A">A.</span> After a hearing held under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-601" title="">Health Occupations Article, §12-601, Annotated Code of Maryland</a>, the Board may deny, suspend, revoke, or place on probation a permit holder, reprimand a permit holder, or impose a fine if the permit holder:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(1)">(1)</span> Is convicted of, or pleads guilty or nolo contendere to, violations of federal, State, or local drug or device laws or regulations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(2)">(2)</span> Is convicted of, or pleads guilty or nolo contendere to, a felony or to a crime involving moral turpitude, whether or not any appeal or other proceeding is pending to have the conviction or plea set aside;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)">(3)</span> Commits any of the following acts:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(a)">(a)</span> Obtains or attempts to obtain a permit by:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(a)(i)">(i)</span> Providing false information to the Board; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(a)(ii)">(ii)</span> Other fraudulent or deceptive means;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(b)">(b)</span> Fails to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(b)(i)">(i)</span> Establish or maintain inventories, records, or written policies and procedures as required by <a class="internal-link " href="/us/md/exec/comar/10.34.22.07" title=".07 Minimum Requirements for Maintenance of Prescription Drug or Device Distribution Records.">Regulation .07 of this chapter</a>;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(b)(ii)">(ii)</span> Register with the Maryland Division of Drug Control, and with the U.S. Drug Enforcement Agency, as required by <a class="internal-link " href="/us/md/exec/comar/10.34.22.07#D" title="">Regulation .07D of this chapter</a>; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(b)(iii)">(iii)</span> Permit the Board, the Maryland Division of Drug Control, the U.S. Drug Enforcement Agency, or other authorized federal, State, or local law enforcement officials showing proper identification, to enter, inspect, copy records, or audit as required by <a class="internal-link " href="/us/md/exec/comar/10.34.22.07#D" title="">Regulation .07D of this chapter</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(c)">(c)</span> Willfully makes or maintains false inventories or records;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(d)">(d)</span> Violates a provision of, or regulation promulgated under, <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(e)">(e)</span> Manufactures, repackages, sells, delivers, or holds or offers for sale any prescription drug or device that is adulterated, misbranded, counterfeit, suspected of being counterfeit, or has otherwise been rendered unfit for distribution or wholesale distribution;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(f)">(f)</span> Adulterates, misbrands, or counterfeits prescription drugs or devices;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(g)">(g)</span> Receives prescription drugs or devices that are adulterated, misbranded, stolen, obtained by fraud or deceit, counterfeit, or suspected of being counterfeit, or delivers or proffers delivery of such prescription drug or device for pay or otherwise;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(h)">(h)</span> Alters, mutilates, destroys, obliterates, or removes the whole or any part of the product labeling of a prescription drug or device, or commits any other act with respect to a prescription drug or device that results in the prescription drug or device being misbranded;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(i)">(i)</span> Forges, counterfeits, simulates, or falsely represents prescription drugs or devices without the authority of the manufacturer, or uses any mark, stamp, tag, label, or other identification device without the authorization of the manufacturer;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(j)">(j)</span> Purchases or receives a prescription drug or device from a person who is not licensed to wholesale distribute prescription drugs or devices to that purchaser or recipient;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(k)">(k)</span> Sells or transfers a prescription drug or device to a person who is not legally authorized to receive a prescription drug or device;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(l)">(l)</span> Provides the Board, its representatives, or federal or State officials with false or fraudulent records, or makes false or fraudulent statements regarding any matter within the provisions of these regulations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(m)">(m)</span> Wholesale distributes prescription drugs or devices that were:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(m)(i)">(i)</span> Purchased by a public or private hospital, or other health care entity;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(m)(ii)">(ii)</span> Donated or supplied at a reduced price to a charitable organization;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(m)(iii)">(iii)</span> Stolen or obtained by fraud or deceit; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(m)(iv)">(iv)</span> Donated to a drop-off site or repository under the Prescription Drug Repository Program set forth in Health-General Article, Title 15, Subtitle 6, Annotated Code of Maryland;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(n)">(n)</span> Fails to obtain a license, or operates without a valid license when a license is required;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(o)">(o)</span> Obtains, or attempts to obtain, a prescription drug or device by fraud, deceit, misrepresentation, or engages in misrepresentation or fraud in the distribution or wholesale distribution of a prescription drug or device;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(p)">(p)</span> Distributes a prescription drug or device to a consumer or patient;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(q)">(q)</span> Fails to obtain, authenticate, or pass on a pedigree when required under these regulations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(r)">(r)</span> Receives a prescription drug pursuant to a wholesale distribution without first receiving a pedigree, when required, that was attested to as accurate and complete by the wholesale distributor;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(s)">(s)</span> Distributes or wholesale distributes a prescription drug or device that was previously dispensed by a pharmacy or distributed by a practitioner;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(t)">(t)</span> Fails to report prohibited acts as listed in these regulations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(u)">(u)</span> Fails to exercise due diligence as provided in <a class="internal-link " href="/us/md/exec/comar/10.34.22.08" title=".08 Due Diligence.">Regulation .08 of this chapter</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(v)">(v)</span> Otherwise conducts the wholesale distribution of prescription drugs or devices in a manner not in accordance with the law;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(w)">(w)</span> Accepts payment or credit for the sale of prescription drugs in violation of <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">Health Occupations Article, §12-6</a>C-09(d), Annotated Code of Maryland; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(3)(x)">(x)</span> If the requirements of <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">Health Occupations Article, §12-6</a>C-09(a), Annotated Code of Maryland, are applicable and are not met, the purchasing or otherwise receiving a prescription drug from a pharmacy; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#A(4)">(4)</span> Is disciplined by a licensing or disciplinary authority of any state or country, or disciplined by a court of any state or country, for an act that would constitute a ground for Board action against a wholesale distributor permit holder under §A or B of this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.05#B">B.</span> Acts prohibited under this regulation do not include a prescription drug manufacturer, or agent of a prescription drug manufacturer, obtaining or attempting to obtain a prescription drug for the sole purpose of testing the prescription drug for authenticity.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.22.06" data-order="|10|34|22|.06|" data-ref-path="10|34|22|.06" class="h__section">.06 Minimum Requirements for the Storage and Handling of Prescription Drugs or Devices.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A">A.</span> Facilities. Facilities at which prescription drugs or devices are stored, warehoused, handled, held, offered, marketed, or displayed shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(1)">(1)</span> Be of suitable size and construction to facilitate:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(1)(a)">(a)</span> Cleaning;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(1)(b)">(b)</span> Maintenance; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(1)(c)">(c)</span> Proper operations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(2)">(2)</span> Have storage areas designed to provide adequate:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(2)(a)">(a)</span> Equipment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(2)(b)">(b)</span> Humidity control;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(2)(c)">(c)</span> Lighting;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(2)(d)">(d)</span> Sanitation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(2)(e)">(e)</span> Security conditions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(2)(f)">(f)</span> Space;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(2)(g)">(g)</span> Temperature; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(2)(h)">(h)</span> Ventilation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(3)">(3)</span> Have a quarantine area for storage of prescription drugs or devices that are:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(3)(a)">(a)</span> Adulterated;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(3)(b)">(b)</span> Damaged;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(3)(c)">(c)</span> Deteriorated;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(3)(d)">(d)</span> In immediate or sealed secondary containers that have been opened;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(3)(e)">(e)</span> Misbranded; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(3)(f)">(f)</span> Outdated;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(4)">(4)</span> Be maintained in a clean and orderly condition; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#A(5)">(5)</span> Be free from infestation by insects, rodents, birds, or vermin.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B">B.</span> Security. A facility:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(1)">(1)</span> Used for wholesale distribution shall be secure from unauthorized entry as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(1)(a)">(a)</span> Access from outside the premises shall be:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(1)(a)(i)">(i)</span> Kept to a minimum; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(1)(a)(ii)">(ii)</span> Well controlled;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(1)(b)">(b)</span> The outside perimeter of the premises shall be well lit; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(1)(c)">(c)</span> Entry into areas where prescription drugs or devices are held shall be limited to authorized personnel;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(2)">(2)</span> Shall be equipped with:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(2)(a)">(a)</span> An alarm system to detect entry after hours;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(2)(b)">(b)</span> A security system that provides protection against theft and diversion;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(2)(c)">(c)</span> Appropriate software to facilitate the identification of evidence of tampering with computers or electronic records;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(2)(d)">(d)</span> An inventory management and control system that protects against, detects, and documents any instances of theft, diversion, or counterfeiting;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(2)(e)">(e)</span> A security system to protect the integrity and confidentiality of data and documents;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(2)(f)">(f)</span> Video monitoring of all entrances and exits, or alternate acceptable security; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#B(2)(g)">(g)</span> A means to make the data and documentation required under this section readily available to the Board, an agent of the Board, or federal and other State law enforcement officials.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#C">C.</span> Storage.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#C(1)">(1)</span> A wholesale distributor shall store a prescription drug or device at appropriate temperatures and under appropriate conditions in accordance with requirements:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#C(1)(a)">(a)</span> If any, of the labeling of the drug or device; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#C(1)(b)">(b)</span> Set forth in the current edition of an official compendium, such as the United States Pharmacopeia/National Formulary (USP/NF), under 21 CFR §205.50(c), as amended.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#C(2)">(2)</span> If no storage requirements are established for a prescription drug or device, the drug or device shall be held at a controlled room temperature, as defined in an official compendium as set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.22.06#C(1)(b)" title="">§C(1)(b) of this regulation</a> to help assure that its identity, strength, quality, and purity are not adversely affected.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#C(3)">(3)</span> A wholesale distributor shall use appropriate manual, electromechanical, or electronic temperature and humidity recording equipment, devices, and logs to document proper storage of prescription drugs or devices.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#C(4)">(4)</span> A wholesale distributor shall follow the record-keeping requirements in <a class="internal-link " href="/us/md/exec/comar/10.34.22.07" title=".07 Minimum Requirements for Maintenance of Prescription Drug or Device Distribution Records.">Regulation .07 of this chapter</a> for stored prescription drugs or devices.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#D">D.</span> Examination of Materials.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#D(1)">(1)</span> Upon receipt, a wholesale distributor shall visually examine each outside shipping container for identity and to prevent the acceptance of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#D(1)(a)">(a)</span> Contaminated prescription drugs or devices; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#D(1)(b)">(b)</span> Prescription drugs or devices that are otherwise unfit for distribution.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#D(2)">(2)</span> The examination required under <a class="internal-link " href="/us/md/exec/comar/10.34.22.06#D(1)" title="">§D(1) of this regulation</a> shall be adequate to reveal container damage that would suggest possible contamination or other damage to the contents.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#D(3)">(3)</span> A wholesale distributor shall carefully inspect each outgoing shipment:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#D(3)(a)">(a)</span> For identity of the prescription drug or device product; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#D(3)(b)">(b)</span> To ensure that there is no delivery of a prescription drug or device that has been damaged in storage or held under improper conditions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#D(4)">(4)</span> A wholesale distributor shall follow the record-keeping requirements in <a class="internal-link " href="/us/md/exec/comar/10.34.22.07" title=".07 Minimum Requirements for Maintenance of Prescription Drug or Device Distribution Records.">Regulation .07 of this chapter</a> for incoming and outgoing prescription drugs or devices.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E">E.</span> Returned, Damaged, and Outdated Prescription Drugs or Devices.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(1)">(1)</span> A wholesale distributor shall quarantine and physically separate prescription drugs or devices that are outdated, damaged, deteriorated, misbranded, or adulterated from other prescription drugs or devices until the quarantined and separated drugs or devices are destroyed or returned to their supplier for proper disposal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(2)">(2)</span> The wholesale distributor shall identify, mark, quarantine, and physically separate from other prescription drugs or devices those prescription drugs or devices whose immediate or sealed outer or sealed secondary containers have been opened or used, until the drugs or devices are either destroyed or returned to their supplier for proper disposal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(3)">(3)</span> Prescription Drugs.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(3)(a)">(a)</span> If the conditions under which a prescription drug has been returned cast doubt on the prescription drug's safety, identity, strength, quality, or purity, then the wholesale distributor shall destroy or return the prescription drug to the supplier, unless examination, testing, or other investigation proves that the prescription drug meets appropriate standards of safety, identity, strength, quality, and purity.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(3)(b)">(b)</span> In determining whether the conditions under which a prescription drug has been returned cast doubt on the prescription drug's safety, identity, strength, quality, or purity, the wholesale distributor shall consider, at a minimum, the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(3)(b)(i)">(i)</span> Conditions under which the prescription drug has been held, stored, or shipped before or during its return; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(3)(b)(ii)">(ii)</span> Condition of the prescription drug and its container, carton, or labeling, as a result of storage or shipping.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(4)">(4)</span> Prescription Devices.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(4)(a)">(a)</span> If the conditions under which a prescription device has been returned cast doubt on the prescription device's safety, identity, or quality, then the wholesale distributor shall destroy or return the prescription device to the supplier, unless examination, testing, or other investigation proves that the prescription device meets appropriate standards of safety, identity, strength, and quality.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(4)(b)">(b)</span> In determining whether the conditions under which a prescription device has been returned cast doubt on the prescription device's safety, identity, or quality, the wholesale distributor shall consider, among other things, the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(4)(b)(i)">(i)</span> Conditions under which the prescription device has been held, stored, or shipped before or during its return; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(4)(b)(ii)">(ii)</span> Condition of the prescription device and its container, carton, or labeling, as a result of storage or shipping.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.06#E(5)">(5)</span> A wholesale distributor shall follow the record-keeping requirements in <a class="internal-link " href="/us/md/exec/comar/10.34.22.07" title=".07 Minimum Requirements for Maintenance of Prescription Drug or Device Distribution Records.">Regulation .07 of this chapter</a> for outdated, damaged, deteriorated, misbranded, or adulterated prescription drugs or devices.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.22.07" data-order="|10|34|22|.07|" data-ref-path="10|34|22|.07" class="h__section">.07 Minimum Requirements for Maintenance of Prescription Drug or Device Distribution Records.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A">A.</span> Record Keeping.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(1)">(1)</span> A wholesale distributor shall establish and maintain inventories and records of transactions regarding the receipt and distribution or other disposition of prescription drugs or devices.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(2)">(2)</span> The records required under <a class="internal-link " href="/us/md/exec/comar/10.34.22.07#A(1)" title="">§A(1) of this regulation</a> shall include the following information:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(2)(a)">(a)</span> The source of the prescription drugs or devices, including the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(2)(a)(i)">(i)</span> Name and principal address of the seller or transferor; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(2)(a)(ii)">(ii)</span> Address of the location from which the prescription drugs or devices were shipped;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(2)(b)">(b)</span> The identity and quantity of the prescription drugs or devices received and distributed or disposed of;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(2)(c)">(c)</span> The dates of receipt and distribution or other disposition of the prescription drugs or devices; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(2)(d)">(d)</span> The pedigrees, if required by <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">Health Occupations Article, §12-6</a>C-10, Annotated Code of Maryland, for prescription drugs that are wholesale distributed outside the normal distribution channel.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(3)">(3)</span> The wholesale distributor shall make available inventories and records for inspection and copying by authorized federal, State, or local law enforcement agency officials for a period of 3 years after their date of creation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(4)">(4)</span> The wholesale distributor shall keep the records described in this regulation readily available for inspection by authorized federal, State, or local law enforcement agency officials during the retention period, either:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(4)(a)">(a)</span> At the inspection site; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(4)(b)">(b)</span> So as to be immediately retrievable by computer or other electronic means.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(5)">(5)</span> Within 5 working days of a request by an authorized official of a federal, State, or local law enforcement agency, the wholesale distributor shall make available for inspection records kept at a central location apart from the inspection site and not electronically retrievable.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(6)">(6)</span> Facilities shall establish and maintain procedures for reporting counterfeit and contraband or suspected counterfeit and contraband drugs or devices or counterfeiting and contraband or suspected counterfeiting and contraband activities to the Board and the FDA.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(7)">(7)</span> Wholesale distributors shall maintain a system for the mandatory reporting of significant inventory losses of prescription drugs and devices where it is known or suspected that diversion is occurring to the Board, the FDA, and, where applicable, to the DEA.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(8)">(8)</span> Wholesale distributors shall consider the following factors when determining if there has been a significant inventory loss:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(8)(a)">(a)</span> The schedule of the missing items;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(8)(b)">(b)</span> The abuse or misuse potential of the missing items;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(8)(c)">(c)</span> The abuse or misuse potential in the wholesale distributor's area of the missing substance;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(8)(d)">(d)</span> The quantity missing in relation to the total quantity purchased (one tablet vs. one bottle or container);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(8)(e)">(e)</span> Whether this is the first time a potentially significant inventory loss has occurred;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(8)(f)">(f)</span> Whether this loss was reported to local law enforcement authorities; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#A(8)(g)">(g)</span> Whether there is a significant resale value of the missing items.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B">B.</span> Written Policies and Procedures.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(1)">(1)</span> A wholesale distributor shall establish, maintain, and adhere to written policies and procedures which shall be followed for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(1)(a)">(a)</span> The receipt, security, storage, inventory, and distribution of prescription drugs or devices;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(1)(b)">(b)</span> Identifying, recording, and reporting losses or thefts; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(1)(c)">(c)</span> Correcting errors and inaccuracies in inventories.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)">(2)</span> A wholesale distributor shall include in the written policies and procedures the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(a)">(a)</span> A procedure by which the oldest approved and unexpired stock of a prescription drug or device is distributed first;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(b)">(b)</span> Procedures to be followed for adequate handling of a recall and withdrawal of a prescription drug or device due to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(b)(i)">(i)</span> An action initiated at the request of the United States Food and Drug Administration or other federal, State, or local law enforcement or other government agency, including the Maryland Division of Drug Control;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(b)(ii)">(ii)</span> A voluntary action by the manufacturer to remove a defective or potentially defective drug or device from the market; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(b)(iii)">(iii)</span> An action undertaken to promote public health and safety by replacing existing merchandise with an improved product or new package design;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(c)">(c)</span> A procedure to ensure that the wholesale distributor is prepared for, protected against, and is able to handle a crisis that affects security or operation of a facility if any of the following situations occurs:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(c)(i)">(i)</span> Strike;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(c)(ii)">(ii)</span> Fire;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(c)(iii)">(iii)</span> Flood;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(c)(iv)">(iv)</span> Catastrophic health emergency as defined in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gps&amp;section=14-3" title="">Public Safety Article, §14-3</a>A-01, Annotated Code of Maryland;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(c)(v)">(v)</span> Terrorist activities;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(c)(vi)">(vi)</span> Other natural disaster; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(c)(vii)">(vii)</span> Other situations of local, State, or national emergency;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(d)">(d)</span> A procedure to ensure that an outdated prescription drug or device is segregated from other drugs or devices and either returned to the manufacturer or destroyed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(e)">(e)</span> A procedure for the disposing and destruction of containers, labels, and packaging to ensure that the containers, labels, and packaging cannot be used in counterfeiting activities, including all necessary documentation, maintained for a minimum of 3 years, and the appropriate witnessing of the destruction of any labels, packaging, immediate containers, or containers in accordance with applicable federal and State requirements; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(2)(f)">(f)</span> A procedure for identifying, segregating, investigating, and reporting prescription drug inventory discrepancies involving counterfeit, suspect of being counterfeit, contraband, or suspect of being contraband, in the inventory and reporting of such discrepancies within 5 business days to the Board and appropriate federal or State agency upon discovery of such discrepancies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(3)">(3)</span> If deviation is appropriate, a wholesale distributor may temporarily deviate from the requirement in <a class="internal-link " href="/us/md/exec/comar/10.34.22.07#B(2)(a)" title="">§B(2)(a) of this regulation</a> that the oldest approved and unexpired stock be distributed first.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#B(4)">(4)</span> The wholesale distributor shall maintain documentation of the disposition of outdated prescription drugs or devices for 2 years after the disposition of the outdated prescription drugs or devices pursuant to procedures under <a class="internal-link " href="/us/md/exec/comar/10.34.22.07#B(2)(d)" title="">§B(2)(d) of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#C">C.</span> Responsible Individuals. A wholesale distributor shall establish and maintain a list of officers, directors, managers, the designated representative, and others in charge of wholesale distribution, storage, and handling, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#C(1)">(1)</span> A description of their duties; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#C(2)">(2)</span> A summary of their qualifications.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#D">D.</span> Compliance with Federal, State, and Local Law. A wholesale distributor shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#D(1)">(1)</span> Operate in compliance with applicable federal, State, and local laws and regulations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#D(2)">(2)</span> Permit at reasonable times and in a reasonable manner, the Board, the State Division of Drug Control, and any other authorized federal, State, and local law enforcement officials showing proper identification to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#D(2)(a)">(a)</span> Enter and inspect the distributor's premises and delivery vehicles; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#D(2)(b)">(b)</span> Audit and copy the distributor's records and written operating procedures; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#D(3)">(3)</span> If dealing in controlled substances:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#D(3)(a)">(a)</span> Register with the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#D(3)(a)(i)">(i)</span> Maryland Division of Drug Control; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#D(3)(a)(ii)">(ii)</span> United States Drug Enforcement Administration; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#D(3)(b)">(b)</span> Comply with all applicable federal, State, and local regulations.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#E">E.</span> Salvaging and Reprocessing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#E(1)">(1)</span> A wholesale distributor is subject to the provisions of applicable federal, State, or local laws or regulations that relate to prescription drug product salvaging or reprocessing, including 21 CFR Parts 207, 210, and 211, as amended.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.07#E(2)">(2)</span> A wholesale distributor is subject to the provisions of any applicable federal, State, or local laws or regulations that relate to prescription device product salvaging or reprocessing.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.22.08" data-order="|10|34|22|.08|" data-ref-path="10|34|22|.08" class="h__section">.08 Due Diligence.</h3>
                <p>Wholesale distributors having transactions with persons not licensed by the Board or not certified by a third party recognized by the Board shall have in place policies and procedures to perform due diligence on transactions that take place that include:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.08#A">A.</span> Verification of alternate licensure;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.08#B">B.</span> Verification of identity; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.08#C">C.</span> Verification of recent inspections by a state or third party entity recognized by the Board.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.22.09" data-order="|10|34|22|.09|" data-ref-path="10|34|22|.09" class="h__section">.09 Reinstatement.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.09#A">A.</span> The wholesale distributor permit shall expire on the last day of its term.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.09#B">B.</span> The Board may not reinstate the wholesale distributor permit unless the applicant pays a reinstatement fee set by the Board.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.22.10" data-order="|10|34|22|.10|" data-ref-path="10|34|22|.10" class="h__section">.10 Required Information and Procedures for Ceasing to Operate.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#A">A.</span> If a wholesale distributor is located in another state, a wholesale distributor anticipating ceasing to operate in Maryland shall return the permit to the Board within 10 days of ceasing to operate in Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B">B.</span> Procedures for Wholesale Distributors Located in this State for Ceasing to Operate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(1)">(1)</span> Notification.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(1)(a)">(a)</span> At least 30 days before a wholesale distributor’s anticipated date of ceasing to operate, the wholesale distributor shall notify the Board in writing, by certified mail, return receipt requested, or hand delivered to the Board’s office, of the day on which the wholesale distributor will cease to operate.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(1)(b)">(b)</span> A wholesale distributor shall:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(1)(b)(i)">(i)</span> Notify drug and device suppliers that supply prescription drugs and devices to the wholesale distributor, at least 30 days in advance of ceasing to operate, of the date that the wholesale distributor will cease to operate;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(1)(b)(ii)">(ii)</span> Notify manufacturers, wholesale distributors, licensed pharmacies and authorized prescribers that receive prescription drugs and devices from the wholesale distributor, at least 30 days in advance of ceasing to operate, of the date that the wholesale distributor will cease to operate; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(1)(b)(iii)">(iii)</span> Comply with applicable federal regulations.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(2)">(2)</span> The wholesale distributor shall submit to and pass a closing inspection conducted by the Board.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(3)">(3)</span> With the exception of controlled dangerous substances, the wholesale distributor shall dispose of prescription drugs or devices in stock by one or more of the following means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(3)(a)">(a)</span> Returning the prescription drugs or devices to a distributor or manufacturer;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(3)(b)">(b)</span> Transferring the prescription drugs or devices to another wholesale distributor, licensed pharmacy, authorized prescriber, or other person or entity approved by the Board; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(3)(c)">(c)</span> Destroying in accordance with this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(4)">(4)</span> Disposition of Controlled Dangerous Substances. The wholesale distributor shall comply with the procedures set forth in this regulation in addition to those set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.03.10" title=".10 Records and Reports Required of Registrants.">COMAR 10.19.03.10</a> governing the transfer, return or disposal of controlled dangerous substances.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)">(5)</span> At the closing inspection, the wholesale distributor shall provide to the Board the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(a)">(a)</span> The exact date on which the wholesale distributor ceased to operate;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(b)">(b)</span> A copy of the inventory of prescription drugs or devices disposed of, transferred, or returned.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(c)">(c)</span> The names, addresses, telephone numbers, and Drug Enforcement Administration registration numbers, if applicable, of the persons or business entities to whom prescription drugs or devices in stock were returned or transferred under this regulation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(d)">(d)</span> The wholesale distributor permit;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(e)">(e)</span> If prescription drugs or devices are destroyed pursuant to this regulation, a letter, signed under oath by the wholesale distributor, stating the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(e)(i)">(i)</span> Date, place and manner in which the prescription drugs or devices were destroyed;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(e)(ii)">(ii)</span> Names, addresses, and telephone numbers of the persons responsible for destroying the prescription drugs or devices; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(e)(iii)">(iii)</span> Name, dosage unit, and quantity of each type of prescription drug or device destroyed; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(f)">(f)</span> If any pedigrees or other documents are transferred, a letter, signed under oath by the wholesale distributor, stating:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(f)(i)">(i)</span> The date, time, place to which and manner in which the pedigrees or other documents were transferred; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(5)(f)(ii)">(ii)</span> The names, addresses, and telephone numbers of the persons responsible for transferring the pedigrees or other documents.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(6)">(6)</span> At the closing inspection, the wholesale distributor shall provide to the Division of Drug Control the following pertaining to controlled dangerous substances:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(6)(a)">(a)</span> The exact date on which the wholesale distributor ceased to operate;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(6)(b)">(b)</span> A copy of the closing inventory of controlled dangerous substances required by the Drug Enforcement Administration.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(6)(c)">(c)</span> The names, addresses, telephone numbers, Drug Enforcement Administration registration numbers, Division of Drug Control registration numbers, and Board permit numbers, if applicable, of the persons or business entities to whom controlled dangerous substances in stock were returned or transferred under this regulation; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.22.10#B(6)(d)">(d)</span> The Maryland Department of Health Controlled Dangerous Substance Registration for cancellation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.22.11" data-order="|10|34|22|.11|" data-ref-path="10|34|22|.11" class="h__section">.11 Relocation.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#A">A.</span> At least 30 days before relocation, a permit holder shall submit an application to the Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#B">B.</span> If relocation is due to a catastrophic event or State of Emergency, the relocation applicant shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#B(1)">(1)</span> Notify the Board within 48 hours; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#B(2)">(2)</span> Submit an application to the Board within 30 days.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#C">C.</span> A relocation applicant:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#C(1)">(1)</span> If the applicant holds products, shall comply with <a class="internal-link " href="/us/md/exec/comar/10.34.22.07" title=".07 Minimum Requirements for Maintenance of Prescription Drug or Device Distribution Records.">Regulation .07 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#C(2)">(2)</span> Shall submit a surety bond or other equivalent means of security acceptable to the State specific to the permit holder’s relocation, in accordance with Regulation .03 if this chapter; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#C(3)">(3)</span> Shall indicate on the application changes in product or personnel from the original application to the Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#D">D.</span> A new or different designated representative or immediate supervisor of a designated representative functioning at the relocated facility shall be required to undergo a criminal history records check as set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.22.03" title=".03 Minimum Application Requirements for Applicants Holding Product.">Regulation .03 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#E">E.</span> As part of the application process, a relocation applicant located in this State shall submit to and pass an opening inspection conducted by the Board, which shall include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#E(1)">(1)</span> Documentation of the permit holder’s notification to suppliers of prescription drugs and devices of the permit holder’s relocation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#E(2)">(2)</span> Documentation from the permit holder evidencing the appropriate transfer, return, or disposal of any prescription drugs or devices not transferred to the facility’s relocation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#F">F.</span> A relocation applicant located in another state shall provide to the Board:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#F(1)">(1)</span> Evidence of approval of the permit holder’s relocation from the accreditation organization that accredited the permit holder’s original location; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.22.11#F(2)">(2)</span> If the relocation applicant is not required to be accredited by an accreditation organization in accordance with Maryland law, inspection reports from the state in which the relocation applicant is located pertaining to the permit holder’s relocation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.23" data-order="|10|34|23|" data-ref-path="10|34|23" class="h__chapter">Chapter 23 Pharmaceutical Services to Patients in Comprehensive Care Facilities</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: October 7, 1996 (23:20 Md. R. 1424)</p>
                  <p>——————</p>
                  <p>Chapter revised effective June 1, 2011 (38:11 Md. R. 671)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.23.03#E" title="">Regulation .03E</a> amended effective September 16, 2013 (40:18 Md. R. 1479)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.23.07#D" title="">Regulation .07D</a>, E amended effective April 2, 2012 (39:6 Md. R. 408)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.23.08#B" title="">Regulation .08B</a> amended effective April 2, 2012 (39:6 Md. R. 408)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.23.09#G" title="">Regulation .09G</a> amended effective September 16, 2013 (40:18 Md. R. 1479)</p>
                  <h3>Authority</h3>
                  <p>Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">12-205</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-301" title="">12-301</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-401" title="">12-401</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-403" title="">12-403</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-501" title="">12-501</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-503" title="">12-503</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-504" title="">12-504</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-505" title="">12-505</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-506" title="">12-506</a>, and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">12-6</a>B-01, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.23.01" data-order="|10|34|23|.01|" data-ref-path="10|34|23|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter applies to pharmacies and licensed pharmacists serving comprehensive care facilities as defined in <a class="internal-link " href="/us/md/exec/comar/10.34.23.02" title=".02 Definitions.">Regulation .02 of this chapter</a>, except for pharmacies providing only emergency services for these facilities.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.23.02" data-order="|10|34|23|.02|" data-ref-path="10|34|23|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(1)">(1)</span> “Chart order” means a lawful order entered on the chart or a medical record of a patient of a comprehensive care facility by an authorized prescriber or the authorized prescriber’s designated agent for a drug or device.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(2)">(2)</span> Comprehensive Care Facility.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(2)(a)">(a)</span> “Comprehensive care facility” means a facility which admits patients suffering from disease, disabilities, or advanced age, requiring medical service and nursing service rendered by or under the supervision of a registered nurse.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(2)(b)">(b)</span> “Comprehensive care facility” does not mean an establishment which provides only:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(2)(b)(i)">(i)</span> Acute care; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(2)(b)(ii)">(ii)</span> Assisted living care.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(3)">(3)</span> "Emergency drug kit" means a container or electronic storage system containing medications which:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(3)(a)">(a)</span> May be required for the emergency need of a patient; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(3)(b)">(b)</span> Are not available from an authorized source in a timely manner.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(4)">(4)</span> "Interim box" means a container or an electronic system holding minimal quantities of medications:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(4)(a)">(a)</span> Agreed upon by the comprehensive care facility’s pharmaceutical services committee, as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.02.15" title=".15 Medical Director — Qualifications.">COMAR 10.07.02.15</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(4)(b)">(b)</span> Intended to expedite immediate initiation of emergency or nonemergency dosing until the pharmacy is able to provide a regular supply.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(5)">(5)</span> “Licensed pharmacist” means a pharmacist who is licensed by the Board to practice pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(6)">(6)</span> “Packaging” means the process by which a medication is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(6)(a)">(a)</span> Removed from a:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(6)(a)(i)">(i)</span> Non-patient specific manufacturer’s original container; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(6)(a)(ii)">(ii)</span> Patient specific container directly received from another pharmacy licensed in Maryland or operated by the government of the United States provided that the manufacturer’s name is present on the container; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(6)(b)">(b)</span> Placed into a new container by a licensed pharmacist or registered pharmacy technician under the supervision of a pharmacist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(7)">(7)</span> "Pharmaceutical services" means the care within practice standards, laws, regulations, and guidelines which is afforded by a licensed pharmacist to the patients of a comprehensive care facility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(8)">(8)</span> "Pharmacy" means a holder of a pharmacy permit issued by the Board, located either on the premises of or outside the comprehensive care facility and which provides pharmaceutical services to patients in a comprehensive care facility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(9)">(9)</span> "Pharmacy area" means that portion of the licensed pharmacy where medication and other products requiring a prescription by federal or State law are stored and where the prescriptions are compounded or prepared.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(10)">(10)</span> “Registered pharmacy technician” means an individual who is registered with the Board to perform delegated pharmacy acts.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(11)">(11)</span> "Verbal order" means a directive that is orally communicated to a licensed pharmacist to accept a prescription order by a person who is authorized to communicate a prescription.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.02#B(12)">(12)</span> "Written order" means a directive that is directly written by an authorized prescriber or a transcription of an order from an authorized prescriber by a person authorized to transcribe an order.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.23.03" data-order="|10|34|23|.03|" data-ref-path="10|34|23|.03" class="h__section">.03 Policies and Procedures.</h3>
                <p>The permit holder shall establish and operate under a policies and procedures manual which:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.03#A">A.</span> Complies with this chapter;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.03#B">B.</span> Defines the scope and method of pharmacy services provided to the patients of the comprehensive care facility;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.03#C">C.</span> Determines when personnel may have access to the pharmacy area;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.03#D">D.</span> Provides for the safe and efficient dispensing and delivery of pharmaceutical products as outlined in this subtitle;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.03#E">E.</span> Includes:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.03#E(1)">(1)</span> Labeling requirements and distribution methods for medication provided in a single container, slot, blister package, or other method of delivering an entire single dosing unit; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.03#E(2)">(2)</span> The conditions in which an interim box may be replenished or prepared, delivered, and stored by the comprehensive care facility in accordance with <a class="internal-link " href="/us/md/exec/comar/10.34.23.09" title=".09 Drug Control and Accountability.">Regulation .09 of this chapter</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.03#F">F.</span> Is provided to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.03#F(1)">(1)</span> The personnel of the pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.03#F(2)">(2)</span> The comprehensive care facility; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.03#F(3)">(3)</span> Upon request, an agent of the Board; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.03#G">G.</span> Is in a form that is:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.03#G(1)">(1)</span> Written or electronic; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.03#G(2)">(2)</span> Readily retrievable.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.23.04" data-order="|10|34|23|.04|" data-ref-path="10|34|23|.04" class="h__section">.04 Personnel.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.04#A">A.</span> Director of Pharmacy. The permit holder shall appoint a licensed pharmacist as director of pharmacy who is:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.04#A(1)">(1)</span> Licensed to engage in the practice of pharmacy in Maryland;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.04#A(2)">(2)</span> Knowledgeable in, and thoroughly familiar with, the specialized functions of comprehensive care facility pharmaceutical services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.04#A(3)">(3)</span> Responsible for and in full and actual charge of the pharmacy and its personnel;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.04#A(4)">(4)</span> Responsible for the operations of the pharmacy and for compliance with the requirements of <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>, and the regulations promulgated under that title;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.04#A(5)">(5)</span> Responsible for reviewing the policies and procedures manual of the pharmacy annually and revising it as necessary;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.04#A(6)">(6)</span> On site full time; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.04#A(7)">(7)</span> Responsible for only one comprehensive care pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.04#B">B.</span> Staff.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.04#B(1)">(1)</span> The permit holder:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.04#B(1)(a)">(a)</span> May employ registered pharmacy technicians as required to provide pharmaceutical services to the patients of the comprehensive care facilities; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.04#B(1)(b)">(b)</span> Shall provide policies and procedures that specify the duties that may be performed by registered pharmacy technicians under the supervision of a licensed pharmacist and the duties that may be performed only by a licensed pharmacist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.04#B(2)">(2)</span> The permit holder may employ unlicensed personnel to provide operational support as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.21.02#B" title="">COMAR 10.34.21.02B</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.23.05" data-order="|10|34|23|.05|" data-ref-path="10|34|23|.05" class="h__section">.05 Physical Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.05#A">A.</span> Storage. The director of pharmacy or designee shall ensure that medications and supplies within the pharmacy are properly stored according to the manufacturer’s specifications and State and federal laws and regulations with respect to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.05#A(1)">(1)</span> Sanitation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.05#A(2)">(2)</span> Temperature;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.05#A(3)">(3)</span> Light;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.05#A(4)">(4)</span> Ventilation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.05#A(5)">(5)</span> Moisture control;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.05#A(6)">(6)</span> Segregation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.05#A(7)">(7)</span> Security.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.05#B">B.</span> Equipment and Materials.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.05#B(1)">(1)</span> The director of pharmacy or designee shall ensure that the pharmacy contains appropriate:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.05#B(1)(a)">(a)</span> Equipment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.05#B(1)(b)">(b)</span> Supplies; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.05#B(1)(c)">(c)</span> Physical facilities for proper compounding, preparation, and dispensing of medications as outlined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19" title="Chapter 19 Sterile Pharmaceutical Compounding">COMAR 10.34.19</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.05#B(2)">(2)</span> The director of pharmacy or designee shall ensure that the pharmacy contains appropriate reference materials to enable personnel to prepare and dispense medications properly as outlined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.07" title="Chapter 07 Pharmacy Equipment">COMAR 10.34.07</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.05#C">C.</span> Security.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.05#C(1)">(1)</span> The director of pharmacy or designee shall ensure that no individual enters the pharmacy area unless a licensed pharmacist is on duty.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.05#C(2)">(2)</span> The permit holder and the director of pharmacy or designee shall ensure compliance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.05" title="Chapter 05 Pharmacy Security">COMAR 10.34.05</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.23.06" data-order="|10|34|23|.06|" data-ref-path="10|34|23|.06" class="h__section">.06 Medication and Device Distribution and Pharmaceutical Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.06#A">A.</span> The director of pharmacy or designee shall be responsible for the safe and efficient dispensing, delivery, control of, and accountability for medications and devices dispensed or distributed by the permit holder.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.06#B">B.</span> The director of pharmacy or designee shall work in cooperation with the professional staff of the comprehensive care facility in:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.06#B(1)">(1)</span> Meeting the responsibilities set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.23.06#C" title="">§C of this regulation</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.06#B(2)">(2)</span> Ordering, storing, and accounting for pharmaceutical materials.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.06#C">C.</span> The director of pharmacy or designee shall be responsible for, at a minimum:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.06#C(1)">(1)</span> The preparation of medications compounded in the pharmacy as applicable;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.06#C(2)">(2)</span> The proper preparation, storage, and distribution of compounded sterile preparations according to  <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19" title="Chapter 19 Sterile Pharmaceutical Compounding">COMAR 10.34.19</a> to the extent that the functions are performed at the pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.06#C(3)">(3)</span> The packaging and labeling of medications;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.06#C(4)">(4)</span> Records of transactions of the pharmacy as may be required by applicable law and as may be necessary to maintain accurate control over and accountability for pharmaceuticals, including patient medication profiles;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.06#C(5)">(5)</span> Participation in those aspects of the comprehensive care facility's quality assurance improvement program which relate to pharmaceutical care and effectiveness; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.06#C(6)">(6)</span> Implementation of the policies and decisions of the appropriate committee or committees of the comprehensive care facility related to these regulations and to other regulations of the facility.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.23.07" data-order="|10|34|23|.07|" data-ref-path="10|34|23|.07" class="h__section">.07 Medication Packaging.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#A">A.</span> A licensed pharmacist shall verify the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#A(1)">(1)</span> Selection of medication to be packaged; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#A(2)">(2)</span> Completed packaging of medication performed by registered pharmacy technicians for the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#A(2)(a)">(a)</span> Accuracy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#A(2)(b)">(b)</span> Completeness;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#A(2)(c)">(c)</span> Appropriateness; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#A(2)(d)">(d)</span> Compliance with the U.S. Food and Drug Administration and current United States Pharmacopeia approved packaging.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#B">B.</span> The licensed pharmacist shall ensure that labeling of the medication container includes the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#B(1)">(1)</span> Brand or generic name of the medication;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#B(2)">(2)</span> Strength of the medication, if appropriate;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#B(3)">(3)</span> Name of the pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#B(4)">(4)</span> Expiration date of the medication.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#C">C.</span> Unless the licensed pharmacist has reason to reduce the time period, the expiration date of the medication is the lesser of:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#C(1)">(1)</span> 12 months from the date of packaging;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#C(2)">(2)</span> The manufacturer's or distributor's listed expiration date; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#C(3)">(3)</span> The maximum time period allowed for the specific packaging used for the medication.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#D">D.</span> Packaged from the Manufacturer’s Original Container. The pharmacy may use a lot number and expiration date assigned by the pharmacy instead of the distributor or manufacturer information in a master log if kept with respect to drugs that are packaged within the pharmacy facility from the original manufacturer’s container which includes the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#D(1)">(1)</span> Name of the drug;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#D(2)">(2)</span> Strength;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#D(3)">(3)</span> Manufacturer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#D(4)">(4)</span> Lot number assigned by the pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#D(5)">(5)</span> Lot number assigned by the distributor or manufacturer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#D(6)">(6)</span> Quantity packaged;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#D(7)">(7)</span> Expiration date as defined in <a class="internal-link " href="/us/md/exec/comar/10.34.23.07#C" title="">§C of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#D(8)">(8)</span> Manufacturer's expiration date;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#D(9)">(9)</span> Date of packaging;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#D(10)">(10)</span> Name of pharmacy technician packaging; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#D(11)">(11)</span> Name and initials of verifying licensed pharmacist.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#E">E.</span> Packaged from Another Pharmacy. The licensed pharmacist may package patient specific medication received from another pharmacy licensed in Maryland or operated by the government of the United States provided that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#E(1)">(1)</span> The licensed pharmacist determines that the medication has been handled in a manner which preserves the strength, quality, purity, and identity of the drug or device during an interim period between the time it was dispensed by the original pharmacy and received by the packaging pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#E(2)">(2)</span> The licensed pharmacist packages and dispenses all at one time the entire quantity of the prescription medications received from another pharmacy for packaging;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#E(3)">(3)</span> The manufacturer’s name is present on the container received from the other pharmacy; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#E(4)">(4)</span> The licensed pharmacist maintains a master log that includes the following information:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#E(4)(a)">(a)</span> Name of the drug;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#E(4)(b)">(b)</span> Lot number assigned by the packaging pharmacy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#E(4)(c)">(c)</span> Strength;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#E(4)(d)">(d)</span> Manufacturer;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#E(4)(e)">(e)</span> Name, address, and telephone number of the original dispensing pharmacy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#E(4)(f)">(f)</span> Prescription number for the original dispensing pharmacy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#E(4)(g)">(g)</span> Quantity packaged;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#E(4)(h)">(h)</span> Expiration date as assigned by the original dispensing pharmacy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#E(4)(i)">(i)</span> Date of packaging;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#E(4)(j)">(j)</span> Name of pharmacy technician packaging;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#E(4)(k)">(k)</span> Name and initials of verifying licensed pharmacist; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.07#E(4)(l)">(l)</span> Name of the patient.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.23.08" data-order="|10|34|23|.08|" data-ref-path="10|34|23|.08" class="h__section">.08 Labeling of Patient Medications.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.08#A">A.</span> The director of pharmacy or designee shall ensure that medications dispensed by the pharmacy and intended for use within the comprehensive care facility are dispensed in appropriate containers and are labeled with the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.08#A(1)">(1)</span> Name and address of the pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.08#A(2)">(2)</span> Date of dispensing;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.08#A(3)">(3)</span> Prescription number assigned by the pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.08#A(4)">(4)</span> Name of the patient;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.08#A(5)">(5)</span> Name, quantity, and strength of the drug;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.08#A(6)">(6)</span> Name of the prescriber;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.08#A(7)">(7)</span> Expiration date of the drug;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.08#A(8)">(8)</span> Required precautionary information regarding controlled substances; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.08#A(9)">(9)</span> Further cautionary information as may be required or desirable for proper use of the medication.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.08#B">B.</span> The director of pharmacy or designee shall ensure that medication provided per dosing period in a single container, slot, blister package, any other method of delivering an entire single dosing unit, or as part of a multi-dose dispensing package is labeled with at least the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.08#B(1)">(1)</span> Drug name;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.08#B(2)">(2)</span> Drug strength;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.08#B(3)">(3)</span> Name of manufacturer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.08#B(4)">(4)</span> Name of the patient;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.08#B(5)">(5)</span> Lot number; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.08#B(6)">(6)</span> Expiration date.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.08#C">C.</span> The director of pharmacy or designee shall be responsible for the safe and efficient dispensing, delivery, control of, and accountability for medications and devices dispensed or distributed by the permit holder.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.08#D">D.</span> The director of pharmacy or designee shall work in cooperation with the other professional staff of the comprehensive care facility in meeting the responsibilities set forth in §B of the regulation and in ordering, storing, and accounting for pharmaceutical materials.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.08#E">E.</span> Compounded Sterile Preparations. When compounding sterile preparations a licensed pharmacist or a registered pharmacy technician under the licensed pharmacist’s supervision, shall comply with the compounding and labeling requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19" title="Chapter 19 Sterile Pharmaceutical Compounding">COMAR 10.34.19</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.23.09" data-order="|10|34|23|.09|" data-ref-path="10|34|23|.09" class="h__section">.09 Drug Control and Accountability.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#A">A.</span> The director of pharmacy or designee shall develop a process for the pharmacy to be notified of medications which have been discontinued.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#B">B.</span> Medications may be accepted for return if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#B(1)">(1)</span> The returned medication is properly labeled and properly sealed in the manufacturer’s package or an individually labeled unit dose of a drug or a device;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#B(2)">(2)</span> The licensed pharmacist determines that the returned medication has been handled in a manner which preserves the strength, quality, purity, and identity of the drug or device during an interim period between the sale of the drug or device and its return to the pharmacy; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#B(3)">(3)</span> The permit holder otherwise complies with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.10.07" title=".07 Disposition and Return of a Prescription Drug or Device.">COMAR 10.34.10.07</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#C">C.</span> Discontinued Medications — Controlled Dangerous Substances.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#C(1)">(1)</span> Except as provided in §§B(2) and C(2) of this regulations, drugs classified as Schedule II, Schedule III, Schedule IV, and Schedule V may not be returned to the inventory of the pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#C(2)">(2)</span> Schedule III, Schedule IV, and Schedule V medications may be returned to inventory of a pharmacy when the pharmacy uses a distribution system that classifies medications as pharmacy inventory until the utilization of the medication by the patient.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#D">D.</span> A compounded sterile preparation may not be returned to the inventory of a pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#E">E.</span> Drugs requiring refrigeration may not be returned to the inventory of a pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#F">F.</span> Emergency Drug Kit.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#F(1)">(1)</span> The director of pharmacy or designee shall ensure that the emergency drug kit is secured with a tamper-evident seal or electronic security system which will indicate the opening of the kit.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#F(2)">(2)</span> Labeling. The director of pharmacy or designee shall ensure that the emergency drug kit meets the following specifications:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#F(2)(a)">(a)</span> The exterior of the emergency drug kit is labeled to indicate clearly and unmistakably that it is an emergency drug kit and that it is for use in emergencies only;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#F(2)(b)">(b)</span> The exterior of the emergency drug kit is labeled to indicate the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#F(2)(b)(i)">(i)</span> Names of the drugs contained in the emergency drug kit;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#F(2)(b)(ii)">(ii)</span> Strengths of the drugs contained in the emergency drug kit;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#F(2)(b)(iii)">(iii)</span> List of contents with expiration dates, with the date of the first item to expire in bold print; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#F(2)(b)(iv)">(iv)</span> The quantity of each drug contained in the emergency drug kit; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#F(2)(c)">(c)</span> Medications contained in the emergency drug kit are labeled with the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#F(2)(c)(i)">(i)</span> Name of the drug;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#F(2)(c)(ii)">(ii)</span> Strength of the drug;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#F(2)(c)(iii)">(iii)</span> Expiration date of the drug;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#F(2)(c)(iv)">(iv)</span> Lot number of the drug; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#F(2)(c)(v)">(v)</span> Other information required by the medical staff.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#F(3)">(3)</span> Replacement of Medications.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#F(3)(a)">(a)</span> A licensed pharmacist or licensed pharmacist's designee shall replace the emergency drug kit or replenish used or expired drugs contained in the emergency drug kit within 72 hours of notification of use or expiration.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#F(3)(b)">(b)</span> A licensed pharmacist shall perform the final check on the contents of the emergency drug kit.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#G">G.</span> Interim Box.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#G(1)">(1)</span> An interim box may be provided by the pharmacy and kept at the comprehensive care facility if comprehensive care facility policies and procedures address an interim box and the pharmacy complies with these policies and procedures.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#G(2)">(2)</span> A licensed pharmacist shall perform the final check on the contents of the interim box.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#H">H.</span> Prescriber Orders.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#H(1)">(1)</span> A licensed pharmacist shall dispense medications from the pharmacy only upon receipt of a valid written prescription, chart order, or verbal order from an authorized prescriber.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#H(2)">(2)</span> A chart order shall be considered a prescription drug order provided that the prescription drug order contains:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#H(2)(a)">(a)</span> The full name of the patient;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#H(2)(b)">(b)</span> The date of issuance;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#H(2)(c)">(c)</span> The name, strength, and dosage form of the drug prescribed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#H(2)(d)">(d)</span> The name, type, and specifications of any device;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#H(2)(e)">(e)</span> The directions for use;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#H(2)(f)">(f)</span> If written, the authorized prescriber’s signature or the signature of the authorized prescriber’s agent (including the name of the authorized prescriber);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#H(2)(g)">(g)</span> If electronically transmitted, prescription requirements as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.20" title="Chapter 20 Format of Prescription Transmission">COMAR 10.34.20</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#H(2)(h)">(h)</span> If verbal, the name of the prescriber and the prescriber’s agent, if applicable.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#H(3)">(3)</span> A written order may be received by the pharmacy by facsimile, electronic transmission, or as the original physician order.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#H(4)">(4)</span> The licensed pharmacist shall document immediately a verbal order in writing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#H(5)">(5)</span> A licensed pharmacist may receive a verbal order:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#H(5)(a)">(a)</span> By telephone with the licensed pharmacist reading back the prescription to the prescriber or the prescriber’s agent; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#H(5)(b)">(b)</span> By a voice messaging system.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#I">I.</span> Controlled Dangerous Substances.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#I(1)">(1)</span> Drug Accountability. The permit holder shall ensure that personnel employed by the pharmacy abide by the laws and regulations as defined in Health-General Article, Title 27, Annotated Code of Maryland, and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.03" title="Chapter 03 Controlled Dangerous Substances">COMAR 10.19.03</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#I(2)">(2)</span> Storage and Security. The permit holder shall establish effective procedures for storage and security of Schedule II controlled dangerous substances including limitation of access to these drugs in the pharmacy to licensed pharmacists and registered pharmacy technicians.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#J">J.</span> Drug Recalls. The director of pharmacy or designee shall develop and implement a recall procedure that can be readily activated to ensure that drugs which have been recalled are returned to the pharmacy, sequestered, and handled as appropriate to the level of the recall.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#K">K.</span> Adverse Drug Reactions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#K(1)">(1)</span> The director of pharmacy or designee shall participate on the appropriate committee of the comprehensive care facility to establish procedures to report and record adverse drug reactions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#K(2)">(2)</span> The director of pharmacy or designee shall ensure the procedures established include, at a minimum:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#K(2)(a)">(a)</span> The reporting of significant adverse drug reactions to the attending prescriber or designee and other parties as specified by the committee of the comprehensive care facility; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#K(2)(b)">(b)</span> The recording in writing of an adverse reaction on the patient’s chart at the time it is reported.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.23.09#L">L.</span> Records and Reports. The director of pharmacy or designee shall maintain records and reports as may be required by law, this chapter, and the policies of the comprehensive care facility.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.23.10" data-order="|10|34|23|.10|" data-ref-path="10|34|23|.10" class="h__section">.10 Quality Management.</h3>
                <p>The director of pharmacy or designee, in cooperation with the pharmaceutical services committee of the comprehensive care facility, shall be responsible for developing procedures for an ongoing quality management program that includes a mechanism for reviewing and evaluating pharmaceutical services as defined in this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.24" data-order="|10|34|24|" data-ref-path="10|34|24" class="h__chapter">Chapter 24 Record of Drug Inventory Acquisition</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: September 17, 2001 (28:18 Md. R. 1621)</p>
                  <h3>Authority</h3>
                  <p><a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">Health Occupations Article, §12-205(a)(3)(ii), </a>Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.24.01" data-order="|10|34|24|.01|" data-ref-path="10|34|24|.01" class="h__section">.01 Purpose.</h3>
                <p>The purpose of this chapter is to establish the minimum requirements for drug acquisition records to be maintained by pharmacy permit holders.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.24.02" data-order="|10|34|24|.02|" data-ref-path="10|34|24|.02" class="h__section">.02 Scope.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.24.02#A">A.</span> This chapter applies to all pharmacy permit holders in this State.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.24.02#B">B.</span> This chapter applies to the acquisition of all prescription medication drug inventories.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.24.02#C">C.</span> This chapter applies to a pharmacy's acquisition of drug inventory from all sources including, but not limited to, pharmacies, distributors, and manufacturers, and through all means including, but not limited to, purchases, barter or exchange, free goods, rebates, and replacement products.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.24.03" data-order="|10|34|24|.03|" data-ref-path="10|34|24|.03" class="h__section">.03 Minimum Requirements for Maintenance of Drug Acquisition Records.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.24.03#A">A.</span> A pharmacy permit holder shall maintain records of all drug inventory acquisitions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.24.03#B">B.</span> The records maintained shall include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.24.03#B(1)">(1)</span> The name and principal address of the source of the drugs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.24.03#B(2)">(2)</span> The identity and quantity of the drugs received; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.24.03#B(3)">(3)</span> The date the drugs were received.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.24.03#C">C.</span> The acquisition records shall be kept for a period of 2 years from the date the inventory was received.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.24.04" data-order="|10|34|24|.04|" data-ref-path="10|34|24|.04" class="h__section">.04 Violation and Inspection.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.24.04#A">A.</span> A pharmacy permit holder shall make the drug inventory acquisition records required under this chapter available for inspection upon request by any federal, state, or local law enforcement agent, or any other duly authorized agent of the Board of Pharmacy or the Division of Drug Control, within 72 hours of the request.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.24.04#B">B.</span> A pharmacy permit holder shall produce and maintain the records required under this chapter for drug acquisitions for all acquisitions except those replaced within 7 days.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.25" data-order="|10|34|25|" data-ref-path="10|34|25" class="h__chapter">Chapter 25 Delivery of Prescriptions</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: December 10, 2001 (28:24 Md. R. 2128)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.25.01" title=".01 Scope.">Regulation .01</a> amended effective March 1, 2012 (39:1 Md. R. 17)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.25.02#B" title="">Regulation .02B</a> amended effective March 1, 2012 (39:1 Md. R. 17)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.25.03" title=".03 Requirements for Packaging and Delivery of Prescription Medication.">Regulation .03</a> repealed and new Regulation .03 adopted effective March 1, 2012 (39:1 Md. R. 17)</p>
                  <p>Regulation .06 repealed effective March 1, 2012 (39:1 Md. R. 17)</p>
                  <h3>Authority</h3>
                  <p><a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">Health Occupations Article, §12-205(a)(3)(ii), </a>Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.25.01" data-order="|10|34|25|.01|" data-ref-path="10|34|25|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter governs the manner in which a Maryland licensed pharmacy delivers filled prescriptions for individual patients by United States Postal Service, common carrier, or delivery service to an address within the State.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.25.02" data-order="|10|34|25|.02|" data-ref-path="10|34|25|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.25.02#A">A.</span> In this chapter, the following terms have the meaning indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.25.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.25.02#B(1)">(1)</span> "Delivery" means to send a prescription medication from a pharmacy by the United States Postal Service, common carrier, or delivery system to an address within the State.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.25.02#B(2)">(2)</span> Depot.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.25.02#B(2)(a)">(a)</span> "Depot" means a location where filled prescriptions are stored before delivery to the intended patient or the intended patient's authorized agent.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.25.02#B(2)(b)">(b)</span> "Depot" does not include:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.25.02#B(2)(b)(i)">(i)</span> A licensed health care facility;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.25.02#B(2)(b)(ii)">(ii)</span> A prescriber's office;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.25.02#B(2)(b)(iii)">(iii)</span> The prescription area of a pharmacy as defined by <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.05.01" title=".01 Definitions.">COMAR 10.34.05.01</a>;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.25.02#B(2)(b)(iv)">(iv)</span> The United States Postal Service or common carrier's warehouse; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.25.02#B(2)(b)(v)">(v)</span> A multiple family residence.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.25.02#B(3)">(3)</span> "Patient" means the individual or companion animal for whom a prescription is written and to whom a prescription medication will be administered.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.25.02#B(4)">(4)</span> "Patient profile" means a record of dispensing activity maintained by a pharmacist for a specific patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.25.02#B(5)">(5)</span> "Residence" means the street address at which a patient resides.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.25.02#B(6)">(6)</span> "Storage" means the maintenance of a supply of medication before receipt of the medication by the patient or an agent authorized by the patient.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.25.03" data-order="|10|34|25|.03|" data-ref-path="10|34|25|.03" class="h__section">.03 Requirements for Packaging and Delivery of Prescription Medication.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.25.03#A">A.</span> Packaging. Prescription medications delivered under this chapter to individuals in the State shall be:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.25.03#A(1)">(1)</span> Enclosed in a container that reveals to the patient any tampering of the container that occurred during delivery or storage;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.25.03#A(2)">(2)</span> Packaged in a shipping container in a manner that does not indicate that the contents are medications;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.25.03#A(3)">(3)</span> Packaged in a manner that indicates:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.25.03#A(3)(a)">(a)</span> The name and address of the patient or authorized agent; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.25.03#A(3)(b)">(b)</span> Any special storage conditions or requirements; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.25.03#A(4)">(4)</span> Packaged to contain:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.25.03#A(4)(a)">(a)</span> Written information regarding the prescription drug or device which is considered significant in the professional judgment of the pharmacist;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.25.03#A(4)(b)">(b)</span> A local or toll-free telephone number for the pharmacy; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.25.03#A(4)(c)">(c)</span> Notification to the patient if the appearance of the patient’s medication has changed from the patient’s last refill.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.25.03#B">B.</span> Delivery.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.25.03#B(1)">(1)</span> Location.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.25.03#B(1)(a)">(a)</span> A prescription medication may be delivered to the patient for whom the prescription is prescribed, wherever the patient is located.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.25.03#B(1)(b)">(b)</span> Instead of delivering medication directly to the patient under <a class="internal-link " href="/us/md/exec/comar/10.34.25.03#B(1)(a)" title="">§B(1)(a) of this regulation</a>, medication may be delivered to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.25.03#B(1)(b)(i)">(i)</span> An agent authorized by the patient; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.25.03#B(1)(b)(ii)">(ii)</span> The residence of the patient, regardless of whether the patient is present at the residence at the time of delivery.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.25.03#B(2)">(2)</span> The pharmacy permit holder shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.25.03#B(2)(a)">(a)</span> Enclose information to inform the patient if the patient’s prescription is a temperature sensitive medication that is at risk for damage due to extreme hot or cold temperatures or moisture:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.25.03#B(2)(a)(i)">(i)</span> During shipment; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.25.03#B(2)(a)(ii)">(ii)</span> After delivery to the patient’s mailbox or other designated location; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.25.03#B(2)(b)">(b)</span> Inform the patient within 24 hours of being notified of the delay if the scheduled delivery of the patient’s prescription will be interrupted or late.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.25.04" data-order="|10|34|25|.04|" data-ref-path="10|34|25|.04" class="h__section">.04 Depots.</h3>
                <p>A pharmacy may not knowingly deliver prescription medications to a depot, or establish or cooperate in the establishment of a depot.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.25.05" data-order="|10|34|25|.05|" data-ref-path="10|34|25|.05" class="h__section">.05 Record Keeping.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.25.05#A">A.</span> If a patient authorizes delivery of prescription medication to an agent at a location other than the pharmacy, or the patient's residence, the pharmacist shall document the authorization:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.25.05#A(1)">(1)</span> On the prescription;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.25.05#A(2)">(2)</span> In the patient profile; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.25.05#A(3)">(3)</span> In another record maintained in the pharmacy and established for this purpose.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.25.05#B">B.</span> If prescription medication is sent to an agent authorized by the patient at a location other than the patient's residence, or the place of business of the patient's authorized prescriber, the pharmacy shall maintain a record of the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.25.05#B(1)">(1)</span> Identity of the agent to whom the medication is sent;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.25.05#B(2)">(2)</span> Location where the medication is sent;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.25.05#B(3)">(3)</span> Date and time the medication is sent; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.25.05#B(4)">(4)</span> Prescription number or description of the medication sent.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.26" data-order="|10|34|26|" data-ref-path="10|34|26" class="h__chapter">Chapter 26 Patient Safety Improvement</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: October 27, 2003 (30:21 Md. R. 1529)</p>
                  <h3>Authority</h3>
                  <p><a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">Health Occupations Article, §12-205(a)(3), </a>Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.26.01" data-order="|10|34|26|.01|" data-ref-path="10|34|26|.01" class="h__section">.01 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.26.01#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.26.01#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.26.01#B(1)">(1)</span> "High-alert medication" means a medication with:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.26.01#B(1)(a)">(a)</span> A significant potential for involvement in a mediation error due to the medication's name, packaging, appearance, dosing, or other characteristics of the agent; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.26.01#B(1)(b)">(b)</span> A high potential for causing serious harm or injury if used incorrectly.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.26.01#B(2)">(2)</span> Medication Error.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.26.01#B(2)(a)">(a)</span> "Medication error" means any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient, or consumer.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.26.01#B(2)(b)">(b)</span> "Medication error" includes events that may be related to professional practice, health care products, procedures, and systems, including prescribing, order communication, product labeling, packaging, nomenclature, compounding, dispensing, distribution, administration, education, monitoring, and use.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.26.01#B(3)">(3)</span> Ongoing Quality Assurance Program.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.26.01#B(3)(a)">(a)</span> "Ongoing quality assurance program" means a program that systematically and routinely reviews the medication delivery system of a pharmacy for the purpose of minimizing the occurrence of medication errors.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.26.01#B(3)(b)">(b)</span> "Ongoing quality assurance program" includes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.26.01#B(3)(b)(i)">(i)</span> The systematic and routine collection of information regarding the performance of the medication delivery system as it becomes available;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.26.01#B(3)(b)(ii)">(ii)</span> The investigation of medication errors at the time the error is reported or discovered, or within a reasonable amount of time after the medication error is reported or discovered; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.26.01#B(3)(b)(iii)">(iii)</span> A record, proceeding, file, or other document maintained to comply with Regulations .03 or .04 of this chapter, <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.21.03" title=".03 Duties of the Permit Holder.">COMAR 10.34.21.03</a>, <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.28.09" title=".09 Education and Training.">COMAR 10.34.28.09</a>, or <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.28.10" title=".10 Quality Assurance Program.">COMAR 10.34.28.10</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.26.02" data-order="|10|34|26|.02|" data-ref-path="10|34|26|.02" class="h__section">.02 Patient Education.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.26.02#A">A.</span> The pharmacy permit holder shall establish methods to provide patients with information regarding the patient's role and responsibility in preventing medication errors in a manner that is reasonably likely to convey the information to the patient, and if applicable, the patient's health care agent or surrogate decision maker, under Health-General Article, Title 5, Subtitle 6, Annotated Code of Maryland, and that is in addition to any other patient counseling or information required to be given by other laws and regulations.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.26.02#B">B.</span> The information in <a class="internal-link " href="/us/md/exec/comar/10.34.26.02#A" title="">§A of this regulation</a> shall be provided to the patient before or at the time the drug or device is presented to the patient.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.26.02#C">C.</span> Exception. If the patient is an inpatient at a health care facility, the information in <a class="internal-link " href="/us/md/exec/comar/10.34.26.02#A" title="">§A of this regulation</a> shall be:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.26.02#C(1)">(1)</span> Provided directly to a patient and, if applicable, a patient's health care agent or surrogate decision maker before discharge; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.26.02#C(2)">(2)</span> Available in a conspicuous location on the institution's premises where the patient and, if applicable, the patient's health care agent or surrogate decision maker, are reasonably likely to have an opportunity to review the information.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.26.02#D">D.</span> The information provided to patients shall include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.26.02#D(1)">(1)</span> A patient's rights when receiving a medication or a prescription;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.26.02#D(2)">(2)</span> The patient's role and responsibility in preventing a medication error;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.26.02#D(3)">(3)</span> The procedures to follow when reporting a suspected medication error to the pharmacy permit holder, pharmacist, health care facility, or other healthcare provider; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.26.02#D(4)">(4)</span> How to report a suspected medication error to the Board.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.26.03" data-order="|10|34|26|.03|" data-ref-path="10|34|26|.03" class="h__section">.03 Pharmacy Staff Education.</h3>
                <p>As part of a pharmacy permit holder's ongoing quality assurance program, the pharmacy permit holder shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.26.03#A">A.</span> Ensure that each member of the pharmacy staff involved in the medication delivery system receive at least once a year, education regarding the role and responsibility of pharmacy staff in preventing medication errors; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.26.03#B">B.</span> Maintain records for a minimum of 2 years:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.26.03#B(1)">(1)</span> Verifying completion of education referred to in <a class="internal-link " href="/us/md/exec/comar/10.34.26.03#A" title="">§A of this regulation</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.26.03#B(2)">(2)</span> Demonstrating the content of the education.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.26.04" data-order="|10|34|26|.04|" data-ref-path="10|34|26|.04" class="h__section">.04 Ongoing Quality Assurance Program.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#A">A.</span> A pharmacy permit holder shall establish and maintain an ongoing quality assurance program to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#A(1)">(1)</span> Identify, investigate, and promote the prevention of medication errors; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#A(2)">(2)</span> Establish protocols and procedures to minimize the potential for medication errors.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#B">B.</span> The ongoing quality assurance program shall include the records, proceedings, files, and any other documents of the ongoing quality assurance program, including for each medication error:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#B(1)">(1)</span> The date of the error;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#B(2)">(2)</span> A brief description of the error;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#B(3)">(3)</span> The results of the evaluation by the ongoing quality assurance program's investigation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#B(4)">(4)</span> Remedial action taken or recommendations.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#C">C.</span> Periodic Review.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#C(1)">(1)</span> A pharmacy permit holder shall analyze the records, proceedings, files, and any other documents of the ongoing quality assurance program required under <a class="internal-link " href="/us/md/exec/comar/10.34.26.04#B" title="">§B of this regulation</a>, including any medication errors relating to automated medication systems or unlicensed personnel, at least every 3 months as part of the periodic review that is required to maintain an ongoing quality assurance program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#C(2)">(2)</span> Each pharmacy permit holder shall conduct an analysis of its medication delivery system at least every 6 months to determine which medications in the prescription area of the pharmacy are high-alert medications, as part of the pharmacy's ongoing quality assurance program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#D">D.</span> Documentation of Periodic Review. The records, proceedings, files, and any other documents of the ongoing quality assurance program shall include for each:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#D(1)">(1)</span> Periodic review required under <a class="internal-link " href="/us/md/exec/comar/10.34.26.04#C(1)" title="">§C(1) of this regulation</a>:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#D(1)(a)">(a)</span> Documentation of the periodic review;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#D(1)(b)">(b)</span> A description of the system's weaknesses found during the periodic review; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#D(1)(c)">(c)</span> A description of the actions taken to remedy any weaknesses identified in the medication system; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#D(2)">(2)</span> Analysis of a pharmacy's medication delivery system to identify high-alert medications required under <a class="internal-link " href="/us/md/exec/comar/10.34.26.04#C(2)" title="">§C(2) of this regulation</a>:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#D(2)(a)">(a)</span> A list of high-alert medications present in the prescription area of the pharmacy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#D(2)(b)">(b)</span> The date that a high-alert medication was added to or removed from the list of high-alert medications;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#D(2)(c)">(c)</span> Dates that the list was reviewed by the pharmacy permit holder; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#D(2)(d)">(d)</span> Remedial actions taken based on the review of the list of high-alert medications and any medication errors relating to the high-alert medications.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#E">E.</span> Unless otherwise specified in law, the permit holder shall maintain the ongoing quality assurance program records referred to in this regulation for 2 years.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.26.04#F">F.</span> The proceedings, records, and files of an ongoing quality assurance program that meets the requirements of <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=1-401" title="">Health Occupations Article, §1-401, Annotated Code of Maryland</a>, and this chapter, are not discoverable and are not admissible in evidence in any civil action, as provided in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=1-401" title="">Health Occupations Article, §1-401, Annotated Code of Maryland</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.27" data-order="|10|34|27|" data-ref-path="10|34|27" class="h__chapter">Chapter 27 Compelling Purpose Disclosure</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: January 7, 2002 (28:26 Md. R. 2273)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.27.01" title=".01 Disclosure for Compelling Public Purpose.">Regulation .01</a> amended effective December 11, 2003 (30:24 Md. R. 1741)</p>
                  <h3>Authority</h3>
                  <p><a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">Health Occupations Article, §12-205(a)(3)</a>;<br/><a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-617" title="">State Government Article, §10-617(h)(3)</a>; Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.27.01" data-order="|10|34|27|.01|" data-ref-path="10|34|27|.01" class="h__section">.01 Disclosure for Compelling Public Purpose.</h3>
                <p>The custodian of records may find that a compelling public purpose warrants disclosure of information in a certification, licensing, or investigative file, regardless of whether there has been a request for the information, if the information concerns:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.27.01#A">A.</span> Possible criminal activity and is disclosed to a federal, state, or local law enforcement or prosecutorial official or authority;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.27.01#B">B.</span> A possible violation of law and is disclosed to a federal, state, or local authority that has jurisdiction over the individual whose conduct may be a violation and the information disclosed is limited to information relevant to the possible violation by that individual; or</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.27.01#C">C.</span> Conduct by an individual that the custodian of records reasonably believes may pose a risk to the public health, safety, or welfare, and is disclosed to a law enforcement authority, administrative official, or agency that regulates the individual, or to a hospital or other health care facility where the individual has privileges.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.27.02" data-order="|10|34|27|.02|" data-ref-path="10|34|27|.02" class="h__section">.02 Other Disclosures.</h3>
                <p>This chapter does not prohibit or limit the ability of the Board to disclose general licensing information as provided in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gsg&amp;section=10-617" title="">State Government Article, §10-617(h), Annotated Code of Maryland</a>, or any information that the Board may otherwise disclose by law.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.28" data-order="|10|34|28|" data-ref-path="10|34|28" class="h__chapter">Chapter 28 Automated Medication Systems</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: August 5, 2002 (29:15 Md. R. 1142)</p>
                  <p>——————</p>
                  <p>Chapter revised effective October 1, 2012 (39:7 Md. R. 493)</p>
                  <h3>Authority</h3>
                  <p>Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">12-205</a>(a) and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-605" title="">12-605</a>, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.28.01" data-order="|10|34|28|.01|" data-ref-path="10|34|28|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter defines the parameters under which a permit holder may allow the use of automated medication systems to facilitate the dispensing and distribution of medication.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.28.02" data-order="|10|34|28|.02|" data-ref-path="10|34|28|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#B(1)">(1)</span> "Automated medication system" means a centralized, decentralized, or remote robotic or computerized device and that device's components designed to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#B(1)(a)">(a)</span> Distribute medications in a licensed health care facility, a related institution as defined in Health-General Article, §19-301, Annotated Code of Maryland, or a medical facility owned and operated by a group model health maintenance organization as defined in Health-General Article, §19-713.6, Annotated Code of Maryland; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#B(1)(b)">(b)</span> Prepare medications for final dispensing by a licensed pharmacist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#B(2)">(2)</span> "Centralized automated medication system" means an automated medication system located in a pharmacy from which medication is distributed or prepared for final dispensing by a licensed pharmacist for a specific patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#B(3)">(3)</span> "Decentralized automated medication system" means an automated medication system that is located outside of the pharmacy in a health care facility, a related institution as defined in Health-General Article, §19-301, Annotated Code of Maryland, or a medical facility owned and operated by a group model health maintenance organization as defined in Health-General Article, §19-713.6, Annotated Code of Maryland, with an on-site pharmacy and in which medication is stored in a manner that may be, but need not be, patient specific.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#B(4)">(4)</span> "Distribution" means the process resulting in the provision of a prescription or nonprescription drug or device to a separate, intervening individual, licensed and practicing under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Annotated Code of Maryland</a>, before the administration of the provided drug or device to a patient and pursuant to an order issued by an authorized prescriber.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#B(5)">(5)</span> “Health care facility” means a hospital or related institution as defined in Health-General Article, §19-301, Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#B(6)">(6)</span> “Interim box” means a tamper evident and secure container or secure electronic storage system holding minimal quantities of medications agreed on by the health care facility intended to expedite immediate initiation of emergency or nonemergency dosing until the pharmacy is able to provide a regular supply.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#B(7)">(7)</span> Remote Automated Medication System.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#B(7)(a)">(a)</span> "Remote automated medication system" means an automated medication system that is located in a health care facility, a related institution as defined in Health-General Article, §19-301, Annotated Code of Maryland, or a medical facility owned and operated by a group model health maintenance organization as defined in Health-General Article, §19-713.6, Annotated Code of Maryland, that does not have an on-site pharmacy and in which medication is stored in a manner that may be, but need not be, patient specific.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#B(7)(b)">(b)</span> “Remote automated medication system” does not include an interim box or other similar medication storage container that:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#B(7)(b)(i)">(i)</span> Does not operate pursuant to the entry of a medication order;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#B(7)(b)(ii)">(ii)</span> Does not require a pharmacist’s review before access to medication;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#B(7)(b)(iii)">(iii)</span> Is stocked with unit dose medications;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#B(7)(b)(iv)">(iv)</span> Has the sole purpose of providing a medication dosage pending the next pharmacy delivery to the health care facility;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#B(7)(b)(v)">(v)</span> Is located in a patient care setting that does not have a pharmacy on site; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#B(7)(b)(vi)">(vi)</span> Is stocked and controlled by a pharmacy providing services to a health care facility.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#B(8)">(8)</span> “Responsible pharmacist” means a licensed pharmacist who ensures the safe and efficient dispensing, repackaging, delivery, control, positive drug identification including bar coding, transaction records, dispensation records, labeling, and accountability for medications in an automated medication system.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#B(9)">(9)</span> "Starter dose" means a dose of medication removed from a remote or decentralized automated medication system within the first 24 hours after it is ordered.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.02#B(10)">(10)</span> “Unit dose” means a medication container or package containing one discrete pharmaceutical dosage form labeled according to federal and State law.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.28.03" data-order="|10|34|28|.03|" data-ref-path="10|34|28|.03" class="h__section">.03 Limitation on Privileges to Administer.</h3>
                <p>In this chapter, "privileges to administer medication" does not include privileges created by delegation from a licensed health care professional to an unlicensed health care professional.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.28.04" data-order="|10|34|28|.04|" data-ref-path="10|34|28|.04" class="h__section">.04 Usage Requirements for Centralized Automated Medication Systems.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.04#A">A.</span> An automated medication system may only be used if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.04#A(1)">(1)</span> Records concerning transactions or operations are maintained in accordance with <a class="internal-link " href="/us/md/exec/comar/10.34.28.11" title=".11 Record Keeping.">Regulation .11 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.04#A(2)">(2)</span> A responsible pharmacist has been designated by the permit holder to supervise and manage the operations of the centralized automated medication system; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.04#A(3)">(3)</span> The permit holder ensures that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.04#A(3)(a)">(a)</span> Patients have prompt access to pharmacy services necessary for the provision of good pharmaceutical care as defined in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-101" title="">Health Occupations Article, §12-101, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.04#A(3)(b)">(b)</span> The centralized automated medication system maintains the integrity of the information in the system and protects patient confidentiality; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.04#A(3)(c)">(c)</span> The centralized automated medication system is subject to a quality assurance program in accordance with <a class="internal-link " href="/us/md/exec/comar/10.34.28.10" title=".10 Quality Assurance Program.">Regulation .10 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.04#B">B.</span> A permit holder shall indicate on the initial, renewal, and reinstatement applications:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.04#B(1)">(1)</span> Whether the permit holder operates a centralized automated medication system; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.04#B(2)">(2)</span> Any other information regarding the system that the Board considers necessary to determine compliance with this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.28.05" data-order="|10|34|28|.05|" data-ref-path="10|34|28|.05" class="h__section">.05 Usage Requirements for Decentralized Automated Medication Systems.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#A">A.</span> A decentralized automated medication system may only be used if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#A(1)">(1)</span> Records concerning transactions or operations are maintained in accordance with <a class="internal-link " href="/us/md/exec/comar/10.34.28.11" title=".11 Record Keeping.">Regulation .11 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#A(2)">(2)</span> A responsible pharmacist has been designated by the permit holder to supervise and manage the operations of the automated medication system;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#A(3)">(3)</span> Except for starter doses, a licensed pharmacist reviews each order for medication:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#A(3)(a)">(a)</span> After the order has been entered into the system; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#A(3)(b)">(b)</span> Before the system permits access to the medication;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#A(4)">(4)</span> The permit holder ensures that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#A(4)(a)">(a)</span> Patients have prompt access to pharmacy services necessary for the provision of good pharmaceutical care as defined in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-101" title="">Health Occupations Article, §12-101, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#A(4)(b)">(b)</span> The decentralized automated medication system maintains the integrity of the information in the system and protects patient confidentiality; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#A(4)(c)">(c)</span> The decentralized automated medication system is subject to a quality assurance program in accordance with <a class="internal-link " href="/us/md/exec/comar/10.34.28.10" title=".10 Quality Assurance Program.">Regulation .10 of this chapter</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#A(5)">(5)</span> It is designed to distribute medications in a licensed health care facility, a related institution as defined in Health-General Article, §19-301, Annotated Code of Maryland, or a medical facility owned and operated by a group model health maintenance organization as defined in Health-General Article, §19-713.6, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#B">B.</span> A starter dose, or a dose in response to an emergency, may be distributed without prior review by a pharmacist of the order if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#B(1)">(1)</span> The pharmacist reviews the order within 24 hours of removal from the decentralized automated medication system; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#B(2)">(2)</span> The prescriber reviews the patient medical history and authorizes the administration of the dose to the patient.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#C">C.</span> Decentralized automated medication systems shall operate in a manner which:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#C(1)">(1)</span> Limits simultaneous access to multiple:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#C(1)(a)">(a)</span> Drug strengths;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#C(1)(b)">(b)</span> Dosage forms; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#C(1)(c)">(c)</span> Drug entities;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#C(2)">(2)</span> Prevents access to medications not ordered for the patient; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#C(3)">(3)</span> Safeguards against the misidentification of medications, dosages, and dosage forms by those accessing the decentralized automated medication system.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#D">D.</span> The requirements listed in §C(1) and (2) of this regulation do not apply to automated supply towers which contain:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#D(1)">(1)</span> Noncontrolled medications that are:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#D(1)(a)">(a)</span> Refrigerated;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#D(1)(b)">(b)</span> Bulk; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#D(1)(c)">(c)</span> Intravenous fluids; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#D(2)">(2)</span> Prescription devices.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#E">E.</span> A permit holder shall indicate on the initial, renewal, and reinstatement applications:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#E(1)">(1)</span> Whether the permit holder operates a decentralized automated medication system; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.05#E(2)">(2)</span> Any other information regarding the system that the Board considers necessary to determine compliance with this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.28.06" data-order="|10|34|28|.06|" data-ref-path="10|34|28|.06" class="h__section">.06 Usage Requirements for Remote Automated Medication Systems.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#A">A.</span> A remote automated medication system may only be used if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#A(1)">(1)</span> Records concerning transactions or operations are maintained in accordance with <a class="internal-link " href="/us/md/exec/comar/10.34.28.11" title=".11 Record Keeping.">Regulation .11 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#A(2)">(2)</span> A responsible pharmacist has been designated by the permit holder to supervise and manage the operations of the remote automated medication system;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#A(3)">(3)</span> Except for starter doses, a licensed pharmacist reviews each order for medication:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#A(3)(a)">(a)</span> After the order has been entered into the system; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#A(3)(b)">(b)</span> Before the system permits access to the medication;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#A(4)">(4)</span> The permit holder ensures that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#A(4)(a)">(a)</span> Patients have prompt access to pharmacy services necessary for the provision of good pharmaceutical care as defined in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-101" title="">Health Occupations Article, §12-101, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#A(4)(b)">(b)</span> The remote automated medication system maintains the integrity of the information in the system and protects patient confidentiality; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#A(4)(c)">(c)</span> The remote automated medication system is subject to a quality assurance program in accordance with <a class="internal-link " href="/us/md/exec/comar/10.34.28.10" title=".10 Quality Assurance Program.">Regulation .10 of this chapter</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#A(5)">(5)</span> It is designed to distribute medications in a licensed health care facility, a related institution as defined in Health-General Article, §19-301, Annotated Code of Maryland, or a medical facility owned and operated by a group model health maintenance organization as defined in Health-General Article, §19-713.6, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#B">B.</span> A starter dose, or a dose in response to an emergency, may be distributed without prior review by a pharmacist of the order if the pharmacist reviews the order within 24 hours of removal from the remote automated medication system.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#C">C.</span> If a licensed pharmacist is not physically present where the remote automated medication system is located, the pharmacist shall have access to the system by electronic and visual means in order to ensure the safe and efficient operation of the system.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#D">D.</span> Remote automated medication systems shall operate in a manner which:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#D(1)">(1)</span> Unless packaging and labeling for a specific patient, limits simultaneous access to multiple:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#D(1)(a)">(a)</span> Drug strengths;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#D(1)(b)">(b)</span> Dosage forms; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#D(1)(c)">(c)</span> Drug entities;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#D(2)">(2)</span> Prevents access to medication not ordered for the patient; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#D(3)">(3)</span> Safeguards against the misidentification of medications, dosages, and dosage forms by those accessing the remote automated medication system.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#E">E.</span> The requirements listed in §D(1) and (2) of this regulation do not apply to automated supply towers which contain:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#E(1)">(1)</span> Noncontrolled medications that are:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#E(1)(a)">(a)</span> Refrigerated;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#E(1)(b)">(b)</span> Bulk; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#E(1)(c)">(c)</span> Intravenous fluids; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#E(2)">(2)</span> Prescription devices.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#F">F.</span> A remote automated medication system may be used only if the system:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#F(1)">(1)</span> Uses positive drug identification, such as bar code technology, to ensure accuracy in:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#F(1)(a)">(a)</span> Loading and selection of medications in the pharmacy for stocking and replenishment of the remote automated medication system; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#F(1)(b)">(b)</span> Loading medications into the remote automated medication system where it is located;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#F(2)">(2)</span> Has electronic reporting capability regarding the identity of persons with access to the system and regarding medications removed from the system;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#F(3)">(3)</span> Restricts access to medications to a licensed pharmacist or an individual authorized to administer medication under Health Occupation Article, Annotated Code of Maryland; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#F(4)">(4)</span> Before administration of a medication to a patient, provides:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#F(4)(a)">(a)</span> A picture of the medication, if available; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#F(4)(b)">(b)</span> If a picture is not available, a written description of the medication specifically by color, shape, and unique manufacturer markings.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#G">G.</span> The permit holder shall ensure that the health care facility where the remote automated medication system is located provides, at a minimum:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#G(1)">(1)</span> A licensed pharmacist available for consultation 24 hours per day;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#G(2)">(2)</span> Technical assistance regarding operation of the system available 24 hours per day; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#G(3)">(3)</span> A quality assurance program as set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.28.10" title=".10 Quality Assurance Program.">Regulation .10 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#H">H.</span> A permit holder shall indicate on the initial, renewal, and reinstatement applications:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#H(1)">(1)</span> Whether the permit holder operated a remote automated medication system; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.06#H(2)">(2)</span> Any other information regarding the system that the Board considers necessary to determine compliance with this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.28.07" data-order="|10|34|28|.07|" data-ref-path="10|34|28|.07" class="h__section">.07 Stocking of Automated Medication Systems.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.07#A">A.</span> Selection of Medication for Stocking. A licensed pharmacist shall verify the accuracy of medications selected for stocking and replenishment of the automated medication system before the medications are stocked in the system.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.07#B">B.</span> Stocking of Automated Medication System. A registered pharmacy technician may stock an automated medication system provided that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.07#B(1)">(1)</span> The pharmacy technician’s selection of medications is verified by a pharmacist; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.07#B(2)">(2)</span> The system uses positive drug identification such as bar code technology.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.28.08" data-order="|10|34|28|.08|" data-ref-path="10|34|28|.08" class="h__section">.08 Return of Unused Medication.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.08#A">A.</span> Single-Drug Unit Dose Packaging.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.08#A(1)">(1)</span> Automated medication systems that distribute medications in single-drug unit dose packaging may allow for return of unused medications to the system provided that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.08#A(1)(a)">(a)</span> The medication is returned to a designated common, secure, one-way returns bin; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.08#A(1)(b)">(b)</span> A licensed pharmacist determines whether the medication is in an unadulterated form.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.08#A(2)">(2)</span> Only a licensed pharmacist may return medications directly to the automated medication system under <a class="internal-link " href="/us/md/exec/comar/10.34.28.08#A(1)" title="">§A(1) of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.08#B">B.</span> Unused medications distributed from a remote or decentralized automated medication system in a manner other than single-drug unit dose packaging shall be:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.08#B(1)">(1)</span> Returned to a designated common, secure, one-way returns bin; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.08#B(2)">(2)</span> Returned to the permit holder for proper disposal.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.08#C">C.</span> Unused medications dispensed from a centralized automated medication system stocked with bulk medications may not be returned to the system.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.28.09" data-order="|10|34|28|.09|" data-ref-path="10|34|28|.09" class="h__section">.09 Education and Training.</h3>
                <p>The permit holder shall ensure that individuals authorized to utilize centralized, decentralized, or remote automated medication systems receive initial and annual training regarding:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.09#A">A.</span> The capabilities and limitations of the system;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.09#B">B.</span> Procedures for the operation of the system; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.09#C">C.</span> Procedures for system downtime.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.28.10" data-order="|10|34|28|.10|" data-ref-path="10|34|28|.10" class="h__section">.10 Quality Assurance Program.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.10#A">A.</span> The responsible pharmacist, in consultation with the health care facility, a related institution as defined in Health-General Article, §19-301, Annotated Code of Maryland, or a medical facility owned and operated by a group model health maintenance organization as defined in Health-General Article, §19.713.6, Annotated Code of Maryland, shall develop, maintain, and review annually a quality assurance program regarding the automated medication system that addresses, at minimum:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.10#A(1)">(1)</span> A testing program which includes daily accuracy sampling that verifies the integrity of the system;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.10#A(2)">(2)</span> Investigation of medication errors related to the automated medication system, and remedial actions taken;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.10#A(3)">(3)</span> Review of discrepancies and transaction reports to identify patterns of inappropriate use and access;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.10#A(4)">(4)</span> Review of the overall functioning of the system2;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.10#A(5)">(5)</span> Security and access:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.10#A(6)">(6)</span> Preventative maintenance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.10#A(7)">(7)</span> Sanitation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.10#A(8)">(8)</span> Storage conditions;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.10#A(9)">(9)</span> Inventory of drugs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.10#A(10)">(10)</span> Drug procurement, delivery, and receipt;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.10#A(11)">(11)</span> Record keeping;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.10#A(12)">(12)</span> Proper labeling procedures; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.10#A(13)">(13)</span> Protocols in the event of a power outage or other situation in which the services of the system are interrupted, that include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.10#A(13)(a)">(a)</span> A plan for insuring continuity of pharmacy services to patients; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.10#A(13)(b)">(b)</span> A plan for system recovery.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.10#B">B.</span> The responsible pharmacist, in consultation with the health care facility, a related institution as defined in Health-General Article, §19-301, Annotated Code of Maryland, or a medical facility owned and operated by a group model health maintenance organization as defined in Health-General Article, §19.713.6, Annotated Code of Maryland, shall develop, maintain, and review annually a quality assurance program regarding the remote or decentralized automated medication system that addresses, at a minimum, system override management to include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.10#B(1)">(1)</span> A list of medications that can be overridden which is limited to starter doses; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.10#B(2)">(2)</span> Review of system overrides to ensure appropriate utilization.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.28.11" data-order="|10|34|28|.11|" data-ref-path="10|34|28|.11" class="h__section">.11 Record Keeping.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#A">A.</span> The permit holder and the responsible pharmacist shall maintain records regarding the automated medication system in a readily retrievable manner for at least 5 years.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B">B.</span> The records referred to in <a class="internal-link " href="/us/md/exec/comar/10.34.28.11#A" title="">§A of this regulation</a> shall include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(1)">(1)</span> Maintenance records and service logs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(2)">(2)</span> System failure reports;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(3)">(3)</span> Documentation of patient outcomes resulting from system failures;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(4)">(4)</span> Accuracy audits and system performance audits;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(5)">(5)</span> Copies of reports and analyses generated as part of the quality assurance program, including daily accuracy sampling;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(6)">(6)</span> Reports or databases related to level of access and changes in the level of access to the system;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(7)">(7)</span> Training records including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(7)(a)">(a)</span> Contents of the training program;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(7)(b)">(b)</span> Dates of training completion; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(7)(c)">(c)</span> The identity of those attending the training program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(8)">(8)</span> Records of destruction of medication waste removed from the system, to include an independent witness signature; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(9)">(9)</span> Transaction information as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(9)(a)">(a)</span> Transactions involving medications stored in or removed, dispensed, or distributed from the system;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(9)(b)">(b)</span> Medications dispensed or distributed for a patient, which shall be recorded to include the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(9)(b)(i)">(i)</span> Identity of the particular automated medication system accessed;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(9)(b)(ii)">(ii)</span> Identification of the individual accessing the system;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(9)(b)(iii)">(iii)</span> Date of transaction;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(9)(b)(iv)">(iv)</span> Name, strength, dosage form, and quantity of drug accessed; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(9)(b)(v)">(v)</span> Name of the patient for whom the drug was accessed; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(9)(c)">(c)</span> Records of stocking or removal of medications from an automated medication system, which shall include the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(9)(c)(i)">(i)</span> Date;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(9)(c)(ii)">(ii)</span> Name, strength, dosage form, and quantity of drug stocked or removed; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.28.11#B(9)(c)(iii)">(iii)</span> Name, initials, or identification code of the individual stocking or removing drugs from the system.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.28.12" data-order="|10|34|28|.12|" data-ref-path="10|34|28|.12" class="h__section">.12 Security.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.12#A">A.</span> The responsible pharmacist shall ensure the security of the automated medication system.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.28.12#B">B.</span> In order to restrict access to the automated medication system to authorized individuals, the responsible pharmacist shall, at a minimum:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.12#B(1)">(1)</span> Establish a clear process of how passwords will be assigned;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.12#B(2)">(2)</span> Develop procedures that prohibit the sharing of passwords and reuse of passwords;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.12#B(3)">(3)</span> Require that the system database be updated daily to remove inactive passwords; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.28.12#B(4)">(4)</span> Require remote locking mechanisms for refrigerated storage associated with the system.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.28.13" data-order="|10|34|28|.13|" data-ref-path="10|34|28|.13" class="h__section">.13 Laws and Compendial Standards.</h3>
                <p>The responsible pharmacist shall ensure compliance with the laws and compendial standards for packaging and labeling.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.28.14" data-order="|10|34|28|.14|" data-ref-path="10|34|28|.14" class="h__section">.14 Controlled Dangerous Substances.</h3>
                <p>Controlled dangerous substances shall only be dispensed and distributed in accordance with applicable State and federal statutes and regulations.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.29" data-order="|10|34|29|" data-ref-path="10|34|29" class="h__chapter">Chapter 29 Drug Therapy Management</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: December 11, 2003 (30:24 Md. R. 1742)</p>
                  <p>——————</p>
                  <p>Chapter revised effective April 15, 2013 (40:7 Md. R. 611)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.29.01#B" title="">Regulation .01B</a> amended effective March 28, 2016 (43:6 Md. R. 409)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.29.02" title=".02 Content of Protocol.">Regulation .02</a> amended effective March 28, 2016 (43:6 Md. R. 409)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.29.03" title=".03 Content of Prescriber-Pharmacist Agreement.">Regulation .03</a> amended effective March 28, 2016 (43:6 Md. R. 409)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.29.04" title=".04 Requirements for Participation in Drug Therapy Management.">Regulation .04</a> amended effective March 28, 2016 (43:6 Md. R. 409)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.29.05" title=".05 Guidelines for Use of Protocols.">Regulation .05</a> amended effective March 28, 2016 (43:6 Md. R. 409)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.29.06" title=".06 Therapy Management Contracts.">Regulation .06</a> amended effective March 28, 2016 (43:6 Md. R. 409)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.29.07" title=".07 Fees.">Regulation .07</a> amended effective March 28, 2016 (43:6 Md. R. 409)</p>
                  <h3>Authority</h3>
                  <p>Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">12-6</a>A-<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=01" title="">01</a> — 12-6A-10, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.29.01" data-order="|10|34|29|.01|" data-ref-path="10|34|29|.01" class="h__section">.01 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.01#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.01#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.01#B(1)">(1)</span> “Amendment” means a change to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.01#B(1)(a)">(a)</span> A protocol or prescriber-pharmacist agreement; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.01#B(1)(b)">(b)</span> The parties to the prescriber-pharmacist agreement.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.01#B(2)">(2)</span> “Applicants” means physicians, pharmacists, podiatrists, or certified advanced practice nurses with prescriptive authority submitting a prescriber-pharmacist agreement and protocol to their respective Boards.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.01#B(2-1)">(2-1)</span> “Authorized prescriber” means a licensed physician, licensed podiatrist, or certified advanced practice nurse with prescriptive authority under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=8-508" title="">Health Occupations Article, §8-508, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.01#B(3)">(3)</span> “Boards” means the Board of Physicians, the Board of Pharmacy, the Board of Podiatric Medical Examiners, and the Board of Nursing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.01#B(4)">(4)</span> "Condition" means a disease-state or health circumstance necessitating monitoring or intervention.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.01#B(5)">(5)</span> "Emergency first care" means triage of emergent conditions or treatment of the condition in those cases in which a protocol specifies treatment for the emergent condition.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.29.02" data-order="|10|34|29|.02|" data-ref-path="10|34|29|.02" class="h__section">.02 Content of Protocol.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#A">A.</span> A protocol shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#A(1)">(1)</span> Be:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#A(1)(a)">(a)</span> Written; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#A(1)(b)">(b)</span> Condition or disease-state specific; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#A(2)">(2)</span> Contain the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#A(2)(a)">(a)</span> The condition that the protocol is designed to manage;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#A(2)(b)">(b)</span> A list of medications that may be used under the auspices of the protocol;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#A(2)(c)">(c)</span> Monitoring parameters including laboratory tests for the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#A(2)(c)(i)">(i)</span> Condition; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#A(2)(c)(ii)">(ii)</span> Medication employed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#A(2)(d)">(d)</span> A list of circumstances requiring contact with the authorized prescriber or authorized prescribers who are a party to the prescriber-pharmacist agreement;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#A(2)(e)">(e)</span> A statement prohibiting substitution of a chemically dissimilar drug product by the pharmacist for the product prescribed by the authorized prescriber unless permitted in the therapy management contract;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#A(2)(f)">(f)</span> A list of circumstances under which the pharmacist may alter doses, modify the treatment regimen, or switch the agent under the terms of the therapy management contract;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#A(2)(g)">(g)</span> Information to be documented;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#A(2)(h)">(h)</span> A listing of provisions within the protocol that may be customized within a therapy management contract; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#A(2)(i)">(i)</span> An action plan for situations when the pharmacist encounters a situation that is not addressed in the protocol.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#B">B.</span> A protocol may authorize:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#B(1)">(1)</span> The modification, continuation, and discontinuation of drug therapy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#B(2)">(2)</span> The ordering of laboratory tests;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#B(3)">(3)</span> Other patient care management measures related to monitoring or improving the outcomes of drug or device therapy; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#B(4)">(4)</span> For protocols by a licensed physician and licensed pharmacist, the initiation of drug therapy under written, disease-state specific protocols.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#C">C.</span> A protocol may not authorize acts that exceed the scope of practice of the parties to the prescriber-pharmacist agreement.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.02#D">D.</span> Technical modifications to the protocol shall be registered with the Board of Pharmacy within 30 days of the technical modification.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.29.03" data-order="|10|34|29|.03|" data-ref-path="10|34|29|.03" class="h__section">.03 Content of Prescriber-Pharmacist Agreement.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.03#A">A.</span> The prescriber-pharmacist agreement shall contain the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.03#A(1)">(1)</span> The names and signatures of the physicians, podiatrists, or certified advanced practice nurses with prescriptive authority and pharmacists authorized to act under a therapy management contract;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.03#A(2)">(2)</span> The locations where the pharmacists may provide therapy management services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.03#A(3)">(3)</span> The titles of the protocols to which the prescriber-pharmacist agreement pertains;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.03#A(4)">(4)</span> The methods and time frames by which documentation and routine communication will occur between the physicians, podiatrists, or certified advanced practice nurses with prescriptive authority and the pharmacists, including the time frames in which the pharmacist will fully update the patient’s record in writing;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.03#A(5)">(5)</span> The name, address, and telephone number of the party to the prescriber-pharmacist agreement who is to receive correspondence from the Boards related to the prescriber-pharmacist agreement;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.03#A(6)">(6)</span> A statement that the physicians, podiatrists, or certified advanced practice nurses with prescriptive authority and pharmacists shall comply with all State and federal laws relating to patient confidentiality; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.03#A(7)">(7)</span> A list of devices available to the pharmacists performing under the prescriber-pharmacist agreement, which are relevant to the disease-states or conditions to be managed.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.03#B">B.</span> Technical modifications to the prescriber-pharmacist agreement shall be registered with the Board of Pharmacy within 30 days of the technical modification.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.03#C">C.</span> The party designated as the contact person to receive correspondence from the Boards shall ensure that the parties to the prescriber-pharmacist agreement are notified in a timely manner of the information received from the Boards.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.03#D">D.</span> If the contact information for the party to the agreement designated to receive correspondence from the Boards changes, the designee shall notify the Boards of the change within 30 days of the change.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.29.04" data-order="|10|34|29|.04|" data-ref-path="10|34|29|.04" class="h__section">.04 Requirements for Participation in Drug Therapy Management.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#A">A.</span> In order to enter into a therapy management contract, a pharmacist:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#A(1)">(1)</span> Shall be licensed by and in good standing with the Board of Pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#A(2)">(2)</span> Shall possess a Doctor of Pharmacy degree or equivalent training as established in <a class="internal-link " href="/us/md/exec/comar/10.34.29.04#B" title="">§B of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#A(3)">(3)</span> May not have:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#A(3)(a)">(a)</span> A public final order by the Board of Pharmacy disciplining the pharmacist's license within the 5 years immediately before the application is submitted; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#A(3)(b)">(b)</span> Limitations placed on the pharmacist's license by the Board of Pharmacy in a public order;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#A(4)">(4)</span> Shall possess relevant advanced training as indicated by one of the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#A(4)(a)">(a)</span> Certification as a specialist related to the disease state specified by the protocol by:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#A(4)(a)(i)">(i)</span> The Board of Pharmacy Specialties;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#A(4)(a)(ii)">(ii)</span> The American Society of Consultant Pharmacist's Certified Geriatric Practitioner certification program; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#A(4)(a)(iii)">(iii)</span> Another credentialing body approved by the Board of Pharmacy; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#A(4)(b)">(b)</span> Successful completion of:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#A(4)(b)(i)">(i)</span> A residency accredited by the American Society of Health-Systems Pharmacists, a body approved by the Board of Pharmacy or offered by a body accredited by the Accreditation Council for Pharmacy Education;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#A(4)(b)(ii)">(ii)</span> A certificate program approved by the Board of Pharmacy;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#A(4)(b)(iii)">(iii)</span> A National Association of Boards of Pharmacy credentialing examination; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#A(4)(b)(iv)">(iv)</span> An examination approved by the Board of Pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#A(5)">(5)</span> Shall have successfully completed:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#A(5)(a)">(a)</span> 1,000 hours of relevant clinical experience; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#A(5)(b)">(b)</span> 320 hours in a structured experience program approved by the Board of Pharmacy; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#A(6)">(6)</span> Shall document training related to the disease state specified in the protocol.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#B">B.</span> A pharmacist who does not possess a Doctor of Pharmacy degree shall document that the pharmacist's training has included the following components:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#B(1)">(1)</span> Designing, implementing, monitoring, evaluating, and modifying or recommending modifications in drug therapy to insure effective, safe, and economical patient care;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#B(2)">(2)</span> Identifying, assessing, and solving medication-related problems, and providing clinical judgments as to the continuing effectiveness of individualized therapeutic plans and intended therapeutic outcomes;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#B(3)">(3)</span> Conducting appropriate physical assessments, evaluating patient problems, and ordering and monitoring medications and laboratory tests in accordance with established standards of practice;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#B(4)">(4)</span> Monitoring patients and patient populations regarding the purposes, uses, effects, and pharmacoeconomics of their medications and related therapy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#B(5)">(5)</span> Providing emergency first care, including cardiopulmonary resuscitation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#B(6)">(6)</span> Using clinical data to optimize therapeutic drug regimens; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#B(7)">(7)</span> Documenting interventions and evaluating pharmaceutical care outcomes.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#C">C.</span> The Board of Pharmacy shall determine whether the pharmacist meets the requirements of §§A and B of this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#D">D.</span> An authorized prescriber who has entered into a prescriber-pharmacist agreement shall submit to the Boards that regulate the authorized prescriber a copy of:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#D(1)">(1)</span> The prescriber-pharmacist agreement;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#D(2)">(2)</span> Subsequent amendments made to the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#D(2)(a)">(a)</span> Prescriber-pharmacist agreement; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#D(2)(b)">(b)</span> Protocols specified in the prescriber-pharmacist agreement; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#D(3)">(3)</span> Changes to participants of the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#D(3)(a)">(a)</span> Prescriber-pharmacist agreement; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#D(3)(b)">(b)</span> Protocols specified in the prescriber-pharmacist agreement.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#E">E.</span> The Boards that regulate the authorized prescriber shall notify the authorized prescriber of any additional information needed within 30 days of the receipt of the submitted information.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#F">F.</span> A licensed pharmacist who has entered into a prescriber-pharmacist agreement shall submit to the Board of Pharmacy a copy of:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#F(1)">(1)</span> The prescriber-pharmacist agreement;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#F(2)">(2)</span> Subsequent amendments made to the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#F(2)(a)">(a)</span> Prescriber-pharmacist agreement; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#F(2)(b)">(b)</span> Protocols specified in the prescriber-pharmacist agreement; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#F(3)">(3)</span> Changes to participants of the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#F(3)(a)">(a)</span> Prescriber-pharmacist agreement; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#F(3)(b)">(b)</span> Protocols specified in the prescriber-pharmacist agreement.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#G">G.</span> The Board of Pharmacy shall determine whether a pharmacist added under <a class="internal-link " href="/us/md/exec/comar/10.34.29.04#F" title="">§F of this regulation</a> meets the requirements of §§A and B of this regulation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.04#H">H.</span> The Board of Pharmacy shall notify the pharmacist of any additional information needed within 30 days of the receipt of the submitted information.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.29.05" data-order="|10|34|29|.05|" data-ref-path="10|34|29|.05" class="h__section">.05 Guidelines for Use of Protocols.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.05#A">A.</span> On receipt of specific instructions from the authorized prescriber regarding a specific patient, the pharmacist may execute the authorized prescriber’s specific instructions even if the instructions deviate from the protocol.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.05#B">B.</span> The protocol may not prohibit the pharmacist from providing other pharmaceutical services that are within the pharmacist's scope of practice.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.05#C">C.</span> Documentation of activities performed under a protocol or the authorized prescriber’s specific instructions shall be maintained in such a manner that it is accessible to the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.05#C(1)">(1)</span> Authorized prescriber; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.05#C(2)">(2)</span> Pharmacist.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.05#D">D.</span> Documentation may be maintained in written or electronic form.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.05#E">E.</span> Oral communications between the authorized prescriber and pharmacist shall be summarized in the documentation maintained by the pharmacist and forwarded to the authorized prescriber.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.05#F">F.</span> Unless an alternative time period is stated in the prescriber-pharmacist agreement, the pharmacist shall inform the authorized prescriber within 48 hours if the pharmacist:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.05#F(1)">(1)</span> Modifies the dose or agent under the therapy management contract;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.05#F(2)">(2)</span> Detects an abnormal result from an assessment activity; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.05#F(3)">(3)</span> Initiates drug therapy under a written, disease-state specific protocol, for protocols by a licensed physician and pharmacist.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.29.06" data-order="|10|34|29|.06|" data-ref-path="10|34|29|.06" class="h__section">.06 Therapy Management Contracts.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.06#A">A.</span> A therapy management contract shall be signed by the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.06#A(1)">(1)</span> Authorized prescriber or authorized prescribers involved in the management of the patient under a prescriber-pharmacist agreement;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.06#A(2)">(2)</span> Pharmacist or pharmacists involved in the management of the patient under a prescriber-pharmacist agreement; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.06#A(3)">(3)</span> Patient receiving care under the therapy management contract.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.06#B">B.</span> A therapy management contract shall contain:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.06#B(1)">(1)</span> A list of allowable substitutions of chemically dissimilar drugs, if any;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.06#B(2)">(2)</span> A statement that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.06#B(2)(a)">(a)</span> None of the parties involved in the therapy management contract have been:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.29.06#B(2)(a)(i)">(i)</span> Coerced into participating in the therapy management contract;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.29.06#B(2)(a)(ii)">(ii)</span> Given economic incentives, excluding normal reimbursement for services rendered; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.29.06#B(2)(a)(iii)">(iii)</span> Involuntarily required to participate in the therapy management contract; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.06#B(2)(b)">(b)</span> The pharmacist shall notify the authorized prescriber under the terms of the prescriber-pharmacist agreement if the pharmacist:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.29.06#B(2)(b)(i)">(i)</span> Modifies the dose or agent under the therapy management contract; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.29.06#B(2)(b)(ii)">(ii)</span> Detects an abnormal result from an assessment activity;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.06#B(3)">(3)</span> Notice to the patient stating:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.06#B(3)(a)">(a)</span> That the patient may terminate the therapy management contract at any time; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.29.06#B(3)(b)">(b)</span> The procedure by which the patient may terminate the therapy management contract;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.06#B(4)">(4)</span> A procedure for periodic review by the authorized prescriber of the drugs modified under the prescriber-pharmacist agreement or changed with the consent of the authorized prescriber;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.06#B(5)">(5)</span> A reference to the protocol or protocols under which the pharmacist shall act; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.29.06#B(6)">(6)</span> Exceptions or limitations to the protocol or protocols for the specific patient.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.29.07" data-order="|10|34|29|.07|" data-ref-path="10|34|29|.07" class="h__section">.07 Fees.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.07#A">A.</span> Scope. This regulation governs authorized prescribers and pharmacists participating in drug therapy management or amendment of authorized prescribers and pharmacists that participate in the prescriber-pharmacist agreements relating to drug therapy management.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.29.07#B">B.</span> Fees. The Board of Pharmacy requires a fee for the prescriber-pharmacist agreement and protocol application (which includes review of the qualifications of the pharmacist participants) of $100 per prescriber-pharmacist agreement.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.30" data-order="|10|34|30|" data-ref-path="10|34|30" class="h__chapter">Chapter 30 Change to Permit — Pharmacy or Wholesale Distribution Permit Holder</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: November 10, 2003 (30:22 Md. R. 1582)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.30.01" title=".01 Application for Name Change.">Regulation .01</a> amended effective July 8, 2013 (40:13 Md. R. 1076)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.30.01" title=".01 Application for Name Change.">Regulation .01</a>-1 adopted effective July 8, 2013 (40:13 Md. R. 1076)</p>
                  <p>——————</p>
                  <p>Chapter revised effective May 20, 2019 (46:10 Md. R. 489)</p>
                  <h3>Authority</h3>
                  <p>Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">12-205</a> and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-206" title="">12-206</a>, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.30.01" data-order="|10|34|30|.01|" data-ref-path="10|34|30|.01" class="h__section">.01 Application for Name Change.</h3>
                <p>The name of an individual or entity required to possess a pharmacy or wholesale distribution permit may be changed on a permit if:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.30.01#A">A.</span> The permit holder submits a notice of name change to the Board within 30 days after the name change, on a form that the Board requires;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.30.01#B">B.</span> The permit holder submits to the Board documentation verifying the name change; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.30.01#C">C.</span> There is no other change in the individual or entity required to possess a pharmacy or wholesale distribution permit including no change in controlling ownership interest, type of business entity, or location.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.30.02" data-order="|10|34|30|.02|" data-ref-path="10|34|30|.02" class="h__section">.02 Application for Name Change — Fee.</h3>
                <p>There is no fee for a name change under this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.30.03" data-order="|10|34|30|.03|" data-ref-path="10|34|30|.03" class="h__section">.03 Applications for Pharmacy or Wholesale Distributor Establishment Change of Ownership.</h3>
                <p>If the controlling interest in ownership of a pharmacy or wholesale distributor changes, the new owner shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.30.03#A">A.</span> Submit an initial application and fee for a pharmacy or wholesale distributor permit, as applicable; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.30.03#B">B.</span> Submit and comply with the requirements of closing and opening operations as set forth in:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.30.03#B(1)">(1)</span> <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.14" title="Chapter 14 Opening and Closing of Pharmacies">COMAR 10.34.14</a>, for pharmacies; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.30.03#B(2)">(2)</span> <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">Health Occupations Article, §12-6</a>C-05(d), Annotated Code of Maryland, and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.10" title=".10 Required Information and Procedures for Ceasing to Operate.">COMAR 10.34.22.10</a>, for wholesale distributors.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.30.04" data-order="|10|34|30|.04|" data-ref-path="10|34|30|.04" class="h__section">.04 Applications for Pharmacy or Wholesale Distributor Establishment Change of Location.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.30.04#A">A.</span> Permits issued to operate a pharmacy or engage in wholesale distribution, whether located in the State or outside the State, are:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.30.04#A(1)">(1)</span> Not transferable; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.30.04#A(2)">(2)</span> Specific to the establishment location that has undergone an opening inspection by the Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.30.04#B">B.</span> A pharmacy or wholesale distributor that intends to change its establishment location shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.30.04#B(1)">(1)</span> Submit an application to the Board on a form required by the Board;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.30.04#B(2)">(2)</span> If located in the State, comply with opening and closing inspection requirements in order to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.30.04#B(2)(a)">(a)</span> Commence operations at the new establishment location; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.30.04#B(2)(b)">(b)</span> Cease operations at the existing establishment location; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.30.04#B(3)">(3)</span> If located outside the State, submit an inspection report for the new location conducted by the authorized entity in the state in which the establishment is located, or provide documentation of supplemental accreditation, if applicable.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.30.05" data-order="|10|34|30|.05|" data-ref-path="10|34|30|.05" class="h__section">.05 Change of Information Provided in Applications.</h3>
                <p>Notwithstanding any other reporting requirements, a permit holder shall provide written notification to the Board at least 30 days prior to any change in information in its application provided to the Board, to include:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.30.05#A">A.</span> Change in hours of operation; or</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.30.05#B">B.</span> Change in the physical structure of the establishment, to include any:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.30.05#B(1)">(1)</span> Deviation from the floorplan submitted by the permit holder as part of the application; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.30.05#B(2)">(2)</span> Other change that may affect the security or storage conditions of prescription drugs or devices.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.30.06" data-order="|10|34|30|.06|" data-ref-path="10|34|30|.06" class="h__section">.06 Incomplete Applications.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.30.06#A">A.</span> The Board may hold an incomplete initial or reinstatement application for a license, registration, or permit for up to one year from the date of receipt.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.30.06#B">B.</span> After 1 year from the date of receipt, the Board shall close a pending application that is incomplete.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.30.06#C">C.</span> If an application has been closed under <a class="internal-link " href="/us/md/exec/comar/10.34.30.06#B" title="">§B of this regulation</a>, the applicant shall submit a new application fee and otherwise comply with all applicable license, registration, or permit requirements.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.30.06#D">D.</span> If an applicant presents extenuating circumstances to the Board, the Board may, in its sole discretion, extend the 1-year application completion period.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.31" data-order="|10|34|31|" data-ref-path="10|34|31" class="h__chapter">Chapter 31 Dispensing or Distributing at a Setting That Does Not Possess a Pharmacy Permit</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: March 1, 2004 (31:4 Md. R. 317)</p>
                  <h3>Authority</h3>
                  <p>Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">12-205</a> and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-307" title="">12-307</a>, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.31.01" data-order="|10|34|31|.01|" data-ref-path="10|34|31|.01" class="h__section">.01 Settings.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.31.01#A">A.</span> If a setting otherwise complies with State and federal laws, a pharmacist may request Board approval to dispense or distribute at a setting that does not possess a pharmacy permit if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.31.01#A(1)">(1)</span> The dispensing or distribution occurs while the pharmacist is providing drug therapy management services in:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.31.01#A(1)(a)">(a)</span> The office of a licensed physician;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.31.01#A(1)(b)">(b)</span> A clinic; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.31.01#A(1)(c)">(c)</span> A medical facility; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.31.01#A(2)">(2)</span> The setting is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.31.01#A(2)(a)">(a)</span> Operated or funded by a public health authority of the State;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.31.01#A(2)(b)">(b)</span> A medical facility or clinic that is operated on a nonprofit basis and is not otherwise required to possess a pharmacy permit; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.31.01#A(2)(c)">(c)</span> A health center that operates on a campus of an institution of higher education.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.31.01#B">B.</span> If the drug therapy management services referred to in <a class="internal-link " href="/us/md/exec/comar/10.34.31.01#A(1)(a)" title="">§A(1)(a) of this regulation</a> include the dispensing or distribution of controlled dangerous substances, the request may be approved by the Board if the physician possesses a dispensing permit issued by the Board of Physicians.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.31.01#C">C.</span> If a pharmacist seeks to obtain Board approval to dispense or distribute at a setting that is not set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.31.01#A" title="">§A of this regulation</a>, the pharmacist shall apply to the Board for a waiver permit under <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.17" title="Chapter 17 Waiver of Full Service Requirements for Recognized Pharmaceutical Specialties">COMAR 10.34.17</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.31.02" data-order="|10|34|31|.02|" data-ref-path="10|34|31|.02" class="h__section">.02 Pharmacist Approval.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.31.02#A">A.</span> Before a pharmacist may dispense or distribute at a setting that does not hold a pharmacy permit under <a class="internal-link " href="/us/md/exec/comar/10.34.31.01#A(1)" title="">Regulation .01A(1) of this chapter</a>, the pharmacist shall submit to the Board a request for approval signed by the pharmacist, which includes:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.31.02#A(1)">(1)</span> The name and license number of the pharmacist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.31.02#A(2)">(2)</span> The scope of services to be provided by the pharmacist at the nonpharmacy setting;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.31.02#A(3)">(3)</span> The name and address of the nonpharmacy setting where the pharmacist intends to dispense or distribute; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.31.02#A(4)">(4)</span> A statement indicating the pharmacist's criminal history, if any.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.31.02#B">B.</span> If the pharmacist intends to provide drug therapy management services in a licensed physician's office under <a class="internal-link " href="/us/md/exec/comar/10.34.31.01#A(1)(a)" title="">Regulation .01A(1)(a) of this chapter</a>, in addition to the requirements of <a class="internal-link " href="/us/md/exec/comar/10.34.31.02#A" title="">§A of this regulation</a>, the pharmacist shall provide:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.31.02#B(1)">(1)</span> The name and license number of the licensed physician; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.31.02#B(2)">(2)</span> Proof of an approved physician-pharmacist agreement with the licensed physician.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.31.03" data-order="|10|34|31|.03|" data-ref-path="10|34|31|.03" class="h__section">.03 Grounds for Denial.</h3>
                <p>The Board may deny a pharmacist's request for approval under <a class="internal-link " href="/us/md/exec/comar/10.34.31.02" title=".02 Pharmacist Approval.">Regulation .02 of this chapter</a> if the:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.31.03#A">A.</span> Pharmacist has:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.31.03#A(1)">(1)</span> A pending or final disciplinary action before the Board; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.31.03#A(2)">(2)</span> A criminal history; or</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.31.03#B">B.</span> Criteria set forth in Regulations .01B or .02 of this chapter are not satisfied.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.31.04" data-order="|10|34|31|.04|" data-ref-path="10|34|31|.04" class="h__section">.04 Change in Information.</h3>
                <p>If any of the information set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.31.02" title=".02 Pharmacist Approval.">Regulation .02 of this chapter</a> changes during the effective period of the Board's approval:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.31.04#A">A.</span> The pharmacist shall immediately advise the Board in writing of the change; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.31.04#B">B.</span> The change in information may cause the Board to withdraw or modify the Board's approval of the nonpharmacy setting.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.31.05" data-order="|10|34|31|.05|" data-ref-path="10|34|31|.05" class="h__section">.05 Approval During Catastrophic Health Emergency.</h3>
                <p>In the event of a catastrophic health emergency proclaimed by the Governor under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=41&amp;section=2-202" title="">Article 41, §2-202, Annotated Code of Maryland</a>, or by the Secretary under Health-General Article, §18-902, Annotated Code of Maryland, assignment of a pharmacist to a location by the State constitutes application and approval under <a class="internal-link " href="/us/md/exec/comar/10.34.31.02" title=".02 Pharmacist Approval.">Regulation .02 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.31.06" data-order="|10|34|31|.06|" data-ref-path="10|34|31|.06" class="h__section">.06 Governing Laws.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.31.06#A">A.</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.34.31.06#B" title="">§B of this regulation</a>, a pharmacist approved by the Board to dispense or distribute at a nonpharmacy setting shall comply with the <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.31.06#B">B.</span> A pharmacist approved by the Board to dispense or distribute at a nonpharmacy setting shall comply with the labeling, storage, and record keeping requirements governing the nonpharmacy setting.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.31.07" data-order="|10|34|31|.07|" data-ref-path="10|34|31|.07" class="h__section">.07 Term and Renewal.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.31.07#A">A.</span> Unless otherwise determined by the Board, the Board's approval of a pharmacist's request to dispense or distribute at a setting that does not possess a pharmacy permit is in effect until the expiration of the pharmacist's license.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.31.07#B">B.</span> The pharmacist shall request renewal of the Board's approval when renewing the pharmacist's license.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.31.08" data-order="|10|34|31|.08|" data-ref-path="10|34|31|.08" class="h__section">.08 Pharmacy Rendered Inoperable.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.31.08#A">A.</span> If a pharmacy for which a permit is issued is destroyed or otherwise rendered inoperable, a pharmacist may dispense or distribute from a temporary site if the permit holder:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.31.08#A(1)">(1)</span> Obtains approval from the Board before continuing pharmacy operations from a temporary site; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.31.08#A(2)">(2)</span> Ensures that the temporary pharmacy site complies with State and federal laws.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.31.08#B">B.</span> Under <a class="internal-link " href="/us/md/exec/comar/10.34.31.08#A" title="">§A of this regulation</a>, the Board may approve the operation of a pharmacy from a temporary site for a period not to exceed 60 days from the date of the original approval, unless an extension is approved by the Board before the expiration of the preceding approval.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.32" data-order="|10|34|32|" data-ref-path="10|34|32" class="h__chapter">Chapter 32 Pharmacist Administration of Vaccinations</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date:</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.32.01" title=".01 Scope.">.01</a>—<a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.32.07" title=".07 Approved Protocols.">.07</a> adopted as an emergency provision effective December 16, 2005 (33:1 Md. R. 34); adopted permanently effective April 24, 2006 (33:8 Md. R. 734)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.32.03#A" title="">Regulation .03A</a> amended effective July 2, 2007 (34:13 Md. R. 1151)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.32.08" title=".08 Fees.">Regulation .08</a> adopted effective July 2, 2007 (34:13 Md. R. 1151)</p>
                  <p>——————</p>
                  <p>Chapter revised effective August 1, 2009 (36:15 Md. R. 1167)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.32.03" title=".03 Requirements to Administer Vaccinations.">Regulation .03</a> amended as an emergency provision effective October 1, 2011 (38:24 Md. R. 1495); amended permanently effective January 23, 2012 (39:1 Md. R. 18)</p>
                  <p>——————</p>
                  <p>Chapter revised effective April 28, 2014 (41:8 Md. R. 472)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.32.03#D" title="">Regulation .03D</a> amended effective December 31, 2018 (45:26 Md. R. 1246)</p>
                  <h3>Authority</h3>
                  <p>Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-101" title="">12-101</a>, <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-102" title="">12-102</a>(b), <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-508" title="">12-508</a>, and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">12-6</a>A-10, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.32.01" data-order="|10|34|32|.01|" data-ref-path="10|34|32|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter does not limit or affect the right of an individual to practice a health occupation that the individual is authorized to practice.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.32.02" data-order="|10|34|32|.02|" data-ref-path="10|34|32|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(1)">(1)</span> "Board" means the State Board of Pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(2)">(2)</span> "Pharmacist" means an individual who practices pharmacy regardless of the location where the activities of practice are performed.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(3)">(3)</span> "Pharmacy" means an establishment holding a permit under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-401" title="">Health Occupations Article, §12-401, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(4)">(4)</span> "Pharmacy permit holder" means a person authorized by the Board to operate a pharmacy while the pharmacy permit is effective.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(5)">(5)</span> "Pharmacy Experiential Program" means a program under the American Council on Pharmacy Education.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(6)">(6)</span> Practice Pharmacy.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(6)(a)">(a)</span> "Practice pharmacy" means to engage in any of the following activities:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(6)(a)(i)">(i)</span> Providing pharmaceutical care;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(6)(a)(ii)">(ii)</span> Compounding, dispensing, or distributing prescription drugs or devices;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(6)(a)(iii)">(iii)</span> Compounding or dispensing nonprescription drugs or devices;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(6)(a)(iv)">(iv)</span> Monitoring prescriptions and nonprescription drugs or devices;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(6)(a)(v)">(v)</span> Providing information, explanation, or recommendations to patients and health care practitioners about the safe and effective use of prescription or nonprescription drugs or devices;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(6)(a)(vi)">(vi)</span> Identifying and appraising problems concerning the use or monitoring of therapy with drugs or devices;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(6)(a)(vii)">(vii)</span> Acting within the parameters of a therapy management contract, as provided under Health Occupations Article, Subtitle 6A, Annotated Code of Maryland; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(6)(a)(viii)">(viii)</span> Administering vaccinations in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-508" title="">Health Occupations Article, §12-508, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(6)(b)">(b)</span> "Practice pharmacy" does not include the operations of a person who holds a permit issued under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-602" title="">Health Occupations Article, §12-602, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(7)">(7)</span> “Primary care provider” means a health care practitioner who provides an individual’s primary care services and is the primary coordinator of health care services for the individual.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(8)">(8)</span> “Vaccination” means a vaccination:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(8)(a)">(a)</span> That is listed in the Centers for Disease Control and Prevention’s Recommended Immunization Adult Schedule authorized by <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-508" title="">Health Occupations Article, §12-508, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(8)(b)">(b)</span> Recommended in the Centers for Disease Control and Prevention’s Health Information for International Travel authorized by <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-508" title="">Health Occupations Article, §12-508, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(8)(c)">(c)</span> Recommended for individuals between 11 years old and 18 years old in the Centers for Disease Control and Prevention’s Recommended Immunization Schedule for Persons aged 0 through 18 years old; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(8)(d)">(d)</span> An influenza vaccination authorized by <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-508" title="">Health Occupations Article, §12-508, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.02#B(9)">(9)</span> “Vaccine information statement” means the information sheet, produced by the Centers for Disease Control and Prevention that explains both the benefits and risks of a specific vaccine to the vaccine recipient, their parent, or their legal representative.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.32.03" data-order="|10|34|32|.03|" data-ref-path="10|34|32|.03" class="h__section">.03 Requirements to Administer Vaccinations.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#A">A.</span> Registration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#A(1)">(1)</span> A licensed pharmacist shall submit a registration to the Board on the form that the Board requires.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#A(2)">(2)</span> The registration form shall include verification from the licensed pharmacist of the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#A(2)(a)">(a)</span> Successful completion of a certification course approved by the Board of Pharmacy that includes the current guidelines and recommendations of the Centers for Disease Control and Prevention regarding vaccinations; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#A(2)(b)">(b)</span> Possession of an active certification in basic cardiopulmonary resuscitation obtained through in-person classroom instruction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#A(3)">(3)</span> A registration authorizing a licensed pharmacist to administer vaccinations expires with the expiration of the license to practice pharmacy unless the licensed pharmacist has completed:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#A(3)(a)">(a)</span> Four hours of continuing education credits related to vaccinations; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#A(3)(b)">(b)</span> All other requirements for licensure renewal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#A(4)">(4)</span> A licensed pharmacist may not administer vaccinations until the licensed pharmacist receives a written confirmation from the Board accepting the licensed pharmacist's registration.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#B">B.</span> A licensed pharmacist may administer an influenza vaccination to an individual who is 9 years old or older in accordance with a protocol that meets the requirements of <a class="internal-link " href="/us/md/exec/comar/10.34.32.07" title=".07 Approved Protocols.">Regulation .07 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#B-1">B-1.</span> A licensed pharmacist may only administer a vaccination that is listed in the Centers for Disease Control and Prevention’s recommended immunization schedule to an individual who:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#B-1(1)">(1)</span> Is between 11 years old and 18 years old; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#B-1(2)">(2)</span> Has a prescription from an authorized prescriber.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#B-2">B-2.</span> Except as provided in §§B and B-1 of this regulation, a licensed pharmacist may administer to an adult a vaccination in accordance with a protocol that meets the requirements of <a class="internal-link " href="/us/md/exec/comar/10.34.32.07" title=".07 Approved Protocols.">Regulation .07 of this chapter</a> that is:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#B-2(1)">(1)</span> Listed in the Center for Disease Control and Prevention’s Recommended Immunization Schedule; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#B-2(2)">(2)</span> Listed in the Center for Disease Control and Prevention’s Health Information for International Travel.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#C">C.</span> A pharmacist shall report to the ImmuNet Program established under Health-General Article, §18-109, Annotated Code of Maryland, a vaccination administered by the pharmacist to an individual.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#D">D.</span> A pharmacist shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#D(1)">(1)</span> Have proof of active certification in basic cardiopulmonary resuscitation readily available.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#D(2)">(2)</span> Provide the patient with a vaccine information statement issued by the Centers for Disease Control and Prevention;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#D(3)">(3)</span> Obtain a signed consent form from the patient or custodial parent; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#D(4)">(4)</span> Observe the patient for a period of at least 15 minutes after administration of the vaccine for adverse effects including syncope.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.03#E">E.</span> A pharmacy student in a Pharmacy Experiential Program, who has successfully completed a Board-approved certification course, may administer vaccinations under direct supervision of a licensed pharmacist who meets requirements in <a class="internal-link " href="/us/md/exec/comar/10.34.32.03#A" title="">§A of this regulation</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.32.04" data-order="|10|34|32|.04|" data-ref-path="10|34|32|.04" class="h__section">.04 Training Program Requirements.</h3>
                <p>In order to administer vaccinations, the Board shall assure that any course that it approves contains at a minimum the following elements:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.04#A">A.</span> Responses to an emergency situation as a result of the administration of a vaccination;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.04#B">B.</span> Administration of intramuscular and subcutaneous injections and intranasal vaccination;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.04#C">C.</span> Record-keeping and reporting requirements; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.04#D">D.</span> Advisory Committee on Immunization Practices and Centers for Disease Control guidelines for vaccines.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.32.05" data-order="|10|34|32|.05|" data-ref-path="10|34|32|.05" class="h__section">.05 Record Keeping.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#A">A.</span> The pharmacy permit holder shall maintain documentation in the pharmacy from which the vaccine was administered for a minimum of 5 years that includes:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#A(1)">(1)</span> The name, address, and date of birth of the individual receiving the vaccination;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#A(2)">(2)</span> The date of administration and route and site of vaccinations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#A(3)">(3)</span> The name, dose, manufacturer’s lot number, and expiration date of the vaccine;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#A(4)">(4)</span> The name and address of the primary health care provider of the individual receiving the vaccination, as identified by that individual;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#A(5)">(5)</span> The name of the pharmacist, pharmacy student, physician, or nurse administering the vaccination;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#A(6)">(6)</span> The version of the vaccination information statement provided to the individual receiving the vaccination;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#A(7)">(7)</span> The copy of the signed patient consent form of those individuals to whom the vaccine was administered;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#A(8)">(8)</span> The nature and outcome of an adverse reaction and documentation that the adverse reaction was reported to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#A(8)(a)">(a)</span> The primary care provider; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#A(8)(b)">(b)</span> The Vaccine Adverse Event Reporting System.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#A(9)">(9)</span> At least one effort made by the pharmacist to inform the individual’s authorized prescriber that the vaccination has been administered; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#A(10)">(10)</span> If the authorized prescriber is not the individual’s primary care provider or if the vaccination has not been administered in accordance with a prescription document, at least one effort made by the pharmacist to inform the individual’s primary care provider or other usual source of care that the vaccination has been administered.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#B">B.</span> The records required in this regulation shall be:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#B(1)">(1)</span> Readily retrievable;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#B(2)">(2)</span> Made available on the request of the Board;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#B(3)">(3)</span> Except for records related to minor patients, maintained for a minimum of 5 years; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#B(4)">(4)</span> In the case of a minor patient, maintained until the patient attains the age of majority plus 3 years or for 5 years after the record is made, whichever is later.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#C">C.</span> The pharmacist administering a vaccination as an independent provider at a location that is not a pharmacy shall maintain the following documentation for a minimum of 5 years:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#C(1)">(1)</span> Name, address, and date of birth of the individual receiving the vaccination;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#C(2)">(2)</span> Date of administration, and route and site of vaccinations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#C(3)">(3)</span> Name, dose, manufacturer's lot number, and expiration date of the vaccine;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#C(4)">(4)</span> Name and address of the primary health care provider of the individual receiving the vaccination, as identified by that individual;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#C(5)">(5)</span> Name of the pharmacist or pharmacy student administering the vaccination;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#C(6)">(6)</span> Version of the vaccination information statement provided to the individual receiving the vaccination;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#C(7)">(7)</span> Copy of the signed patient consent form of those individuals to whom the vaccine was administered;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#C(8)">(8)</span> Nature and outcome of an adverse reaction, and documentation that the adverse reaction was reported to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#C(8)(a)">(a)</span> The primary care provider; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#C(8)(b)">(b)</span> The Vaccine Adverse Event Reporting System.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#C(9)">(9)</span> At least one effort made by the pharmacist to inform the individual’s authorized prescriber that the vaccination has been administered; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#C(10)">(10)</span> If the authorized prescriber is not the individual’s primary care provider or if the vaccination has not been administered in accordance with a prescription document, at least one effort made by the pharmacist to inform the individual’s primary care provider or other usual source of care that the vaccination has been administered.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#D">D.</span> The pharmacist administering a vaccination on behalf of a permit holder at a location that is not a pharmacy shall maintain the following documentation with the permit holder for a minimum of 5 years:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#D(1)">(1)</span> Name, address, and date of birth of the individual receiving the vaccination;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#D(2)">(2)</span> Date of administration, and route and site of vaccinations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#D(3)">(3)</span> Name, dose, manufacturer's lot number, and expiration date of the vaccine;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#D(4)">(4)</span> Name and address of the primary health care provider of the individual receiving the vaccination, as identified by that individual;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#D(5)">(5)</span> Name of the pharmacist or pharmacy student administering the vaccination;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#D(6)">(6)</span> Version of the vaccination information statement provided to the individual receiving the vaccination;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#D(7)">(7)</span> Copy of the signed patient consent form of those individuals to whom the vaccine was administered;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#D(8)">(8)</span> Nature and outcome of an adverse reaction, and documentation that the adverse reaction was reported to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#D(8)(a)">(a)</span> The primary care provider; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#D(8)(b)">(b)</span> The Vaccine Adverse Event Reporting System.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#D(9)">(9)</span> At least one effort made by the pharmacist to inform the individual’s authorized prescriber that the vaccination has been administered; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.05#D(10)">(10)</span> If the authorized prescriber is not the individual’s primary care provider or if the vaccination has not been administered in accordance with a prescription document, at least one effort made by the pharmacist to inform the individual’s primary care provider or other usual source of care that the vaccination has been administered.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.32.06" data-order="|10|34|32|.06|" data-ref-path="10|34|32|.06" class="h__section">.06 Patient Information and Consent.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.06#A">A.</span> Every patient receiving a vaccination shall be provided with a current vaccine information statement.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.06#B">B.</span> Every patient receiving a vaccination shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.06#B(1)">(1)</span> Sign a consent form consenting to the administration of the vaccine; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.06#B(2)">(2)</span> Be given a copy of the consent form for the patient's future reference.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.06#C">C.</span> The consent form shall disclose the credentials of the pharmacist administering the vaccination.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.32.07" data-order="|10|34|32|.07|" data-ref-path="10|34|32|.07" class="h__section">.07 Approved Protocols.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#A">A.</span> A pharmacist shall have and maintain a written protocol for any vaccine to be administered, including influenza vaccination.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#B">B.</span> The pharmacist shall administer vaccinations in accordance with the written protocol.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C">C.</span> The written protocol for each vaccine shall contain at least the following elements:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(1)">(1)</span> Identity and license number of the participating pharmacist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(2)">(2)</span> Vaccine;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(3)">(3)</span> Precautions to vaccine use;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(4)">(4)</span> Contraindications to vaccine use;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(5)">(5)</span> Process to be followed for screening for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(5)(a)">(a)</span> Indications;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(5)(b)">(b)</span> Precautions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(5)(c)">(c)</span> Contraindications; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(5)(d)">(d)</span> Allergies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(6)">(6)</span> Process for obtaining and documenting consent;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(7)">(7)</span> Process for verification of prescription for patients 11—17 years old for vaccinations other than the influenza vaccine;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(8)">(8)</span> Dose or doses of the vaccine that will be administered;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(9)">(9)</span> The route or routes and site or sites of administration of the vaccine;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(10)">(10)</span> The injection or administration procedures;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(11)">(11)</span> Post-vaccination procedures, including waiting requirements;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(12)">(12)</span> Process for handling adverse reactions, including but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(12)(a)">(a)</span> Acute anaphylactic reactions; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(12)(b)">(b)</span> Other acute emergencies; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)">(13)</span> Process for documenting and maintaining a vaccination record including at least:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(a)">(a)</span> Patient:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(a)(i)">(i)</span> Name;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(a)(ii)">(ii)</span> Date of birth; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(a)(iii)">(iii)</span> Address;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(b)">(b)</span> Vaccination administration:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(b)(i)">(i)</span> Date;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(b)(ii)">(ii)</span> Dose;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(b)(iii)">(iii)</span> Site; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(b)(iv)">(iv)</span> Route;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(c)">(c)</span> Vaccine:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(c)(i)">(i)</span> Manufacturer;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(c)(ii)">(ii)</span> Lot number; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(c)(iii)">(iii)</span> Expiration date;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(d)">(d)</span> Required Vaccine Information Statement:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(d)(i)">(i)</span> Version; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(d)(ii)">(ii)</span> Provision date;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(e)">(e)</span> Name of the patient’s primary care provider or prescriber;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(f)">(f)</span> Documentation:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(f)(i)">(i)</span> Of at least one attempt to inform the patient’s primary care provider or prescriber that the vaccination has been administered; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(f)(ii)">(ii)</span> That the patient has no primary care provider;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(g)">(g)</span> Documentation of an attempt to inform the patient’s primary care provider that the influenza vaccination has been administered may not be required; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#C(13)(h)">(h)</span> The name of the vaccinator.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#D">D.</span> The protocol shall be:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#D(1)">(1)</span> Signed and dated at least annually by the pharmacist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#D(2)">(2)</span> Available and presented for inspection to the Board of Pharmacy upon request; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.32.07#D(3)">(3)</span> Reviewed and updated as necessary.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.32.08" data-order="|10|34|32|.08|" data-ref-path="10|34|32|.08" class="h__section">.08 Fees.</h3>
                <p>Fees charged for the administration of vaccinations may not exceed $50 in addition to the cost of each vaccination.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.33" data-order="|10|34|33|" data-ref-path="10|34|33" class="h__chapter">Chapter 33 Prescription Drug Repository Program</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: January 29, 2007 (34:2 Md. R. 137)</p>
                  <p>——————</p>
                  <p>Chapter revised effective May 9, 2016 (43:9 Md. R. 530)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§15-601 — 15-609, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.33.01-1" data-order="|10|34|33|.01-1|" data-ref-path="10|34|33|.01-1" class="h__section">.01-1 Incorporation by Reference.</h3>
                <p>In this chapter, the Secure and Responsible Drug Disposal Act of 2010, 21 U.S.C. 822 (as amended), has been incorporated by reference.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.33.01" data-order="|10|34|33|.01|" data-ref-path="10|34|33|.01" class="h__section">.01 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(1)">(1)</span> "Board" means the State Board of Pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(1-1)">(1-1)</span> “Donation program” means pharmacies that voluntarily participate as a drop-off site or repository, or both, to accept donated drugs or medical supplies for purposes of re-dispensing those donated drugs or medical supplies to needy individuals.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(1-2)">(1-2)</span> “Disposal program” means pharmacies that voluntarily participate as repositories to collect returned drugs and medical supplies for purposes of safe disposal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(2)">(2)</span> “Drop-off site” means a pharmacy or other health care facility designated by the Board for the purpose of receiving donated prescription drugs or medical supplies as part of the donation program and forwarding the drugs or medical supplies to a repository.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(3)">(3)</span> Health Care Facility.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(3)(a)">(a)</span> "Health care facility" means:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(3)(a)(i)">(i)</span> A hospital, as defined in Health-General Article, §19-301(g), Annotated Code of Maryland;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(3)(a)(ii)">(ii)</span> A limited service hospital, as defined in Health-General Article, §19-301(e), Annotated Code of Maryland;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(3)(a)(iii)">(iii)</span> A related institution, as defined in Health-General Article, §19-301(o), Annotated Code of Maryland;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(3)(a)(iv)">(iv)</span> An ambulatory surgical facility;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(3)(a)(v)">(v)</span> A rehabilitation facility;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(3)(a)(vi)">(vi)</span> A home health agency, as defined in Health-General Article, §19-401(b), Annotated Code of Maryland;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(3)(a)(vii)">(vii)</span> A hospice, as defined in Health-General Article, §19-901, Annotated Code of Maryland;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(3)(a)(viii)">(viii)</span> A kidney disease treatment facility, or the kidney disease treatment stations and services provided by or on behalf of a hospital, if the facility or the services do not include kidney transplant services or programs;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(3)(a)(ix)">(ix)</span> The office of one or more individuals licensed to practice dentistry under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 4, Annotated Code of Maryland</a>, for the purposes of practicing dentistry;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(3)(a)(x)">(x)</span> A comprehensive care facility located in Maryland; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(3)(a)(xi)">(xi)</span> Other health institutions, services, or programs that may be specified as requiring a Certificate of Need under State law.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(3)(b)">(b)</span> "Health care facility" does not mean a hospital or related institution operated, or listed and certified, by the First Church of Christ Scientist, Boston, Massachusetts.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(4)">(4)</span> "Health care practitioner" means an individual who is licensed, certified, or otherwise authorized under the <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Annotated Code of Maryland</a>, to provide health care services in the ordinary course of business or practice of a profession and has prescribing authority in this State.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(5)">(5)</span> "Pharmacist" means an individual who practices pharmacy regardless of the location where the activities of practice are performed.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(6)">(6)</span> "Pharmacy" means an establishment holding a permit under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-401" title="">Health Occupations Article, §12-401, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(7)">(7)</span> "Program" means the Prescription Drug Repository Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(8)">(8)</span> “Repository” means a pharmacy that applies to and is designated by the Board for the purpose of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(8)(a)">(a)</span> Accepting, inspecting, and dispensing donated prescription drugs or medical supplies received from a drop-off site as part of the donation program; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.01#B(8)(b)">(b)</span> Collecting prescription drugs or medical supplies for disposal as part of the disposal program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.33.02" data-order="|10|34|33|.02|" data-ref-path="10|34|33|.02" class="h__section">.02 Donation Program — Eligible Drugs.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.02#A">A.</span> Prescription drugs or medical supplies may be donated at a drop-off site.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.02#B">B.</span> Prescription drugs or medical supplies may be accepted for dispensing if the prescription drugs and medical supplies are:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.02#B(1)">(1)</span> In their original unopened and sealed packaging; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.02#B(2)">(2)</span> Packaged in single unit doses when the outside packaging is opened if the single unit dose packaging is undisturbed.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.33.03" data-order="|10|34|33|.03|" data-ref-path="10|34|33|.03" class="h__section">.03 Donation Program — Ineligible Drugs.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.03#A">A.</span> Prescription drugs or medical supplies may not be accepted for dispensing if the prescription drugs or medical supplies:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.03#A(1)">(1)</span> Bear an expiration date that is less than 90 days from the date the drug is donated to ensure the potency and quality of the prescription drugs or medical supplies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.03#A(2)">(2)</span> Have been adulterated, according to the standards of Health-General Article, §21-216, Annotated Code of Maryland, because adulterated prescription drugs or medical supplies have been determined to be a threat to public health;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.03#A(3)">(3)</span> Are designated controlled dangerous substances by the U.S. Drug Enforcement Administration which has determined that controlled dangerous substances may not be donated under a repository program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.03#A(4)">(4)</span> Require refrigeration because the potency and quality may not be guaranteed; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.03#A(5)">(5)</span> Have been previously compounded because compounded prescription drugs are patient specific.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.03#B">B.</span> The repository shall dispose of donated prescription drugs or medical supplies if they are not accepted into the Program for the purpose of dispensing.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.33.04" data-order="|10|34|33|.04|" data-ref-path="10|34|33|.04" class="h__section">.04 Donation Program — Donor Form.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.04#A">A.</span> A donor of a prescription drug or medical supply shall sign a form containing the following statements:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.04#A(1)">(1)</span> That the donor is the owner or the owner's representative of the prescription drug or medical supply; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.04#A(2)">(2)</span> That the donor intends to voluntarily donate the prescription drug or medical supply to the Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.04#B">B.</span> The drop-off site shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.04#B(1)">(1)</span> Require that the donor form contain:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.04#B(1)(a)">(a)</span> The signature of the donor or the donor's representative;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.04#B(1)(b)">(b)</span> Contact information of the donor or the donor's representative; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.04#B(1)(c)">(c)</span> The date of donation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.04#B(2)">(2)</span> Require that the donor form be completed before any donation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.04#B(3)">(3)</span> Provide a copy of the donor form to the donor or the donor's representative; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.04#B(4)">(4)</span> Maintain a copy of the donor form for 5 years.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.33.05" data-order="|10|34|33|.05|" data-ref-path="10|34|33|.05" class="h__section">.05 Donation Program — Drop-Off Sites Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#A">A.</span> In order to become a drop-off site, a pharmacy or other health care facility:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#A(1)">(1)</span> Shall submit an application to the Board to be designated as a voluntary drop-off site;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#A(2)">(2)</span> Shall be in good standing with the Board or the Office of Health Care Quality;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#A(3)">(3)</span> May not have a final disciplinary order issued against it by a health occupations board;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#A(4)">(4)</span> May not be owned or operated by a health care practitioner who has not fulfilled the requirements of a final disciplinary order that may have been issued against the owner or operator by a health occupations boards;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#A(5)">(5)</span> Shall maintain records of donated prescription drugs or medical supplies; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#A(6)">(6)</span> Shall assign a pharmacist or other health care practitioner the responsibility to accept donated prescription drugs or medical supplies at the drop-off site.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#B">B.</span> Assigned Pharmacist or Other Health Care Practitioner's Responsibility. A pharmacist or health care practitioner accepting donated prescription drugs or medical supplies at a drop-off site as set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.33.05#A(6)" title="">§A(6) of this regulation</a>:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#B(1)">(1)</span> May not delegate acceptance of donated prescription drugs or medical supplies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#B(2)">(2)</span> May refuse to accept hazardous prescription drugs or medical supplies for donation if the decision is based on professional judgment, experience, knowledge, or available reference materials;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#B(3)">(3)</span> Shall be in good standing with the pharmacist's or health care practitioner's respective health occupations board; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#B(4)">(4)</span> Shall have fulfilled the requirements of a final disciplinary order that may have been issued against the pharmacist or health care practitioner by a health occupations board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#C">C.</span> Record Requirements. A drop-off site shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#C(1)">(1)</span> Obtain a signed donor form releasing the prescription drug or medical supplies to the Program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#C(2)">(2)</span> Provide a copy of the signed donor form to the donor; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#C(3)">(3)</span> Maintain records of signed donor forms for 5 years.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#D">D.</span> Procedures for Handling of Donated Prescription Drugs or Medical Supplies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#D(1)">(1)</span> A drop-off site shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#D(1)(a)">(a)</span> Place the donated prescription drug or medical supply and the donor form in a sealed bag;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#D(1)(b)">(b)</span> Store the bag containing the donated prescription drugs or medical supplies in an area accessible only to those pharmacists or health care practitioners who have been assigned the responsibility to accept the donated prescription drugs or medical supplies; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#D(1)(c)">(c)</span> Forward the sealed bags of donated prescription drugs or medical supplies to the repository at least every 2 weeks.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#D(2)">(2)</span> A drop-off site may not:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#D(2)(a)">(a)</span> Dispense donated prescription drugs or medical supplies;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#D(2)(b)">(b)</span> Resell prescription drugs or medical supplies donated to the Program;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#D(2)(c)">(c)</span> Charge a fee for accepting a donation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#D(2)(d)">(d)</span> Accept donated prescription drugs or medical supplies until the drop-off site applicant has been approved by the Board; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.05#D(2)(e)">(e)</span> Accept prescription drugs for disposal.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.33.06-1" data-order="|10|34|33|.06-1|" data-ref-path="10|34|33|.06-1" class="h__section">.06-1 Repositories Participating in the Donation Program.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#A">A.</span> Designated Pharmacist. A repository in the donation program shall designate a pharmacist who shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#A(1)">(1)</span> Accept donated prescription drugs or medical supplies forwarded by:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#A(1)(a)">(a)</span> A drop-off site; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#A(1)(b)">(b)</span> A manufacturer regulated by the U.S. Food and Drug Administration;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#A(2)">(2)</span> Inspect donated prescription drugs or medical supplies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#A(3)">(3)</span> Accept donated prescription drugs or medical supplies that meet the requirements of Regulations .02 and .03 of this chapter; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#A(4)">(4)</span> Obliterate from the labels of donated prescription drugs or medical supplies patient specific information for which the donated prescription drugs or medical supplies were originally dispensed when it is placed in inventory.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#B">B.</span> Record Requirements. A repository in the Donation Program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#B(1)">(1)</span> Maintain a separate inventory of donated prescription drugs or medical supplies for a minimum of 5 years;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#B(2)">(2)</span> Maintain separate prescription files for patients receiving donated prescription drugs or medical supplies for a minimum of 5 years; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#B(3)">(3)</span> Submit an annual report on its activities to the Board that includes at least information on the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#B(3)(a)">(a)</span> Number of recipients by county;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#B(3)(b)">(b)</span> Approximate market value of the prescription drugs or medical supplies dispensed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#B(3)(c)">(c)</span> 50 prescription drugs or medical supplies most frequently dispensed; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#B(3)(d)">(d)</span> Total number of donations to the Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#C">C.</span> Procedures for Handling of Donated Prescription Drugs or Medical Supplies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#C(1)">(1)</span> A repository in the Donation Program shall store donated prescription drugs or medical supplies in a secure location separate from other inventory in accordance with State and federal laws and regulations.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#C(2)">(2)</span> A repository may not:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#C(2)(a)">(a)</span> Resell prescription drugs or medical supplies donated to the Program; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#C(2)(b)">(b)</span> Establish or maintain a waiting list for prescription drugs or medical supplies dispensed by the Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#C(3)">(3)</span> A repository may charge a fee of not more than $10 for each prescription drug or medical supply dispensed under the Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#D">D.</span> Limitations. A repository in the Donation Program is under no obligation to obtain a prescription drug or medical supply that is not in inventory at the time of the request.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#E">E.</span> Procedure for Dispensing Donated Prescription Drugs or Medical Supplies. A repository in the Donation Program shall dispense donated prescription drugs or medical supplies in compliance with applicable federal and State laws and regulations for dispensing prescription drugs or medical supplies.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#F">F.</span> Procedure for Shipping Donated Prescription Drugs or Medical Supplies. A repository in the Donation Program shall comply with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.25" title="Chapter 25 Delivery of Prescriptions">COMAR 10.34.25</a> when shipping donated prescription drugs or medical supplies to recipients of this Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#G">G.</span> Procedures for Disposing of Donated Prescription Drugs or Medical Supplies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#G(1)">(1)</span> A repository in the Donation Program shall dispose of donated prescription drugs or medical supplies that do not meet the eligibility requirements of <a class="internal-link " href="/us/md/exec/comar/10.34.33.02" title=".02 Donation Program — Eligible Drugs.">Regulation .02 of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#G(2)">(2)</span> A repository in the Donation Program shall dispose of donated prescription drugs or medical supplies in compliance with applicable State and federal laws and regulations for disposing of prescription drugs or medical supplies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#G(3)">(3)</span> A repository shall maintain records of disposal of donated prescription drugs or medical supplies.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#H">H.</span> Determination of Patient Eligibility for the Donation Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#H(1)">(1)</span> A recipient of the Donation Program shall be a resident of the State.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#H(2)">(2)</span> A health care practitioner with prescribing authority shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#H(2)(a)">(a)</span> Determine, at the health care practitioner’s discretion, the financial need of a patient to participate in the Donation Program; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#H(2)(b)">(b)</span> Indicate on the patient’s prescription eligibility for the Donation Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#I">I.</span> Recipient Form. Recipients of a donated prescription drug or medical supply under the Donation Program shall sign a Board approved form before receiving the prescription drug or medical supply to confirm that the recipient understands that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#I(1)">(1)</span> The recipient is receiving prescription drugs or medical supplies that have been donated as part of the Donation Program; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06-1#I(2)">(2)</span> Entities involved in the Donation Program have immunity from liability in accordance with Health-General Article, §15-607, Annotated Code of Maryland.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.33.06" data-order="|10|34|33|.06|" data-ref-path="10|34|33|.06" class="h__section">.06 Repositories — General Requirements.</h3>
                <p>In order to become a repository, a pharmacy:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06#A">A.</span> Shall submit an application to the Board to be designated as a repository;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06#B">B.</span> Shall indicate on the application to the Board if the applicant intends to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06#B(1)">(1)</span> Participate in the Donation Program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06#B(2)">(2)</span> Participate in the Disposal Program by collecting only non-controlled dangerous substances and medical supplies for safe disposal; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06#B(3)">(3)</span> Participate in the Disposal Program by collecting controlled dangerous substances, non-controlled dangerous substances, and medical supplies for safe disposal;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06#C">C.</span> Shall be in good standing with the Board;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06#D">D.</span> May not have a final disciplinary order issued against it by the Board; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.06#E">E.</span> May not be owned or operated by a health care practitioner who has not fulfilled the requirements of a final disciplinary order that may have been issued against the owner or operator by a health occupations board.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.33.07" data-order="|10|34|33|.07|" data-ref-path="10|34|33|.07" class="h__section">.07 Disposal Program — Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.07#A">A.</span> Pharmacies that collect returned prescription drugs or medical supplies for proper disposal shall be approved by the Board as repositories.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.07#B">B.</span> Repositories that collect only non-controlled dangerous substances for proper disposal shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.07#B(1)">(1)</span> Dispose of prescription drugs or medical supplies collected for disposal in compliance with applicable State and federal laws and regulations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.07#B(2)">(2)</span> Have policies and procedures regarding the safe and secure handling and disposal of prescription drugs and medical supplies, to include specific guidelines for prescription drugs requiring special disposal or care;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.07#B(3)">(3)</span> Dispose of collected prescription drugs and medical supplies through a third party processor or a reverse distributor, as appropriate; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.07#B(4)">(4)</span> Maintain a separate secure container behind the prescription counter that is clearly marked for the Disposal Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.07#C">C.</span> A pharmacist may not delegate to a pharmacy technician the collection of prescription drugs or medical supplies under <a class="internal-link " href="/us/md/exec/comar/10.34.33.07#B" title="">§B of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.33.07#D">D.</span> Repositories that collect controlled dangerous substances for disposal:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.07#D(1)">(1)</span> Shall comply with the requirements of the Secure and Responsible Drug Disposal Act of 2010;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.07#D(2)">(2)</span> May collect non-controlled dangerous substances and medical supplies in the same manner; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.33.07#D(3)">(3)</span> May commingle the collection of controlled and non-controlled dangerous substances and medical supplies in accordance with the Secure and Responsible Drug Disposal Act of 2010.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.34" data-order="|10|34|34|" data-ref-path="10|34|34" class="h__chapter">Chapter 34 Pharmacy Technicians</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: January 28, 2008 (35:2 Md. R. 127)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.34.05" title=".05 Registration Requirements.">Regulation .05</a> amended effective July 1, 2015 (42:7 Md. R. 569); February 12, 2018 (45:3 Md. R. 157)</p>
                  <p>——————</p>
                  <p>Chapter revised effective January 28, 2024 (50:26 Md. R. 1132)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.34.02#B" title="">Regulation .02B</a> amended effective November 11, 2024 (51:22 Md. R. 963)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.34.03" title=".03 Delegated Pharmacy Acts.">Regulation .03</a> amended effective November 11, 2024 (51:22 Md. R. 963)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.34.07" title=".07 Standards for Pharmacy Technician Training Programs.">Regulation .07</a> amended effective November 11, 2024 (51:22 Md. R. 963)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.34.10#A" title="">Regulation .10A</a> amended effective November 11, 2024 (51:22 Md. R. 963)</p>
                  <h3>Authority</h3>
                  <p>Health-Occupations Article, §§12-101, 12-205, 12-206, 12-315—12-317, 12-319, 12-320, 12-403, 12-505, 12-707, and 12-6B-01—12-6B-14, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.34.01" data-order="|10|34|34|.01|" data-ref-path="10|34|34|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter applies to applicants for registration as pharmacy technicians and to registered pharmacy technicians.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.34.02" data-order="|10|34|34|.02|" data-ref-path="10|34|34|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(1)">(1)</span> “Board” means the State Board of Pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(2)">(2)</span> Compounding.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(2)(a)">(a)</span> “Compounding” means the preparation, mixing, assembling, packaging, or labeling of a drug or device:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(2)(a)(i)">(i)</span> As the result of a practitioner's prescription drug order or initiative based on the practitioner/patient/pharmacist relationship in the course of professional practice; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(2)(a)(ii)">(ii)</span> For the purpose of, or incident to, research, teaching, or chemical analysis and not for the sale or dispensing of the drug or device.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(2)(b)">(b)</span> “Compounding” includes the preparation of drugs or devices in anticipation of a prescription drug order based on routine, regularly observed prescribing patterns.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(3)">(3)</span> Delegated Pharmacy Act.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(3)(a)">(a)</span> “Delegated pharmacy act” means an activity that constitutes the practice of pharmacy delegated by a licensed pharmacist under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Subtitle 6B, Annotated Code of Maryland</a>, and this chapter.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(3)(b)">(b)</span> “Delegated pharmacy act” does not include:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(3)(b)(i)">(i)</span> An act within the parameters of a Drug Therapy Management contract as provided under Health Occupations Article, Subtitle 6A, Annotated Code of Maryland;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(3)(b)(ii)">(ii)</span> The delegation of a pharmacy act by a registered pharmacy technician, pharmacy student, or pharmacy technician trainee;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(3)(b)(iii)">(iii)</span> A pharmacy activity performed by a pharmacy student in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-301" title="">Health Occupations Article, §12-301(b), Annotated Code of Maryland</a>; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(3)(b)(iv)">(iv)</span> A pharmacy activity performed by an applicant for a license to practice pharmacy, if the applicant does not perform delegated pharmacy acts for more than 10 months.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(4)">(4)</span> “Direct supervision” means that a licensed pharmacist is physically available onsite to supervise the performance of delegated pharmacy acts.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(5)">(5)</span> “Experiential learning rotation” means a course offered by an Accreditation Council for Pharmacy Education accredited school of pharmacy that is designed to provide pharmacy practice experiences to students seeking the doctor of pharmacy degree.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(6)">(6)</span> Final Product Verification.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(6)(a)">(a)</span> “Final product verification” means:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(6)(a)(i)">(i)</span> Confirming the accuracy of the device or drug product, and dosage form of a filled prescription or medication order; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(6)(a)(ii)">(ii)</span> Confirming the accuracy of the device or drug product, and dosage form of a prescription or medication selected for stocking into a medication distribution system.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(6)(b)">(b)</span> “Final product verification” does not include determining the appropriateness of the prescription device or drug product, dosage form, directions for use, labeling, packaging, or any other determination that requires the application of a pharmacist’s clinical expertise.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(7)">(7)</span> “Medication distribution system” means an automated medication system, emergency box, interim box, medication carousel or cart, or other storage and dispensing system.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(8)">(8)</span> “National pharmacy technician certification program” means a program approved by a Board-recognized national accrediting body.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(9)">(9)</span> “Pharmacy student” means an individual who is enrolled as a student in a school or college of pharmacy approved by the Board or accredited by the Accreditation Council for Pharmacy Education.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(10)">(10)</span> “Pharmacy technician trainee” means an individual engaged in a Board-approved pharmacy technician training program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(11)">(11)</span> “Registered pharmacy technician” means an individual who is registered with the Board to perform delegated pharmacy acts.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(12)">(12)</span> “Registration” means, unless the context requires otherwise, a registration issued by the Board to perform delegated pharmacy acts under the direct supervision of a licensed pharmacist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(13)">(13)</span> “Supervision” means reviewing the work, guiding and directing the activities, and monitoring the performance of an individual.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(14)">(14)</span> “Unit dose” means a package labeled with bar code scanning or other similar technology containing a single dose of a device, drug, or medication ordered or prescribed for a patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(15)">(15)</span> “Unit-of-use” means a package or container, such as a unit dose (injectable, liquid, or solid), otic, ophthalmic product, otic product, topical product, or a prescription vial filled from a stock bottle or in the original manufacturer’s packaging, designed to be dispensed to a patient that is labeled with bar code scanning or other similar technology.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.02#B(16)">(16)</span> “Validated pharmacy technician” means a registered pharmacy technician who has obtained a product verification certificate issued by a Board-approved national training program and satisfied other regulatory requirements.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.34.03" data-order="|10|34|34|.03|" data-ref-path="10|34|34|.03" class="h__section">.03 Delegated Pharmacy Acts.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#A">A.</span> A pharmacy technician may not:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#A(1)">(1)</span> Represent themselves as a pharmacist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#A(2)">(2)</span> Dispense prescription medications when the pharmacist is not in the pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#A(3)">(3)</span> Be present in the pharmacy when the pharmacist is not physically available onsite;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#A(4)">(4)</span> Provide information, explanation, or recommendations to patients and health care practitioners about the safe and effective use of prescription or nonprescription drugs or devices;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#A(5)">(5)</span> Delegate a pharmacy act that was delegated to the pharmacy technician or individual engaging in a Board-approved technician training program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#A(6)">(6)</span> Act within the parameters of a therapy management contract as provided under Health Occupations Article, Subtitle 6A, Annotated Code of Maryland;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#A(7)">(7)</span> Provide the final verification for accuracy, appropriateness, completeness, or validity of a filled prescription or medication order, except as provided for in Regulation .04 under this chapter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#A(8)">(8)</span> Make decisions that require a pharmacist's professional judgment;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#A(9)">(9)</span> Clinically evaluate the patient's profile relative to the pharmaceuticals that have been or will be dispensed;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#A(10)">(10)</span> Consult with the patient concerning the utilization of their pharmaceuticals;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#A(11)">(11)</span> Accept or transcribe new prescriptions;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#A(12)">(12)</span> Give or accept a transferred prescription for controlled dangerous substances;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#A(13)">(13)</span> Accept a transferred prescription;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#A(14)">(14)</span> Independently compound prescriptions;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#A(15)">(15)</span> Administer medications;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#A(16)">(16)</span> Accept the return of prescription drugs or devices directly from a patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#A(17)">(17)</span> Administer an injectable medication; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#A(18)">(18)</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.34.34.03#B" title="">§B of this regulation</a>, administer a vaccine.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#B">B.</span> Technician Administration of Certain Vaccines.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#B(1)">(1)</span> A registered pharmacy technician that meets the requirements set forth in §B(2) and (3) of this regulation, may administer the following vaccines as a delegated pharmacy act:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#B(1)(a)">(a)</span> Coronavirus (COVID-19), influenza, or pneumococcal pneumonia vaccines to an individual 18 years old or older; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#B(1)(b)">(b)</span> Respiratory syncytial virus (RSV) or herpes zoster vaccines to an individual 50 years old or older.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#B(2)">(2)</span> In order for a registered pharmacy technician to administer a vaccine, the registered pharmacy technician shall submit notification to the Board on a form that the Board requires attesting to the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#B(2)(a)">(a)</span> Successful completion of a practical training program approved by the Accreditation Council for Pharmacy Education (ACPE) that includes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#B(2)(a)(i)">(i)</span> Hands-on injection technique;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#B(2)(a)(ii)">(ii)</span> Clinical evaluation of indications and contraindications of vaccines; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#B(2)(a)(iii)">(iii)</span> Recognition and treatment of emergency reactions to vaccines; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#B(2)(b)">(b)</span> Possession of an active certification in basic cardiopulmonary resuscitation (CPR) obtained through in-person classroom instruction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#B(3)">(3)</span> A registered pharmacy technician may not administer a vaccine as a delegated pharmacy act until the registered pharmacy technician receives written confirmation from the Board accepting the notification form.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#B(4)">(4)</span> The delegating supervising pharmacist shall confirm that a registered pharmacy technician has met the requirements set forth in §B(2) and (3) of this regulation before delegating the administration of a vaccine to the registered pharmacy technician.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#B(5)">(5)</span> A pharmacy technician trainee may not administer a vaccine.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#C">C.</span> A pharmacy technician shall be clearly identified as such to the public;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#D">D.</span> When performing tasks in the prescription area, a pharmacy technician shall maintain proper:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#D(1)">(1)</span> Sanitation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#D(2)">(2)</span> Hygiene;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#D(3)">(3)</span> Biohazard precautions; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#D(4)">(4)</span> Infection control.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#E">E.</span> Off-Site Data Entry.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#E(1)">(1)</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.34.34.03#E(2)" title="">§E(2) of this regulation</a>, a registered pharmacy technician shall perform delegated pharmacy acts under the direct supervision of a licensed pharmacist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#E(2)">(2)</span> A registered pharmacy technician may perform prescription data entry at a remote location outside of a licensed pharmacy provided that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#E(2)(a)">(a)</span> The registered pharmacy technician has immediate electronic access to a supervising pharmacist who can assist as needed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#E(2)(b)">(b)</span> The data entry is not required to be performed by a pharmacist;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#E(2)(c)">(c)</span> The data entry is appropriate to the education, training, and experience of the registered pharmacy technician and supervising pharmacist; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.03#E(2)(d)">(d)</span> If the data entry involves access to protected patient information under the Health Insurance Portability and Accountability Act (HIPAA), it can be performed in a manner that maintains the confidentiality of patient information.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.34.04" data-order="|10|34|34|.04|" data-ref-path="10|34|34|.04" class="h__section">.04 Validated Pharmacy Technician.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#A">A.</span> Validated Pharmacy Technician — Minimum Requirements.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#A(1)">(1)</span> Experience. Prior to working as a validated pharmacy technician, an individual shall have a minimum of 1 year of experience as a registered pharmacy technician in the State.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#A(2)">(2)</span> Training. In addition to the requirements for pharmacy technician registration, to act as a validated pharmacy technician, an individual shall possess an active product verification certificate issued by a Board-approved national pharmacy technician certification program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#B">B.</span> Validated Pharmacy Technician — Final Product Verification. A pharmacist may delegate responsibility to perform the final verification of a prescription device, drug product, or medication order to a validated pharmacy technician under the following circumstances:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#B(1)">(1)</span> Prescription or Medication Order.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#B(1)(a)">(a)</span> A pharmacist shall verify the data entry of the prescription device, drug product, or medication order in the pharmacy management system or, if applicable, the electronic health record for:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#B(1)(a)(i)">(i)</span> Accuracy;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#B(1)(a)(ii)">(ii)</span> Appropriateness of the device, drug product, or medication;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#B(1)(a)(iii)">(iii)</span> Appropriateness of the dosage form;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#B(1)(a)(iv)">(iv)</span> Directions for use;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#B(1)(a)(v)">(v)</span> Labeling;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#B(1)(a)(vi)">(vi)</span> Packaging; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#B(1)(a)(vii)">(vii)</span> Any other determination that requires the application of clinical expertise.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#B(1)(b)">(b)</span> Bar code scanning or similar technology is utilized during the filling process and at the verification step to validate device, drug product, or medication selection accuracy.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#B(1)(c)">(c)</span> The product being verified is packaged in unit-dose or unit-of-use packaging.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#B(2)">(2)</span> Stocking or Replenishing a Medication Distribution System. Notwithstanding any other regulation, a validated pharmacy technician may perform the final product verification of a prescription device, drug product, or medication selected for stocking into a medication distribution system provided that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#B(2)(a)">(a)</span> The medication distribution system utilizes bar code scanning or other similar technology to validate the device, drug product, or medication selection; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#B(2)(b)">(b)</span> The pharmacy responsible for the medication distribution system maintains and reviews annually a quality assurance policy which includes routine audits of the system to ensure the accuracy of stocked prescriptions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#B(3)">(3)</span> A validated pharmacy technician may not perform the final product verification of a prescription device, drug product, or medication that the technician personally prepared.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#C">C.</span> Validated Pharmacy Technician — Pharmacy Permit Holder’s Responsibilities. A pharmacy utilizing a validated pharmacy technician shall maintain records for a minimum of 2 years, and have those records readily available to the Board upon request, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#C(1)">(1)</span> A current list of all validated pharmacy technicians;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#C(2)">(2)</span> A job description for each validated pharmacy technician; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#C(3)">(3)</span> Policies and standard operating procedures for validated pharmacy technicians.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#D">D.</span> Validated Pharmacy Technician – Pharmacist’s Responsibilities.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#D(1)">(1)</span> A pharmacist may not delegate the final product verification of a compounded medication under any circumstance.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.04#D(2)">(2)</span> Notwithstanding any delegation of a pharmacy act to a validated pharmacy technician, a pharmacist shall maintain professional responsibility for every medication or prescription dispensed, and for each medication or prescription stocked into a medication distribution system under the supervision of the pharmacist.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.34.05" data-order="|10|34|34|.05|" data-ref-path="10|34|34|.05" class="h__section">.05 Registration Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#A">A.</span> An applicant currently certified by a national pharmacy technician certification program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#A(1)">(1)</span> Submit to the Board a signed completed application on a form provided by the Board;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#A(2)">(2)</span> Submit to the Board evidence of current certification by a national pharmacy certification program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#A(3)">(3)</span> Pay a fee as set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09" title="Chapter 09 Fees">COMAR 10.34.09</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#A(4)">(4)</span> Submit a request for a State Criminal History Records check.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#B">B.</span> An applicant that does not qualify under <a class="internal-link " href="/us/md/exec/comar/10.34.34.05#A" title="">§A of this regulation</a> shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#B(1)">(1)</span> Submit to the Board a signed completed application on a form provided by the Board;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#B(2)">(2)</span> Be 17 years old or older;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#B(3)">(3)</span> Meet the following educational requirements:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#B(3)(a)">(a)</span> Be a high school graduate or have attained a high school equivalency diploma;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#B(3)(b)">(b)</span> Be enrolled and in good standing at a high school; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#B(3)(c)">(c)</span> Meet the requirements of <a class="internal-link " href="/us/md/exec/comar/10.34.34.05#C" title="">§C of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#B(4)">(4)</span> Provide satisfactory proof to the Board of the applicant's successful completion of a pharmacy technician training program approved by the Board that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#B(4)(a)">(a)</span> Is no longer than 6 months duration; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#B(4)(b)">(b)</span> Includes 160 hours of work experience;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#B(5)">(5)</span> Pass an examination approved by the Board as set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.34.06" title=".06 Pharmacy Students —Exemptions.">Regulation .06 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#B(6)">(6)</span> Pay a fee as set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09" title="Chapter 09 Fees">COMAR 10.34.09</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#B(7)">(7)</span> Submit a request for a State Criminal History Records check.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#C">C.</span> An applicant who does not meet the requirements of §A or B of this regulation shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#C(1)">(1)</span> Submit to the Board a signed application on a form provided by the Board;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#C(2)">(2)</span> Comply with the age requirements as set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.34.05#B" title="">§B of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#C(3)">(3)</span> Provide written verification from the pharmacy permit holder that the applicant has worked in the pharmacy area of a pharmacy operated by the same pharmacy permit holder continuously since January 1, 2006;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#C(4)">(4)</span> Provide written verification from the pharmacist who has supervised the applicant for at least 6 months that the applicant has performed competently;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#C(5)">(5)</span> Pay a fee as set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09" title="Chapter 09 Fees">COMAR 10.34.09</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#C(6)">(6)</span> Submit a request for a State Criminal History Records check.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.05#D">D.</span> The Board of Pharmacy shall provide the pharmacy technician with a registration card and pocket identification card upon initial registration and renewal.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.34.06" data-order="|10|34|34|.06|" data-ref-path="10|34|34|.06" class="h__section">.06 Pharmacy Students —Exemptions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.06#A">A.</span> Pharmacy students who are practicing in a pharmacy as part of a school of pharmacy sanctioned experiential learning rotation are not subject to the registration requirements of <a class="internal-link " href="/us/md/exec/comar/10.34.34.04" title=".04 Validated Pharmacy Technician.">Regulation .04 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.06#B">B.</span> Pharmacy students who are currently completing the first year of a professional pharmacy education program and are not in a school of pharmacy sanctioned experiential learning rotation may perform delegated pharmacy acts provided that the pharmacy student:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.06#B(1)">(1)</span> Submits to the Board a signed completed application for exemption from the registration requirements of <a class="internal-link " href="/us/md/exec/comar/10.34.34.04" title=".04 Validated Pharmacy Technician.">Regulation .04 of this chapter</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.06#B(2)">(2)</span> Provides verification of enrollment and good standing at an accredited school of pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.06#C">C.</span> A pharmacy student may begin work under this exemption upon compliance with <a class="internal-link " href="/us/md/exec/comar/10.34.34.06#B" title="">§B of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.06#D">D.</span> An exemption from registration granted under this regulation is effective only during the first year of the pharmacy students professional pharmacy education program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.06#E">E.</span> Pharmacy students granted an exemption from registration under this regulation are not subject to renewal requirements as set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.34.08" title=".08 Standards for Examination Approval.">Regulation .08 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.06#F">F.</span> A pharmacy student granted an exemption from registration under this regulation shall perform delegated pharmacy acts under the direct supervision of a licensed pharmacist and in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Subtitle 6B, Annotated Code of Maryland</a>, and this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.34.07" data-order="|10|34|34|.07|" data-ref-path="10|34|34|.07" class="h__section">.07 Standards for Pharmacy Technician Training Programs.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A">A.</span> Minimum Standards.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)">(1)</span> Pharmacy technician training programs shall, at a minimum, cover the following areas of pharmacy practice:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(a)">(a)</span> Roles and responsibilities of the pharmacy technician;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(b)">(b)</span> Knowledge of prescription medications;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(c)">(c)</span> Knowledge of strengths or dose, dosage forms, physical appearance, routes of administration, and duration of drug therapy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(d)">(d)</span> The dispensing process;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(e)">(e)</span> Pharmaceutical calculations;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(f)">(f)</span> Interacting with patients;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(g)">(g)</span> Third party prescriptions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(h)">(h)</span> Extemporaneous compounding;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(i)">(i)</span> Requirements and professional standards for:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(i)(i)">(i)</span> Preparing;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(i)(ii)">(ii)</span> Labeling;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(i)(iii)">(iii)</span> Dispensing;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(i)(iv)">(iv)</span> Storing;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(i)(v)">(v)</span> Prepackaging;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(i)(vi)">(vi)</span> Distributing; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(i)(vii)">(vii)</span> How medications are administered;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(j)">(j)</span> Confidentiality;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(k)">(k)</span> Drugs used to treat the following indications:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(k)(i)">(i)</span> Hypertension;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(k)(ii)">(ii)</span> Antihyperlipidemia;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(k)(iii)">(iii)</span> Diabetes mellitus;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(k)(iv)">(iv)</span> Arthritis;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(k)(v)">(v)</span> Gastrointestinal disorders;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(k)(vi)">(vi)</span> Asthma and allergy; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(k)(vii)">(vii)</span> Infectious diseases;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(l)">(l)</span> Federal and State laws and regulations governing the practice of pharmacy; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(1)(m)">(m)</span> Knowledge of special dosing considerations for pediatric and geriatric populations.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(2)">(2)</span> Pharmacy technician training programs may be offered by:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(2)(a)">(a)</span> Pharmacy employers;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(2)(b)">(b)</span> Nationally recognized pharmacy technician training programs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(2)(c)">(c)</span> Accredited educational institutions pharmacy technician programs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(2)(d)">(d)</span> Pharmacy technician programs approved by the Maryland State Department of Education and the Maryland Higher Education Commission; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(2)(e)">(e)</span> Pharmacy technician training programs offered by the U.S. Armed Forces.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(3)">(3)</span> Training programs may not be longer than 6 months.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#A(4)">(4)</span> Training programs shall include 160 hours of work experience, which shall be completed within 6 months of the date of the pharmacy technician trainee’s enrollment in the program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#B">B.</span> Board Approval of Pharmacy Technician Training Programs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#B(1)">(1)</span> A program shall submit an application on a form provided by the Board.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#B(2)">(2)</span> A program shall provide the Board with the course outline and any other information requested by the Board.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#B(3)">(3)</span> A pharmacy that pairs 160 hours of on-site work experience with a pharmacy technician training program that is Board-approved for its didactic content only shall obtain independent Board approval as a pharmacy technician training program prior to the delegation of any pharmacy act to a pharmacy technician trainee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#B(4)">(4)</span> Any changes in course content shall require notification and approval from the Board.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#B(5)">(5)</span> The Board shall have final approval of a pharmacy technician training program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#B(6)">(6)</span> The Board may withdraw approval of a program if the Board finds that the program is in violation of this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.07#B(7)">(7)</span> The Board shall approve pharmacy technician training programs offered by the U.S. Armed Forces.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.34.08" data-order="|10|34|34|.08|" data-ref-path="10|34|34|.08" class="h__section">.08 Standards for Examination Approval.</h3>
                <p>The Board shall approve examinations which have:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.08#A">A.</span> Content criteria set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.34.06" title=".06 Pharmacy Students —Exemptions.">Regulation .06 of this chapter</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.08#B">B.</span> A minimum of 100 multiple choice questions;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.08#C">C.</span> Sufficient additional questions so that the examination questions may be rotated twice a year; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.08#D">D.</span> A passing score of 75 percent or higher.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.34.09" data-order="|10|34|34|.09|" data-ref-path="10|34|34|.09" class="h__section">.09 Renewal Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.09#A">A.</span> The pharmacy technician's registration shall expire on the last day of the birth month following 1 year after initial registration.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.09#B">B.</span> Following initial registration, a pharmacy technician's registration:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.09#B(1)">(1)</span> Expires on the date set by the Board unless it is renewed for an additional term; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.09#B(2)">(2)</span> May not be renewed for a term longer than 2 years.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.09#C">C.</span> At least 1 month before the registration expires, the Board shall issue a renewal notice to the pharmacy technician registrant that states:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.09#C(1)">(1)</span> The date on which the current registration expires;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.09#C(2)">(2)</span> The date by which the renewal application shall be received by the Board for the renewal to be issued and mailed before the registration expires; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.09#C(3)">(3)</span> The amount of the renewal fee.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.09#D">D.</span> The registrant may renew the registration for an additional term of 2 years if the registrant:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.09#D(1)">(1)</span> Otherwise is entitled to be registered;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.09#D(2)">(2)</span> Pays to the Board a renewal fee set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09" title="Chapter 09 Fees">COMAR 10.34.09</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.09#D(3)">(3)</span> Submits to the Board:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.09#D(3)(a)">(a)</span> A renewal application on the form that the Board requires; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.09#D(3)(b)">(b)</span> Satisfactory evidence of compliance with the continuing education requirements set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.34.09" title=".09 Renewal Requirements.">Regulation .09 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.34.10" data-order="|10|34|34|.10|" data-ref-path="10|34|34|.10" class="h__section">.10 Continuing Education.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#A">A.</span> Requirements.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#A(1)">(1)</span> A pharmacy technician registered to practice in Maryland shall<em>:</em></p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#A(1)(a)">(a)</span> Earn 20 hours of approved continuing pharmaceutical education within the 2-year period immediately preceding the registrant’s renewal application; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#A(1)(b)">(b)</span> If the registrant administers a vaccine in accordance with <a class="internal-link " href="/us/md/exec/comar/10.34.34.03" title=".03 Delegated Pharmacy Acts.">Regulation .03 of this chapter</a>, earn 2 hours of continuing pharmaceutical education focused on vaccination as part of the 20 hours of continuing pharmaceutical education required for renewal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#A(2)">(2)</span> For the first renewal period during which continuing education is mandatory for a pharmacy technician, the Board of Pharmacy shall require only 10 hours of continuing education requirements.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#A(3)">(3)</span> A pharmacy technician shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#A(3)(a)">(a)</span> Attest to the fact that the pharmacy technician has completed the continuing pharmacy technician education requirement on the required form; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#A(3)(b)">(b)</span> Retain supporting documents for inspection by the Board for 4 years after the date of renewal for which the continuing education credits were used.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#B">B.</span> Accredited Continuing Education Providers.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#B(1)">(1)</span> The following providers are approved for any programs they offer which otherwise qualify for continuing education credit:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#B(1)(a)">(a)</span> Accreditation Council on Pharmaceutical Education (ACPE);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#B(1)(b)">(b)</span> All schools of pharmacy accredited by the American Association of Colleges of Pharmacy (AACP); and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#B(1)(c)">(c)</span> Out-of-State providers approved by a state board of pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#B(2)">(2)</span> Procedures for Approval of Additional Programs.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#B(2)(a)">(a)</span> Other providers shall initially request Board approval for individual programs.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#B(2)(b)">(b)</span> An approved program is valid for a 2-year period.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#B(2)(c)">(c)</span> The approved provider shall submit to the Board changes to the program that differ from the initial submission of information for Board approval.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#B(2)(d)">(d)</span> Failure to submit to the Board changes to an approved program may result in the Board withdrawing approval of the program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#B(3)">(3)</span> Providers of continuing education shall furnish a certificate of completion to participants who qualify that includes the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#B(3)(a)">(a)</span> Name of the participant;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#B(3)(b)">(b)</span> Name of the provider;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#B(3)(c)">(c)</span> Description of course work;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#B(3)(d)">(d)</span> Number of hours;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#B(3)(e)">(e)</span> Date of completion; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#B(3)(f)">(f)</span> Program identification number or provider number on the certificate.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#C">C.</span> Miscellaneous.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#C(1)">(1)</span> Credits may not be carried over from one continuing education period to another.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#C(2)">(2)</span> The Board of Pharmacy may grant an exception from the continuing education requirements if the pharmacy technician presents evidence that failure to comply was due to circumstances beyond the pharmacy technician's control.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#C(3)">(3)</span> Falsifying continuing education records is grounds for disciplinary action under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">Health Occupations Article, §12-6</a>B-09(2) and (3), Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.10#C(4)">(4)</span> If the Board provides a form for information, the pharmacy technician shall use the form to supply the requested information to the Board.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.34.11" data-order="|10|34|34|.11|" data-ref-path="10|34|34|.11" class="h__section">.11 Reinstatement.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.11#A">A.</span> A pharmacy technician whose Maryland registration expired less than 2 years before applying for reinstatement shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.11#A(1)">(1)</span> Complete 20 hours of continuing education; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.11#A(2)">(2)</span> Pay to the Board the reinstatement fee established by the Board in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09" title="Chapter 09 Fees">COMAR 10.34.09</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.11#B">B.</span> A pharmacy technician whose Maryland registration expired more than 2 years before applying for reinstatement, shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.11#B(1)">(1)</span> Complete 20 hours of continuing education;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.11#B(2)">(2)</span> Pay to the Board the reinstatement fee established by the Board in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09" title="Chapter 09 Fees">COMAR 10.34.09</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.11#B(3)">(3)</span> Pass a Board-approved exam.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.34.12" data-order="|10|34|34|.12|" data-ref-path="10|34|34|.12" class="h__section">.12 Reciprocity.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.12#A">A.</span> An individual applying to register as a pharmacy technician by reciprocity shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.12#A(1)">(1)</span> Submit to the Board an application on a form approved by the Board;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.12#A(2)">(2)</span> Pay to the Board the fee set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09" title="Chapter 09 Fees">COMAR 10.34.09</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.12#A(3)">(3)</span> Submit a request for a State Criminal History Records check.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.34.12#B">B.</span> An individual applying to register as a pharmacy technician by reciprocity shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.12#B(1)">(1)</span> Submit to the Board evidence of the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.12#B(1)(a)">(a)</span> Registration in another state under requirements similar to the registration requirements of this chapter; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.34.12#B(1)(b)">(b)</span> Evidence of being in good standing in the state or states of current registration; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.34.12#B(2)">(2)</span> Evidence of having worked as a pharmacy technician in another state for at least 6 months.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.35" data-order="|10|34|35|" data-ref-path="10|34|35" class="h__chapter">Chapter 35 Infusion Pharmacy Services in an Alternate Site Care Environment</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: March 1, 2012 (38:23 Md. R. 1421)</p>
                  <h3>Authority</h3>
                  <p>Health-Occupations Article, §12-205, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.35.01" data-order="|10|34|35|.01|" data-ref-path="10|34|35|.01" class="h__section">.01 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(1)">(1)</span> “Alternate site care environment” means the location where the patient is receiving infusion therapy other than an inpatient hospital setting.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(2)">(2)</span> “Compounding worksheet” means a document or electronic record which:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(2)(a)">(a)</span> Specifies instructions for a specific compounded parenteral medication;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(2)(b)">(b)</span> Documents the manufacturer’s:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(2)(b)(i)">(i)</span> Ingredients;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(2)(b)(ii)">(ii)</span> Lot numbers; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(2)(b)(iii)">(iii)</span> Expiration dates; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(2)(c)">(c)</span> Includes a copy of the prescription label.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(3)">(3)</span> Delegated Pharmacy Act.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(3)(a)">(a)</span> "Delegated pharmacy act" means an activity that constitutes the practice of pharmacy delegated by a licensed pharmacist under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Subtitle 6B, Annotated Code of Maryland</a>, and this chapter.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(3)(b)">(b)</span> "Delegated pharmacy act" does not include:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(3)(b)(i)">(i)</span> An act within the parameters of a Drug Therapy Management contract as provided under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Subtitle 6A, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(3)(b)(ii)">(ii)</span> The administration of an influenza vaccination in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-508" title="">Health Occupations Article, §12-508, Annotated Code of Maryland</a>, or <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(3)(b)(iii)">(iii)</span> The delegation of a pharmacy act by a pharmacy technician, pharmacy student, or pharmacy technician trainee;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(3)(b)(iv)">(iv)</span> A pharmacy activity performed by a pharmacy student in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-301" title="">Health Occupations Article, §12-301(b), Annotated Code of Maryland</a>;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(3)(b)(v)">(v)</span> A pharmacy activity performed by an applicant for a license to practice pharmacy, if the applicant does not perform delegated pharmacy acts for more than 10 months; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(3)(b)(vi)">(vi)</span> The performance of other functions prohibited in regulations adopted by the Board.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(4)">(4)</span> “End of therapy” means the conclusion of parenteral infusion therapy as ordered by the prescriber.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(5)">(5)</span> “Infusion nurse” means a registered nurse providing infusion therapy as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.27.20.02#B" title="">COMAR 10.27.20.02B</a> in an alternate site environment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(6)">(6)</span> “Infusion pharmacy” means a pharmacy that provides pharmaceutical care to patients receiving parenteral therapy in an alternate site care environment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(7)">(7)</span> “Licensed authorized prescriber of record” means an individual with the authority to prescribe and monitor a patient’s parenteral infusion therapy for the duration of the patient’s infusion therapy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(8)">(8)</span> “Parenteral infusion access device” means, but is not limited to, intravenous, subcutaneous, intrathecal, epidural, or peripheral nerve catheter device through which parenteral medications may be administered.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(9)">(9)</span> “Patient care plan” means an individualized care plan that reflects the patient’s parenteral infusion therapy pharmaceutical monitoring plan aimed at optimizing the outcome of therapy while minimizing untoward effects from the medication.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(10)">(10)</span> “Patient triage form” means a written or electronic tool used by a clinician or by a registered pharmacy technician when communicating with a patient, a patient’s caregiver, or an infusion nurse to document the patient’s current status, including but not limited to, the patient’s response to therapy, medication changes or adverse reactions, and pain level.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(11)">(11)</span> "Permit holder" means a person, corporation, or other legal entity authorized by the Board to establish and operate a pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(12)">(12)</span> "Pharmacy technician" means an individual who is registered with the Board to perform delegated pharmacy acts.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(13)">(13)</span> “Pharmacist” means an individual who is licensed to practice pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.01#B(14)">(14)</span> “Supervision” means the on-site provision of management, direction, oversight and review of tasks assigned to personnel.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.35.02" data-order="|10|34|35|.02|" data-ref-path="10|34|35|.02" class="h__section">.02 Permit Holder Responsibilities.</h3>
                <p>The permit holder shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.02#A">A.</span> Develop and maintain a policy and procedure manual which establishes the pharmacy’s policies and standard operating procedures related to the provision of infusion therapy services;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.02#B">B.</span> Ensure that an annual review of the policy and procedure manual is performed by a qualified clinician or clinicians to assure that the policies and procedures meet the current standards of practice and regulatory requirements;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.02#C">C.</span> Ensure that there is a process to verify the name, address, and contact information of the licensed authorized prescriber of record before initiation of therapy;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.02#D">D.</span> Establish and maintain a training program which includes, but is not limited to, the requirements set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.35.07" title=".07 Training Requirements.">Regulation .07 of this chapter</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.02#E">E.</span> If the infusion pharmacy is performing sterile compounding, ensure compliance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19" title="Chapter 19 Sterile Pharmaceutical Compounding">COMAR 10.34.19</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.02#F">F.</span> If the infusion pharmacy outsources sterile compounding to another pharmacy, confirm that the secondary pharmacy is appropriately licensed and in compliance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.04" title="Chapter 04 Transfer and Outsourcing of Prescriptions and Prescription Orders">COMAR 10.34.04</a> and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19" title="Chapter 19 Sterile Pharmaceutical Compounding">COMAR 10.34.19</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.02#G">G.</span> Assign a supervising pharmacist to provide oversight of the facility and operations as specified in <a class="internal-link " href="/us/md/exec/comar/10.34.35.03" title=".03 Supervising Pharmacist Responsibilities.">Regulation .03 of this chapter</a>;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.02#H">H.</span> Ensure adequate supervision to unlicensed personnel;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.02#I">I.</span> Limit access to the infusion pharmacy area to authorized personnel;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.02#J">J.</span> Secure the facility and patient records in compliance with federal and State laws and regulations; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.02#K">K.</span> Develop and implement a written performance improvement program as set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.35.08" title=".08 Performance Improvement Program.">Regulation .08 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.35.03" data-order="|10|34|35|.03|" data-ref-path="10|34|35|.03" class="h__section">.03 Supervising Pharmacist Responsibilities.</h3>
                <p>The supervising pharmacist or the supervising pharmacist's designee shall ensure compliance with:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.03#A">A.</span> State and federal regulations;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.03#B">B.</span> Infusion pharmacy practice standards:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.03#B(1)">(1)</span> As set forth in this chapter; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.03#B(2)">(2)</span> As established by nationally recognized professional organizations and accrediting bodies as appropriate;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.03#C">C.</span> The infusion pharmacy’s policies and procedures manual;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.03#D">D.</span> An established training program; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.03#E">E.</span> An established performance improvement program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.35.04" data-order="|10|34|35|.04|" data-ref-path="10|34|35|.04" class="h__section">.04 Pharmacist Responsibilities.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#A">A.</span> A pharmacist in an infusion pharmacy shall adhere to the policies and procedures set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.35.06" title=".06 Minimum Requirements for Policies and Procedures.">Regulation .06 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B">B.</span> A pharmacist shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(1)">(1)</span> Provide infusion therapy services in accordance with:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(1)(a)">(a)</span> Orders issued by a licensed authorized prescriber of record; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(1)(b)">(b)</span> Where applicable, protocols issued by a licensed authorized prescriber of record.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)">(2)</span> Perform and document initial and ongoing assessments of the appropriateness of infusion therapy using the following information:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(a)">(a)</span> Patient demographics including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(a)(i)">(i)</span> Name;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(a)(ii)">(ii)</span> Address;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(a)(iii)">(iii)</span> Telephone number;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(a)(iv)">(iv)</span> Gender; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(a)(v)">(v)</span> Date of birth;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(b)">(b)</span> Emergency contact information;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(c)">(c)</span> Diagnoses, including:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(c)(i)">(i)</span> Diagnosis being treated; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(c)(ii)">(ii)</span> Concurrent conditions, including pregnancy and lactation status if applicable;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(d)">(d)</span> Medical history;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(e)">(e)</span> Allergies;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(f)">(f)</span> If applicable, height;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(g)">(g)</span> Weight;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(h)">(h)</span> Parenteral medication orders, including length of therapy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(i)">(i)</span> Parenteral infusion access device:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(i)(i)">(i)</span> Location;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(i)(ii)">(ii)</span> Type; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(i)(iii)">(iii)</span> If available, date of placement;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(j)">(j)</span> Ongoing medication profile review and reconciliation at end of therapy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(k)">(k)</span> First dose status;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(l)">(l)</span> Caregiver information including, but not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(l)(i)">(i)</span> Name;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(l)(ii)">(ii)</span> Address;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(l)(iii)">(iii)</span> Phone number; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(l)(iv)">(iv)</span> Relationship to patient;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(m)">(m)</span> If applicable, contact information for other agencies or individuals involved in the patient’s home care;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(n)">(n)</span> Documented applicable medical and social factors and functional limitations which may affect infusion therapy including but not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(n)(i)">(i)</span> Language;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(n)(ii)">(ii)</span> Sight;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(n)(iii)">(iii)</span> Hearing;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(n)(iv)">(iv)</span> History of IV drug abuse;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(n)(v)">(v)</span> History of drug or alcohol abuse; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(n)(vi)">(vi)</span> Other physical or mental limitations; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(2)(o)">(o)</span> If applicable to therapy, baseline labs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(3)">(3)</span> Create a patient care plan specific to the patient’s:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(3)(a)">(a)</span> Diagnosis;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(3)(b)">(b)</span> Prescribed therapy; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(3)(c)">(c)</span> Concurrent conditions;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(4)">(4)</span> When compounding sterile preparations, comply with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19" title="Chapter 19 Sterile Pharmaceutical Compounding">COMAR 10.34.19</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(5)">(5)</span> If sterile compounding is outsourced, comply with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.04" title="Chapter 04 Transfer and Outsourcing of Prescriptions and Prescription Orders">COMAR 10.34.04</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(6)">(6)</span> As applicable, retrieve and assess lab values and other monitoring parameters;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(7)">(7)</span> Document in the patient chart:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(7)(a)">(a)</span> New prescription orders;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(7)(b)">(b)</span> Changes in prescription orders;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(7)(c)">(c)</span> Information obtained from the patient or caregiver; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(7)(d)">(d)</span> Other necessary information obtained from the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(7)(d)(i)">(i)</span> Patient;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(7)(d)(ii)">(ii)</span> Caregiver;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(7)(d)(iii)">(iii)</span> Infusion nurse;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(7)(d)(iv)">(iv)</span> Licensed authorized prescriber of record; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(7)(d)(v)">(v)</span> Other sources relevant to patient care;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(8)">(8)</span> Verify prescription label accuracy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(9)">(9)</span> Communicate as appropriate, throughout the patient’s therapy with the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(9)(a)">(a)</span> Licensed authorized prescriber of record or agent of the licensed authorized prescriber of record;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(9)(b)">(b)</span> Patient’s infusion nurse;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(9)(c)">(c)</span> Patient; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(9)(d)">(d)</span> Caregiver; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.04#B(10)">(10)</span> Review therapy-specific considerations such as pain and nutrition status.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.35.05" data-order="|10|34|35|.05|" data-ref-path="10|34|35|.05" class="h__section">.05 Support Personnel.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#A">A.</span> Pharmacy Technicians.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#A(1)">(1)</span> A pharmacist working in an infusion pharmacy may delegate pharmacy acts to a pharmacy technician in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.34" title="Chapter 34 Pharmacy Technicians">COMAR 10.34.34</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#A(2)">(2)</span> A pharmacy technician working in an infusion pharmacy may not perform delegated pharmacy acts as set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.34.03" title=".03 Delegated Pharmacy Acts.">COMAR 10.34.34.03</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#A(3)">(3)</span> A pharmacy technician working in an infusion pharmacy shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#A(3)(a)">(a)</span> Communicate immediately to the pharmacist reported changes in:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#A(3)(a)(i)">(i)</span> Patient condition;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#A(3)(a)(ii)">(ii)</span> Patient medication list; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#A(3)(a)(iii)">(iii)</span> Allergies; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#A(3)(b)">(b)</span> Obtain pharmacist approval before processing refills.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#A(4)">(4)</span> A pharmacy technician working in an infusion pharmacy may not:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#A(4)(a)">(a)</span> Except as provided in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.34" title="Chapter 34 Pharmacy Technicians">COMAR 10.34.34</a>, accept or transcribe a new or change verbal order from an licensed authorized prescriber of record or the licensed authorized prescriber of record’s agent;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#A(4)(b)">(b)</span> Perform the clinical assessment of a patient;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#A(4)(c)">(c)</span> Communicate clinical matters except as required in <a class="internal-link " href="/us/md/exec/comar/10.34.35.05#A(3)(a)" title="">§A(3)(a) of this regulation</a>s;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#A(4)(d)">(d)</span> Provide therapy-related direction to a patient or caregiver; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#A(4)(e)">(e)</span> Create a patient care plan specific to a patient’s therapy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#B">B.</span> Unlicensed Personnel.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#B(1)">(1)</span> Unlicensed personnel working in an infusion pharmacy under the supervision of a pharmacist may perform operational support which the unlicensed personnel have been trained to adequately perform in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.21" title="Chapter 21 Standard of Practice for Unlicensed Personnel">COMAR 10.34.21</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#B(2)">(2)</span> Unlicensed personnel shall be appropriately trained to perform the following tasks, as applicable, including but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#B(2)(a)">(a)</span> Schedule delivery dates based on;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#B(2)(a)(i)">(i)</span> Patient supply needs;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#B(2)(a)(ii)">(ii)</span> Patient or caregiver availability; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#B(2)(a)(iii)">(iii)</span> If applicable, geographic delivery zones;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#B(2)(b)">(b)</span> Create delivery tickets;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#B(2)(c)">(c)</span> Communicate with the infusion nurse or pharmacist concerning supply needs and problems; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#B(2)(d)">(d)</span> Clean, test, and maintain patient-use equipment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#B(3)">(3)</span> Unlicensed personnel working in an infusion pharmacy shall refer clinical questions or concerns reported by patients or caregivers immediately to the pharmacist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.05#B(4)">(4)</span> Unlicensed personnel may not perform delegated pharmacy acts.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.35.06" data-order="|10|34|35|.06|" data-ref-path="10|34|35|.06" class="h__section">.06 Minimum Requirements for Policies and Procedures.</h3>
                <p>The policies and procedures shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#A">A.</span> Be congruent with State regulations and standards of care from accrediting bodies and professional organizations; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B">B.</span> Address:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(1)">(1)</span> Personnel:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(1)(a)">(a)</span> Training and Orientation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(1)(b)">(b)</span> Duties; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(1)(c)">(c)</span> Qualifications;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(2)">(2)</span> Security of the facility;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(3)">(3)</span> Standards of patient care;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(4)">(4)</span> Infection control;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(5)">(5)</span> Initial and ongoing home safety assessments;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(6)">(6)</span> The provision of patient or caregiver education including, but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(6)(a)">(a)</span> Drug and therapy administration-specific information and precautions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(6)(b)">(b)</span> Reporting adverse drug reactions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(6)(c)">(c)</span> Reporting side effects;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(6)(d)">(d)</span> Infusion pharmacy contact information;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(6)(e)">(e)</span> Emergency measures related to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(6)(e)(i)">(i)</span> Changes in patient condition requiring medical intervention; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(6)(e)(ii)">(ii)</span> Events which may delay or prevent delivery of pharmaceuticals or nursing care; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(6)(f)">(f)</span> Equipment use and safety.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(7)">(7)</span> Patient care operations, including but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(7)(a)">(a)</span> If applicable, pharmacist checking procedures related to order entry and compounding accuracy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(7)(b)">(b)</span> Therapy-specific monitoring parameters for:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(7)(b)(i)">(i)</span> Laboratory testing;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(7)(b)(ii)">(ii)</span> Appropriate frequency of testing; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(7)(b)(iii)">(iii)</span> Patient follow-up; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(7)(c)">(c)</span> Pump, or other patient-use equipment, between-patient cleaning, testing, and preventive maintenance, which include specific:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(7)(c)(i)">(i)</span> Procedures and documentation of cleaning, testing and preventive maintenance for patient equipment according to manufacturer’s guidelines; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(7)(c)(ii)">(ii)</span> Frequencies for all equipment maintenance activities;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(8)">(8)</span> Delivery arrangements;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(9)">(9)</span> Patient confidentiality and the Health Insurance Portability and Accountability Act, 45 CFR Parts 160 and 164; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(10)">(10)</span> Availability of a pharmacist on call after-hours to respond to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(10)(a)">(a)</span> Pharmacy related patient or caregiver inquiries; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.06#B(10)(b)">(b)</span> Medication or supply needs.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.35.07" data-order="|10|34|35|.07|" data-ref-path="10|34|35|.07" class="h__section">.07 Training Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#A">A.</span> Personnel shall be trained in the following areas where appropriate:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#A(1)">(1)</span> Patient rights and responsibilities;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#A(2)">(2)</span> Patient safety;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#A(3)">(3)</span> Performance improvement program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#A(4)">(4)</span> Universal precautions which are incorporated by reference in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.06.01.01" title=".01 Scope.">COMAR 10.06.01.01</a>-1;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#A(5)">(5)</span> Warehouse and equipment orientation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#A(6)">(6)</span> Waste management;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#A(7)">(7)</span> Handling hazardous substances;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#A(8)">(8)</span> Policies and procedures;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#A(9)">(9)</span> Recognizing signs of patient abuse and neglect;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#A(10)">(10)</span> Recognizing signs of IV drug abuse;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#A(11)">(11)</span> Customer service and cultural sensitivity training;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#A(12)">(12)</span> Emergency policies and procedures which support the continuum of patient care during natural or manmade disasters; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#A(13)">(13)</span> Patient confidentiality and the Health Insurance Portability and Accountability Act, 45 CFR Parts 160 and 164.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#B">B.</span> A pharmacist shall be trained and evaluated in the following areas, including but not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#B(1)">(1)</span> Clinical management of therapies and disease states managed by the infusion pharmacy services, including but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#B(1)(a)">(a)</span> Specific dosing and monitoring protocols;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#B(1)(b)">(b)</span> Care planning;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#B(1)(c)">(c)</span> Lab value ranges; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#B(1)(d)">(d)</span> Side effects;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#B(2)">(2)</span> Pump use and programming;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#B(3)">(3)</span> Parenteral infusion access devices and therapy-specific appropriateness by device;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#B(4)">(4)</span> Supplies by therapy and device;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#B(5)">(5)</span> Accurate set-up of compounding worksheet instructions;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#B(6)">(6)</span> Pharmacist functions on computer systems;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#B(7)">(7)</span> Documentation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#B(8)">(8)</span> If performing sterile compounding, <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19" title="Chapter 19 Sterile Pharmaceutical Compounding">COMAR 10.34.19</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#B(9)">(9)</span> Medication storage;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#B(10)">(10)</span> IV compatibility and stability;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#B(11)">(11)</span> Calculations to ensure:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#B(11)(a)">(a)</span> IV dose appropriateness; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#B(11)(b)">(b)</span> Compounding accuracy, if applicable; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#B(12)">(12)</span> On-call requirements and procedures for handling after-hours care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#C">C.</span> A pharmacy technician obtaining clinical information shall be trained and evaluated in the following areas, including but not limited to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#C(1)">(1)</span> Pharmacy technician functions on computer systems;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#C(2)">(2)</span> Parenteral infusion access devices</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#C(3)">(3)</span> Supplies specific to therapy and device</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#C(4)">(4)</span> Storage and shipping protocols;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#C(5)">(5)</span> Pharmaceutical calculations for IV compounding, if applicable;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#C(6)">(6)</span> Patient triage forms — therapy-specific training and communication with the pharmacist as specified in <a class="internal-link " href="/us/md/exec/comar/10.34.35.05#A(3)(a)" title="">Regulation .05A(3)(a) of this chapter</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#C(7)">(7)</span> Documentation of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#C(7)(a)">(a)</span> Communication with patients or caregiver; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#C(7)(b)">(b)</span> Delivery scheduling.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#D">D.</span> Unlicensed personnel shall be trained and evaluated in the following areas as applicable:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#D(1)">(1)</span> Insurance pre-authorization;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#D(2)">(2)</span> Billing;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#D(3)">(3)</span> Delivery procedures;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#D(4)">(4)</span> Supplies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#D(5)">(5)</span> Picking and packing of supplies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#D(6)">(6)</span> Drug storage;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#D(7)">(7)</span> Shipping protocols; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.07#D(8)">(8)</span> Cleaning, testing, and maintenance of patient-use equipment according to manufacturers’ specifications.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.35.08" data-order="|10|34|35|.08|" data-ref-path="10|34|35|.08" class="h__section">.08 Performance Improvement Program.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A">A.</span> The performance improvement program shall consist of:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(1)">(1)</span> A committee which:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(1)(a)">(a)</span> Consists of representation of personnel and varied areas of job responsibility; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(1)(b)">(b)</span> Is responsible for analysis of data, reporting trends and corrective actions; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(1)(c)">(c)</span> Meets at least quarterly;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(2)">(2)</span> Quality assurance and performance improvement monitoring parameters;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(3)">(3)</span> Documentation requirements for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(3)(a)">(a)</span> Established monitoring parameters;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(3)(b)">(b)</span> Trend analyses; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(3)(c)">(c)</span> Retention of committee meeting minutes for 3 years;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(4)">(4)</span> Documentation of tracking, trending, analyzing, resolving, and developing corrective action plans as appropriate for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(4)(a)">(a)</span> Medication errors;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(4)(b)">(b)</span> Adverse drug reactions; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(4)(c)">(c)</span> Equipment malfunctions;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(5)">(5)</span> Reporting of adverse events to regulatory and standard-setting bodies as applicable to State and federal regulations;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(6)">(6)</span> Documentation and resolution of patient care issues involving:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(6)(a)">(a)</span> Incorrect equipment, supplies, or medications;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(6)(b)">(b)</span> Delays in delivery of care;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(6)(c)">(c)</span> Missed doses;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(6)(d)">(d)</span> Patient infections;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(6)(e)">(e)</span> Failures in after-hours care; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(6)(f)">(f)</span> Patient, caregiver, or health care provider complaints;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(7)">(7)</span> Documentation of patient outcomes;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(8)">(8)</span> Recall management;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(9)">(9)</span> Patient compliance monitoring; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#A(10)">(10)</span> Staff training and competency compliance.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.08#B">B.</span> The permit holder shall review the performance improvement program at a minimum of every 3 years.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.35.09" data-order="|10|34|35|.09|" data-ref-path="10|34|35|.09" class="h__section">.09 Discontinuation of Infusion Therapy.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.09#A">A.</span> If not addressed in the initial order, the infusion pharmacy shall verify an end of therapy order.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.09#B">B.</span> The infusion pharmacist shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.09#B(1)">(1)</span> Communicate with the licensed authorized prescriber of record or agent of the prescriber of record to verify:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.09#B(1)(a)">(a)</span> An end of therapy order, if not addressed in the initial order; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.09#B(1)(b)">(b)</span> Parenteral infusion access device disposition, including orders for removal or line maintenance; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.09#B(2)">(2)</span> Forward the most current medication list to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.09#B(2)(a)">(a)</span> The licensed authorized prescriber of record; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.35.09#B(2)(b)">(b)</span> To the patient or caregiver.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.09#C">C.</span> If appropriate, the infusion pharmacy shall arrange with the patient or caregiver for pick-up of medical equipment.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.35.10" data-order="|10|34|35|.10|" data-ref-path="10|34|35|.10" class="h__section">.10 Reference Materials.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.10#A">A.</span> An infusion pharmacy shall maintain an adequate reference library to enable it to prepare and dispense infusion therapy properly.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.35.10#B">B.</span> In addition to the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.07.03" title=".03 Reference Libraries.">COMAR 10.34.07.03</a>, an infusion pharmacy’s reference library shall include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.10#B(1)">(1)</span> Material Safety Data Sheets (MSDSs);</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.10#B(2)">(2)</span> IV compatibility references;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.10#B(3)">(3)</span> Stability and extended stability references;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.10#B(4)">(4)</span> Websites and electronic references authored by established medical publishers recognized within the field of infusion pharmacy practice as a supplement to its printed library;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.10#B(5)">(5)</span> Pediatric dosing reference, if applicable; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.35.10#B(6)">(6)</span> Appropriate clinical references for the population served.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.36" data-order="|10|34|36|" data-ref-path="10|34|36" class="h__chapter">Chapter 36 Pharmaceutical Services to Residents in Assisted Living Programs and Group Homes</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: June 15, 2013 (40:9 Md. R. 789)</p>
                  <h3>Authority</h3>
                  <p>Health-Occupations Article, §§12-205, 12-301, 12-401, 12-403, 12-501, and 12-503 — 12-506, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.36.01" data-order="|10|34|36|.01|" data-ref-path="10|34|36|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter applies to pharmacies and licensed pharmacists serving assisted living programs or group homes as defined in <a class="internal-link " href="/us/md/exec/comar/10.34.36.02" title=".02 Definitions.">Regulation .02 of this chapter</a>, except for pharmacies providing only emergency services for assisted living programs or group homes.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.36.02" data-order="|10|34|36|.02|" data-ref-path="10|34|36|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(1)">(1)</span> Assisted Living Program.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(1)(a)">(a)</span> "Assisted living program" means a residential or facility-based program that provides housing and supportive services, supervision, personalized assistance, health-related services, or a combination of these services 24 hours a day, 7 days a week, to meet the needs of individuals who are unable to perform, or who need assistance in performing, the activities of daily living or instrumental activities of daily living, in a way that promotes optimum dignity and independence for the individuals.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(1)(b)">(b)</span> "Assisted living program" does not include:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(1)(b)(i)">(i)</span> A nursing home or comprehensive care facility, as defined under Health-General Article, §19-301, Annotated Code of Maryland;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(1)(b)(ii)">(ii)</span> A State facility, as defined under Health-General Article, §10-101, Annotated Code of Maryland;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(1)(b)(iii)">(iii)</span> A program licensed or approved by the Department under Health-General Article, Title 7 or Title 10, Annotated Code of Maryland;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(1)(b)(iv)">(iv)</span> A hospice care program licensed by the Department under Health-General Article, Title 19, Annotated Code of Maryland;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(1)(b)(v)">(v)</span> Services provided by family members;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(1)(b)(vi)">(vi)</span> Services provided by a licensed residential service agency or licensed home health agency in an individual's own home; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(1)(b)(vii)">(vii)</span> A Certified Adult Residential Environment Program that is certified by the Department of Human Services under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=88A&amp;section=140" title="">Article 88A, §140, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(2)">(2)</span> “Chart order” means a lawful order entered on the chart or a medical record of a resident of an assisted living program or group home by an authorized prescriber or the authorized prescriber’s designated agent for a drug or device.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(3)">(3)</span> "Group home" means a residence owned, leased, or operated by a licensed group home provider that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(3)(a)">(a)</span> Provides residential services for individuals who, because of a developmental disability, require specialized living arrangements;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(3)(b)">(b)</span> Admits at least two, but not more than eight individuals; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(3)(c)">(c)</span> Provides 10 or more hours of supervision per week.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(4)">(4)</span> "Interim box" means a tamper evident container or an electronic system holding minimal quantities of medications:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(4)(a)">(a)</span> Agreed upon by the appropriate committee of the assisted living program; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(4)(b)">(b)</span> Intended to expedite immediate initiation of emergency or nonemergency dosing until the pharmacy is able to provide a regular supply.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(5)">(5)</span> “Licensed pharmacist” means a pharmacist who is licensed by the Board to practice pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(6)">(6)</span> “Packaging” means the process by which a medication is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(6)(a)">(a)</span> Removed from a:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(6)(a)(i)">(i)</span> Non-patient specific manufacturer’s original container; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(6)(a)(ii)">(ii)</span> Patient specific container directly received from another pharmacy licensed in Maryland or operated by the government of the United States provided that the manufacturer’s name is present on the container;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(6)(b)">(b)</span> Placed into a new container by a licensed pharmacist or registered pharmacy technician under the direct supervision of a pharmacist; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(6)(c)">(c)</span> Packaged as further defined in <a class="internal-link " href="/us/md/exec/comar/10.34.36.07" title=".07 Medication Packaging.">Regulation .07 of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(7)">(7)</span> "Pharmaceutical services" means the care within practice standards, laws, regulations, and guidelines which is afforded by a licensed pharmacist to the residents of an assisted living program or group home.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(8)">(8)</span> "Pharmacy area" means that portion of the licensed pharmacy where over-the-counter medications and other products requiring a prescription by federal or State law are stored and where the prescriptions are compounded or prepared.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(9)">(9)</span> “Registered pharmacy technician” means an individual who is registered with the Board to perform delegated pharmacy acts.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(9)(a)">(a)</span> Licensed to engage in the practice of pharmacy in Maryland;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(9)(b)">(b)</span> Knowledgeable in, and thoroughly familiar with, the specialized functions of an assisted living program's or group home's pharmaceutical services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(9)(c)">(c)</span> Responsible for and in full and actual charge of the pharmacy and its personnel.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(10)">(10)</span> “Responsible pharmacist” means a pharmacist who is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(10)(a)">(a)</span> Licensed to engage in the practice of pharmacy in Maryland;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(10)(b)">(b)</span> Knowledgeable in, and thoroughly familiar with, the specialized functions of an assisted living program’s or group home’s pharmaceutical services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(10)(c)">(c)</span> Responsible for and in full and actual charge of the pharmacy and its personnel<em>.</em></p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(11)">(11)</span> "Verbal order" means a directive that is orally communicated to a licensed pharmacist to accept a prescription order by a person who is authorized to communicate a prescription.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.02#B(12)">(12)</span> "Written order" means a directive that is directly written by an authorized prescriber or a transcription of an order from an authorized prescriber by a person authorized to transcribe an order.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.36.03" data-order="|10|34|36|.03|" data-ref-path="10|34|36|.03" class="h__section">.03 Policies and Procedures.</h3>
                <p>The permit holder shall establish and operate under a policies and procedures manual which:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.03#A">A.</span> Complies with this chapter;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.03#B">B.</span> Defines the scope and method of pharmacy services provided to the residents of the assisted living program or group home;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.03#C">C.</span> Determines under what circumstances personnel may have access to the pharmacy area;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.03#D">D.</span> Provides for the safe and efficient dispensing and delivery of pharmaceutical products as outlined in this subtitle;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.03#E">E.</span> Includes:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.03#E(1)">(1)</span> Labeling requirements and distribution methods for medication provided in a single container, slot, blister package, or other method of delivering an entire single dosing unit; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.03#E(2)">(2)</span> The conditions in which an interim box may be replenished or prepared, delivered, and stored by the assisted living program;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.03#F">F.</span> Is provided to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.03#F(1)">(1)</span> The personnel of the pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.03#F(2)">(2)</span> The assisted living program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.03#F(3)">(3)</span> Group home; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.03#F(4)">(4)</span> Upon request, an agent of the Board; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.03#G">G.</span> Is in a form that is:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.03#G(1)">(1)</span> Written or electronic; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.03#G(2)">(2)</span> Readily retrievable.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.36.04" data-order="|10|34|36|.04|" data-ref-path="10|34|36|.04" class="h__section">.04 Personnel.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.04#A">A.</span> The permit holder shall appoint a responsible pharmacist who shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.04#A(1)">(1)</span> Be responsible for the operations of the pharmacy and for compliance with the requirements of <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>, and the regulations promulgated under that title;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.04#A(2)">(2)</span> Be responsible for reviewing the policies and procedures manual of the pharmacy annually and revising it as necessary;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.04#A(3)">(3)</span> Be responsible for the safe and efficient dispensing, delivery, and control of, and be accountable for, medications and devices dispensed or distributed by the pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.04#A(4)">(4)</span> Work in cooperation with the other professional staff of the assisted living program or group home in meeting the responsibilities set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.36.06" title=".06 Medication and Device Distribution and Pharmaceutical Services.">Regulation .06 of this chapter</a> and in ordering, storing, and accounting for pharmaceutical materials; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.04#A(5)">(5)</span> Develop a process for the pharmacy to be notified of medications which have been discontinued.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.04#B">B.</span> Staff.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.04#B(1)">(1)</span> The permit holder:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.04#B(1)(a)">(a)</span> May employ registered pharmacy technicians as required to provide pharmaceutical services to the residents of the assisted living program or group home; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.04#B(1)(b)">(b)</span> Shall provide policies and procedures that specify the duties that may be performed by registered pharmacy technicians under the supervision of a licensed pharmacist and the duties that may be performed only by a licensed pharmacist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.04#B(2)">(2)</span> The permit holder may employ unlicensed personnel to provide operational support as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.21.02#B" title="">COMAR 10.34.21.02B</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.36.05" data-order="|10|34|36|.05|" data-ref-path="10|34|36|.05" class="h__section">.05 Physical Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.05#A">A.</span> Storage. The permit holder or designee shall ensure that medications and supplies within the pharmacy are properly stored according to the manufacturer’s specifications and State and federal laws and regulations with respect to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.05#A(1)">(1)</span> Sanitation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.05#A(2)">(2)</span> Temperature;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.05#A(3)">(3)</span> Light;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.05#A(4)">(4)</span> Ventilation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.05#A(5)">(5)</span> Segregation; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.05#A(6)">(6)</span> Security.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.05#B">B.</span> Equipment and Materials.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.05#B(1)">(1)</span> The permit holder or designee shall ensure that the pharmacy contains as appropriate to the level of services provided:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.05#B(1)(a)">(a)</span> Equipment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.05#B(1)(b)">(b)</span> Supplies; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.05#B(1)(c)">(c)</span> Physical facilities for proper compounding, preparation, and dispensing of medications as outlined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19" title="Chapter 19 Sterile Pharmaceutical Compounding">COMAR 10.34.19</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.05#B(2)">(2)</span> The permit holder or designee shall ensure that the pharmacy contains appropriate reference materials to enable personnel to prepare and dispense medications properly as outlined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.07" title="Chapter 07 Pharmacy Equipment">COMAR 10.34.07</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.05#C">C.</span> Security.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.05#C(1)">(1)</span> The permit holder or designee shall ensure that no individual enters the pharmacy area unless a licensed pharmacist is on duty.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.05#C(2)">(2)</span> The permit holder or designee shall ensure compliance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.05" title="Chapter 05 Pharmacy Security">COMAR 10.34.05</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.36.06" data-order="|10|34|36|.06|" data-ref-path="10|34|36|.06" class="h__section">.06 Medication and Device Distribution and Pharmaceutical Services.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.06#A">A.</span> The responsible pharmacist shall be accountable for, at a minimum:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.06#A(1)">(1)</span> The preparation of medications compounded in the pharmacy as applicable;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.06#A(2)">(2)</span> The proper preparation, storage, and distribution of compounded sterile preparations according to <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19" title="Chapter 19 Sterile Pharmaceutical Compounding">COMAR 10.34.19</a> to the extent that the functions are performed at the pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.06#A(3)">(3)</span> The packaging and labeling of medications;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.06#A(4)">(4)</span> Records of transactions of the pharmacy as may be required by applicable law and as may be necessary to maintain accurate control over and accountability for pharmaceuticals;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.06#B">B.</span> In addition to <a class="internal-link " href="/us/md/exec/comar/10.34.36.06#A" title="">§A of this regulation</a>, the responsible pharmacist may:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.06#B(1)">(1)</span> Participate in those aspects of the assisted living program’s or group home’s quality assurance improvement program, if such program exists, which relate to pharmaceutical care and effectiveness; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.06#B(2)">(2)</span> Implement the policies and decisions of the appropriate committee or committees of the assisted living program or group home related to these regulations and to other regulations of the assisted living program or group home.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.36.07" data-order="|10|34|36|.07|" data-ref-path="10|34|36|.07" class="h__section">.07 Medication Packaging.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#A">A.</span> A licensed pharmacist shall verify the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#A(1)">(1)</span> Selection of medication to be packaged; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#A(2)">(2)</span> Completed packaging of medication performed by registered pharmacy technicians for the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#A(2)(a)">(a)</span> Accuracy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#A(2)(b)">(b)</span> Completeness;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#A(2)(c)">(c)</span> Appropriateness; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#A(2)(d)">(d)</span> Compliance with the U.S. Food and Drug Administration and current United States Pharmacopeia approved packaging.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#B">B.</span> A licensed pharmacist shall ensure that labeling of the medication container includes the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#B(1)">(1)</span> Brand or generic name of the medication;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#B(2)">(2)</span> Strength of the medication;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#B(3)">(3)</span> Name of the pharmacy; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#B(4)">(4)</span> Expiration date of the medication.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#C">C.</span> Unless a pharmacist has reason to reduce the time period, the expiration date of the medication is the lesser of:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#C(1)">(1)</span> 12 months from the date of packaging;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#C(2)">(2)</span> The manufacturer's or distributor's listed expiration date; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#C(3)">(3)</span> The maximum time period allowed for the specific packaging used for the medication.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#D">D.</span> Packaged from the Manufacturer’s Original Container. The pharmacy may use a lot number and expiration date assigned by the pharmacy instead of the distributor or manufacturer information in a master log if kept with respect to drugs that are packaged within the pharmacy facility from the original manufacturer’s container which includes the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#D(1)">(1)</span> Name of the drug;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#D(2)">(2)</span> Strength;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#D(3)">(3)</span> Manufacturer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#D(4)">(4)</span> Lot number assigned by the pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#D(5)">(5)</span> Lot number assigned by the distributor or manufacturer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#D(6)">(6)</span> Quantity packaged;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#D(7)">(7)</span> Expiration date as defined in <a class="internal-link " href="/us/md/exec/comar/10.34.36.07#C" title="">§C of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#D(8)">(8)</span> Manufacturer's expiration date;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#D(9)">(9)</span> Date of packaging;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#D(10)">(10)</span> Name of pharmacy technician packaging; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#D(11)">(11)</span> Name and initials of verifying licensed pharmacist.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#E">E.</span> Packaged from Another Pharmacy. A licensed pharmacist may package medication received directly from another pharmacy licensed in Maryland or operated by the government of the United States provided that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#E(1)">(1)</span> A licensed pharmacist determines that the medication has been handled in a manner which preserves the strength, quality, purity, and identity of the drug or device during an interim period between the time it was dispensed by the original pharmacy and received by the packaging pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#E(2)">(2)</span> A licensed pharmacist packages and dispenses all at one time the entire quantity of the prescription medications received from another pharmacy for packaging;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#E(3)">(3)</span> The manufacturer’s name is present on the container received from the other pharmacy; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#E(4)">(4)</span> A licensed pharmacist maintains a master log that includes the following information:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#E(4)(a)">(a)</span> Name of the drug;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#E(4)(b)">(b)</span> Lot number assigned by the packaging pharmacy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#E(4)(c)">(c)</span> Strength;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#E(4)(d)">(d)</span> Manufacturer;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#E(4)(e)">(e)</span> Name, address, and telephone number of the original dispensing pharmacy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#E(4)(f)">(f)</span> Prescription number from the original dispensing pharmacy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#E(4)(g)">(g)</span> Quantity packaged;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#E(4)(h)">(h)</span> Expiration date as assigned by the original dispensing pharmacy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#E(4)(i)">(i)</span> Date of packaging;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#E(4)(j)">(j)</span> Name of pharmacy technician packaging;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#E(4)(k)">(k)</span> Name and initials of verifying licensed pharmacist; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.07#E(4)(l)">(l)</span> Name of the resident.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.36.08" data-order="|10|34|36|.08|" data-ref-path="10|34|36|.08" class="h__section">.08 Labeling of Resident Medications.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#A">A.</span> A licensed pharmacist shall ensure that medications dispensed by the pharmacy and intended for use within an assisted living program or group home are dispensed in appropriate containers and are labeled with the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#A(1)">(1)</span> Name and address of the pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#A(2)">(2)</span> Date of dispensing;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#A(3)">(3)</span> Prescription number assigned by the pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#A(4)">(4)</span> Name of the resident, patient, or consumer, as appropriate;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#A(5)">(5)</span> Name, quantity, and strength of the drug;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#A(6)">(6)</span> Name of the prescriber;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#A(7)">(7)</span> Expiration date of the drug;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#A(8)">(8)</span> Required precautionary information regarding controlled substances;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#A(9)">(9)</span> Directions for use as set forth in the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#A(9)(a)">(a)</span> Medication administration record; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#A(9)(b)">(b)</span> Prescriber’s orders; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#A(10)">(10)</span> Further cautionary information as may be required or necessary for proper use of the medication.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#B">B.</span> A licensed pharmacist shall ensure that medication provided per dosing period in a single container, slot, blister package, any other method of delivering an entire single dosing unit, or as part of a multi-dose dispensing package, are labeled with at least the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#B(1)">(1)</span> Drug name;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#B(2)">(2)</span> Drug strength;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#B(3)">(3)</span> Name of manufacturer;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#B(4)">(4)</span> Name of the resident, patient or consumer, as appropriate;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#B(5)">(5)</span> Lot number, unless prepared extemporaneously;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#B(6)">(6)</span> Directions for use as set forth in the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#B(6)(a)">(a)</span> Medication administration record; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#B(6)(b)">(b)</span> Prescriber’s orders; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#B(7)">(7)</span> Expiration date.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.08#C">C.</span> Compounded Sterile Preparations. When compounding sterile preparations a licensed pharmacist or a registered pharmacy technician under the licensed pharmacist’s supervision, shall comply with the compounding and labeling requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19" title="Chapter 19 Sterile Pharmaceutical Compounding">COMAR 10.34.19</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.36.09" data-order="|10|34|36|.09|" data-ref-path="10|34|36|.09" class="h__section">.09 Drug Control and Accountability.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#A">A.</span> Medications may be accepted for return if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#A(1)">(1)</span> The returned medication is properly labeled and properly sealed in the manufacturer’s package or an individually labeled unit dose of a drug or a device;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#A(2)">(2)</span> A licensed pharmacist determines that procedures are in place that the returned medication has been handled in a manner which preserves the strength, quality, purity, and identity of the drug or device during an interim period between the sale of the drug or device and its return to the pharmacy; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#A(3)">(3)</span> The permit holder otherwise complies with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.10.07" title=".07 Disposition and Return of a Prescription Drug or Device.">COMAR 10.34.10.07</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#B">B.</span> Discontinued Medications — Controlled Dangerous Substances.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#B(1)">(1)</span> Except as provided in §§B(2) and C(2) of this regulations, drugs classified as Schedule II, Schedule III, Schedule IV, and Schedule V may not be returned to the inventory of the pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#B(2)">(2)</span> Schedule III, Schedule IV, and Schedule V medications may be returned to inventory of a pharmacy when the pharmacy uses a distribution system that classifies medications as pharmacy inventory until the utilization of the medication by the resident.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#C">C.</span> A compounded sterile preparation may not be returned to the inventory of a pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#D">D.</span> Drugs requiring refrigeration may not be returned to the inventory of a pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#E">E.</span> Interim Box. An interim box may be provided to an assisted living program by a permit holder if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#E(1)">(1)</span> A licensed nurse is present on site 24 hours a day, 7 days a week;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#E(2)">(2)</span> The assisted living program is compliant with the pharmacy’s policies and procedures regarding usage of the interim box under <a class="internal-link " href="/us/md/exec/comar/10.34.36.03" title=".03 Policies and Procedures.">Regulation .03 of this chapter</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#E(3)">(3)</span> The contents of the interim box are part of the pharmacy inventory until administered.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#F">F.</span> Prescriber Orders.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#F(1)">(1)</span> A licensed pharmacist shall dispense medications from the pharmacy only upon receipt of a valid written prescription, chart order, or verbal order from an authorized prescriber.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#F(2)">(2)</span> A chart order shall be considered a prescription drug order provided that the prescription drug order contains:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#F(2)(a)">(a)</span> The full name of the resident, patient, or consumer, as appropriate;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#F(2)(b)">(b)</span> The date of issuance;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#F(2)(c)">(c)</span> The name, strength, and dosage form of the drug prescribed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#F(2)(d)">(d)</span> The name, type, and specifications of any device;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#F(2)(e)">(e)</span> The directions for use;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#F(2)(f)">(f)</span> If written, the authorized prescriber’s signature or the signature of the authorized prescriber’s agent (including the name of the authorized prescriber);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#F(2)(g)">(g)</span> If electronically transmitted, prescription requirements as described in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.20" title="Chapter 20 Format of Prescription Transmission">COMAR 10.34.20</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#F(2)(h)">(h)</span> If verbal, the name of the prescriber and the prescriber’s agent, if applicable.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#F(3)">(3)</span> A written order may be received by the pharmacy by facsimile, electronic transmission, or as the original physician order.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#F(4)">(4)</span> The licensed pharmacist shall document immediately a verbal order in writing.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#F(5)">(5)</span> A licensed pharmacist may receive a verbal order:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#F(5)(a)">(a)</span> By telephone with the licensed pharmacist reading back the prescription to the prescriber or the prescriber’s agent; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#F(5)(b)">(b)</span> By a voice messaging system.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#G">G.</span> Controlled Dangerous Substances.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#G(1)">(1)</span> Drug Accountability. The permit holder shall ensure that personnel employed by the pharmacy abide by the laws and regulations as defined in:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#G(1)(a)">(a)</span> Health-General Article, Title 27, Annotated Code of Maryland; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#G(1)(b)">(b)</span> <a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.03" title="Chapter 03 Controlled Dangerous Substances">COMAR 10.19.03</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#G(2)">(2)</span> Storage and Security. The permit holder shall establish effective procedures for storage and security of Schedule II controlled dangerous substances including limitation of access to these drugs in the pharmacy to licensed pharmacists and registered pharmacy technicians.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#H">H.</span> Drug Recalls. The licensed pharmacist shall develop and implement a recall procedure that can be readily activated to ensure that drugs which have been recalled are:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#H(a)">(a)</span> Returned to the pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#H(b)">(b)</span> Sequestered; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#H(c)">(c)</span> Handled as appropriate to the level of the recall.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#I">I.</span> Adverse Drug Reactions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#I(1)">(1)</span> The licensed pharmacist shall participate on the appropriate committee, if applicable of the assisted living program or group home, to establish procedures to report and record adverse drug reactions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#I(2)">(2)</span> The licensed pharmacist shall ensure the procedures established include, at a minimum:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#I(2)(a)">(a)</span> The reporting of significant adverse drug reactions to the attending prescriber or designee and other parties as specified by the appropriate committee of the assisted living program or group home; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#I(2)(b)">(b)</span> The recording in writing of an adverse reaction on the resident’s chart at the time it is reported.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.09#J">J.</span> Records and Reports. The licensed pharmacist shall maintain records and reports as may be required by law, this chapter, and the policies of the assisted living program or group home.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.36.10" data-order="|10|34|36|.10|" data-ref-path="10|34|36|.10" class="h__section">.10 Quality Management.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.10#A">A.</span> The responsible pharmacist, in cooperation with the appropriate committee of the assisted living program, shall develop procedures for an ongoing quality management program that includes a mechanism for reviewing and evaluating pharmaceutical services as defined in this chapter and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.07.14.29" title=".29 Resident Record.">COMAR 10.07.14.29</a> where appropriate.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.36.10#B">B.</span> The responsible pharmacist, in cooperation with the appropriate committee of the group home, if applicable, may develop procedures for an ongoing quality management program that includes a mechanism for reviewing and evaluating pharmaceutical services as defined in this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.37" data-order="|10|34|37|" data-ref-path="10|34|37" class="h__chapter">Chapter 37 Pharmacy Permit Holder Requirements — Wholesale Distribution and Nonresident Pharmacy Operations</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: July 1, 2014 (41:10 Md. R. 561)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.37.01" title=".01 Scope.">Regulation .01</a> amended effective October 9, 2017 (44:20 Md. R. 945)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.37.04" title=".04 Requirements for Nonresident Pharmacy Operations.">Regulation .04</a> adopted effective October 9, 2017 (44:20 Md. R. 945)</p>
                  <h3>Authority</h3>
                  <p>Health-Occupations Article, §§12-205, 12-403, and 12-406, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.37.01" data-order="|10|34|37|.01|" data-ref-path="10|34|37|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter establishes requirements for a pharmacy licensed by the Maryland Board of Pharmacy that:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.37.01#A">A.</span> Engages in wholesale distribution; or</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.37.01#B">B.</span> Operates as a nonresident pharmacy.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.37.02" data-order="|10|34|37|.02|" data-ref-path="10|34|37|.02" class="h__section">.02 Pharmacies Issued a Waiver Permit.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.37.02#A">A.</span> A pharmacy that is issued a waiver permit by the Board under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12" title="">Health Occupations Article, §12</a>–403(c), Annotated Code of Maryland, may engage in wholesale distribution, provided that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.02#A(1)">(1)</span> The waiver pharmacy only engages in wholesale distribution with another pharmacy; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.02#A(2)">(2)</span> The wholesale distribution business does not exceed 5 percent of the waiver pharmacy’s annual sales.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.37.02#B">B.</span> Record Keeping Requirements. A waiver pharmacy that conducts wholesale distribution as set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.37.02#A" title="">§A of this regulation</a> shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.02#B(1)">(1)</span> Maintain records of the waiver pharmacy’s wholesale distribution separately from its other records; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.02#B(2)">(2)</span> Make records of wholesale distribution available for inspection by the Board.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.37.03" data-order="|10|34|37|.03|" data-ref-path="10|34|37|.03" class="h__section">.03 Requirements for Wholesale Distribution.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.37.03#A">A.</span> General Requirements.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.03#A(1)">(1)</span> A full service pharmacy may conduct wholesale distribution provided that the wholesale distribution business does not exceed 5 percent of the full service pharmacy’s annual sales.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.03#A(2)">(2)</span> A full service pharmacy may conduct wholesale distribution:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.37.03#A(2)(a)">(a)</span> With another pharmacy; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.37.03#A(2)(b)">(b)</span> With a wholesale distributor, if the full service pharmacy reports to the Board within a week, on a form approved by the Board, of the full service pharmacy’s wholesale distribution to a wholesale distributor.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.37.03#B">B.</span> Recordkeeping Requirements. A full service pharmacy that conducts wholesale distribution as set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.37.03#A" title="">§A of this regulation</a> shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.03#B(1)">(1)</span> Maintain records of wholesale distribution separately from its other records;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.03#B(2)">(2)</span> Maintain records of wholesale distribution to wholesale distributors separately from its records of wholesale distribution to pharmacies; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.03#B(3)">(3)</span> Make records of wholesale distribution available for inspection by the Board.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.37.04" data-order="|10|34|37|.04|" data-ref-path="10|34|37|.04" class="h__section">.04 Requirements for Nonresident Pharmacy Operations.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#A">A.</span> A Maryland licensed pharmacist may not be employed by more than one nonresident pharmacy at a time.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B">B.</span> A nonresident pharmacy shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(1)">(1)</span> Hold a pharmacy permit issued by the Board;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(2)">(2)</span> Have a pharmacist on staff who is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(2)(a)">(a)</span> Licensed by the Board;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(2)(b)">(b)</span> Designated as the pharmacist responsible for providing pharmaceutical services to patients in the State; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(2)(c)">(c)</span> Regularly available on-site as needed to meet Maryland patient’s needs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(3)">(3)</span> Designate another Maryland licensed pharmacist as the pharmacist on staff within 60 days upon the loss of the current designated pharmacist on staff;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(4)">(4)</span> Be located and equipped so that the pharmacy may be operated without endangering the public health or safety;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(5)">(5)</span> Maintain at all times a current reference library that is appropriate to meet the needs of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(5)(a)">(a)</span> The practice specialty of that pharmacy; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(5)(b)">(b)</span> The consumers the pharmacy serves;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(6)">(6)</span> Comply with the regulations adopted by the Board establishing the types of texts required to be included in the reference libraries in each of the various practice specialty pharmacies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(7)">(7)</span> Maintain at all times the minimum professional and technical equipment and sanitary appliances that are necessary in a pharmacy to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(7)(a)">(a)</span> Prepare and dispense prescriptions properly; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(7)(b)">(b)</span> Otherwise operate a pharmacy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(8)">(8)</span> Be equipped with the minimum equipment and appliances specified by the Board under this regulation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(9)">(9)</span> Be kept in a clean and orderly manner;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(10)">(10)</span> Store all prescription or nonprescription drugs or devices properly and safely as set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.22.06" title=".06 Minimum Requirements for the Storage and Handling of Prescription Drugs or Devices.">COMAR 10.34.22.06</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(11)">(11)</span> On an annual basis and within 30 days after a change of office, corporate officer, or pharmacist, disclose to the Board the location, names, and titles of all principal corporate officers and all pharmacists who are dispensing prescriptions for drugs or devices to persons in this State;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(12)">(12)</span> Comply with all lawful directions and requests for information from the regulatory or licensing agency of the state in which it is located and all requests for information made by the Board pursuant to this regulation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(13)">(13)</span> Maintain at all times a valid, unexpired permit to conduct a pharmacy in compliance with the laws of the state in which it is located;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(14)">(14)</span> Maintain records of prescription drugs or devices dispensed to patients in this State so that the records are readily retrievable;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(15)">(15)</span> During the pharmacy’s regular hours of operation, but not less than 6 days a week, and for a minimum of 40 hours per week, provide a toll-free telephone service to facilitate communication between patients in this State and a pharmacist or an individual who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(15)(a)">(a)</span> Has access to the patient’s prescription records; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(15)(b)">(b)</span> Is required to refer patients in the State to the responsible pharmacist licensed in the State, as appropriate;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(16)">(16)</span> Disclose the pharmacy’s toll-free telephone number on a label affixed to each container of drugs or devices;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(17)">(17)</span> Comply with the laws of this State relating to the confidentiality of prescription records if there are no laws relating to the confidentiality of prescription records in the state in which the nonresident pharmacy is located;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(18)">(18)</span> With regard to a prescription drug that is delivered in this State by the United States Postal Service, a common carrier, or a delivery service and is not personally hand delivered directly to a patient or to the agent of the patient at the residence of the patient or at another location designated by the patient:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(18)(a)">(a)</span> Provide a general written notice in each shipment of a prescription drug that alerts a consumer that, under certain circumstances, a medication’s effectiveness may be affected by exposure to extremes of heat, cold, or humidity; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(18)(b)">(b)</span> Provide a specific written notice in each shipment of a prescription drug that provides a consumer with a toll-free or local consumer access telephone number accessible during regular hours of operation, which is designed to respond to consumer questions pertaining to medications;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(19)">(19)</span> Provide information regarding the process for resolving incorrectly filled prescriptions in accordance with existing regulations by:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(19)(a)">(a)</span> Posting a sign that is conspicuously positioned and readable by consumers at the point where prescription drugs are dispensed to consumers; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(19)(b)">(b)</span> Including written information regarding the process with each prescription dispensed; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(20)">(20)</span> If dispensing compounded sterile preparations to patients in the State, comply with:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(20)(a)">(a)</span> USP standards; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#B(20)(b)">(b)</span> <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19" title="Chapter 19 Sterile Pharmaceutical Compounding">COMAR 10.34.19</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#C">C.</span> A nonresident pharmacy may not:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#C(1)">(1)</span> Offer pharmaceutical services under any term or condition that tends to interfere with or impair the free and complete exercise of professional pharmaceutical judgment or skill;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#C(2)">(2)</span> Make any agreement that denies a patient a free choice of pharmacist or pharmacy services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#C(3)">(3)</span> Participate in any activity that is a ground for Board action against:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#C(3)(a)">(a)</span> A licensed pharmacist under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12" title="">Health Occupations Article, §12</a>–313, Annotated Code of Maryland;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#C(3)(b)">(b)</span> A registered pharmacy technician under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12" title="">Health Occupations Article, §12</a>–6B–09, Annotated Code of Maryland; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#C(3)(c)">(c)</span> A registered pharmacy intern under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12" title="">Health Occupations Article, §12</a>–6D–11, Annotated Code of Maryland; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.37.04#C(4)">(4)</span> Allow an unauthorized individual to represent that the individual is a pharmacist, a registered pharmacy intern, or registered pharmacy technician.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.38" data-order="|10|34|38|" data-ref-path="10|34|38" class="h__chapter">Chapter 38 Pharmacy Interns</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: July 1, 2015 (42:7 Md. R. 569)</p>
                  <h3>Authority</h3>
                  <p>Health-Occupations Article, §§12-205, 12-206, 12-301, 12-315 — 12-317, 12-319, 12-320, 12-505, 12-6D-01 — 12-6D-15, and 12-707, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.38.01" data-order="|10|34|38|.01|" data-ref-path="10|34|38|.01" class="h__section">.01 Scope.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.01#A">A.</span> This chapter applies to applicants for registration as pharmacy interns and to registered pharmacy interns.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.01#B">B.</span> This chapter does not apply to pharmacy students:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.01#B(1)">(1)</span> In a school of pharmacy sanctioned experiential learning program; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.01#B(2)">(2)</span> Registered as pharmacy technicians with the Board performing delegated pharmacy acts.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.01#C">C.</span> This chapter applies to individuals functioning as a pharmacy intern regardless of whether they are paid.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.38.02" data-order="|10|34|38|.02|" data-ref-path="10|34|38|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.02#B(1)">(1)</span> “Board” means the State Board of Pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.02#B(2)">(2)</span> “Direct supervision” means that a licensed pharmacist is physically available, notwithstanding appropriate breaks, on-site and in the prescription area or in an area where pharmacy services are provided to supervise the practice of pharmacy and delegated pharmacy acts.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.02#B(3)">(3)</span> “Pharmacy student” means an individual who is enrolled as a student in a school or college of pharmacy:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.38.02#B(3)(a)">(a)</span> Accredited by the Accreditation Council for Pharmacy Education; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.38.02#B(3)(b)">(b)</span> Having precandidate or candidate status by the Accreditation Council for Pharmacy Education.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.02#B(4)">(4)</span> “Registered pharmacy intern” means an individual who is registered with the Board to practice pharmacy under the direct supervision of a pharmacist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.02#B(5)">(5)</span> “Registration” means in this chapter, unless the context requires otherwise, a registration issued by the Board to practice pharmacy under the direct supervision of a licensed pharmacist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.02#B(6)">(6)</span> “Supervision” means reviewing the work, guiding and directing the activities, and monitoring the performance of an individual.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.38.03" data-order="|10|34|38|.03|" data-ref-path="10|34|38|.03" class="h__section">.03 Prohibited Pharmacy Acts.</h3>
                <p>A registered pharmacy intern may not:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.03#A">A.</span> Delegate a pharmacy act;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.03#B">B.</span> Perform a final verification of a prescription drug or device before dispensing;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.03#C">C.</span> Perform any act that has not been authorized by the supervising pharmacist;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.03#D">D.</span> Represent themselves as a pharmacist;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.03#E">E.</span> Dispense prescription medications when the pharmacist is not in the pharmacy;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.03#F">F.</span> Be present in the pharmacy when the pharmacist is not physically available onsite;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.03#G">G.</span> Act within the parameters of a therapy management contract as provided under Health Occupations Article, Subtitle 6A, Annotated Code of Maryland;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.03#H">H.</span> Independently compound prescriptions; or</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.03#I">I.</span> Accept the return of prescription drugs or devices directly from a patient.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.38.04" data-order="|10|34|38|.04|" data-ref-path="10|34|38|.04" class="h__section">.04 General Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.04#A">A.</span> Each registered pharmacy intern shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.04#A(1)">(1)</span> Display the pharmacy intern’s registration in the office or place of business in which the pharmacy intern is practicing pharmacy under the direct supervision of a licensed pharmacist; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.04#A(2)">(2)</span> Have the registration on the pharmacy intern’s person available for viewing.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.04#B">B.</span> When practicing pharmacy under the direct supervision of a licensed pharmacist, the registered pharmacy intern shall wear identification that conspicuously identifies the registered pharmacy intern as a registered pharmacy intern.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.04#C">C.</span> When performing tasks in the prescription area, a pharmacy intern shall maintain proper:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.04#C(1)">(1)</span> Sanitation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.04#C(2)">(2)</span> Hygiene;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.04#C(3)">(3)</span> Biohazard precautions; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.04#C(4)">(4)</span> Infection control.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.04#D">D.</span> A pharmacy intern, who has obtained a registration as an actively enrolled student, shall immediately notify the Board if the pharmacy intern’s enrollment as a student has been revoked, suspended, terminated, or otherwise discontinued.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.38.05" data-order="|10|34|38|.05|" data-ref-path="10|34|38|.05" class="h__section">.05 Limitation on Supervision.</h3>
                <p>A licensed pharmacist may not directly supervise more than two registered pharmacy interns at one time.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.38.06" data-order="|10|34|38|.06|" data-ref-path="10|34|38|.06" class="h__section">.06 Registration Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.06#A">A.</span> An applicant shall be an individual who:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.06#A(1)">(1)</span> Is currently enrolled and has completed 1 year of professional pharmacy education in a doctor of pharmacy program:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.38.06#A(1)(a)">(a)</span> Accredited by the Accreditation Council for Pharmacy Education; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.38.06#A(1)(b)">(b)</span> Having precandidate or candidate status by the Accreditation Council for Pharmacy Education;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.06#A(2)">(2)</span> Has graduated from a doctor of pharmacy program accredited by the Accreditation Council for Pharmacy Education; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.06#A(3)">(3)</span> Is a graduate of a foreign school of pharmacy who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.38.06#A(3)(a)">(a)</span> Has established educational equivalency as approved by the Board; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.38.06#A(3)(b)">(b)</span> Has passed an examination of oral English approved by the Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.06#B">B.</span> An applicant identified in <a class="internal-link " href="/us/md/exec/comar/10.34.38.06#A" title="">§A of this regulation</a> shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.06#B(1)">(1)</span> Submit to the Board a signed completed application on a form provided by the Board;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.06#B(2)">(2)</span> Pay a fee as set forth in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.09" title="Chapter 09 Fees">COMAR 10.34.09</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.06#B(3)">(3)</span> Submit a request for a State Criminal History Records check; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.06#B(4)">(4)</span> Be of good moral character.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.06#C">C.</span> The Board may not approve an application until the State Criminal History Records Check is completed.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.06#D">D.</span> The Board of Pharmacy shall provide the pharmacy intern with a registration card and pocket identification card upon initial registration and renewal.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.38.07" data-order="|10|34|38|.07|" data-ref-path="10|34|38|.07" class="h__section">.07 Renewal Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.07#A">A.</span> The pharmacy intern’s registration shall expire on the last day of the birth month following 1 year after initial registration.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.07#B">B.</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.34.38.07#C" title="">§C of this regulation</a>, the Board shall send to each registrant, at least 1 month before a registration expires, a renewal notice by first–class mail to the last known address of the registrant.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.07#C">C.</span> If requested by a registrant, the Board shall send to the registrant, at least two times within the month before a registration expires, a renewal notice by electronic means to the last known electronic address of the registrant.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.07#D">D.</span> If a renewal notice sent by electronic means under <a class="internal-link " href="/us/md/exec/comar/10.34.38.07#C" title="">§C of this regulation</a> is returned to the Board as undeliverable, the Board shall send to the registrant a renewal notice by first-class mail to the last known address of the registrant.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.07#E">E.</span> A renewal notice sent under this regulation shall state:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.07#E(1)">(1)</span> The date on which the current registration expires;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.07#E(2)">(2)</span> The date by which the renewal application must be received by the Board for the renewal to be issued and mailed before the registration expires; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.07#E(3)">(3)</span> The amount of the renewal fee.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.07#F">F.</span> A registered pharmacy intern who qualifies for registration under <a class="internal-link " href="/us/md/exec/comar/10.34.38.06#A(1)" title="">Regulation .06A(1) of this chapter</a> may renew the registration one time if the registered pharmacy intern is:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.07#F(1)">(1)</span> Otherwise entitled to be registered as a pharmacy intern;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.07#F(2)">(2)</span> Submits to the Board a renewal application on the form that the Board requires; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.38.07#F(3)">(3)</span> Pays to the Board a renewal fee set by the Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.07#G">G.</span> A registered pharmacy intern who qualifies for registration under Regulation .06A(2) and (3) of this chapter may not renew the registration.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.07#H">H.</span> The registration of a pharmacy intern registered under this chapter is void when the registered pharmacy intern becomes a licensed pharmacist.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.38.07#I">I.</span> The Board shall renew the registration of each pharmacy intern who meets the requirements of this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.39" data-order="|10|34|39|" data-ref-path="10|34|39" class="h__chapter">Chapter 39 Pharmacist Administration of Self-Administered Drugs</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: May 9, 2016 (43:9 Md. R. 530)</p>
                  <h3>Authority</h3>
                  <p>Health-Occupations Article, §§12-101, 12-102(b), and 12-509, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.39.01" data-order="|10|34|39|.01|" data-ref-path="10|34|39|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter does not limit or affect the right of an individual to practice a health occupation that the individual is authorized to practice.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.39.02" data-order="|10|34|39|.02|" data-ref-path="10|34|39|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(1)">(1)</span> “Board” means the State Board of Pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(2)">(2)</span> “Pharmacist” means an individual who practices pharmacy regardless of the location where the activities of practice are performed.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(3)">(3)</span> “Pharmacy” means an establishment holding a permit under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-401" title="">Health Occupations Article, §12-401, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(4)">(4)</span> “Pharmacy Experiential Program” means a program under the American Council on Pharmacy Education.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(5)">(5)</span> Practice Pharmacy.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(5)(a)">(a)</span> “Practice pharmacy” means to engage in any of the following activities:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(5)(a)(i)">(i)</span> Providing pharmaceutical care;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(5)(a)(ii)">(ii)</span> Compounding, dispensing, or distributing prescription drugs or devices;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(5)(a)(iii)">(iii)</span> Compounding or dispensing nonprescription drugs or devices;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(5)(a)(iv)">(iv)</span> Monitoring prescriptions and nonprescription drugs or devices;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(5)(a)(v)">(v)</span> Providing information, explanation, or recommendations to patients and health care practitioners about the safe and effective use of prescription or nonprescription drugs or devices;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(5)(a)(vi)">(vi)</span> Identifying and appraising problems concerning the use or monitoring of therapy with drugs or devices;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(5)(a)(vii)">(vii)</span> Acting within the parameters of a therapy management contract, as provided under Health Occupations Article, Subtitle 6A, Annotated Code of Maryland; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(5)(a)(viii)">(viii)</span> Administering vaccinations in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-508" title="">Health Occupations Article, §12-508, Annotated Code of Maryland</a> or self-administered drugs in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-509" title="">Health Occupations Article, §12-509, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(5)(a)(ix)">(ix)</span> Delegating a pharmacy act to a registered pharmacy technician, pharmacy student, or an individual engaged in a Board approved pharmacy technician training program;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(5)(a)(x)">(x)</span> Supervising a delegated pharmacy act performed by a registered pharmacy technician, pharmacy student, or an individual engaged in a Board approved pharmacy technician training program; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(5)(a)(xi)">(xi)</span> Providing drug therapy management in accordance with Health-General Article, §19-713.6, Annotated Code of Maryland.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(5)(b)">(b)</span> “Practice pharmacy” does not include the operations of a person who holds a permit issued under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-602" title="">Health Occupations Article, §12-602, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(6)">(6)</span> “Registered pharmacy intern” means an individual who is registered with the Board to practice pharmacy under the direct supervision of a pharmacist.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(7)">(7)</span> Self-Administered Drug.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(7)(a)">(a)</span> “Self-administered drug” means a drug that is regularly administered by the patient for whom the drug is prescribed or by an individual who is not otherwise authorized to administer drugs under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-509" title="">Health Occupations Article, §12-509, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(7)(b)">(b)</span> “Self–administered drug” includes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(7)(b)(i)">(i)</span> Eye drops;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(7)(b)(ii)">(ii)</span> A drug that is administered by an intramuscular injection or a subcutaneous injection;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(7)(b)(iii)">(iii)</span> Ear drops;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(7)(b)(iv)">(iv)</span> Inhalation therapies;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(7)(b)(v)">(v)</span> Intranasal therapies; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.39.02#B(7)(b)(vi)">(vi)</span> Topical therapies.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.39.03" data-order="|10|34|39|.03|" data-ref-path="10|34|39|.03" class="h__section">.03 Requirements to Administer Self-Administered Drugs.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.39.03#A">A.</span> A licensed pharmacist shall attest that the pharmacist has the appropriate training in administration of self-administered drugs that consists of instruction on:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.39.03#A(1)">(1)</span> Ear drops;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.39.03#A(2)">(2)</span> Eye drops;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.39.03#A(3)">(3)</span> Inhalation therapies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.39.03#A(4)">(4)</span> Intramuscular injections;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.39.03#A(5)">(5)</span> Intranasal therapies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.39.03#A(6)">(6)</span> Subcutaneous injections; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.39.03#A(7)">(7)</span> Topical therapies.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.39.03#B">B.</span> A licensed pharmacist shall possess an active certification in basic cardiopulmonary resuscitation obtained through in-person classroom instruction.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.39.03#C">C.</span> A licensed pharmacist, certified under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-508" title="">Health Occupations Article, §12-508, Annotated Code of Maryland</a>, is deemed to have satisfied the training requirements in this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.39.03#D">D.</span> A licensed pharmacist may administer a self-administered drug in accordance with a prescription.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.39.03#E">E.</span> A pharmacy student in a Pharmacy Experiential Program or a registered pharmacy intern, may administer a self-administered drug under direct supervision of a licensed pharmacist who meets the requirements in §A or B of this regulation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.39.04" data-order="|10|34|39|.04|" data-ref-path="10|34|39|.04" class="h__section">.04 Record Keeping.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.39.04#A">A.</span> The pharmacist shall document in the patient record the administration of a self-administered drug that includes the following information:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.39.04#A(1)">(1)</span> Name of the drug;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.39.04#A(2)">(2)</span> Dosage administered;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.39.04#A(3)">(3)</span> Site of administration;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.39.04#A(4)">(4)</span> Date and time of administration; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.39.04#A(5)">(5)</span> Any instructions provided to the patient.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.39.04#B">B.</span> The patient record shall be maintained for 5 years, unless otherwise required by law, and be:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.39.04#B(1)">(1)</span> Readily retrievable; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.39.04#B(2)">(2)</span> Made available on the request of the Board.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.40" data-order="|10|34|40|" data-ref-path="10|34|40" class="h__chapter">Chapter 40 Pharmacists Prescribing Contraceptives</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: July 2, 2018 (45:13 Md. R. 668)</p>
                  <h3>Authority</h3>
                  <p>Health-Occupations Article, §§12-101, 12-102(b), 12-205(a), and 12-511, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.40.01" data-order="|10|34|40|.01|" data-ref-path="10|34|40|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter does not limit or otherwise affect the right of an individual to practice pharmacy or any other health occupation that the individual is authorized to practice.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.40.02" data-order="|10|34|40|.02|" data-ref-path="10|34|40|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.40.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.40.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.02#B(1)">(1)</span> “Board” means the Maryland Board of Pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.02#B(2)">(2)</span> “Contraceptives” means contraceptive medications and self-administered contraceptive devices approved by the U.S. Food and Drug Administration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.02#B(3)">(3)</span> “Pharmacist” means an individual who practices pharmacy under the <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-101" title="">Health Occupations Article, §12-101, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.02#B(4)">(4)</span> “Pharmacy” means an establishment holding a permit under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-401" title="">Health Occupations Article, §12-401, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.02#B(5)">(5)</span> “Practicing pharmacy” has the same meaning stated in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-101" title="">Health Occupations Article, §12-101(x), Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.02#B(6)">(6)</span> “Primary care practitioner” means a licensed health care practitioner who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.40.02#B(6)(a)">(a)</span> Provides an individual’s primary care services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.40.02#B(6)(b)">(b)</span> Is the primary coordinator of health care services for the individual.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.02#B(7)">(7)</span> “Reproductive health care practitioner” means a licensed health care practitioner who provides an individual’s reproductive health services.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.02#B(8)">(8)</span> “Visit summary” means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.40.02#B(8)(a)">(a)</span> A written record of either the contraceptives dispensed or a brief explanation as to why contraceptives were not prescribed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.40.02#B(8)(b)">(b)</span> Written information about the importance of seeing the patient’s primary care practitioner or reproductive health care practitioner to obtain recommended tests and screenings; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.40.02#B(8)(c)">(c)</span> A copy of the patient’s completed Self-Screening Risk Assessment Questionnaire.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.40.03" data-order="|10|34|40|.03|" data-ref-path="10|34|40|.03" class="h__section">.03 Requirements to Prescribe Contraceptives.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#A">A.</span> Board Responsibilities. The Board shall develop and adopt the following items, in consultation with stakeholders to be determined by the Board:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#A(1)">(1)</span> A self-screening risk assessment questionnaire that a patient shall complete before a pharmacist may prescribe contraceptives for a patient;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#A(2)">(2)</span> A standard procedure contraceptive algorithm which the pharmacist shall use to perform a patient assessment for purposes of determining:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#A(2)(a)">(a)</span> Whether to prescribe contraceptives; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#A(2)(b)">(b)</span> Which contraceptive options to prescribe;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#A(3)">(3)</span> A notification form to be submitted by a pharmacist before prescribing contraceptives; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#A(4)">(4)</span> Other forms and procedures for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#A(4)(a)">(a)</span> The prescription of contraceptives; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#A(4)(b)">(b)</span> Referral to a primary care or reproductive health care practitioner for treatment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#B">B.</span> Notification.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#B(1)">(1)</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.34.40.03#B(2)" title="">§B(2) of this regulation</a>, at least 15 days before prescribing contraceptives, a pharmacist shall submit to the Board a notification form, which includes an attestation of completion of a Board-approved training program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#B(2)">(2)</span> A pharmacist who has undergone training for prescribing contraceptives as part of the pharmacist’s formal educational program:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#B(2)(a)">(a)</span> Is exempt from completing a Board-approved training program; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#B(2)(b)">(b)</span> At least 15 days before prescribing contraceptives, shall submit to the Board a notification form, which includes an attestation of the pharmacist’s formal education program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#B(3)">(3)</span> A pharmacist may not prescribe contraceptives until the pharmacist receives a written confirmation from the Board accepting the pharmacist’s notification form.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#C">C.</span> Pharmacist Responsibilities.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#C(1)">(1)</span> For each new patient requesting contraceptive services, and at a minimum of every 12 months for each returning patient, a participating pharmacist shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#C(1)(a)">(a)</span> Obtain the completed Board-approved self-screening risk assessment questionnaire from the patient; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#C(1)(b)">(b)</span> Utilize and follow the Board-approved standard procedure contraceptive algorithm to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#C(1)(b)(i)">(i)</span> Perform the patient assessment;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#C(1)(b)(ii)">(ii)</span> Determine whether to prescribe contraceptives; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#C(1)(b)(iii)">(iii)</span> Determine which contraceptive options to prescribe.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#C(2)">(2)</span> Upon completion of all requirements established by the Board and after review of all relevant information, a pharmacist may prescribe contraceptives, if deemed clinically appropriate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#C(3)">(3)</span> If contraceptives are prescribed, the pharmacist shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#C(3)(a)">(a)</span> Refer the patient:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#C(3)(a)(i)">(i)</span> For additional care to their primary care practitioner or reproductive health care practitioner; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#C(3)(a)(ii)">(ii)</span> If the patient does not have a primary care practitioner or a reproductive health care practitioner, to a family planning provider or a licensed clinician who provides reproductive health care services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#C(3)(b)">(b)</span> Provide the patient with a visit summary; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#C(3)(c)">(c)</span> Document the encounter and maintain records pursuant to <a class="internal-link " href="/us/md/exec/comar/10.34.40.05" title=".05 Record Keeping.">Regulation .05 of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#C(4)">(4)</span> Upon completion of all requirements established by the Board and after review of all relevant information, if the pharmacist does not prescribe contraceptives, the pharmacist will provide a visit summary to the patient which provides the basis for the decision not to prescribe contraceptives.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.03#C(5)">(5)</span> A pharmacist may not prescribe contraceptives before January 1, 2019.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.40.04" data-order="|10|34|40|.04|" data-ref-path="10|34|40|.04" class="h__section">.04 Training Program Requirements.</h3>
                <p>At a minimum, a Board-approved training program shall contain the following elements:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.40.04#A">A.</span> An overview of contraceptive medications and self-administered contraceptive devices;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.40.04#B">B.</span> An overview of the self-screening risk assessment questionnaire;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.40.04#C">C.</span> An overview of the standard procedure contraceptive algorithm; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.40.04#D">D.</span> An overview of the U.S. Medical Eligibility Criteria for Contraceptive Use and other Center for Disease Control guidance on contraception.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.40.05" data-order="|10|34|40|.05|" data-ref-path="10|34|40|.05" class="h__section">.05 Record Keeping.</h3>
                <p>For a minimum of 5 years, a pharmacy whose pharmacists prescribe contraceptives shall maintain documentation, in electronic or other form, which includes:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.40.05#A">A.</span> The type of contraceptive prescribed, and dosage, if applicable, or the basis for not prescribing a contraceptive;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.40.05#B">B.</span> The name, address, and date of birth of the patient;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.40.05#C">C.</span> The name of the pharmacist who prescribed the contraceptive or determined a contraceptive would not be prescribed;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.40.05#D">D.</span> The date the contraceptive was prescribed or that the patient was advised that a  contraceptive would not be prescribed;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.40.05#E">E.</span> A copy of the patient’s visit summary;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.40.05#F">F.</span> A copy of the patient’s self screening risk assessment questionnaire; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.40.05#G">G.</span> The name and address of the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.05#G(1)">(1)</span> Patient’s primary care practitioner or reproductive health care practitioner, if provided by the patient; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.40.05#G(2)">(2)</span> Family planning provider or licensed clinician who provides reproductive health care services referred by the pharmacist, if the patient does not have a primary care practitioner or reproductive health care practitioner.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.40.06" data-order="|10|34|40|.06|" data-ref-path="10|34|40|.06" class="h__section">.06 Continuing Education Requirement.</h3>
                <p>A pharmacist who prescribes contraceptives in Maryland shall earn 1 hour of Board-approved continuing pharmaceutical education related to contraception before the pharmacist’s license renewal date.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.41" data-order="|10|34|41|" data-ref-path="10|34|41" class="h__chapter">Chapter 41 Administration of a Maintenance Injectable Medication</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: June 13, 2022 (49:12 Md. R. 640)</p>
                  <h3>Authority</h3>
                  <p>Health-Occupations Article, §§12-101(o-1) and 12-509, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.41.01" data-order="|10|34|41|.01|" data-ref-path="10|34|41|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter does not limit or otherwise affect the right of an individual to practice pharmacy or any other health occupation that the individual is authorized to practice.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.41.02" data-order="|10|34|41|.02|" data-ref-path="10|34|41|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.41.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.41.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.02#B(1)">(1)</span> “Authorized prescriber” means a practitioner licensed and authorized under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Annotated Code of Maryland</a>, to prescribe prescription drugs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.02#B(2)">(2)</span> “Board” means the Maryland Board of Pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.02#B(3)">(3)</span> Maintenance Injectable Medication.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.41.02#B(3)(a)">(a)</span> “Maintenance injectable medication” means a medication that:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.02#B(3)(a)(i)">(i)</span> Is administered by injection other than intravenously;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.02#B(3)(a)(ii)">(ii)</span> Except as authorized for a self-administered drug pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-509" title="">Health Occupations Article, §12-509, Annotated Code of Maryland</a>, is not a biological product; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.02#B(3)(a)(iii)">(iii)</span> Treats a chronic need, condition, or disorder.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.41.02#B(3)(b)">(b)</span> “Maintenance injectable medication” includes, but is not limited to, a medication for:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.02#B(3)(b)(i)">(i)</span> The treatment of a psychiatric disorder;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.02#B(3)(b)(ii)">(ii)</span> The treatment of a substance use disorder;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.02#B(3)(b)(iii)">(iii)</span> Contraception; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.02#B(3)(b)(iv)">(iv)</span> Vitamins.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.02#B(4)">(4)</span> “Pharmacist” means an individual who practices pharmacy under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-101" title="">Health Occupations Article, §12-101, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.02#B(5)">(5)</span> “Practicing pharmacy” has the meaning stated in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-101" title="">Health Occupations Article, §12-101(x), Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.02#B(6)">(6)</span> “Primary care practitioner” means a licensed health care practitioner who provides an individual’s primary care services and is the primary coordinator of health care services for the individual.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.41.03" data-order="|10|34|41|.03|" data-ref-path="10|34|41|.03" class="h__section">.03 Requirements to Administer a Maintenance Injectable Medication — Pharmacist’s Responsibilities.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.41.03#A">A.</span> Upon completion of all requirements established by the Board in this chapter, and after review of all relevant information, a pharmacist may administer a maintenance injectable medication.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.41.03#B">B.</span> In order to administer a maintenance injectable medication, a pharmacist shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.03#B(1)">(1)</span> Utilize and follow the Board-approved procedure set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.41.07" title=".07 Standard Procedures.">Regulation .07 of this chapter</a> to administer a maintenance injectable medication;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.03#B(2)">(2)</span> Refer a patient for additional care to the patient’s primary care practitioner or the authorized prescriber, if necessary;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.03#B(3)">(3)</span> Provide the patient and the authorized prescriber with a copy of the visit summary, including a written record of the maintenance injectable medication that was administered;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.03#B(4)">(4)</span> Document the encounter and maintain records pursuant to <a class="internal-link " href="/us/md/exec/comar/10.34.41.05" title=".05 Record Keeping.">Regulation .05 of this chapter</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.03#B(5)">(5)</span> Notify the authorized prescriber that the medication was administered to the specific patient and any relevant information about the patient’s condition.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.41.03#C">C.</span> A pharmacist shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.03#C(1)">(1)</span> Obtain written approval from the patient’s authorized prescriber prior to administering an initial dose of a maintenance injectable medication; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.03#C(2)">(2)</span> Notify the patient of all fees that the patient is required to pay before administering a maintenance injectable medication.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.41.04" data-order="|10|34|41|.04|" data-ref-path="10|34|41|.04" class="h__section">.04 Training Program Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.41.04#A">A.</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.34.41.04#C" title="">§C of this regulation</a>, a pharmacist shall successfully complete a Board-approved training program for the administration of injectable maintenance medications prior to administering injectable maintenance medications.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.41.04#B">B.</span> At a minimum, a Board-approved training program consists of the following elements:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.04#B(1)">(1)</span> Administration of a maintenance injectable medication;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.04#B(2)">(2)</span> Management of the patient populations served by a pharmacist;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.04#B(3)">(3)</span> Knowledge of the specific maintenance injectable medications that a pharmacist may administer; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.04#B(4)">(4)</span> Current guidelines relating to the specific patient populations served by a pharmacist and the specific maintenance injectable medications that a pharmacist may administer, if applicable.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.41.04#C">C.</span> The training program requirement set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.41.04#A" title="">§A of this regulation</a> is waived for a pharmacist who has undergone the training as part of a formal education program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.41.04#D">D.</span> A pharmacy student in a Pharmacy Experiential Program or a registered pharmacy intern, who has successfully completed a Board-approved certification course under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-508" title="">Health Occupations Article, §12-508, Annotated Code of Maryland</a>, may administer a maintenance injectable medication under the direct supervision of a licensed pharmacist who meets the requirements set forth in <a class="internal-link " href="/us/md/exec/comar/10.34.41.03" title=".03 Requirements to Administer a Maintenance Injectable Medication — Pharmacist’s Responsibilities.">Regulation .03 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.41.05" data-order="|10|34|41|.05|" data-ref-path="10|34|41|.05" class="h__section">.05 Record Keeping.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.41.05#A">A.</span> A pharmacy that staffs a pharmacist that administers a maintenance injectable medication shall maintain the records of a minor patient, including the information listed in <a class="internal-link " href="/us/md/exec/comar/10.34.41.05#B" title="">§B of this regulation</a>, until the minor patient attains the age of majority plus 3 years or for 5 years after the record was made, whichever is later.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.41.05#B">B.</span> For a minimum of 5 years, except for records related to minors, a pharmacy that staffs a pharmacist that administers a maintenance injectable medication shall maintain documentation, in electronic or other form, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.05#B(1)">(1)</span> The type and dose of maintenance injectable medication administered;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.05#B(2)">(2)</span> The name, address, and date of birth of the patient;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.05#B(3)">(3)</span> The name of the pharmacist who administered the maintenance injectable medication;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.05#B(4)">(4)</span> The date that the maintenance injectable medication was administered;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.05#B(5)">(5)</span> A copy of the patient’s visit summary, including any pertinent details about the patient’s condition; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.05#B(6)">(6)</span> The name and address of the authorized prescriber of the maintenance injectable medication.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.41.05#C">C.</span> A pharmacist who administers an injectable maintenance medication as an independent provider at a location that is not a pharmacy shall maintain records as required by §§A and B of this regulation.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.41.06" data-order="|10|34|41|.06|" data-ref-path="10|34|41|.06" class="h__section">.06 Patient Information and Consent.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.41.06#A">A.</span> A pharmacist that administers a maintenance injectable medication shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.06#A(1)">(1)</span> Obtain a paper or electronic consent form signed by the patient, or the patient’s legal guardian, that authorizes the pharmacist to administer the maintenance injectable medication;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.06#A(2)">(2)</span> Provide the patient, or the patient’s legal guardian, with a copy of the consent form for future reference upon request;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.06#A(3)">(3)</span> Provide the patient, or the patient’s legal guardian, and the authorized prescriber with a copy of the visit summary, including a written record of the maintenance injectable medication that was administered; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.06#A(4)">(4)</span> Notify the patient of the need to attend any upcoming appointments the patient has scheduled with the prescriber for additional care.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.41.06#B">B.</span> The administering pharmacist shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.06#B(1)">(1)</span> Disclose their credentials on the consent form; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.06#B(2)">(2)</span> Provide every patient with notification of the fee for service prior to administration.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.41.07" data-order="|10|34|41|.07|" data-ref-path="10|34|41|.07" class="h__section">.07 Standard Procedures.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#A">A.</span> Before a pharmacist administers a maintenance injectable medication, a pharmacist shall have and maintain a written procedure for any maintenance injectable medication that may be administered.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B">B.</span> A pharmacist shall administer a maintenance injectable medication in accordance with the written procedure, including:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(1)">(1)</span> Recording and maintaining the prescription files in accordance with <a class="internal-link " href="/us/md/exec/comar/10.34.41.05" title=".05 Record Keeping.">Regulation .05 of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(2)">(2)</span> Reviewing and screening for the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(2)(a)">(a)</span> Indications;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(2)(b)">(b)</span> Precautions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(2)(c)">(c)</span> Contraindications; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(2)(d)">(d)</span> Allergies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(3)">(3)</span> Reviewing the process for handling adverse reactions, including but not limited to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(3)(a)">(a)</span> Acute anaphylactic reactions; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(3)(b)">(b)</span> Other acute emergencies;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(4)">(4)</span> Following injection or administration procedures;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(5)">(5)</span> Advising the patient of post-administration procedures, including waiting requirements; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)">(6)</span> Documenting and maintaining a maintenance injectable medication record, including:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)(a)">(a)</span> Patient’s:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)(a)(i)">(i)</span> Name;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)(a)(ii)">(ii)</span> Date of birth;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)(a)(iii)">(iii)</span> Address;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)(a)(iv)">(iv)</span> Consent form;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)(a)(v)">(v)</span> Authorized prescriber; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)(a)(vi)">(vi)</span> Administering pharmacist’s name and license number;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)(b)">(b)</span> Administration:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)(b)(i)">(i)</span> Date;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)(b)(ii)">(ii)</span> Dose;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)(b)(iii)">(iii)</span> Site; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)(b)(iv)">(iv)</span> Route;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)(c)">(c)</span> Maintenance injectable medication:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)(c)(i)">(i)</span> Name, generic or brand;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)(c)(ii)">(ii)</span> Manufacturer;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)(c)(iii)">(iii)</span> Lot number; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)(c)(iv)">(iv)</span> Expiration date;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)(d)">(d)</span> Notification to the authorized prescriber that the patient received a specific maintenance injectable medication; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)(e)">(e)</span> Verification that the prescription is:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)(e)(i)">(i)</span> Not for the patient’s initial dose, if applicable; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#B(6)(e)(ii)">(ii)</span> For the patient’s initial dose and the patient’s record contains documented approval from the authorized prescriber.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#C">C.</span> The pharmacist shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#C(1)">(1)</span> Sign and date the standard procedure at least annually;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#C(2)">(2)</span> Make the standard procedure available for inspection by the Board upon request; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.41.07#C(3)">(3)</span> Review and update the standard procedure as necessary.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.34.42" data-order="|10|34|42|" data-ref-path="10|34|42" class="h__chapter">Chapter 42 Pharmacist Prescribing of a Nicotine Replacement Therapy Medication</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: October 14, 2024 (51:20 Md. R. 899)</p>
                  <h3>Authority</h3>
                  <p>Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-205" title="">12-205</a> and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-514" title="">12-514</a>, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.34.42.01" data-order="|10|34|42|.01|" data-ref-path="10|34|42|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter does not limit or otherwise affect the right of an individual to practice pharmacy or any other health occupation that the individual is authorized to practice.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.42.02" data-order="|10|34|42|.02|" data-ref-path="10|34|42|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.42.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.42.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.42.02#B(1)">(1)</span> “Board” means the Maryland Board of Pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.42.02#B(2)">(2)</span> “Nicotine replacement therapy medication” means a nicotine-based treatment, including inhalers, gums, lozenges, nasal sprays, and patches, approved by the United States Food and Drug Administration that assists an individual to cease the use of products that contain nicotine.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.42.02#B(3)">(3)</span> “Primary care practitioner” means a licensed health care practitioner who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.42.02#B(3)(a)">(a)</span> Provides an individual’s primary care services; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.42.02#B(3)(b)">(b)</span> Is the primary coordinator of health care services for the individual.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.42.02#B(4)">(4)</span> “Visit summary” means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.42.02#B(4)(a)">(a)</span> A written record of the nicotine replacement therapy medication dispensed;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.42.02#B(4)(b)">(b)</span> The name and contact information for the prescribing pharmacist; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.42.02#B(4)(c)">(c)</span> The information on the importance of regular appointments with the individual’s primary care practitioner.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.34.42.03" data-order="|10|34|42|.03|" data-ref-path="10|34|42|.03" class="h__section">.03 Requirements to Prescribe and Dispense a Nicotine Replacement Therapy Medication.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.42.03#A">A.</span> Training Requirements.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.42.03#A(1)">(1)</span> Prior to prescribing and dispensing a nicotine replacement therapy medication, a pharmacist shall complete a training program developed for the prescribing of a nicotine replacement therapy medication approved by the Board that is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.42.03#A(1)(a)">(a)</span> Offered by an accredited school of pharmacy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.42.03#A(1)(b)">(b)</span> Offered by an accredited school of medicine; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.34.42.03#A(1)(c)">(c)</span> Accredited by the Accreditation Council for Pharmacy Education.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.42.03#A(2)">(2)</span> A pharmacist who obtained training to prescribe a nicotine replacement therapy medication as part of their formal education is exempt from completing an additional training program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.34.42.03#B">B.</span> Standard Procedures. When an individual requests a nicotine replacement therapy medication, a pharmacist shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.42.03#B(1)">(1)</span> Provide the individual with appropriate counseling in the use of the prescribed nicotine replacement therapy medication;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.42.03#B(2)">(2)</span> Provide the individual with a visit summary;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.42.03#B(3)">(3)</span> Refer the patient to the individual’s primary care provider for additional care; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.34.42.03#B(4)">(4)</span> Record the prescribing and dispensing of the nicotine replacement therapy medication in any health record maintained for the individual by the pharmacist.</p>
                <hr class="section-separator" aria-hidden="true"/>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.33" aria-label="Subtitle 33 BOARD OF EXAMINERS OF NURSING HOME ADMINISTRATORS">
                <div class="h__ui">Previous</div>
                <span>Subtitle 33 BOARD OF EXAMINERS OF NURSING HOME ADMINISTRATORS</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.35" aria-label="Subtitle 35 POSTMORTEM EXAMINERS COMMISSION">
                <div class="h__ui">Next</div>
                <span>Subtitle 35 POSTMORTEM EXAMINERS COMMISSION</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
            <p>The codes and laws on this page are released under a CC-BY-SA license. 180 days after publication they will be dedicated to the public domain under the CC0 license.</p>
            <p>
      Please do not scrape. Instead, bulk download the CC-BY-SA <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p>
            <p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p>
          </div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
